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Summary    
 
Testing for Human Papillomavirus (HPV) is being incorporated into the cervical 
screening programme, with the probable future introduction of HPV as a primary 
test and a possibility of HPV self-sampling. In anticipation of this development, it is 
imperative to identify potential barriers to HPV self-sampling. The work presented 
in this thesis identified women’s attitudes and intentions regarding the possible 
introduction of primary HPV self-sampling, and developed a preliminary 
intervention designed to address barriers and increase intentions to HPV self-
sample. A mixed-methods approach was used to explore women’s attitudes and 
intentions regarding HPV self-sampling through a cross-sectional questionnaire 
survey, in-depth qualitative interviews and intervention user testing.  
 
A questionnaire based on the extended Health Belief Model was developed and 
validated using content validity assessment and cognitive interviews. A survey of 
194 women recruited through Cervical Screening Wales and in community settings 
identified that perceiving more barriers than benefits to HPV self-sampling, 
reporting lower self-efficacy in relation to self-sampling, and lower HPV knowledge 
were associated with lower hypothetical intention to HPV self-sample. Qualitative 
interviews with a sub-sample of 19 survey participants revealed further barriers 
including lack of confidence in ability to self-sample correctly, lack of confidence in 
self-sampling results, concerns about sample contamination and identity theft, and 
low confidence in the rationale for the introduction of a new screening programme. 
Content designed to address these barriers was incorporated into a leaflet designed 
to increase intentions to HPV self-sample. The leaflet was well received in user 
testing. 
 
Overall, findings suggest that if HPV self-sampling is incorporated into the cervical 
screening programme, personal and system barriers as well as concerns about 
operational factors will need to be addressed. The pilot HPV self-sampling 
intervention may be a mechanism for increasing intention to HPV self-sample by 
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improving women’s HPV knowledge, confidence in their ability to self-sample 
properly, and confidence in operational factors. It is anticipated that this may 
alleviate women’s concerns about a new method of cervical screening, ultimately 
leading to increased uptake.  
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Chapter 1 
 
Introduction and thesis overview 
 
1.1 Chapter Overview 
 
The present chapter will provide an overview of the clinical background to cervical 
cancer, the current cervical screening programme in the United Kingdom, 
incorporation of Human Papillomavirus (HPV) testing, and the possibility of HPV 
self-sampling as a primary screening modality. In the absence of an organised HPV 
self-sampling programme in the UK, evidence regarding barriers to the use of 
another self-sampling method for cancer screening (colorectal cancer) will be 
examined. Psychological determinants of primary HPV self-sampling uptake 
including knowledge, attitudes towards HPV self-sampling and HPV self-sampling 
intentions will be presented.  The need for an intervention that addresses barriers 
to HPV self-sampling will be outlined, followed by description of the aims, 
objectives and the rationale of the PhD. Finally, an outline of the PhD research 
phases and methods will be presented. 
 
1.2 Clinical Background 
 
1.2.1 Cervical cancer incidence 
 
Cervical cancer is the second most common cancer in women with 527,000 cases 
diagnosed worldwide (Ferlay J. et al. 2013). Cervical cancer rates are highest in 
Eastern Africa and lowest in Western Asia. In Europe, it is the sixth most common 
cancer for females with around 58,400 new cases diagnosed in 2012. European age 
standardised rates of cervical cancer were identified as the highest in Romania and 
the lowest in Switzerland (2012) (Ferlay J. et al. 2013). In the UK cervical cancer is 
the third most common gynaecological cancer after ovarian and uterine cancer 
(Cancer Research UK 2015). Variation between countries may reflect differences in 
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provision of cervical screening such as age of screening onset, perceived risk factors 
and diagnostic methods. 
 
1.2.2 Cervical abnormalities  
  
Cervical cancer occurs following the development of invasive cervical intraepithelial 
neoplasia (cervical abnormalities). Cervical intraepithelial neoplasia (CIN) is graded 
in severity between CIN1 which constitutes low grade cervical lesion precursors, 
through to CIN2 and CIN3 which constitute high grade lesion precursors of invasive 
cervical cancer. Treatment of screen detected lesions (particularly CIN2 and CIN3) 
by ablative or excisional procedures is necessary to stop the natural progression of 
CIN into invasive cervical cancer and to reduce the incidence of mortality from the 
disease. 
 
1.3 Current cervical screening method 
 
1.3.1 Cervical screening through cervical smear test 
 
Cervical screening can detect cervical abnormalities at an early stage when the 
initiation of treatment has a high probability of preventing the abnormalities 
developing into cervical cancer, or in curing an existing cervical cancer. Cervical 
screening tests such as the Papanicolaou (Pap) test, or cervical smear test, have 
been the backbone of one of the most successful cancer reduction programmes in 
the public health system (Petignat and Vassilakos 2012). The cervical smear test is 
able to detect precancerous lesions (CIN), therefore identifying cervical cancer 
before it becomes advanced. In countries with high-quality and broad-coverage use 
of this test, invasive cervical cancer incidence has declined significantly (National 
Cancer Institute 2014). The national cervical screening call/recall programme was 
implemented in the UK in 1988 and involves the collection of a sample of cervical 
cells by a healthcare professional during a smear test. The sample is passed to a 
pathology laboratory for slide preparation and screening by a cytologist under a 
microscope, and women are notified of their results in writing. 
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 Although the cervical smear test has proven to be useful in the detection and 
reduction of cervical cancer, it has several limitations. False negative screening test 
results are possible due to the subjective nature of cytological assessment or 
inadequate sampling. For example, 22% of women with a fully invasive cervical 
cancer have had a negative smear test result within three years of diagnosis (Sasieni 
et al. 1996). False positives may also occur because cytological inspection cannot 
distinguish identified low grade abnormalities which may resolve without 
treatment, from those which will develop into invasive cervical cancer. It has been 
estimated that 60% of identified low grade abnormalities will spontaneously regress 
to normal cervical healthy state (Largo-Janssen and Schijf 2005). As a result, many 
women may undergo unnecessary procedures and experience elevated levels of 
anxiety. Furthermore, cervical screening participation has an impact on the 
development of invasive cervical cancer with 60% of cervical cancer cases being 
associated with inadequate uptake of screening (National Institutes of Health 
Consensus Development Panel 1996). 
 
1.3.2 The UK Cervical Screening programme. 
 
Cervical screening in the UK is routinely offered to all eligible women, with the aim 
of detecting cervical abnormalities which if left untreated will develop into cervical 
cancer. Currently, cervical screening is offered to women between the ages of 25-
64 years in England, Wales and Northern Ireland and 20-60 years in Scotland. 
Women under 50 years of age are invited for screening every three years, whilst 
women over 50 years of age are invited for screening every five years. Cervical 
screening is free and offered by regional National Health Service (NHS) Cervical 
Screening programmes. At the beginning of the current PhD research, cervical 
screening policy in Wales differed to the rest of the UK countries, with screening 
initiated in women from the age of 20 years until 64 years every three years.  In 
2013, the Welsh cervical screening programme was brought in line with English 
guidelines: first screening invitation at 25 years with three yearly screening until age 
50, and five yearly screening for women aged 50-64.  Most women invited to 
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cervical screening have their initial screening test at their GP surgery or at an NHS 
community clinic such as a family planning clinic.    
 
1.3.3 Cervical screening uptake 
 
Over the past decade, cervical screening coverage has been steadily declining 
throughout the UK (Health and Social Care Information Centre 2013-2014; Cervical 
Screening Wales 2013-2014), and is now below the NHS cervical screening target of 
80% needed to ensure cost-effectiveness and to significantly reduce cervical cancer 
incidence (Baker and Middleton 2003). Cervical screening coverage is defined as the 
proportion of eligible women in a population who were screened adequately within 
a specified time point. Current cervical screening rates are 78.6% in Wales and 
78.3% in England (Cervical Screening Wales 2013-2014; Health and Social Care 
Information Centre 2013-2014). Attendance in women aged 25-29 years has been 
particularly negatively affected (Cervical Sceening Programme: England 2006; 
Willoughby et al. 2006; Lancuck et al. 2008; Cervical Screening Wales 2013-2014; 
Health and Social Care Information Centre 2013-2014).  
 
1.3.4 Barriers to cervical screening 
 
Cervical screening barriers have been identified in the literature. It has been found 
that women from certain sociodemographic groups are less likely to participate in 
cervical screening, including younger women (Lancuck et al. 2008; Cervical 
Screening Wales 2013-2014), women in the most socioeconomically deprivation 
quintiles, and those from ethnic minority backgrounds (Moser et al. 2009; Marlow 
et al. 2015). Inconvenient appointment times (Waller et al. 2009), the gender of the 
medical practitioner (Oscarsson and Wijma 2008), embarrassment (Sutton and 
Rutherford 2005), a lack of trust (Blomberg et al. 2008) and concerns about 
discomfort have often been cited as barriers to cervical screening uptake (Chiu 
2003). Research suggests that practical barriers such as difficulties with taking time 
off work to attend appointments may be more influential in determining cervical 
screening uptake than emotional barriers such as embarrassment and fear of 
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discomfort during the test (Cervical Sceening Programme: England 2006; Szarewski 
et al. 2009; Wilson 2009). Sociodemographic differences in reasons for non-
attendance have been found. In particular, it has been found that older women 
attribute cervical screening non-attendance to a lower perceived risk of cervical 
cancer, whilst younger women are more likely to attribute non-attendance to 
competing time demands (Szarewski et al. 2011). Furthermore, a recent study by 
(Cadman et al. 2014) found that women from an ethnic minority background were 
more likely to report emotional barriers, such as embarrassment and shame 
associated with a diagnosis of cervical cancer (Marlow et al. 2015). Non-attenders 
are at higher risk of developing cervical cancer and encouraging women to attend 
cervical screening can save lives and reduce costs associated with invasive cancer 
treatment (Szarewski et al. 2011).   
 
1.4 Advances in cervical cancer aetiology 
 
1.4.1 Human Papillomavirus  
 
The main aetiological agent in the development of cervical cancer has now been 
recognised as being a sexually transmitted infection of a viral nature called Human 
Papillomavirus (HPV) (Bosch et al. 2002). HPV infections are common and most 
sexually active men and women will become infected with HPV at some point in 
their lives (Cervical Screening Wales: HPV Facts). Although in most cases the 
infection will clear on its own, persistent low-risk types of HPV (non-oncogenic) are 
associated with genital warts, and high risk types of HPV (oncogenic) are associated 
with cancers of the cervix, vulva, vagina, penis, anus and rectum. There are 14 
strains of HPV that are identified as “high risk” and can cause cancer. The high risk 
types of HPV 16 and 18 are known to be responsible for around 70% of all cervical 
cancer cases. High risk infections usually self-resolve and do not cause any health 
problems (Rodriguez et al. 2008). Of the minority of infections that do persist, some 
will cause precancerous changes to the cervical cells, which if left untreated may 
become invasive cervical cancer. The identification of oncogenic types of HPV has 
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provided an opportunity to prevent cervical cancer on two fronts: by immunisation 
with HPV vaccines and by screening using HPV DNA assays (Almonte et al. 2011).  
 
1.4.2 HPV vaccination 
 
The HPV vaccination programme was introduced in the UK in 2008 for girls aged 12-
13 years (Henderson et al. 2011), alongside a catch-up programme for girls aged 14-
17 years (Almonte et al. 2011). The vaccine does not offer complete protection 
against all cervical cancers, but among the most common high-risk types of 16 and 
18. The vaccines used in the UK are the Cervarix® vaccine and the quadrivalent 
Guardasil® vaccine. The national average for HPV vaccination uptake in the UK is 
high and currently stands at 86.7% (Public Health England 2014)  
 
The implementation of universal HPV vaccination for all young girls is the best 
prospect for controlling cervical cancer; however, this benefit is unlikely to be 
observed for several decades due to the latency between HPV infection and the 
development of cervical cancer (Almonte et al. 2011). Therefore, the NHS cervical 
screening programme continues to play an important role in cervical screening 
despite the introduction of HPV vaccination, and protects women who have not 
received the HPV vaccine. Cervical screening also helps protect HPV vaccinated girls 
from cervical cancers that are caused by high-risk types of HPV that are not 
included in the vaccine, and helps prevent cervical cancer in those already infected 
with HPV prior to being vaccinated. Despite vaccination advances, it is therefore 
imperative that cervical screening uptake remains high. 
 
It has been suggested that as vaccinated cohorts reach the age of cervical 
screening, the rate of cervical cytology screen-detected disease will decrease, 
leading to a reduction of between 40-60% of current colposcopy referral rates (Ault 
2007). Such reductions are likely to translate to savings for the healthcare system; 
however, vaccine-induced disease in cervical lesions may lead to a degradation of 
cytological performance. It has been suggested that the positive predictive value of 
cytology will decrease as lesions become less common (Cuzick et al. 2008). 
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Therefore, the screening performance characteristics of HPV testing such as its high 
positive predictive value and long-term negative predictive value make it an 
attractive alternative to cervical cytology (Almonte et al. 2011). 
 
1.4.3 Primary HPV testing for cervical screening   
 
The use of HPV testing in cervical cancer screening has gained momentum, firstly 
with the issue of the 2012 guidelines by professional societies (Saslow et al. 2012) 
and the approval of high risk (HPV) testing for the use of first-line cervical screening,  
and most recently with the publication of interim clinical guidance on the use of 
primary HPV screening instead of cervical cytology in women aged 25-29 (Huh et al. 
2015). This is a significant advance, as it has been shown that around 30% of 
women with grade III cervical intraepithelial neoplasia (CIN3) are between the ages 
of 25-29 years (Baker 2015). This is a lower age threshold compared to the 2012 
guidelines which recommended HPV testing in addition to cervical smear testing for 
women aged 30-65.   
 
Sensitive and cost effective tests for high-risk types of HPV have been developed 
(Kim et al. 2002) and are widely advocated as a means of conducting HPV testing. 
Trials have shown that HPV testing has a higher sensitivity for cervical 
intraepithelial neoplasia grade 2 or worse and that high risk HPV testing on clinician 
taken cervical scrapes provides better protection against cervical cancer than 
cytology (Rijkaart et al. 2012). In particular, the ATHENA trial (Wright et al. 2015) 
involving 47,000 women demonstrated that cervical screening via cytology 
performed poorly in its ability to detect CIN3+ disease. Overall, the trial identified 
that compared to cervical cytology, HPV primary screening provided a 28.3% 
increase in sensitivity for CIN3+ in women over 25 years of age. Furthermore, the 
trial identified that the negative predictive value of primary HPV testing was more 
significant than cervical screening via cytology. The trial identified that the 
cumulative incidence rate of high-grade pre-cancer (CIN3) and cancer (CIN3+) in 
women over 25 years of age who were HPV negative at enrolment was 
approximately half of those women who were cytologically negative at enrolment.   
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Although HPV testing can lack some specificity (Miller 2001), it offers a number of 
advantages compared to conventional cervical screening. These include a higher 
sensitivity to high grade precancerous disease (Wright et al, 2015), the potential to 
extend screening intervals for women who have tested negative for HPV, and the 
reduction of unnecessary colposcopy examinations in women with borderline 
abnormal smears (Solomon et al. 2001).  Consequently, there is growing interest in 
the use of HPV testing as a primary screening tool in the UK, (Petignat and 
Vassilakos 2012). however, issues remain about how it may be widely implemented 
(Almonte et al. 2011).  
 
1.4.4 Implementation of HPV testing within the U.K cervical screening programme 
 
Cervical screening programmes in the UK are changing to facilitate a new era of 
cervical screening. HPV testing for high risk HPV is currently being incorporated 
throughout the UK, although it is not yet used as a primary screening modality. The 
evaluation of how to incorporate HPV testing into the cervical screening 
programme began in 2008 in England with the Sentinel Sites project. HPV testing as 
triage for women with borderline and low-grade dyskaryosis results has become 
routine practice in Northern Ireland and England. Wales and Scotland have 
introduced HPV testing as a test of cure following colposcopy. Recommendations 
are being made to the Welsh Assembly Government on potential plans to also 
adopt HPV triage alongside test of cure in Wales (British Society for Colposcopy and 
Cervical Pathology 2015).  
 
Due to growing evidence of superior sensitivity and negative predictive value 
compared to cervical cytology, as well as the considerations discussed previously 
regarding the new post-HPV vaccination era (Isidean and Franco 2014), it seems 
likely that future cervical cancer screening in high resource settings such as the UK 
will evolve to include primary HPV testing. Broad implementation of primary HPV 
testing and the possibility of lengthening of screening intervals due to the superior 
negative predictive value of primary HPV testing, may result in a new cervical 
screening system that is more cost-effective and provides greater safety than 
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cervical cytology (Isidean and Franco 2014). However, implementation of HPV 
screening requires consideration of important logistical challenges such as 
ascertaining appropriate screening intervals, defining triage and management 
policies for HPV positive women, ensuring quality and adherence to revised 
policies, and most importantly the type of HPV screening test to be used and its 
acceptability to women.  
 
1.4.5 Human Papillomavirus Self-sampling 
 
Primary HPV self-sampling for cervical screening may be possible using self-
sampling methods (Petignat and Vassilakos 2012).  Samples for HPV testing can be 
conducted similarly to cervical smear tests, using a swab taken by a healthcare 
professional or by the individual themselves through self-sampling. Self-sampling 
methods are increasingly advocated in tests for sexually transmitted infections 
(Waller et al. 2006) as well as for cancer screening such as faecal occult blood (FOB) 
testing in colorectal cancer screening (Hardcastle et al. 1996).  
 
Similarly to cervical screening, HPV self-sampling is a preventative health behaviour 
undertaken by a seemingly healthy individual for the sole purpose of preventing or 
detecting disease before symptoms occur (Tanner-Smith and Brown 2010). Self-
sampling for cervical screening is a method where a woman can collect a sample of 
her own cells for HPV DNA testing. To carry out HPV self-sampling, a woman will 
need to insert a soft swab into the vagina and follow simple instructions for 
collection of cells. She will then need to put the swab into a safe transportation 
device, such as a sealed tube containing preserving liquid, and post it to a 
laboratory using a pre-addressed envelope through the standard mail service. The 
sample will then be tested in a laboratory for the presence of high risk HPV. Women 
will be notified of their result through a letter in the post explaining whether any 
further action such as colposcopy examination needs to be conducted. 
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1.4.6 HPV self-sampling sensitivity  
 
As discussed previously, it is now well recognised that HPV testing on cervical 
samples provides better protection against cervical cancer than cytology (Snijders 
et al. 2013; Bosgraaf et al. 2014). HPV self-sampling using a clinically validated self-
sampling device and HPV test, has been found to have a sensitivity for detecting 
high grade CIN similar to that of HPV DNA testing on clinician collected material 
(Schmeink et al. 2011; Arbyn et al. 2014; Galbraith et al. 2014). Furthermore, a UK 
randomised trial study of HPV self-sampling found that 99% of returned self-
sampling kits had an adequate sample for analysis, versus 91.2% of clinician 
obtained smear test samples for cervical cytology (Szarewski et al. 2011). This has 
supported the concept of introducing HPV self-sampling as an alternative means for 
cervical cancer screening (Petignat and Vassilakos 2012). If self-sampling proves to 
be an acceptable cervical screening method to women it may be possible to make it 
widely available. Laboratories around the UK are in a state of change, and have 
been adapted or are currently being adapted to facilitate the recent introduction of 
HPV testing on abnormal cervical samples and as a test of cure. Furthermore, as the 
sample is sent to a laboratory through the post, the service does not need to be 
available in every hospital/laboratory but can be concentrated at sites of expertise 
and capacity.   
 
1.5 Current self-sampling methods for cancer screening:  the UK colorectal cancer 
screening programme  
  
The first UK population screening programme to use a self-sampling method is 
colorectal cancer screening (CRC). Secondary prevention of CRC through regular 
screening is important because CRC can have a long period during which the 
disease is detectable but asymptomatic, much like cervical cancer (Winawer et al. 
1993).  CRC can be diagnosed through various means, including faecal occult blood 
testing (FOBT) that is conducted through self-sampling. Annual or biannual 
screening using FOBT has been found to reduce colorectal cancer mortality by 27% 
in those who use the test (Scholefield et al. 2002).  
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The FOBT test can be conducted with a self-sampling kit which is sent through the 
post, so that individuals collect their own stool samples over a period of days for 
FOBT. A national screening programme was initiated in England in 2006, offering 
FOBT for adults aged 60-69 years. The eligible population is re-invited every two 
years until age 69 years.  Individuals are instructed to post their FOBT test kit in a 
hygienically sealed free-post envelope to a laboratory for sample analysis, with a 
test result received within two weeks. If the result is positive, the person concerned 
may be asked to repeat the test or invited to have a colonoscopy. The bowel 
screening programme has been shown to be feasible and is now routinely 
implemented in the UK (Weller et al. 2003). However, uptake is currently around 
60%  (Weller et al. 2006) and demonstrates a socioeconomic gradient, ranging from 
35% uptake in the most deprived areas to 61% uptake in the least deprived areas 
(von Wagner et al. 2011). It has also been found that FOBT uptake is lower in the 
most ethnically diverse areas independent of socioeconomic group, age and gender 
(von Wagner et al. 2011). 
 
Reasons for low uptake of FOBT include practical objections such as a perceived 
hygiene risk in handling, storing and sending faecal matter through the post, as well 
as the perception of complex or unfeasible instructions and processes (von Wagner 
et al. 2011; Hall et al. 2013; Palmer et al. 2014). Perceived risks and taboo 
associated with handling faeces have been identified, and include the belief that 
conducting the test might physically pollute the individual or their environment, 
and that individuals would need to take extreme measures to manage the 
possibility of such pollution (Palmer et al. 2014).  Another reported reason for non-
uptake of FOBT is the lack of familiarity with FOBT and habituation to screening 
tests being conducted by healthcare professionals (Palmer et al. 2014).  
 
The FOB test programme has demonstrated that a self-sampling screening method 
for cancer is a feasible and cost-effective alternative to conventional outpatient 
screening, as long as the relevant population engages in the screening process. The 
introduction of FOBT self-sampling into the UK setting has also identified that 
although the FOBT test avoids many of the commonly reported barriers to cancer 
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screening such as embarrassment and attending healthcare appointments, it is not 
acceptable to a large proportion of the population and presents different barriers. 
This needs to be considered in future self-sampling programmes such as HPV self-
sampling. Indeed, the perception that conducting HPV self-sampling is “dirty” or 
taboo has been reported in a UK study investigating HPV self-sampling perceptions 
in Hindu women (Cadman et al, 2014). 
 
1.6 Uptake of HPV self-sampling 
 
HPV self-sampling is a promising means of increasing cervical screening coverage, 
potentially enabling the programme to reach women in their own homes and 
reducing the need for surgery appointments, as well as the financial and labour 
costs associated with repeat smear taking. Self-sampling may also be useful in 
reaching women from lower socioeconomic groups, ethnic minority groups (Webb 
et al. 2004; Sutton and Rutherford 2005; Marlow et al. 2015) and younger age 
groups, who are less likely to attend cervical screening.  Participation rate is a 
fundamental factor determining the acceptability, cost effectiveness and reach of a 
potential HPV self-sampling screening programme, therefore careful consideration 
of any influences that may affect its successful implementation is crucial (Verdoodt 
et al. 2015). 
 
The majority of research into acceptability of HPV self-sampling has been 
conducted in women who are cervical screening non-responders or those who are 
under-screened. The rationale behind this research is evident: for a cervical 
screening programme to function well, uptake must remain high and therefore 
efforts are often concentrated on women who do not participate as they are known 
to be at higher risk of developing cervical cancer. A recent systematic review and 
meta-analysis of HPV self-sampling versus usual care in cervical screening non-
attenders identified an increased participation in self-sampling when kits were 
mailed directly to women (Verdoodt et al. 2015). The meta-analysis included 
sixteen trials, two of which were conducted in the UK (Szarewski et al. 2011; 
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Cadman et al. 2015), and concluded that HPV self-sampling may provide an 
alternative cervical screening method that is acceptable to non-responders. 
 
Results from meta-analysis should be interpreted with caution however, since they 
provide a very general overview of uptake and differences between studies need to 
be considered. The UK study conducted by Szarewski et al (2011) reported a 
significantly lower uptake rate of HPV self-sampling compared to studies in the 
Netherlands and Sweden which identified uptake rates of 34% (Bais et al. 2007), 
39% (Sanner et al. 2009b) and 27% (Gok et al. 2010). Szarewski et al (2011) found 
that when persistent non-responders (defined as women who have not responded 
to at least two invitations for cervical screening) were sent a self-sampling kit, a 
total uptake of 10.2% was achieved, of which 6.4% utilised the kit and 3.8% 
attended cytological screening. Of those who utilised self-sampling and underwent 
colposcopy, high-grade disease (CIN) was found in 43% of women. This relatively 
high yield of abnormalities is consistent with that expected among a hard to reach 
and relatively high-risk group of non-responders. The different uptake rates 
observed between different countries may therefore be attributed to 
characteristics of the populations sampled. However, methodological differences 
between studies may also explain this phenomenon, for example non-responders in 
Sweden and the Netherlands were contacted more than once to encourage them to 
participate. A further limitation of the Szarewski et al (2011) study is that only 10% 
of participants were under 35 years old. This is an important limitation as research 
has identified that women from younger age groups are less likely to participate in 
cervical screening. Further work is needed to ascertain women’s attitudes towards 
HPV self-sampling in women from different groups (Szarewski et al. 2011), such as 
different sociodemographic backgrounds and cervical screening histories. 
 
Studies have shown that although HPV self-sampling can increase cervical screening 
acceptance in some non-responders, the majority of non-responders do not 
participate in HPV self-sampling. This is important when considering that it is a 
method which addresses many of the commonly identified barriers to cervical 
smear, testing such as test-related issues including pain, discomfort or 
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embarrassment and doctor-related issues including access, difficulty obtaining 
appointments or time constraints. This poses the question of whether HPV self-
sampling may be better suited as a primary cervical screening method and if it 
would be acceptable to cervical screening responders, when compared to cervical 
smear tests. A study by Waller et al. (2006) found HPV self-sampling to be more 
acceptable than a clinician-administered test in women attending for a cervical 
smear screen. Participants were able to compare the two different modes of 
screening because they were asked to conduct HPV self-sampling at the clinic they 
were attending, followed by their standard cervical smear test. The study 
highlighted women’s lack of confidence in conducting self-sampling. A limitation of 
the study is that women conducted self-sampling in a health care setting. This 
might have avoided perceived barriers associated with suitability of environment 
for self-sampling (as identified in FOBT literature) which may have been present if 
women were performing the self-sampling procedure at home. Therefore, the 
observed lack of confidence in conducting self-sampling properly, may have been 
even higher if participants were conducting the test at home. Furthermore, because 
women were aware that they were also receiving a clinician test as well as HPV self-
sampling, it is possible that anxiety levels might have been lower, because 
participants might have perceived the clinician cervical screening tests as a 
safeguard should self-sampling be conducted incorrectly. Therefore, further 
research investigating acceptability of HPV self-sampling in cervical screening 
responders is needed. 
 
1.6.2 Psychological determinants of HPV self-sampling uptake  
 
1.6.2.1 Attitudes towards HPV self-sampling  
A mixture of positive and negative attitudes towards HPV self-sampling have been 
identified in studies exploring women’s attitudes towards HPV self-sampling in 
different countries. Although the majority of studies have been conducted in 
women who are classified as non-responders to cervical screening, they provide 
important insight into attitudes towards HPV self-sampling.  Whilst some studies 
have found HPV self-sampling to be an acceptable form of cervical screening  
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(Harper et al. 2002; Waller et al. 2006; Galbraith et al. 2014; Broquet et al. 2015; 
Hanley et al. 2015; Sultana et al. 2015),others have identified that HPV self-
sampling would raise significant concerns and might not be an acceptable form of 
screening (Cadman et al. 2014; Fargnoli et al. 2015). A reduction in time 
commitment needed compared to attending a clinic for a cervical smear test and 
the reduction of discomfort and embarrassment by avoiding gynaecological 
examinations, (Barata et al. 2008; Bosgraaf et al. 2014; Fargnoli et al. 2015; 
Llangovan et al. 2016), as well as the perception that women feel more relaxed 
conducting self-sampling (Hanley et al. 2015) have been identified as benefits. 
However, the belief that self-sampling is not safe (Barata et al. 2008; Hanley et al. 
2015), concerns over performing self-sampling properly (Forrest et al. 2004; 
Cadman et al. 2014; Hanley et al. 2015) and a subsequent lack of trust in the results 
(Sultana et al. 2015) have been identified as barriers.  
Sociodemographic differences have been reported in women’s concern over 
performing self-sampling correctly. A UK study found that women from Indian and 
African-Caribbean backgrounds were significantly more likely to be worried about 
doing the test properly (66% and 70% respectively) compared to White or Pakistani 
women (Forrest et al. 2004). In contrast, a preference for HPV self-sampling has 
been identified in a study of women from lower socioeconomic groups (Galbraith et 
al. 2014), who found that most women (92%) trusted that a HPV self-sampling test 
would be able to detect cervical cancer if it is present (sensitivity). However, only 
26% of women trusted that a positive test result correctly identified those who had 
cervical cancer (positive predictive value).  
 
Later studies have reported preferences for cervical smear tests over HPV self-
sampling (Szarewski et al. 2009; Cadman et al. 2014; Fargnoli et al. 2015). For 
example, a mixed methods study by Cadman et al (2014) in Hindu women from 
London identified that preferences for smear testing were underpinned by higher 
confidence in clinician collected samples, and the perception that a positive HPV 
test may cause relationship problems. This study also noted generational 
differences in attitudes, represented in the belief that younger women would be 
more comfortable with conducting self-sampling compared to older women. The 
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study included cervical screening responders and provided an insight into the views 
of women who attend cervical screening; however, it involved a highly selected 
sample of educated Hindu women, resulting in limited generalisability of findings.  
Fargnoli et al. (2015) also highlighted generational differences in women’s attitudes 
towards HPV self-sampling in Switzerland. It was found that younger women who 
were more used to regular gynaecological appointments were less in favour of a 
new screening test, compared to older women who were less used to regular 
gynaecological appointments and those who had a bad experience with pelvic 
examinations in the past. However, the cervical screening in Switzerland is 
opportunistic and primarily conducted by gynaecologists, whilst in the U.K cervical 
screening is conducted primarily by nurses and is facilitated by a cervical screening 
recall system. The differences in the way cervical screening is organised in the U.K. 
and Switzerland might explain the different views reported.  
A recent study by Llangovan et al. (2016) investigated the acceptability of HPV self-
sampling in uninsured Haitian and Latino women in the U.S. It was reported that 
acceptability of HPV self-sampling was high overall, most (over 90%) of women 
reported that HPV self-sampling was easy to perform and that they felt they 
conducted the test correctly. However, it was found that when provided with a 
choice between HPV self-sampling and cervical cytology, Haitian women were less 
likely to choose self-sampling (60% vs 87%) compared with Latino women. Although 
the difference in cervical screening method might be due to ethnic differences, it 
might also be because the majority of Haitian women have less experience with 
cervical cytology than Latino women (Seay et al. 2015). It has been identified that 
preference for cervical smear over HPV self-sampling has been associated with 
adherence to cervical screening (Winer et al. 2016). Consequently, the Haitian 
women might have been more amenable to a different form of screening. 
Furthermore, the study was conducted in two safety-net clinics that provide 
accessible healthcare to individuals who do not have health insurance. The 
healthcare centre that provided service to the Haitian women required an extra fee 
for conducting a cervical smear test, whilst the cost of obtaining a cervical smear 
was included when conducted as part of a visit.  Therefore, financial considerations 
might have also influenced Haitian women’s preference for HPV self-sampling. 
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Financial considerations have been identified by Fargnoli et al. (2015) who reported 
that migrant women  perceived HPV self-sampling as less expensive than cervical 
smear tests. Although, healthcare in the U.K. is free and provided by the National 
Health Service (NHS), women might have specific perceptions about the financial 
impact of HPV self-sampling on the NHS. 
Further studies exploring women’s attitudes to HPV self-sampling from different 
screening histories, cultural backgrounds, age ranges and socioeconomic 
backgrounds need to be conducted. 
 
1.6.2.2 HPV knowledge 
 
Despite the recent introduction of HPV testing and the introduction of the HPV 
vaccine, women’s HPV-related knowledge has remained low (Marlow et al. 2013; 
Galbraith et al. 2014). Mixed results have been reported relating to knowledge that 
HPV can cause cervical cancer. A U.S. study reported that the majority of 
participants (63%) could identify HPV as a cause of cervical cancer (Galbraith et al. 
2014). However, other studies have reported lower HPV-related knowledge, with 
the majority of women being unaware that cervical cancer is caused by a sexually 
transmitted infection (STI) (Marlow et al. 2007). An international survey conducted 
in the UK, US and Australia found that 39% of participants had not heard of HPV 
before taking part in the research (Dodd et al. 2014). International variation in HPV 
knowledge levels may be partly attributable to differential implementation of HPV 
testing between countries, and variable HPV coverage by public health campaigns 
and news stories. HPV knowledge has also been associated with educational level, 
with more educated individuals often being more aware of HPV and HPV testing 
(Marlow et al. 2013; Dodd et al. 2014). Variation of HPV knowledge by ethnicity has 
also been found, with women from ethnic minority backgrounds reporting a lower 
level of HPV knowledge (Galbraith et al. 2014).   
 
As well as a general lack of knowledge about HPV, low understanding of HPV test 
results and their emotional consequences have been observed (Daley et al. 2015). 
Women have reported negative emotional reactions to positive HPV test results 
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including anxiety, distress, embarrassment and concern about sexual relationships 
(McCaffery et al 2006). Women with normal cytology undergoing a follow-up HPV 
test 12 months after an initial positive HPV test reported disappointment that the 
virus had not cleared up, fear and concerns about fertility (Waller et al. 2007). In 
addition, it has been found that women may not understand the implications of a 
negative HPV result (e.g. the knowledge that a negative HPV test means that a 
woman’s cervical cancer risk is low at that point in time) (Dodd et al. 2014). HPV 
testing may therefore raise some difficult issues for women. Although HPV is 
extremely common amongst the sexually active population, awareness of the role 
of this virus and its interaction with cervical cancer may raise concerns about stigma 
surrounding a potential diagnosis (Forrest et al. 2004). Improving knowledge that 
HPV causes the majority of cervical cancer cases and understanding of the 
implications of HPV results may help to increase HPV testing acceptability and 
minimise negative psychological consequences associated with HPV results (Dodd 
et al. 2014; Crofts et al. 2015). 
 
1.6.2.3 HPV self-sampling intentions 
 
Some studies have focused on investigating HPV self-sampling intentions because 
HPV self-sampling is not routinely available. Studies have reported mixed findings 
regarding women’s intentions to HPV self-sample. One study found that 56% of 
women would use HPV self-sampling if it was available (Forrest et al. 2004). 
However, it was found that intention was affected by ethnic background and HPV 
knowledge, with intention rate varying between 71% in White British women to 
46% in women from Indian and Pakistani backgrounds.  This finding might reflect 
the differences in attitudes towards HPV self-sampling that have been described 
earlier in women from different sociodemographic groups. A recent study by Smith 
et al. (2014) that investigated women’s intentions to conduct HPV self-sampling 
compared to having a cervical smear test, has reported HPV self-sampling 
intentions of 45.6%. This study also reported socioeconomic differences in 
intention, with women from a higher educational background were more likely to 
intend to HPV self-sample. 
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Although research on intention to self-sample suggests that HPV self-sampling 
might be an acceptable form of screening in certain populations, intentions can 
vary from actual behaviour. A recent systematic review and meta-analysis of 
sixteen randomised controlled trials (Verdoodt et al. 2015) identified an average 
HPV self-sampling participation rate of 23% (range from 6.4% -34%) in cervical 
screening non-attenders who were mailed a HPV self-sampling kit. The wide range 
of reported participation highlights the heterogeneity observed in the included 
studies, in terms of study characteristics such as the use of reminders as well as the 
contextual differences in studies which were conducted in different countries.  
 
Although evidence regarding women’s intentions to HPV self-sample is invaluable in 
facilitating understanding of their potential behaviour. Should HPV self-sampling 
become available, it must be interpreted with caution. Reported intentions to HPV 
self-sample do not automatically result in uptake of HPV self-sampling. Intention 
formation is influenced by beliefs about the value of engaging in HPV self-sampling, 
in terms of benefits and barriers, as well as an individual’s perceived ability to 
perform the behaviour in question (e.g. collecting a sample for HPV testing). 
Although intentions are necessary, they are not sufficient for behaviour change 
(Fishbein and Ajzen 1975). Behavioural intentions are defined as “instructions that 
people give to themselves to behave in certain ways” (Triandis 1980). Therefore, a 
behavioural intention represents an individual’s motivation to perform a certain 
behaviour, such as HPV self-sampling. It has been found that more than half of 
individuals who form an intention fail to put that intention into practice (Orbell and 
Sheeran 1998). This is known as the intention-behaviour gap and should be 
considered when interpreting findings presented, especially when correlations as 
low as 0.03 between intentions and behaviour for cancer screening have been 
found (Montano and Taplin 1991). Furthermore, the intention-behaviour gap may 
be larger in research that uses hypothetical scenarios compared to research 
investigating attitudes towards services available. The intention-behaviour gap 
could be bridged by the use of post-intentional constructs focusing on how people 
pursue goals after an intention has been formed. It has been suggested that as well 
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as setting specific implementation-intention tasks (Gollwitzer and Sheeran 2006), 
an increase in self-efficacy, particularly ‘coping self-efficacy’ (Schwarzer 2008) 
which refers to the ability to cope with impediments to the desired behaviour, can 
help translate intentions into behaviour.   
 
1.7 Interventions designed to increase screening uptake  
 
As previously discussed the success of any cancer screening programme is 
dependent on its uptake, and uptake of HPV self-sampling could be potentially be 
increased by an intervention. To date, only one intervention designed to increase 
HPV self-sampling uptake has been identified in the literature. Sossauer et al. 
(2014) reported that a video, which included culturally tailored messages, was able 
to increase knowledge about cervical cancer and HPV, as well as increase the 
acceptability of HPV self-sampling. However, this study was conducted in 
Cameroon, a low income country without an organised cervical screening 
programme, therefore the results may not be generalizable to the UK setting.   
 
In light of the limited evidence regarding interventions designed to increase HPV 
self-sampling uptake, evidence from other types of screening interventions will be 
discussed. Although inferences will be drawn from studies reporting the 
effectiveness of interventions to increase uptake of cervical and colorectal cancer 
screening, a detailed review is outside of the scope of this thesis. Evidence from the 
current cervical and colorectal screening programmes will be presented due to 
similarities with HPV self-sampling (screening for cervical cancer and self-sampling).  
 
The most recent Cochrane review of interventions targeted to encourage cervical 
screening has suggested that interventions which provide educational materials and 
those that have been developed with involvement of a lay person (e.g. showing 
mastery of a certain behaviour) are effective in increasing cervical screening 
participation (Everett et al. 2011).  Interventions have attempted to increase 
participation in colorectal cancer screening, for example it has been found that a 
mailed psychoeducational intervention in a community setting was able to increase 
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screening attendance by modifying individual’s attitudes (Wardle et al. 2003). 
Interventions designed to increase FOBT colorectal cancer screening may be 
particularly useful, as the screening mode is similar to that of HPV self-sampling. 
Studies have shown promising results in increasing colorectal cancer screening 
rates using interventions designed to increase FOBT utilisation (Davis et al. 2014). 
Interventions have included patient directed interventions such as written materials 
and reminders (Lee et al. 2009). A recent UK study has identified that interventions 
which focus on reducing delay in completion of FOBT kit and facilitating preparation 
to conduct the procedure may be useful in increasing intention to FOBT self-sample 
(Lo et al. 2015). These findings suggest that there is potential for the development 
of a HPV self-sampling intervention with the aim of increasing future uptake.  
 
1.8 The need to develop a HPV self-sampling intervention 
 
Interventions have been designed to increase uptake of screening in cervical and 
other forms of cancer. However, to date, interventions to increase women’s 
intentions to HPV self-sample have not been developed in the UK setting. Should 
HPV self-sampling be incorporated into the U.K cervical screening programme as a 
primary cervical screening modality, the development of an intervention will be 
needed to help increase potential uptake of HPV self-sampling.  The Medical 
Research Council (MRC) framework for developing and evaluating complex 
interventions (Craig et al. 2008) states that development phase research must be 
conducted to enable the development of suitable key messages to be included in an 
intervention, and that interventions must be based on the best available evidence 
for the target population (which for this PhD research is women from the general 
population).   
 
Studies to date have mainly involved cervical screening non-responder samples, or 
have been conducted in countries with different healthcare systems. The 
characteristics of women who are cervical screening non-responders may be 
different to those of women who adhere to current cervical screening guidelines. 
Population based surveys have found that women who are non-responders are 
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more likely to be from an ethnic minority background, single, younger in age and to 
have fewer educational qualifications (Sutton and Rutherford 2005; Lancuck et al. 
2008; Marlow et al. 2008; Moser et al. 2009).  Some non-responders are disengaged 
with the cervical screening programme (Marlow et al. 2015), which might reflect 
different barriers to potential HPV self-sampling uptake.  Where the views of 
cervical screening responders have been sought in the UK, research has mainly 
focused on the views of women from ethnic minority backgrounds. Whilst research 
into women from ethnic minority backgrounds is crucial for understanding potential 
uptake of HPV self-sampling, in women who may present specific cultural barriers, 
findings may not be representative of the population as a whole. If HPV self-
sampling is to be used as a primary screening tool for the whole population, rather 
than targeted at cervical screening non-responders, then it will be important to 
understand the barriers and facilitators to HPV self-sampling in women from a 
range of demographic backgrounds.  
 
1.9 Summary and research gap 
 
Testing for Human Papillomavirus (HPV) is currently being incorporated into the 
cervical screening programme, with the probable future introduction of HPV as a 
primary test and the possibility of HPV self-sampling. In anticipation of this 
development, research into the psychological factors associated with 
acceptance/rejection of HPV self-sampling in a general population sample is needed 
to explore the acceptability of this method. The majority of studies examining 
women’s attitudes towards HPV self-sampling have focused on cervical screening 
non-responders, therefore the views of women who are currently engaged in the 
cervical screening system are underrepresented.  
 
The identification of constructs associated with intention to engage in HPV self-
sampling in a general population sample will facilitate the exploration of women’s 
views on the possible future introduction of primary HPV self-sampling. Insights 
into women’s attitudes towards HPV self-sampling could be used in the 
development of policy and practice regarding the possible incorporation of HPV 
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self-sampling into the cervical screening programme, as well as the development of 
an intervention to increase acceptability. The development of an intervention will 
help ensure that cervical screening uptake does not decline, should HPV self-
sampling be incorporated into the cervical screening system in the future. 
Psychological theory will be applied in the investigation of women’s hypothetical 
attitudes and intentions to HPV self-sampling and the development of an 
intervention designed to increase self-sampling uptake (Craig et al. 2008).  
 
1.10 Aims and objectives 
The overarching aims of the PhD research are to examine women’s attitudes 
towards HPV self-sampling, with a particular focus on self-efficacy, and to develop 
and pilot an intervention designed to increase the acceptability of HPV self-
sampling.  
 
Specific objectives are: to gain a rich understanding of women’s attitudes, 
knowledge and intentions regarding HPV self-sampling using relevant health 
psychology theory; to explore the influence of self-efficacy on intentions to self-
sample using a mixed-methods approach; to produce messages to be used in an 
intervention designed to increase the acceptability of HPV self- sampling, to 
develop a HPV self-sampling intervention, and to conduct preliminary user testing 
with women and service providers to explore acceptability of intervention as well as 
barriers and facilitators to implementation. 
 
1.11 Study design 
 
The investigation of complex health behaviours such as HPV self-sampling, requires 
the use of a multi-level investigative approach. Mixed methods research combines 
qualitative methods, such as in-depth interviews to understand individual 
experiences and barriers and facilitators to action, with quantitative methods such 
as surveys of attitudes and beliefs (Plano Clark 2010). For the purpose of this PhD 
research, the mixed methods approach will be defined as an approach that 
(Creswell et al. 2011): 
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 focuses on research questions that call for real-life contextual 
understandings and multi-level perspectives 
 employs quantitative research assessing magnitude and frequency of 
constructs with qualitative research to explain the meaning and 
understanding of the constructs 
 employs multiple methods such as surveys and interviews 
 combines the methods to draw on the strengths of each respective method 
 frames the investigation within a theoretical position. 
 
1.12 Research Phases 
 
The PhD research is presented in five phases: 
 
Phase one identified and evaluated health behaviour theories that can be used to 
help understand women’s attitudes towards HPV self-sampling. A suitable theory 
was be selected to structure subsequent mixed-methods research stages. 
 
Phase two presented the development of a structured survey based on health 
behaviour theory, designed to examine women’s attitudes towards HPV self-
sampling. The questionnaire was developed using content validity analysis and 
cognitive interviewing. 
 
Phase three utilised the survey developed in Phase two to survey attitudes towards 
primary HPV self-sampling and to quantify HPV self-sampling intentions in a cross-
sectional sample of women from South-East Wales. The influence of HPV 
knowledge, attitudes, self-efficacy, and clinical and demographic background 
characteristics including previous cervical screening history on HPV self-sampling 
intentions was examined.  
 
Phase four explored in depth women’s attitudes towards primary HPV self-
sampling, using semi-structured interviews with women purposively sampled from 
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the Phase three questionnaire survey who reported low intentions to HPV self-
sample. 
 
Phase five utilised the information gathered in previous phases to develop an 
intervention designed to increase HPV self-sampling intention, followed by a 
preliminary user testing of the draft intervention using pre and post-questionnaire 
and semi-structured interviews with a small sample of potential users and 
providers. 
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Chapter 2 
 
 Review of health behaviour models and theories relevant to HPV self-sampling.  
 
2.1 Chapter Overview 
This chapter will explore the theoretical background to the PhD, in order to 
facilitate an understanding of the likely influences on women’s intentions to HPV 
self-sample. The use of theory is an important recommendation from the MRC 
intervention development guidelines (Craig et al 2008) for the successful 
development of complex behaviour change interventions.  
A range of theoretical approaches will be described in order to highlight the effect 
of health beliefs on intention and behaviour in relation to cervical screening, and to 
identify relevant theories that can be used to investigate HPV self-sampling 
intention. A justification for the use of the extended Health Belief Model (HBM) 
with its focus on self-efficacy to inform the current research will be presented.  
Finally, an outline of how the extended HBM will be utilised in the subsequent PhD 
phases will be presented. 
 
2.2 Introduction 
 
The aim of the NHS cervical screening programme is to ensure that at least 80% of 
eligible women in the UK receive a cervical screen. Health beliefs have been shown 
to be influential in determining uptake of screening such as cervical smear tests, 
FOBT tests and HPV self-sampling (see Chapter 1). These studies have helped to 
form an understanding of why certain population groups may not engage in 
screening. However, the possible introduction of an alternative method of cervical 
screening, may raise different barriers and facilitators to engaging in screening that 
have not been previously reported. Since HPV self-sampling has not yet been 
incorporated into the cervical screening programme, theories that have been found 
useful for exploring barriers to other forms of cancer screening need to be reviewed 
regarding their relevance and usefulness in context of HPV self-sampling.  
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As recommended by the MRC guidelines (Craig et al. 2008), a theoretical 
underpinning to any intervention is crucial to help explain the mechanisms of 
behaviour change. The MRC complex intervention guidelines specify that a clear 
description of how intervention components interact to achieve a desired outcome, 
such as an increase in intention to HPV self-sample, is required.   
Therefore, the incorporation of theory in the design of this PhD research and the 
development of the HPV self-sampling intervention was important for a number of 
reasons. Firstly, the use of theory to inform the study of women’s attitudes towards 
HPV self-sampling can facilitate the development of study materials such as surveys 
and interview schedules. Secondly, theory can provide a framework for the 
intervention designer to consider which beliefs need to be modified, thereby 
identifying motivational processes relating to HPV self-sampling intention (Michie 
et al. 2011). Thirdly, theorising about the mechanisms that may influence intention 
to HPV self-sample promotes the assessment of appropriate mediators for 
intervention inclusion. This enables the determination of whether the intervention 
has influenced the hypothesised mediator and subsequently whether that mediator 
has an effect on intention to self-sample. Therefore the use of theory can facilitate 
the identification of ‘active ingredients’ present in behaviour change interventions 
(Michie and Abraham 2004). Finally, designing an intervention based on a specific 
theory also enables the theory to be evaluated in terms of its ability to explain a 
particular behaviour, such as women’s intentions to HPV self-sample.  
 
Although many theories have been proposed to explain the adoption of health 
protective behaviours, the aim of this chapter is to discuss health behaviour 
theories that are considered to be most relevant to HPV self-sampling. Health 
behaviour theories can be used to explain determinants of a behaviour in a specific 
context. Therefore, when considering which theories might be most suitable for the 
exploration of women’s attitudes towards HPV self-sampling, it was important that 
theories that have previously been used to explain engaging in preventative health 
behaviours, such as cervical screening, were considered. Furthermore, because the 
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emphasis is placed on the individual to conduct HPV self-sampling, theories that 
incorporated the concept of self-efficacy were also explored.  
The theories that will be presented in this chapter are: the Trans-Theoretical Model 
of Health Behaviour Change (TTM), Protection Motivation Theory (PMT), the Theory 
of Reasoned Action (TRA) and Theory of Planned Behaviour (TPB), Social Cognitive 
Theory (SCT) and the Health Belief Model (HBM). The theories and their relevance 
to HPV self-sampling will be described, and their strengths and weaknesses will be 
critically appraised. 
 
A focus on the use of theory in understanding intention to engage in primary HPV 
self-sampling will be presented. As well as research relating to HPV self-sampling, 
studies of cervical, breast and FOBT cancer screening will also be outlined. Cervical, 
breast and FOBT screening studies will also be presented because they are the main 
organised cancer screening campaigns in the UK that are comparable to a future 
primary HPV self-sampling programme.  
A wide range of psychological theories and models have been used to understand 
and identify reasons for low rates of participation in cancer screening (Austin et al. 
2002). Due to the voluntary, infrequent and non-habitual nature of cervical 
screening through smear tests, or HPV self-sampling in the future, it is possible that 
individuals make a decision whether to engage in cervical screening each time they 
are invited to participate (Bish et al. 2000). Therefore, uptake of cervical screening, 
such as HPV self-sampling, may be a behaviour that is particularly suited to study 
with social cognition models.  
 
However, some previous research has identified social cognition models as poor 
predictors of screening behaviour (Godin and Kok 1996). Although it is possible that 
some cognition models might have a limited utility in predicting certain behaviour, 
this finding should be interpreted with caution. The categories of health behaviour 
used by the above study were broad and included early detection behaviour such as 
self-examination and seeking medical care for symptoms, as well as screening 
behaviours such as participating in mammography. Early detection behaviours 
require awareness of symptoms and are thus different to preventative screening 
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behaviour which is asymptomatic. Therefore, the lack of predictive ability of health 
cognition models reported by Godin and Kok (1996) might be due to the type of 
screening behaviour studied and the specific models chosen, different models 
might be better suited to different types of behaviour. In fact, it has been found 
that participation in different forms of screening is predicted by specific beliefs 
about the different types of screening (Marteau 1993), as well as previous 
experiences. For example, private breast self-examination (BSE) may be a more 
acceptable form of screening for a woman who may be anxious at the prospect of a 
cervical smear screen that involves participation of a health care professional.  
 
2.3 Trans-Theoretical Model of Behaviour Change (TTM) 
 
The fundamental concept of the TTM (Prochaska 1993; Prochaska and Velicer 1997) 
is that behaviour change is most successful when behavioural strategies called 
processes of change are applied at the correct time (Prochaska et al. 1992). The 
model was initially developed as an approach to psychotherapy, but was then 
applied to health and lifestyle behaviours such as tobacco cessation and cancer 
screening behaviour (Prochaska et al. 1992). The TTM proposes that a behaviour 
change occurs in five different stages from precontemplation (not planning to 
change within the next six months), contemplation (thinking about changing), 
preparation (taking steps to change), action (attempting the change) and 
maintenance (having changed for at least six months). Although the stages are 
presented in a linear fashion, in reality individuals may pass back and forth through 
different stages. It is proposed that individuals in the early stages of change use 
cognitive or experiential strategies, such as self-re-evaluation, to progress forward 
through the stages of change. Individuals in the later stages use behavioural 
processes such as helping relationships or stimulus control more frequently. As the 
individual progresses further through the processes of change, the cons relating to 
a particular health behaviour should decrease whilst the pros should increase. 
 
The TTM processes as applied to HPV self-sampling will be outlined below. The first 
stage (precontemplation) involves increasing awareness about HPV self-sampling 
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and improving accuracy of information about HPV self-sampling and the self 
(consciousness raising), experiencing and releasing feelings about HPV self-sampling 
and engaging in HPV self-sampling (dramatic relief), and thinking that engaging in 
HPV self-sampling would impact on the social environment (environmental re-
evaluation). The second stage (contemplation) refers to the cognitive and affective 
assessments of how engaging in HPV self-sampling may impact on the individual’s 
self-image. The third stage (preparation) refers to an individual’s belief that they 
are able to overcome previous barriers related to HPV self-sampling and their 
commitment to act on the belief (self-liberation). The fourth stage is the action 
stage and refers to the utility and availability of helping relationships, counter-
conditioning, reinforcement management and stimulus control. The final stage is 
maintenance and involves social liberation, social, policy or environmental changes 
that support healthy behaviour. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: The TTM applied to HPV self-sampling (SS), adapted from (Prochaska 
and DiClemente 1982) 
 
A further two intervening variables are proposed to influence movement from 
stage to stage: decisional balance and self-efficacy. Decisional balance refers to the 
perceived benefits and barriers associated with engaging in health behaviour such 
Contemplation 
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as self-sampling. When more benefits are perceived, a change is more likely. Self-
efficacy is defined as a person’s beliefs about their ability to carry out behaviour in 
any given situation (Michie et al. 2014). Self-efficacy refers to both behaviour 
change and to temptations to carry out the problem behaviour (or in the case of 
self-sampling to avoid the healthy behaviour). Self-efficacy influences the processes 
of change throughout the different stages. Self-efficacy level increases and 
temptation levels decrease over time (Michie et al. 2014).  
 
The TTM has been utilised as a theoretical framework in a number of studies 
investigating cervical screening and mammography attendance (Rimer et al. 1996; 
Kelaher et al. 1999; Abdullah and Su 2013). Studies have identified that cervical 
smear test screening and mammography behaviour were largely influenced by 
women’s decisional balance of pros and cons. Cons included advanced age, lack of 
education and misconceptions about the screening method (Rimer et al. 1996). 
Abdullah and Su (2013) identified that women who were in the pre-contemplation 
stage were most likely to be at an action stage following exposure to an 
intervention designed to increase cervical screening, such as the introduction of a 
call/recall system.  
 
Although the TTM has been used to investigate women’s intentions to engage in 
cervical smear test screening attendance, staging as proposed by the TTM may be 
problematic in the cervical screening context, in which the behaviour occurs once 
every three or five years. The TTM has been criticised for the concept of staging and 
the proposition that discreet and categorical stages exist for any given behaviour 
(Sutton 2000). It has been argued that individuals do not progress through discreet 
stages but that they progress along a continuum of change (Sutton 2000). Staging 
for cervical screening behaviour, such as HPV self-sampling, can be difficult because 
of variations in screening recommendations based on previous cervical screening 
history and policy variations between different countries. Cervical screening 
recommendations in terms of age of onset of cervical screening, frequency of 
screening and the introduction of HPV testing, have been modified as further 
advances in cervical screening have been made. Furthermore, cervical screening is 
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stratified based on women’s previous cervical screening history (e.g. women who 
have had a previous cervical abnormality are under increased surveillance and 
screened more frequently, whilst in some areas in the UK older women are 
screened at longer intervals). Therefore, if staging for cervical screening occurs 
every three years, depending on which cervical screening strata (e.g. standard 
screening vs increase surveillance) a woman is in, she could be classified as being in 
an action stage or a relapse stage (Spencer et al. 2005).  
 
The TTM is better used to account for frequent behaviour, especially 
operationalising the issue of resisting temptation (as in smoking cessation) as well 
as the stages from action to maintenance. A cancer detection behaviour that might 
be better suited to this model is breast self-examination (BSE) behaviour, which can 
be conducted and maintained at regular time points. Although it may be argued 
that cervical screening may be seen as a habitual behaviour (as women may have 
up to twelve routine cervical screens in their lifetime), it still requires re-
engagement with the programme, booking of an appointment and having the 
cervical smear conducted. This would also be applicable to the potential routine 
introduction of HPV self-sampling as a primary screening method at infrequent 
intervals, similarly to the UK cervical smear and the FOBT screening programmes. 
Therefore, a theory that does not delineate specific staging of habitual behaviour 
would be better suited to understanding women’s attitudes towards HPV self-
sampling.  
 
2.4 Protection Motivation Theory (PMT) 
 
Protection motivation theory (Rogers 1975, 1983) is a model of cognitive appraisal 
that occurs in reaction to a health threat. The theory was originally developed to 
explain the effect of fear appeals on health related attitudes and behaviours and 
later revised to include self-efficacy and reward components. PMT proposes that 
cognitive appraisal is initiated by sources of information that can be environmental 
(e.g. verbal persuasion) or intrapersonal (e.g. prior experience). The theory 
stipulates that behaviour is a result of decision making processes based on the 
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expected consequences of engaging in behaviour and the value of those 
consequences. Threat appraisal in the context of HPV self-sampling can include 
perceived susceptibility to HPV infection and perceived severity of HPV infection. 
During threat appraisal, factors that increase or decrease the likelihood of a 
maladaptive response are appraised. Intrinsic (e.g. avoiding effort required to 
conduct HPV self-sampling) and extrinsic rewards (e.g. not having to wait for an 
appointment in G.P. surgery) are proposed as factors that facilitate maladaptive 
responses, whilst severity of threat and perceptions of vulnerability to threat 
decrease the probability of maladaptive behaviour. Factors that influence an 
individual’s ability to cope with a threat are described as being response efficacy 
(beliefs about how effective a coping response would be) and self-efficacy (beliefs 
about whether one is capable of performing the coping response). Factors that 
decrease the likelihood of a coping response are costs associated with coping (e.g. 
embarrassment of conducting HPV self-sampling). 
 
As shown in Figure 2.2 protection motivation for engaging in HPV self-sampling may 
arise as a product of high perceived severity of HPV, vulnerability to developing 
cervical abnormalities, response efficacy such as the belief that the HPV self-
sampling test would be able to identify a problem, high self-efficacy referring to the 
belief that the individual is able to conduct the HPV self-sampling procedure 
properly, low perceptions of intrinsic/extrinsic rewards and costs such as scheduling 
a time to conduct HPV self-sampling.  
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             Figure 2.2 A schematic representation of PMT, applied to HPV self-sampling (SS), adapted from Boer and Sydel 
(1996). 
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A number of studies have adopted the PMT to explore uptake of cervical 
screening and mammography, with mixed results. A study by Orbell and 
Sheeran (1998) of non-responders to cervical smear tests identified perceived 
vulnerability, self-efficacy and response efficacy costs of adaptive behaviour as 
determinants of intention to engage in future cervical screening. A meta-
analysis by Milne et al. (2000) of studies focusing on the effect of PMT on the 
prediction of health related behaviours identified that self-efficacy had the 
largest effect size in predicting intention. However, other studies have identified 
weak predictive ability for a large number of the PMT variables (Plotnikoff and 
Higginbotham 1998; Murgraff et al. 1999). 
 
The PMT theory has often been criticised for its assumption of rational 
appraisal, although the most recent adaptation of the theory states that action 
may not always be determined by protection motivation and can be irrational. 
Action is determined by protection motivation and may not be rational as 
appraisals can also be biased by heuristic judgements (Michie et al. 2014). 
Nevertheless, the assumption behind protection motivation is a rational 
weighing up of threat and the costs of adaptive behaviour. Furthermore, beliefs 
that health-impairing behaviour is rewarding but that giving it up is costly are 
not fully applicable in the current context. It is difficult to describe non-uptake 
of cervical screening through HPV self-sampling as a rewarding behaviour, in 
contrast to smoking which can be described as providing a physical reward of 
nicotine. It is therefore likely that the PMT theory may be better able to explain 
addictive behaviours such as cigarette smoking and over-eating. Furthermore, 
the subdivision of response efficacy and self-efficacy is questionable and it has 
been suggested that an individual would not consider themselves as capable of 
performing an action if they did not have the means by which to engage in the 
action (Bandura 1997). Therefore, a model that accounts for the benefits and 
barriers of engaging in HPV self-sampling, as well as the influence of self-
efficacy without differentiating response efficacy, is needed.  
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2.5 Social Cognitive Theory (SCT) 
 
SCT proposes a multi-faceted causal structure for explaining health behaviour 
(Bandura 1997). The theory proposes that self-efficacy beliefs operate alongside 
goals, outcome expectations, perceived environmental impediments and 
facilitators in the regulation of human health behaviour (Figure 2.3). The model 
proposes that knowledge about health risks and benefits help create a desire 
for health behaviour change, but that the construct of self-efficacy is crucial in 
facilitating the change in behaviour.  The SCT assumes that people with higher 
self-efficacy are better able to initiate new health behaviours and are able to 
place more effort into initiating and maintaining these behaviours. It has been 
suggested that efficacy may be influenced by previous behaviour, vicarious 
experience, physiological signs and receiving strong verbal persuasion (Bandura 
1997). SCT also proposes that health behaviour is affected by the outcome 
expectations of individuals. Physical outcomes can be pleasurable or aversive 
effects that accompany an action (e.g. material loss), as well as social outcomes 
such as social approval and self-evaluative reactions. 
 
Self-efficacy has been identified as the most influential construct on health 
behaviour within the SCT (Armitage and Conner 2000). Self-efficacy is highly 
relevant to HPV self-sampling due to the emphasis placed on the individual to 
conduct self-sampling independently. However, the SCT assumes that 
environmental changes will automatically result in changes in the individual, 
when this may not always be the case. Although environmental changes may 
help alleviate some of the barriers associated with engaging in HPV self-
sampling, it may not be enough to individually modify behaviour. Furthermore, 
the theory does not seem to specify the nature of the dynamic between the 
individual, behaviour and environment, and which elements may be more 
influential than others.  Although SCT highlights the relevance of self-efficacy to 
engaging in HPV self-sampling, the lack of guidance in assessing the importance 
and interaction between the environmental and individual factors in affecting 
behaviour makes it unsuitable for the study of attitudes towards HPV self-
sampling. A theory that incorporates the construct of self-efficacy and provides 
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specific guidance regarding the way in which theoretical constructs might 
influence intention to HPV self-sample is needed. 
 
 
 
Figure 2.3: A schematic representation of the Social Cognitive Theory, applied 
to HPV self-sampling (SS), adopted from Bandura (2004). 
 
2.6 The extended Health Belief Model (HBM) 
 
The extended HBM (Rosenstock et al. 1988) was developed to predict the 
likelihood of an individual adopting a health behaviour and has served as one of 
the most widely used frameworks for examining and explaining health 
behaviour (Burak and Myer 1997). The extended HBM posits is that health 
behaviour is determined by personal beliefs about a disease and the strategies 
that can be adopted to protect oneself from its occurrence. The extended HBM 
views health behaviour change as an appraisal of the balance between the 
benefits and barriers attributed to engaging in health behaviour, as well as the 
susceptibility and severity of a health threat. The original constructs of the 
model were: perceived benefits, perceived barriers, perceived susceptibility and 
perceived severity. Each construct can be used to explain health behaviour 
individually or collectively. Becker and Maiman (1975) refined the extended 
HBM by incorporating modifying factors such as knowledge about the disease, 
sex and age. The extended HBM was later extended to include the concept of 
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self-efficacy as well as cues to action (Rosenstock et al. 1988). Applied to HPV 
self-sampling, self-efficacy refers to a person’s beliefs about whether or not 
they are capable of properly conducting HPV self-sampling (Michie et al. 2014), 
whilst cues to action refer to any external stimuli that can motivate an 
individual to engage in HPV self-sampling. High perceived severity and 
susceptibility to HPV, low perceived barriers and high perceived benefits to HPV 
self-sampling increase the likelihood of engaging in HPV self-sampling. Most of 
the model’s components are regarded as independent predictors, please refer 
to Figure 2.4.  
 
Studies have generally found that the extended HBM is able to predict women’s 
intentions to have a cervical smear test and in many cases the use of the 
extended HBM framework has resulted in the extraction of important 
information regarding participant beliefs (Burak and Myer 1997). The extended 
HBM has been found to predict 32% of the variance in intentions to have a 
cervical smear test in a sample of women aged 18-70 years (Hill et al. 1985). 
Other studies have reported lower prediction rates of around 27% (Henning and 
Knowles 1990; Burak and Myer 1997). Perceived benefits of conducting cancer 
screening behaviours have been identified as highly influential in predicting 
bowel screening uptake (Frank et al. 2004) and BSE. Other studies have 
identified perceived susceptibility as one of the more powerful extended HBM 
constructs in promoting people to engage in healthy behaviours. High perceived 
susceptibility has been identified as motivating individuals to engage in 
preventative health behaviours such as vaccination programmes (Chen et al. 
2007), whilst low perceived susceptibility has been identified as a risk factor for 
not participating in FOBT testing (Moattar et al. 2014). As previously described 
(in SCT), the construct of self-efficacy has also been identified as an important 
predictor of engaging in health behaviour. An individual is unlikely to engage in 
a behaviour if they do not believe that they would be able to conduct that 
behaviour correctly, even if they believe they are at risk (high perceived 
susceptibility) and that engaging in a health behaviour is useful (high perceived 
benefit). For example, it has been found that women who believe that they are 
unable to conduct BSE are less likely to engage in the behaviour (Umeh and 
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Rogan-Gibson 2001). The studies described above suggest that self-efficacy, 
perceived susceptibility and benefits and barriers are influential in the adoption 
of health behaviours, and indicate that the extended HBM may be particularly 
suited to the investigation of HPV self-sampling intentions. 
 
 
 
Figure 2.4: The extended HBM (Rosenstock et al. 1988) applied to HPV self-
sampling.  
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2.7 The Theory of Reasoned Action (TRA) and Theory of Planned Behaviour 
(TPB) 
 
The TPB (Ajzen 1985) is one of the most widely applied behaviour theories. The 
TPB is an extended version of the TRA (Fishbein and Ajzen 1975) (Figure 2.5). 
The TPB evolved from the TRA which proposed intention to act as the best 
predictor of behaviour. The TPB is differentiated from the TRA by the addition 
of perceived behavioural control. The TPB assumes that the immediate 
cognitive precursors to behaviour are not an individual’s attitudes towards a 
particular behaviour but their behavioural intentions. Behavioural intentions are 
proposed to be a complex mix of prior beliefs that form attitudes towards a 
behaviour. According to the TPB intentions are determined by three constructs: 
attitudes towards a certain behaviour, perceived behavioural control and 
subjective norms. Attitudes refer to an individual’s positive or negative 
evaluation of behaviour such as engaging in cervical screening. Subjective 
norms involve perceptions of how other people think the individual should 
behave, for example whether they perceive that significant others would 
endorse participation in HPV self-sampling. Perceived behavioural control refers 
to the perceptions of personal control over carrying out the particular 
behaviour, for example having the physical and mental capacity to collect a 
sample using a HPV self-sampling kit. The TPB has been used to explain both 
health-related and non-health related behaviours (Godin and Kok 1996). 
 
The TPB is a value-expectancy theory and lacks the perceived benefits and 
barriers and susceptibility and severity constructs seen in the extended HBM, 
although it may be argued that the attitudinal component of the TPB partly 
reflects these constructs (Taylor et al. 2007). The TPB was developed to 
promote understanding of volitional behaviours, rather than behaviours 
determined by situational factors outside the individual’s control, although the 
addition of the perceived behavioural control construct to the TPB has gone 
some way in counteracting this. For example, perceived behavioural control 
might be influenced by social positioning as well as external factors such as 
economic and environmental barriers to service access.  PBC refers to both 
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internal and external constraints on control (Ajzen 1991). However, it is possible 
that external and internal constraints are not the same (Terry and O'Leary 1995) 
and therefore it is difficult to group them into one variable of PBC.  Internal 
constraints may be classified as being close to the concept of self-efficacy 
(Bandura 1977), whereas external constraints are beyond the individual’s 
control (Bish et al. 2000). A benefit to the TBP is that it provides explicit rules 
regarding how to combine constructs, which is not observed in other theories 
such as the extended HBM. Consequently, a model that can differentiate 
between external constraints and internal constraints on intention to engage in 
HPV self-sampling is needed. 
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Beliefs about the outcome of 
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If I HPV self-sample, I will identify high 
risk HPV and reduce my chance of 
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Figure 2.5: A schematic representation of the TRA and TPB applied to HPV self-sampling, adapted from Taylor et al. 
(2007). 
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2.8 Chosen theoretical approach to understanding HPV self-sampling 
 
The theories and models of health-related behaviour described in this chapter 
postulate that health beliefs play a major role in explaining and determining intention 
to HPV self-sample. To aid the understanding of women’s attitudes towards HPV self-
sampling, a theoretical approach that incorporates the concept of self-efficacy without 
differentiating response efficacy, includes individual perceptions of benefits and 
barriers to HPV self-sampling, and that differentiates between internal and external 
constraints is needed. The model that is able to incorporate these factors is the 
extended Health Belief Model (HBM) (Rosenstock et al. 1988). The extended HBM was 
also chosen over other theoretical frameworks because of its proven relevance to 
preventative health behaviour, such as participation in screening programmes (Brewer 
and Fazekas 2007). With the foundations of the extended HBM in value-expectancy 
theories, it is primarily a cognitive approach which posits that individuals will engage in 
preventive health behaviour if they believe themselves to be threatened by an illness 
and if they believe that the benefits of taking action will outweigh the barriers or costs 
of that action (Rosenstock 1974). More recently, the extended HBM has also been used 
to understand health service utilisation and engaging in health behaviour such as 
cervical and FOBT screening. The extended HBM has been criticised for a lack of clear 
definition of individual constructs and a lack of clear combinational guidance of 
extended HBM constructs (Armitage and Conner 2000). Therefore, the extended HBM 
can be regarded as a descriptive model that is suitable for exploring new health 
behaviours such as HPV self-sampling. The constructs underlying the extended HBM 
and their relevance to HPV self-sampling will be discussed in further detail below.  
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2.8.1 Perceived susceptibility and perceived severity  
 
Although perceived severity might often be attributed to medical knowledge, it may 
also be formed from beliefs that an individual has about the difficulties a disease may 
cause to their life, as well as past experiences formed from significant others or media 
portrayal. For example, women with a family member or relative who has been treated 
for low grade cervical abnormalities, and who has recovered quickly and well following 
treatment, may perceive cervical abnormalities as a health threat that is easily treated 
with minimum disruption to their life. Conversely, an individual with a family member 
who has been diagnosed with high grade cervical abnormalities and has had extensive 
treatment and has taken a long time to recover and return to normal daily function 
might have a different perception of the severity of the illness. The belief that 
screening could reduce ‘susceptibility’ and ‘severity’ of bowel cancer has been found to 
be influential in uptake of FOBT self-sampling (Brouse et al, 2003).  However, it has also 
been suggested that perceived severity might not be as important as perceived 
susceptibility in influencing the adoption of health protective behaviour (Bandura 
1997).  
 
Perceived susceptibility has been described as a powerful influence in promoting the 
adoption of healthy behaviour. Higher perceived susceptibility has been significantly 
associated with increased uptake of screening behaviours such as cervical smear tests 
(Nadarzynski et al. 2012) and preventative health behaviours such as hepatitis B 
vaccination (deWit et al. 2005), and the use of condoms to decrease HIV infection 
(Belcher et al. 2005). Perceived susceptibility has also been shown to motivate 
individuals to engage in health behaviours such as influenza vaccination (Chen et al. 
2007), sunscreen use for the prevention of cancer, and teeth flossing for prevention of 
gum disease (Hayden 2014). Conversely, it has been reported that older women who 
might perceive themselves as less susceptible to cervical cancer are less likely to 
engage in cervical smear testing (Cervical Screening Wales 2013-2014). Although the 
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perception of increased susceptibility has often been associated with healthier 
behaviour and decreased susceptibility with unhealthy behaviour, this is not always the 
case, especially in young individuals. It has been found that the perception of 
susceptibility has rarely been associated with health behaviour such as sun exposure in 
university students even when perception of susceptibility is high (Lamanna 2004). 
Similar findings have been reported in research in unsafe sex behaviour (Belcher et al. 
2005). For example, it has been found that students who report a high perceived 
susceptibility to HIV infection are not more likely to practice safe sex behaviour, than 
those who report a lower perceived susceptibility (Lewis and Malow 1997). These 
findings should be considered as HPV self-sampling would involve women from a wide 
age range.  
 
2.8.2 Perceived Barriers and Benefits 
 
According to the extended HBM, likelihood of action can be influenced by an 
individual’s perceptions of benefits and barriers associated with HPV self-sampling. In 
fact, one of the most recent and comprehensive meta-analyses (Carpenter 2010) of the 
extended HBM’s effectiveness in predicting behaviour concluded that perceived 
barriers and perceived benefits were consistently the strongest predictors of screening 
behaviour. Perceived benefits are particularly important in the adoption of secondary 
prevention behaviours such as engaging in cervical screening (Glanz et al. 2008). 
Perceived barriers refer to an individual’s own interpretation of the challenges 
associated in adopting a healthy behaviour. In order for a healthy behaviour to be 
adopted, the individual has to believe that the benefits of the new behaviour outweigh 
the benefits of continuing old behaviour and the barriers associated with the new 
behaviour. When applied to FOBT, Moattar et al. (2014) found that cost and motivation 
in terms of perceived barriers to screening, such as lack of time and symptoms of 
colorectal cancer in FOBT screening, and perceived benefits to screening are key 
predictors of participation in FOBT. Furthermore, Davis et al (2014) identified that 
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complex health literacy interventions designed to overcome key FOBT related barriers, 
such as access to tests, lack of recommendation, negative beliefs, poor self-efficacy and 
complexity of independently completing the test, are useful in increasing FOBT uptake. 
 
2.8.3 Cues to action 
 
Cues to action are any environmental or personal cues that may facilitate an individual 
to engage in health protective behaviour such as HPV self-sampling. Cues to action may 
be system-related such as reminder letters, social such as normative pressures from 
significant others to engage in screening or they could be specific interventions 
designed to promote uptake of screening. Cues to action that have utilised the 
extended HBM in the form of interventions for increasing uptake of FOBT self-sampling 
will be discussed later in this chapter. The extended HBM model has been used to 
guide development of health interventions, which can act as cues to action 
(Rosenstock et al. 1988). For example, interventions based on the extended HBM have 
been used as cues to action in enhancing uptake of colorectal cancer screening (Davis 
et al. 2014; Moattar et al. 2014).  
 
2.8.4 Self-efficacy   
 
Expectations of self-efficacy are self-regulatory cognitions that determine whether 
instrumental actions will be initiated, how much effort will be expended and how long 
it will be sustained in the face of obstacles (Bandura 1977, 1997). Self-efficacy beliefs 
are considered to be one of the most powerful predictors of health behaviour 
(Rosenstock et al. 1988; Schwarzer and Fuchs 1996) and have been shown to predict 
uptake of FOBT self-sampling (Brouse et al. 2003), cervical smear screening (Fernandez 
et al. 2009) and breast self-examination (Chalmers and Luker 1996; Norman and Brain 
2005). It has been argued that a conceptual distinction can be made between feelings 
of confidence in one’s ability to perform a behaviour (self-efficacy) and the perception 
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of barriers towards that behaviour (Rosentstock et al. 1988). Perceived self-efficacy is 
highly relevant to HPV self-sampling because of the emphasis placed on women’s 
ability to carry out the succession of actions involved in self-sampling.  
 
Individuals with high self-efficacy beliefs about a task call on these beliefs and abilities 
to engage in the behaviour (Bandura and Adams 1977; Manne et al. 2006). For 
example, individuals who believe that they will be able to perform a task and that the 
behaviour will lead to a favourable outcome, are considered likely to be more strongly 
motivated, set themselves higher goals and to have the strength to carry out the act 
than those with low self-efficacy beliefs (Bandura 1997). Self-efficacy has been shown 
to be highly influential in influencing engagement in preventative health behaviours, 
such as cervical smear testing (Fernandez et al. 2009), breast self-examination (BSE) 
(Chalmers and Luker 1996) and FOBT (Brouse et al. 2003).  
 
2.8.5 Trait and state self-efficacy 
 
It has been suggested that self-efficacy can exist as both as a transient state and a 
generalised trait. Self-efficacy as a state can be defined as the individual’s belief that 
they can achieve required performance for a specific task e.g. HPV self-sampling. When 
considered as a trait, self-efficacy can be defined as one’s belief in their overall 
competence to achieve required performance across different situations.  Generalised 
trait self-efficacy can affect the susceptibility of external influences on specific state 
self-efficacy, for example an individual with high trait self-efficacy may be less worried 
about conducting HPV self-sampling incorrectly than someone who holds low trait self-
efficacy. However, trait self-efficacy alone has been found to poor at predict behaviour 
(Bandura 1997). Therefore, a relationship between generalised traits and task specific 
self-efficacy has been suggested (Chen et al. 2000).  
It seems likely that self-efficacy encompasses a general state-like self-efficacy belief 
accompanied with a task-specific self-efficacy belief. Bandura (1997) claimed that trait 
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self-efficacy measures “bear little or no relation either to efficacy beliefs related to 
particular activity domains or behaviour” (p.42). Bandura’s original self-efficacy 
concept referred to one’s belief that one can perform a behaviour-specific task. 
Therefore, for the purposes of this PhD research, self-efficacy will be regarded as a 
specific state and not a generalised trait. 
 
 Investigating the way in which state self-efficacy influences an individual’s intentions 
to HPV self-sample will help further our understanding of the contributory factors 
associated with HPV self-sampling, and inform the development of key messages to be 
used in a future HPV self-sampling intervention.  As a psychological state, it is likely 
that there are many components to perceived self-efficacy when relating to HPV self-
sampling. These may include previous experience with other self-sampling 
technologies, previous experience with cervical screening, a general sense of ability to 
carry out the procedure, and motivation for accomplishment of the self-sampling task. 
Due to the behaviour specific nature of perceived self-efficacy, specific questions need 
to be developed to investigate it (Bandura 1977). Furthermore, specific techniques 
such as vicarious experience and social persuasion (Bandura 1998) can be devised and 
incorporated into a HPV self-sampling intervention to facilitate and improve perceived 
self-efficacy if it is identified as a barrier.   
 
2.9 Summary 
 
This chapter has presented a rationale for the use of theory in this PhD research study. 
Different health behaviour models and theories have been outlined and critiqued. The 
utility of the extended HBM in exploring women’s attitudes towards HPV self-sampling 
has been highlighted and a justification for the use of the extended HBM has been 
presented. The extended HBM has been found particularly useful when studying 
screening behaviour such as cervical screening (Barata et al. 2008) and FOBT self-
sampling (Moattar et al. 2014). The extended HBM has also been able to account for a 
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relatively high amount of variance in attitudes towards cervical screening (Burak and 
Myer 1997), although it has been criticised for a lack of combinational rules (Armitage 
and Conner 2000).  The extended HBM has traditionally been used as an exploratory 
model to assess why people do not use preventive health services (e.g. cervical 
screening) and eventually to understand why people use or fail to use other health 
services in general (Becker 1974). The extended HBM has provided the theoretical 
framework for many studies examining a variety of health behaviours such as breast 
self-examination (Sensiba and Stewart 1995; Norman and Brain 2010), condom use 
(Hiltabiddle 1996), diabetes self-care (Pham et al. 1996) and needle practices for HIV 
(Falck et al. 1995), and most importantly cervical smear testing and FOBT self-sampling 
(Moattar et al. 2014). 
 
The extended HBM will be used throughout the study to help inform and structure 
both quantitative and qualitative methods, which will be used to quantify and explore 
women’s attitudes towards primary HPV self-sampling. The extended HBM and the 
results from the mixed methods used throughout the phases of this PhD research will 
be used to inform the content of a HPV self-sampling intervention.  
 
2.10 PhD study phases and the use of the extended HBM 
 
Phase one of the research utilised survey data. The extended HBM will be used to 
structure the survey to explore potential barriers and facilitators to HPV self-sampling. 
The survey will facilitate the collection of large amounts of data in a short period of 
time, as well as the identification and quantification of key determinants of HPV self-
sampling intention. Furthermore, results obtained from the survey will facilitate testing 
of the utility of the extended HBM. Traditionally, survey methods limit respondents to 
pre-set responses and although useful for the quantification of key determinants of 
HPV self-sampling intention, they cannot explore the way identified determinants 
affect intention.  
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The second phase of the research will facilitate the further exploration of the extended 
HBM constructs and the opportunity for the identification of new influences through 
the use of semi-structured interviews. Interviews will be conducted according to an 
interview schedule that will explore the HBM determinants identified in the survey 
phase, and provide the opportunity for the extrapolation of new unidentified 
determinants. Interviews are particularly useful for the study of complex and sensitive 
data, and enable the study of a small number of participants in depth. The use of 
mixed-methods in phase 1 and 2 will combine the strengths of quantitative and 
qualitative methods to help understand women’s intentions to HPV self-sample.  
 
Phase three will involve the synthesis of findings generated from phase one and phase 
two to inform the content of an intervention designed to increase intention to HPV 
self-sample by addressing identified determinants of self-sampling. Phase three will 
also involve the pilot testing of the intervention. The intervention will be based on the 
extended HBM and will consist of the ‘active ingredients’ identified through the mixed 
methods approach (Craig et al. 2008). The theoretical basis will also be useful in 
informing and measuring the effects of the intervention during user testing (Craig et al. 
2008). The user testing will utilise a mixed methodology: short pre and post 
intervention surveys and interviews. The surveys will be used to identify a potential 
change in knowledge and intention to self-sample following intervention exposure. 
Qualitative interviews will be used to explore perceptions of the intervention, to 
understand what part/s of the intervention had the most effect on intention to self-
sample, and to identify areas for improvement. 
 
The following chapter will describe the development and preliminary validity testing of 
the theoretically based phase one quantitative survey. 
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CHAPTER 3 
 
Development and preliminary validation of a survey to investigate women’s 
intentions to HPV self-sample.  
 
3.1 Chapter overview 
The current chapter describes the development of survey measures used to investigate 
women’s attitudes and intentions to HPV self-sample. Methods used to develop survey 
measures that included a literature search, development of initial survey items, 
content validity analysis, and cognitive interviewing will be discussed.   
 
3.2 Introduction 
 
The lack of evidence regarding women’s intentions to engage in primary HPV self-
sampling, and the limited information about the HPV self-sampling perceptions of 
women from the general population, was presented in Chapter 1. It was important that 
intentions to HPV self-sample in women from a general population were investigated 
because of the possibility of primary HPV self-sampling in the future. To aid 
understanding of HPV self-sampling intentions, the constructs of the extended Health 
Belief Model (HBM) were operationalised in the development of a survey.  
 
The constructs of interest in the survey were the core HBM constructs: perceived 
severity, perceived susceptibility, perceived benefits and barriers to HPV self-sampling 
and cervical screening, and the concept of self-efficacy. Measurement of the extended 
HBM constructs and intention to HPV self-sample is complex because constructs are 
ambiguous in nature and open to differential interpretation. Nevertheless, surveys 
form an important method of data collection for the social sciences and have been 
extensively used (Grant and Davis 1997). Preliminary validity and reliability of the 
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survey were explored. Validity refers to whether the survey items actually measure the 
constructs that they are intended to measure (Kline 2005). Reliability refers to the 
extent to which scores are free from random error, therefore the extent to which 
scores are precise, consistent and repeatable (Kline 2005). The adequacy of construct 
definition and measurement in the survey is critical because there is no overall 
agreement on what is meant by HBM constructs (Kline 2005). Poor construct definition 
and measurement may elicit responses that are not representative of the construct. 
Furthermore, if the construct definitions and measures used in the survey are not 
clearly defined, the survey results will be less likely to detect the hypothesised 
relationships between extended HBM constructs and intention to HPV self-sample. 
Data from an invalid instrument can over-represent, underrepresent or even omit 
notions of the construct in question (Haynes et al. 1995). Exploration of the survey 
validity is presented in this chapter, whilst validity assessment is presented in Chapter 
4. The development of the survey measures as well as the methods used to investigate 
construct validity and face validity will be presented below.   
 
3.3 Content validity 
 
It was imperative that the extended HBM constructs were represented as clearly and 
fully as possible, because survey responses were to be subsequently used in structuring 
the phase two interview schedule and shaping the HPV self-sampling intervention. 
Content validity is a form of construct validity that refers to the degree to which survey 
items represent the intended constructs, in this context the extended HBM and 
intention constructs, as well as HPV knowledge (Pallant 2007). This was examined using 
content validity analysis. Content validity analysis is a consensus estimate (Stemler 
2004) that examines the extent to which experts share a common interpretation of a 
construct, and are able to agree on how to apply the rating scale to the items (Polit et 
al. 2007).  In the current context, the aim of content validity analysis was to establish 
the extent to which the components of the survey were relevant to and representative 
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of core HBM constructs: perceived benefits, perceived barriers, perceived 
susceptibility, perceived severity and perceived self-efficacy.  Knowledge and intention 
constructs were also validated through content validity analysis. Specific objectives 
were to assess the relevance of survey items to the construct specified and function of 
the survey, and to examine the representativeness of survey items in reflecting and 
measuring all facets of a construct.   
 
3.4 Face validity 
 
Following content validation, the face validity of survey items was assessed using 
cognitive interviewing techniques to investigate whether participants interpreted the 
items as intended, and whether the items were easily understood and accessible (Davis 
and DeMaio 1993).  The use of cognitive interviewing as a means of investigating face 
validity in surveys has become increasingly popular (Willis 1999). The cognitive 
interview can be used to evaluate sources of response error in a participant’s 
understanding of items and/or response categories, to facilitate understanding of how 
participants interpret survey items and what mental processes they engage in to 
answer each item. It was anticipated that the use of cognitive interviewing in survey 
modification would improve uptake and completion of the subsequent HPV self-
sampling survey. 
 
Although there are various cognitive theory models (Jobe and Herrmann 1996), 
Tourangeau (1984) model is most commonly used in cognitive interviewing and was 
used in the current study. The model consists of four processes: 
1. Question comprehension: what the participants believe the question is asking 
and what certain phrases may mean to different participants. 
2. Information retrieval:  the types of information that participants need to recall 
and the strategies that they use to elicit that information. 
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3. Decisional processes: the amount of effort devoted by the participants so that 
they can answer particular questions and whether social desirability may have 
an effect on their answers. 
4. Response processes: whether the participants are able to match their internally 
generated answer to the response categories provided by the survey. 
Think aloud and verbal probing methods are traditionally used in cognitive 
interviewing. The think aloud method explicitly instructs participants to articulate their 
thoughts and feelings as they answer each question and map their answer onto the 
response categories provided (Fonteyn et al. 1993; Charters 2003). Verbal probing 
involves asking specific ‘probes’ for each item to assess each of the four processes as 
described above by Tourangeau (1984). 
 
3.5 Aims and objectives  
 
The aims of the current phase of research were to develop a psychometrically sound 
tool to examine the effects of extended HBM constructs on women’s intentions to HPV 
self-sample, and to inform the content of the subsequent interview topics. Specific 
objectives were: 1) to examine previous literature in order to identify whether a survey 
based on the extended HBM has been developed to investigate HPV self-sampling 
intention, 2) to develop theoretically based survey items to identify determinants of 
women’s intentions to HPV self-sample, and 3) to perform preliminary validation of the 
developed survey items.  
 
The methods and results of the literature search, development of initial survey items, 
content validity analysis, and cognitive interviewing are presented below.   
3.6 Literature search: Identifying previous HBM based HPV self-sampling surveys  
 
Two literature searches were conducted to identify whether any previous studies had 
utilised the extended HBM in understanding women’s intentions to HPV self-sample, 
 55 
 
and whether a survey had been used to do this. An initial literature search was 
conducted in October 2010 prior to survey development, and a supplementary replica 
search in 2012 to identify any new studies. 
 
 
3.7 Methods 
 
Search Strategy and Inclusion Criteria 
 
Six electronic databases were searched: PsychInfo, PubMed, Web of Knowledge, 
CINAHL, EMBASE and SCOPUS. No date restrictions were imposed, however it was 
specified that the articles must be presented in English. Search strategies combined the 
following free text search terms and were specifically limited to article title and 
abstract: Health Belief Model, HBM, Human Papillomavirus, HPV, self-sampling, home 
testing. Follow-up searching by hand was conducted by scanning the reference lists of 
identified papers. Key inclusion criteria were: (i) participants were female, (ii) the study 
focus was on HPV self-sampling, (iii) the study utilised the extended HBM in its material 
development, (iv) the study investigated attitudes or behaviour. Studies which involved 
male participants, that were laboratory based or that focused on HPV vaccination were 
excluded. 
 
Study Identification 
 
Identified study titles and abstracts were screened for relevance. Study bibliographies 
were also searched. Full texts of potentially relevant studies were evaluated. Data were 
extracted regarding study design and context, participant characteristics, theoretical 
framework used, and study findings.  
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3.8 Results 
 
Electronic searches in 2010 yielded eighteen studies. Following removal of duplicate 
studies, four studies were identified (Burak and Myer 1997; Barata et al. 2008; Marlow 
et al. 2009; Reiter et al. 2009). These four studies underwent data extraction to aid 
identification of relevant studies (please refer to Appendix 3.2).  One study (Barata et 
al. 2008) out of the four met inclusion criteria.  The studies that did not meet inclusion 
criteria focused on HPV vaccination (Marlow et al. 2009) and cytology (Burak and Myer 
1997; Reiter et al. 2009). The supplementary search in 2012 yielded 108 studies. 
Following removal of duplicate references (n=78), 30 studies were identified and 
underwent data extraction. One out of the thirty studies met the inclusion criteria, and 
was the study originally identified in 2010 (Barata et al. 2008). 
 
The qualitative study by Barata et al (2008) used HBM constructs to develop an 
interview topic guide for discussions with women about HPV self-sampling. The study 
identified barriers such as low HPV knowledge, the belief that HPV self-sampling is 
unsafe, and the perception that HPV self-sampling is not as accurate as cervical smear 
testing. Benefits identified included convenience and a reduction of cultural taboos 
associated with cervical smear testing. It was found that themes identified were able to 
map onto the HBM. However, the population sampled were women from Canada, 
where the health system and cervical screening recommendations are different to 
those in Wales: at the time the literature search was conducted, onset of screening age 
was 20 years in Wales as opposed to 25 years in Canada. These differences may have 
affected the way the way in which the HBM based topic guide was developed and 
executed in the focus groups, and may have influenced the perceptions of women 
regarding HPV self-sampling and cervical screening in general.  
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The literature search results and identification of only one qualitative study confirmed 
the need to develop a new scale based on the extended HBM constructs in order to 
investigate women’s intentions to HPV self-sample.  
3.9 Development of initial survey items 
 
Hypothetical HPV self-sampling intention, the constructs of the extended HBM, HPV 
knowledge and cervical screening history were operationalised for the development of 
a priori survey items. Items reflecting benefits and barriers were constructed by 
identifying benefits and barriers to HPV self-sampling and cervical screening reported 
in previous studies (Chapter 1). Conceptual definitions of the extended HBM constructs 
were developed. Items were developed to assess each construct and response 
categories were created. The number of items needed to investigate each construct 
was determined by whether the construct was defined as being unitary or multiple. A 
multiple construct required a number of different items to assess each multiple aspect. 
It was crucial that the constructs were clearly operationalised, because imperfections 
within a construct definition can result in deficiency or contamination of survey items 
and/or response formats during development. 
Women’s intentions to HPV self-sample are influenced by their attitudes towards HPV 
self-sampling. Attitudes are by nature continuous tendencies defined as  “a 
psychological tendency that is expressed by evaluating a particular entity with some 
degree of favour or disfavour" (Eagly and Chaiken 1993). Therefore, a continuous 
response measurement scale was needed to measure women’s attitudes to HPV self-
sampling. The process of filling out a survey has been shown to be ‘reactive’ (French 
and Sutton 2010b). Reactive refers to the notion that survey items often pose 
opportunity for personal reflection of past experiences and actions, which in turn can 
affect thoughts about self-sampling and predicted behaviour. Therefore, it was 
important that issues such as measurement reactivity (French and Sutton 2010b) and 
question framing were considered during the development of the initial HBM-HPV 
survey because they can affect responses. For example, positively framed questions 
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are more likely to elicit positive attitudes, whilst negatively framed questions are more 
likely to elicit negative attitudes (French and Sutton 2010a). Items were framed 
neutrally to try and avoid effects of item framing on reported intentions to self-sample.  
Likert scales ranging from 1 (not at all likely) to 5 (very likely) were used in line with 
Likert scale development guidelines (Kline, 2005). This was done to encourage the 
participants to ‘lean’ towards either a positive or negative attitude, without pre-
defining an ‘undecided’ response. Survey items examining past screening history and 
sociodemographic details were explored through categorical items and response 
formats (Streiner and Norman 2008). 
A free text box was included in the HPV self-sampling section to encourage comments 
from participants, with the aim of discovering any new considerations/issues regarding 
HPV self-sampling.  The items pertaining to cervical screening history and attitudes 
towards cervical screening were included to enable categorisation of participants 
according to their previous screening history and attitudes towards cervical screening. 
This facilitated the comparison of women’s attitudes and intention towards HPV self-
sampling and their attitudes towards and past utilisation of cervical screening. 
 
Table 3.1 displays construct definitions which were used to develop a priori survey 
items designed to measure HPV self-sampling intention and extended HBM constructs 
applied to HPV and cervical cancer. The initial survey is shown in Appendix 3.3. The first 
page provided information about HPV self-sampling and instructed women on how 
self-sampling would need to be conducted. Subsequent pages contained items divided 
into four sections: intentions and attitudes towards HPV self-sampling, HPV knowledge, 
thoughts about cervical cancer, experiences of cervical screening and cervical cancer, 
demographic details. Intention to HPV self-sample was the first item on the survey in 
order to minimise measurement reactivity and order effects. Measurement reactivity 
and order effects have been shown to influence emotional responses to questions 
concerning the prospect of future disease (e.g. HPV infection or cervical cancer) 
(Schwarz 1999), which might alter intention to HPV self-sample. 
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Table 3.1: HBM construct definitions and a priori items
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3.10 Content validity analysis 
 
The content validity of individual survey items was examined in order to establish the 
extent to which each item measured the intended construct (Hyrkas et al. 2003). 
Experts were asked to review item content, with the purpose of eliminating irrelevant 
items (Chaiyawat and Brown 2000), re-phrasing or supplying new wording for the items 
representing relevant constructs (Hughes 1998; Aminzadeh et al. 1999). 
 
3.10.1 Methods 
 
Content validity analysis materials 
 
A content validity analysis (CVA) protocol was developed and was sent to expert 
participants (see Appendix 3.4). The protocol was divided into various sections: an 
explanation of the purpose of the survey, a definition of CVA and the steps that the 
method entailed, a description of participant eligibility and definition of the survey 
constructs that needed to be evaluated. Instructions on how to carry out CVA and a 
CVA score card were also included (Appendix 3.4). 
 
Recruitment of content experts 
Experts were purposively recruited based on their expertise in health behaviour 
measurement. Some participants were directly e-mailed asking if they would serve as a 
content expert, whilst others were recruited through a general mailshot to all 
researchers in the Institute of Primary Care and Public at Cardiff University. Further 
input from an individual with clinical expertise in HPV and cervical screening was 
sought. 
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3.10.2 Rating 
 
A priori items were rated by the content experts in relation to their relevance to and 
representativeness of operationalised constructs. Each rater independently scored 
each of the items in the HPV self-sampling survey (items QV1 to QV27, with the 
exception of Q9 which was a free text question). Items 28-31 were excluded from the 
content validity analysis because they were items about demographic details. Scoring 
took place according to the following criteria: 
Relevance: the appropriateness of the items in relation to both the construct 
and the function of the survey 
Representativeness: whether the items covered a representative sample of the 
construct. 
Raters were instructed to score each item on a scale of 1 to 4 for relevance and 
representativeness, respectively (where 1 = poor relevance/representativeness and 4 = 
very good relevance/representativeness). Raters were also asked to provide free text 
comments, particularly if they gave a score of less than 3 to any item. 
 
3.10.3 Analysis 
 
The content validity index for each item was calculated as the percentage of raters who 
gave a high score in terms of relevance and representativeness. For each item, the 
number of raters giving a rating of 3 or 4 for relevance or representativeness was 
calculated. This was then divided by the total number of raters to give a content 
validity index for relevance and representativeness, respectively. As there is no 
universally agreed threshold for defining adequate content validity, content validity 
was considered to be adequate if the index was greater than 78% (Schwarzer and 
Fuchs 1996). This is a level at which chance agreement is unlikely to explain a high 
score (Schwarzer and Fuchs 1996). 
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If the content validity was less than 78% for any of the items on any dimension, the 
following were considered: 1) whether the item was not sufficiently comprehensive to 
collect data on the construct, 2) whether the item measured constructs other than the 
one of interest, 3) whether the item should be removed, 4) whether further items were 
needed, 5) free text data provided by the experts. Free text data were used to help re-
phrase items that scored under 78%. Additionally, items that scored over 78% but 
received substantial critique in the free text comments section were also re-evaluated.  
  
3.10.4 Results 
 
A total of nine experts were recruited: eight with expertise in health psychology and 
healthcare research, and one with clinical expertise on HPV and cervical screening.  
 
Nine out of thirty four items had scores of 78% or less on either the representativeness 
or relevance dimensions (see Appendix 3.5 for individual item scores and Appendix 3.6 
for all rater comments). As summarised in Table 3.2, three items were removed and 
eight items were added. The usefulness of the item ‘Do you think that HPV can clear up 
by itself’ was questioned by reviewers. However, it was decided that this item would 
be retained and examined in the cognitive interview phase of validation. Table 3.2 
presents the main item modifications. 
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N.B. The construct each item was intended to measure is shown in brackets and italics 
Table 3.2: Modifications made to the survey following CVA
Items removed  Items added Item retained for further cognitive testing 
1. How sure are you that you will be 
able to understand the 
instructions provided in the 
home test kit? (Self-efficacy) 
2. How sure are you that your 
completed test kit will be good 
enough for testing? (Self-efficacy) 
3. Using a home kit seems less 
painful than a smear test. 
(Perceived benefits to SS) 
 
1. I would be worried about the self-
sampling kit getting lost in the post 
and not reaching the laboratory. 
(Perceived barrier to SS) 
2. Having a smear test is painful. 
(Perceived barrier to smear test) 
3. Going for smear tests can be difficult 
because I have to make 
arrangements (e.g. time off work, 
childcare). (Perceived barrier to 
smear test) 
4. Going for smear tests provides me 
with reassurance. (Perceived benefit 
to smear test) 
5. I trust the GP/nurse to take an 
adequate sample. (Trust) 
6. I worry about my sample getting lost. 
(Perceived barrier to smear test) 
7. I don’t trust the results of the smear 
test. (Perceived barrier) 
8. I worry that others (e.g. family 
members, friends, people at the GP 
surgery) will know that I am being 
screened for cervical cancer. 
(Perceived barrier to smear test) 
1. Do you think that HPV can clear up by 
itself? (Perceived severity of HPV 
infection)  
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3.11 Cognitive interviewing 
 
Establishing the face validity of the survey was an essential step following content 
validity analysis. It was imperative that face validity was investigated to help ensure 
that items were easily and correctly understood by participants and that the format 
was accessible. The number of cognitive processes investigated in each item depended 
on the complexity of that item (Tourangeau, 1984). Trivial questions such as ‘Have you 
ever had a smear test’ necessitated the investigation of fewer processes, whilst non-
trivial questions such as ‘I expect that I would use a self-sampling kit for HPV?’ required 
investigation of multiple processes. 
 
3.11.1 Methods 
 
Prior to recruitment for cognitive interviewing during 2012, approvals were obtained 
from the South East Wales Research Ethics Committee and Public Health Wales Risk 
Review Committee for Research and Development. 
 
Participant recruitment 
 
Women resident in Cardiff or Newport were targeted for recruitment because it was 
considered important that the women participating in the cognitive interviews were 
from the same geographical area as the women who were to receive the survey.  
 
Three recruitment strategies were utilised: 
1. An e-mail campaign was targeted at female administrative staff at the School of 
Medicine in Cardiff University in order to reduce the likelihood of prior exposure to 
cognitive interviewing or survey development. Potential participants were sent a 
recruitment e-mail asking if they would be interested in taking part in an interview 
study looking at the usability of a recently developed survey. Women who were 
interested in taking part in the cognitive interviews contacted the researcher directly 
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via e-mail. Women who expressed interest were e-mailed a participant information 
sheet and consent form. If participants were happy to take part in the study, a suitable 
time and location was arranged. All interviews were conducted at Cardiff University.   
2. Female administrative staff at Cardiff City Football Club. Women were alerted to the 
study by their line manager a day before the researcher visited the Club. Potential 
participants were provided with an information sheet and consent form. The 
researcher visited the club and explained the study in further detail to potential 
participants. Participants who were happy to participate were interviewed individually 
at the football club. 
3. Snowball sampling of participants identified through participants from Cardiff City 
Football Club as well as researcher contacts. 
 
 
Consent process 
 
Potential participants who expressed an interest in the cognitive interviewing study 
were given a participant information sheet and consent form (see Appendix 3.8). 
Women read the information sheet in their own time and had opportunity to ask 
questions. Women were reassured that participation was voluntary, that they could 
withdraw from the interview at any point without providing a reason, and that their 
participation would have no effect on their future healthcare.   
 
Cognitive interview process 
 
A structured pre-interview phase was conducted to ensure that participants were 
aware that ‘think aloud’ and verbal probing cognitive interviewing techniques were 
going to be applied throughout the interview, and to minimise bias in the way that 
participants examined and reported on items. The interviewer explained how the 
interview was going to be conducted and outlined the reasons why participants were 
being asked to ‘think aloud’, using a standard operating procedures document (SOP) 
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for each interview. The SOP outlined a series of steps that were to be conducted 
(Appendix 3.8). The think aloud and verbal probing techniques were discussed during 
the SOP with participants. Participants were encouraged to report out loud their 
thoughts when answering survey items. The interviewer then provided an example of 
how someone may ‘think aloud’. Participants were made to feel as comfortable as 
possible during the cognitive interview, in order to encourage open and honest 
discussion of the survey items. 
 
The main phase of cognitive interviewing was structured according to a pre-defined 
interview schedule (Appendix 3.10). Interviews lasted between 20 minutes and 1 hour. 
A concurrent probing technique was applied and the interview schedule was 
developed following guidance on cognitive interviewing (Willis 1999). The interview 
schedule explored the participants’ cognitive processes relating to item comprehension 
and how participants reached their answers. Participants were provided with the 
survey and were instructed to read each item individually and answer it by mapping 
their answer onto the response categories provided. Participants were encouraged to 
think aloud at the time of reading and answering the item. Once the item was 
answered, participants’ responses were explored using the probes. Specific probe 
questions (Appendix 3.10) were used throughout the interview schedule to assess how 
participants interpreted the questions and what mental processes were engaged to 
answer them (Davis and DeMaio 1993).    
 
Informal discussions with Cervical Screening Wales were conducted during the 
cognitive interview phase and suggested revisions to survey items were also 
incorporated.  
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3.11.2 Analysis 
 
A thematic analysis approach was applied (Braun and Clarke 2006)  which focused on 
characterising the reasons why participants had identified items or response categories 
as problematic to answer. The term ‘problematic’ refers to a difficulty in understanding 
an item, difficulty in answering an item in general, or difficulty in mapping response to 
the response scale/categories provided. Following coding of all transcripts, codes were 
grouped together into overarching themes. 
 
3.11.3 Results 
 
Sample characteristics 
 
Of a total ten participants recruited for cognitive interviewing, two were from the 
School of Medicine in Cardiff University, five from Cardiff City Football Club, and three  
from snowball sampling. Please refer to Table 3.3 for participant characteristics. 
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Table 3.3:  Participant demographic details and recruitment source. 
 
3.11.3.1 Interview themes 
 
Overall, the survey was received positively and all women found its content and layout 
user friendly. Two broad themes for improvement of survey items were identified: 
mismatch and irrelevance. 
 
Mismatch 
 
The majority of identified issues with the survey related to a perceived mismatch 
between the terminologies used in survey items and answer scales, causing difficulty in 
Participant 
no 
Age Highest 
Educational 
Level 
Own 
home 
Ethnicity  Recruitment 
Source 
1 39 A level or 
equivalent 
Yes Welsh Cardiff 
University 
2 26 Degree No Welsh Cardiff 
University 
3 29 GCSE or O 
level 
Yes Welsh Football 
Club 
4 26 GCSE or 0 
level 
No Welsh Football 
Club 
5 20 A level or 
equivalent 
No Welsh Football 
Club 
6 24 A level or 
equivalent 
No English Football 
Club 
7 27 GCSE or 
equivalent 
No Welsh Football 
Club 
8 63 Left school 
at or before 
age of 15 
Yes British Snowball 
Sampling 
9 51 Degree Yes Welsh Snowball 
Sampling 
10 58 Left school 
at or before 
15 
Yes Welsh Snowball 
Sampling 
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mapping answers. Two items were identified as being mismatched with their response 
categories. For example, the item “How much of a risk factor do you think HPV is in 
developing cervical cancer” (1- Not important at all- 5 Very important). Participants 
understood what the term risk factor was pertaining to, however they described being 
unable to relate their answers to the response options. Participants seemed to identify 
the term as ‘risk factor’ as synonymous with the term ‘important’.  
 
P- it’s really difficult because where it’s on a scale of not at all likely or 
very likely and it’s I want to use, to me that should be yes, no or unsure… 
I- so you are saying that the question kind of does not transfer to the 
responses 
P- yeah (P2) 
 
P- […]so I don’t really understand it straightaway…so like I want to use 
one…I am likely to use one or I am not likely to use one 
I-[…] so would you like me to put would you like to use 
P- yeah how likely am I to use or how likely are you to use and then 
obviously not at all likely and very likely (P5) 
   
P- um, I don’t really know where to go on the scale as it says how much 
of a risk factor do you think, but then it says not important or very 
important (P1) 
 
Irrelevance 
 
The item “Have you made any lifestyle choices to try and reduce your risk of cervical 
cancer?” was consistently misunderstood and perceived as irrelevant by most 
participants. Participants perceived it to be asking about general lifestyle choices, as 
opposed to choices that participants have actively made to try and reduce their risk of 
cervical cancer. Participants used the item to reflect their current lifestyle choices. 
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However, when participants were alerted to the fact that this item was specifically 
designed to identify any conscious efforts made to reduce risk of cervical cancer or 
HPV, they stated that their responses did not relate to a conscious effort to reduce 
cervical cancer risk. This theme was prevalent throughout transcripts. For example: 
 
P- I don’t know how to answer that one, practicing safe sex, I practice safe sex 
to avoid pregnancy not to avoid catching STI’s or STD’s because I know that my 
partner and myself don’t carry anything ... it is a choice I am choosing to 
practice safe sex,  
which I am (P2) 
I- would it have been something that you would have thought of to reduce your 
risk of cervical cancer (Interviewer) 
P- no  (P2) 
 
P- yeah well I don’t smoke (P5) 
I- but you haven’t given up smoking to stop cervical cancer (Interviewer) 
P- no (P5) 
 
Following participant comments, the utility of the item was re-addressed. The aim of 
the item was to establish whether participants have consciously made lifestyle changes 
to reduce their risk of cervical cancer. However, following cognitive interviewing it was 
established that the choices presented were lifestyle choices in general and not choices 
that were specifically adopted to reduce the risk of cervical cancer. The utility of the 
item was re-evaluated and it was decided that the item should be removed 
 
3.12 Survey modification  
 
 In addition to changes to survey items, the survey front cover was modified following 
participant uncertainty about the current availability of HPV self-sampling (whether it 
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is currently available through the NHS). Guidance was sought from Cervical Screening 
Wales. The information was modified to make it clear to women that the HPV self-
sampling kit was not routinely available through the NHS and that it was important 
that women attend their cervical smear appointments. The final survey was can be 
seen in Appendix 3.11. Ten appropriate revisions to address the themes of mismatch 
and irrelevance, as well as changes suggested following review by Cervical Screening 
Wales, were made (Table 3.4). An item investigating whether participants have had the 
HPV vaccine was added, as this was considered potentially important as a moderating 
factor for intention to HPV self-sample. 
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Survey 
Modification 
type 
Original Question Question following Cognitive Interviewing 
Re-wording of 
item 
 
6 items were reworded: 
1. I want to use a self-sampling kit for HPV. 
2. If made available to me I intend to use the self-
sampling kit for HPV. 
3. How much of a risk factor do you think HPV is in 
developing cervical cancer? 
4. Going for regular smear tests means that 
cervical cancer can be found early on. 
5. The three yearly reminders I get help me 
remember to attend my smear test 
appointments. 
The items were further modified: 
1. I would be likely to use a self-sampling kit for 
HPV. 
2. If made available to me, I would use the self-
sampling kit for HPV. 
3. How important do you think HPV is in developing 
cervical cancer? 
4. Going for regular smear tests means that cervical 
abnormalities would be found early on. 
5. The reminders I get help me remember to attend 
my smear test appointments. 
6. I trust the nurse/doctor to take a good sample. 
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6. I trust the nurse/GP to take an adequate 
sample. 
 
Response 
category 
modification 
A response category on 1 item was modified: 
How confident, are you that you would notice a symptom 
of cervical cancer? 
Not at all 
confident 
Slightly 
confident 
About 
the 
same 
Fairly 
confident 
Very 
confident 
1 2 3 4 5 
 
A response category was deleted from 1 item: 
What is the highest level of education you have? 
Left school at or before age 15  
GCSE or O level or equivalent  
A level or equivalent  
Further education but not a degree  
Degree or higher (e.g. Masters, PhD)  
None of the above  
 
The response category was further modified: 
How confident are you that you would notice a symptom 
of cervical cancer? 
Not at all 
confident 
Slightly 
confident 
Unsure Fairly 
confident 
Very 
confident 
1 2 3 4 5 
 
The response category was deleted respectively: 
 What is the highest level of education you have? 
Left school at or before age 15  
GCSE or O level or equivalent  
A level or equivalent  
Further education but not a 
degree 
 
Degree or higher (e.g. Masters, 
PhD) 
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Removal of 
Question 
 
The following item was removed: 
Have you made any lifestyle choices to try and reduce 
your risk of cervical cancer? 
 
Attending smear appointments  
Practicing safe sex  
Limiting number of sexual partners  
Not smoking  
Getting immunized against HPV  
Other (please describe)  
I have not made any specific lifestyle choices to 
reduce my risk of cervical cancer 
 
 
Removal of item in the ‘Your thoughts about cervical 
cancer’ section of the survey. 
Addition of 
Question 
The following item was added: 
Have you had the HPV vaccine? 
Yes  
No  
 
Inclusion of additional item in the ‘Your views on HPV’ 
section of the survey 
Table 3.4: Modifications made to the survey following cognitive interviewing. 
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3.13 Discussion 
 
A preliminary questionnaire was developed to measure women’s attitudes and 
intentions regarding HPV self-sampling, in order to examine the determinants of 
anticipated uptake should HPV self-sampling become routinely available. A search 
of the empirical literature on intentions to HPV self-sample highlighted the need to 
develop appropriate survey measures of extended HBM constructs.  
 
The use of content validity analysis provided preliminary validation that some a 
priori survey items adequately reflected the constructs of interest. The content 
validity analysis facilitated the development of the survey by highlighting the need 
for item refinement or removal, and the development of additional items. The 
findings of cognitive interviews helped to ensure that the format of the survey was 
accessible, and that individual items were easily and correctly understood. Overall, 
the survey was very well received by participants with two themes identified for 
improvement (mismatch and irrelevance). 
 
Strengths and Limitations  
 
The use of content validity analysis helped to ensure that the survey did not over-
represent, omit or under-represent facets of the extended HBM constructs, and 
that variables which were not part of the construct definition were not reflected in 
the survey items (Haynes et al. 1995) 
The recruitment of nine experts to perform CVA (Lynn 1986) and the threshold of 
78% for positive agreement (Hobbs and Vignoles 2007) reduced the probability of 
drawing incorrect conclusions about items that needed to be modified due to 
chance agreement. Although the survey validation through content validity analysis 
did not establish test integrity, it helped determine the degree of confidence that 
can be placed on conclusions made (Streiner and Norman 2008) about the way that 
the HBM constructs may affect women’s intentions to self-sample.  
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However, content validity indices are specific to the particular function of the 
survey and the particular population, in this case the assessment of women’s 
intentions to HPV self-sample and the factors that may affect these intentions. The 
content validity of the survey is only valid within this particular context and 
population, therefore limiting wider generalisability of construct validity. 
Furthermore, because the definition of many constructs can evolve over time, the 
relevance and representativeness of the survey is likely to degrade over time 
(Haynes et al. 1995).  Therefore, conditional validity was established for the items 
of the survey. Conditional validity refers to the notion that indices of validity are 
relevant for one function of a survey (e.g. postal survey examining HPV self-
sampling attitudes) and also the target population (Mitchell 1986).  
 
The use of the cognitive interview to help pre-test the survey following content 
validity analysis facilitated the further evaluation of possible sources of response 
error. The in-depth exploratory features of the cognitive interview made it 
particularly suitable for further validation of the survey through examining both 
overt and covert responses. Although some variability of participant characteristics 
was observed such as educational level, the sample was largely homogenous. Little 
variability was achieved in terms of age and ethnicity as the majority of 
respondents were relatively young and either White Welsh or British/English. 
Younger respondents might represent different understanding of items compared 
with women from an older generation. Furthermore, the lack of representation of 
women from different ethnic backgrounds further limits the generalisability of 
findings, as women from other ethnic groups and those whose first language is not 
English, might hold different interpretations.  It was not feasible to specifically 
target older women and women from different ethnic backgrounds due to time 
constrains, however it is acknowledged that the homogenous nature of the sample 
may serve as a barrier for determining the general validity of the survey outside the 
sample population. 
 
Both concurrent verbal probing and think aloud techniques were adopted in the 
cognitive interviews. The initial instruction for participants to ‘think aloud’ when 
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processing items helped support an open-ended format throughout the interview. 
This ensured that the participants had the opportunity to provide information that 
might have been unanticipated by the interviewer and helped establish the notion 
that personal reflection by the participant was highly beneficial for the interview. 
However, the use of the think aloud techniques has been criticised for placing too 
much burden on the participants to verbalise cognitive processes and a bias in the 
individuals’ information processing. Thinking aloud encourages individuals to invest 
considerable amount of mental effort into processing the questions compared to 
the amount of mental effort used when individuals are simply answering questions. 
This may therefore lead to over-processing of information and a different 
interpretation of the items in hand as opposed to when answering items in a real-
life survey setting. Furthermore, the majority of participants provided simplistic 
answers, expressing that the question is ‘ok’ or ‘clear’. Consequently, the majority 
of participants’ verbalisation relied heavily on the probes used throughout the 
interview. Probes were targeted to guide the participants’ focus on the items and 
the response formats presented. Throughout the course of the interview, the use of 
probes actually facilitated participants to think aloud and offer their own 
spontaneous thoughts and critiques, because participants seemed to expect the use 
of probes and pre-empted responses in some cases. The use of concurrent probing 
enabled the exploration of information that was still fresh in the participant’s mind, 
resulting in it being easier to access and discuss. Verbal probing has been criticised 
for its potential to bias participant responses by the probes selected and the way 
that they are phrased. The possibility of bias was minimised in this study by only 
using non-leading probes.  
 
Cognitive validity analysis and cognitive interviewing served as preliminary forms of 
construct validation.  Alternative forms of validation can be applied to further 
assess the validity of the survey items, such as convergent validity and further types 
of construct validity.  Construct validity examines how well survey items represent 
underlying extended HBM constructs. The construct validity of survey items was 
further examined using principal components analysis, presented in Chapter 4. 
Convergent validity can be established by correlating a measure with other 
 79 
 
established measures that have proven validity. For example, the HPV knowledge 
measure used in the survey can be compared against a measure of HPV knowledge 
such as that developed by Waller et al. (2013). However the HPV knowledge 
measure was not available at the time of this research (2012). Internal reliability of 
factor-derived scales was also investigated, and is presented in Chapter 4 using 
inter-item correlations and Cronbach’s alpha to determine whether constituent 
items were measuring the same underlying construct. 
 
3.14 Conclusion 
 
The use of the content validity analysis and cognitive interviews resulted in item 
modifications that helped to increase the content and face validity of questionnaire 
items, prior to their use in identifying women’s attitudes and intentions to HPV self-
sample. The internal consistency of measures and the fit of underlying components 
with the proposed extended HBM constructs will be reported in the next chapter. 
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Chapter 4 
 
Identifying factors associated with women’s intentions to HPV self-sample using 
survey methods. 
 
4.1 Chapter Overview 
Previous literature on women’s intentions and beliefs regarding HPV self-sampling 
has mainly focused on women who are non-responders to cervical screening. Few 
studies have been conducted involving women from the general population, the 
majority of whom attend cervical screening and might present different barriers to 
HPV self-sampling compared to women who do not participate in cervical 
screening. A cross-sectional study is presented, in which the ability of the extended 
HBM (Rosenstock, 1988) to explain women’s intentions to HPV self-sample was 
tested. The findings will be used to guide the development of a qualitative 
interview schedule (Chapter 5) to explore women’s intentions to HPV self-sample in 
greater depth, as well as to inform the content of an intervention designed to 
increase intentions to HPV self-sample. 
 
4.2 Introduction 
Understanding women’s intentions to engage in primary HPV self-sampling will 
provide insight into the possible impact of introducing primary HPV self-sampling 
on cervical screening attendance. The extended HBM (Rosenstock et al. 1988) 
proposes that individuals are more likely to HPV self-sample if they believe 
themselves to be highly susceptible to HPV, they perceive HPV infection as serious, 
they believe that the benefits of taking action outweigh the barriers or costs of 
conducting in HPV self-sampling, and they believe that they are able to conduct 
HPV self-sampling properly (high self-efficacy). Please refer to Chapter 2 for a 
detailed discussion of the extended HBM constructs. 
 
Due to the reliance on the individual to perform the sampling procedure in HPV 
self-sampling independently, it is possible that perceived HPV related self-efficacy 
may have a significant impact on women’s intentions to self-sample. Although a 
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lack of confidence in conducting HPV self-sampling properly has been identified 
(Waller et al. 2006; Cadman et al. 2014), the way in which self-efficacy may affect 
intention to self-sample has not been investigated. It was therefore important to 
examine associations between intention to HPV self-sample and self-efficacy, as 
well as to identify which aspects of the HPV self-sampling procedure may be 
particularly associated with lower self-efficacy.  
 
In addition to extended HBM constructs, modifying factors that will be investigated 
include HPV knowledge, clinical details such as cervical screening history, HPV 
vaccination history and family history of cervical cancer, and sociodemographic 
characteristics such as age, socioeconomic group and ethnicity. Cues to action can 
also be seen as modifying factors that can increase intention to engage in a health 
behaviour. However, cues to action were investigated in relation to actual cervical 
screening testing rather than hypothetical HPV self-sampling intention. Cues to 
action were investigated in relation to cervical screening because a HPV self-
sampling programme is not available. It was felt that exploring the influence of the 
standard cue to action (receiving a call/recall letter for a cervical smear) would 
provide information about its effectiveness in promoting women to attend cervical 
screening and could be extrapolated for HPV self-sampling programme 
recommendations. 
 
4.2.1 Aim of the present study  
 
The extended HBM was used to identify correlates of HPV self-sampling intention in 
women drawn from the general population. The primary study hypothesis was that 
higher self-efficacy would be associated with higher intention to HPV self-sample. 
 
Secondary hypotheses were that higher intention would be associated with higher 
perceived severity of HPV and/or cervical cancer, higher perceived susceptibility to 
HPV and/or cervical cancer, greater perceived benefits of HPV self-sampling and 
fewer perceived barriers to HPV self-sampling and greater perceived barriers to 
cervical smear tests. 
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4.3 Materials and Methods 
 
A questionnaire-based survey (described in Chapter 3) was used to investigate 
women’s intentions to HPV self-sample using opportunistic sampling methods. In 
order to increase the sample size and the heterogeneity of the participants, the 
research was conducted in two waves of recruitment: primary recruitment through 
Cervical Screening Wales (Cervical Screening Wales), followed by supplementary 
recruitment through healthcare practices and community groups. The survey was 
conducted between April-August 2013. 
 
Ethical Approval 
 
Ethical approval was obtained from the South East Wales Research Ethics 
Committee Panel C and Public Health Wales Risk Review Committee for Research 
and Development.  
 
4.3.1 Primary recruitment via Cervical Screening Wales 
 
For the primary recruitment, recruitment cards were sent alongside women’s 
cervical screening call/recall letter from Cervical Screening Wales (Appendix 4.1). 
The recruitment card was designed to look colourful and attractive with a bold 
statement “Cervical Screening- Your opinion counts!” to try and engage the reader. 
The study information outlined the sampling criteria (women need to be 20-64 
years), and provided basic information about the research question and HPV self-
sampling. The study information stated that HPV self-sampling was not currently 
available and that women should therefore attend their cervical smear 
appointment. The section entitled “What would you need to do” provided simple 
instructions on how women could get involved with the study and what to expect if 
they expressed interest. The reverse side of the card provided researcher details 
and a section to be completed by the potential participant. The card content was 
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approved by Cervical Screening Wales and assessed for accuracy of information 
provided.  
 
Inclusion/Exclusion Criteria 
 
Inclusion criteria stipulated that women were aged 20-64 years, were living in South 
East Wales and had given written consent to participate. Women were excluded if 
they were outside the recommended cervical screening age at the time of the 
survey (20-64 years) or were unable to speak English. Only women who were in the 
age bracket for cervical screening were targeted because they would be the 
potential individuals who would receive a HPV self-sampling kit. 
 
4.3.1.1 Procedures 
 
Recruitment materials were sent to 11,961 women with their cervical screening 
invitation/recall letter from Cervical Screening Wales. Women were due to be 
invited for their cervical screening via invite/reminder letter in the Bro Taf Health 
Authority Area during March 2013. Women who were interested in participating 
were instructed to fill in their details on the reverse of the recruitment card 
(Appendix 4.1) and to return it using the supplied pre-paid envelope. Women who 
returned the completed recruitment card were then sent the full participant pack 
and survey. 
 
Sample Size Calculation 
 
Sample size was calculated with the advice of a statistician and based on previous 
studies that have found uptake of HPV self-sampling to be around 30%  (Gok et al. 
2012). Assuming that 30% of individuals likely to participate in self-sampling have a 
high self-efficacy level, it was proposed that intention to self-sample would be 
approximately 15% in respondents who are at the mid-way point on a perceived 
self-efficacy scale. Informed by an article describing the relationship between self-
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efficacy and cervical screening (Fernandez et al. 2009) which reported a 2.69 effect 
size of self-efficacy on cervical screening, it was decided to consider an odds ratio 
effect size of 2 (adjusted for the influence of sociodemographic variables such as 
age). The effect size of 2 was somewhat less than the 2.69 odds ratio reported by 
Fernandez et al. (2009) to facilitate a more conservative sample size calculation. A 
two-sided test at the 5% significance level was chosen, which enabled bi-directional 
study of the effect of self-efficacy on intentions to self-sample. Using these figures, 
and the formula described by Hsieh, Bloch and Larsen (Hsieh et al. 1998), it was 
calculated that a sample size of  172 would achieve 90% power to detect the effect 
of self-efficacy on intention to HPV self-sample.   
 
A predicted response rate of 7% for the recruitment card was informed by a 
reported response rate of 7% from a study that used a postal questionnaire to 
examine women’s attitudes towards cervical screening (Szarewski et al. 2011). 
Therefore, it was predicted that the number of recruitment leaflets that needed to 
be sent through Cervical Screening Wales was approximately 12,000, based on an 
estimated 7% (n=840)  response rate to the recruitment card, and a conservative 
estimated 25% response rate to the questionnaire packs (210/840). 
 
4.3.2 Supplementary recruitment 
 
In order to reach the target sample size and to increase sample variation in terms of 
sociodemographic factors, alternative recruitment was initiated at sites including a 
sexual health clinic, community groups and GP practices. 
 
4.3.2.1 Procedures 
 
The same inclusion/exclusion criteria applied to primary recruitment were applied 
to the supplementary recruitment.  Participants recruited through the sexual health 
clinic were provided with a study recruitment card from the receptionist at the 
clinic. The receptionist briefly outlined the study and asked women if they would be 
happy to be provided with more information about the study. Potential participants 
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were provided with a study pack containing an information sheet, consent form, 
questionnaire and a pre-paid return envelope. The majority of participants 
completed their questionnaire whilst waiting for their appointment.  
 
Community leaders were initially approached and asked if they would be happy for 
the researcher to attend a group meeting and provide information about the study. 
If community leaders expressed interest in the study, the researcher attended the 
group to present the study to group members and distributed recruitment cards. 
The researcher returned during the subsequent meeting to distribute 
questionnaires to the individuals who had expressed an interest in participating in 
the study. The researcher left the study information packs and surveys with the 
potential participants and returned after the ‘session’ had ended and collected any 
completed surveys. Subsequent return and collection of the surveys ensured that 
potential participants did not feel obliged to participate due to researcher 
presence. 
 
Recruitment through GP practices involved practice nurses distributing study 
recruitment card and pre-paid return envelopes to women aged 20-64 in their clinic 
appointments. Women who returned a completed recruitment card were sent the 
study pack.  
 
4.4 Measures 
 
The development of items used to investigate women’s intentions to HPV self-
sample was presented in detail in Chapter 3. Please refer to Table 4.1 for an outline 
of items used to investigate HBM a priori survey constructs and women’s intentions 
to HPV self-sample. All HBM and intention items were scored on a Likert scale 
ranging from one to five. Three items were used to measure perceived benefits and 
three items were used to measure perceived barriers to self-sampling, whilst five 
items were used to measure barriers to cervical smear tests and three items were 
used to measure benefits to cervical smear tests. Five items were used to measure 
perceived self-efficacy in conducting HPV self-sampling.  Perceived susceptibility to 
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and perceived severity of HPV and cervical cancer were investigated with one item 
each (four items in total). One item was used to measure the effect of cues to 
action in relation to cervical smear screening. 
 
HPV knowledge, clinical variables such as cervical screening history and variables 
such as age, socioeconomic status (determined by postcode deprivation level), 
home ownership, ethnicity and educational level were measured using categorical 
response formats. Women were asked for consent for re-contact by the inclusion of 
an item asking women to indicate whether they would be happy to participate in a 
follow-up interview study.
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Variable Item/s in questionnaire and response scale range. 
Intention to 
HPV self-
sample 
I would be likely to use a self-sampling kit for HPV. 1= Not at all likely, 5= Very likely 
How likely would you be to use the self-sampling kit instead of going for a smear test? 1= Not at all likely, 5= Very likely 
I expect that I would use a self-sampling kit for HPV. 1= Not at all likely, 5= Very likely 
If made available to me, I would use the self-sampling kit for HPV. 1= Not at all likely, 5= Very likely 
Self-efficacy How certain are you that you would do the test well enough? 1=Not certain, 5= Very certain 
How certain are you that you would be able to carry out the sampling procedure (placing swab in vagina)?  
1= Not certain, 5= Very certain 
How certain are you that you would be able to place the swab into the tube containing the special liquid without 
touching or dropping the swab? 1=Not certain, 5= Very certain 
How certain are you that you would be able to carry out the self-sampling procedure despite other commitments (e.g. 
work/children)? 1= Not certain, 5= Very certain 
How certain are you that you would be able to send off the completed test within the time allowed (2 weeks)? 
1= Not certain, 5= Very certain 
Benefits to 
HPV self-
sampling. 
Using a self-sample kit is convenient because it can be done at home and means that I would not have to make 
arrangements (e.g. going to a GP surgery/taking time off work /arranging childcare.)   
1= Strongly disagree, 5= Strongly agree 
Using a self-sample kit would mean that no-one will know that I am having cervical screening.  
1= Strongly disagree, 5= Strongly agree 
Using a self-sample kit would be less embarrassing than having a GP or nurse do a smear test.  
1= Strongly disagree, 5= Strongly agree 
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Barriers to 
HPV self-
sampling. 
I am worried that I would hurt myself using the self-sample kit. 1= Strongly disagree, 5= Strongly agree 
I wouldn’t trust the results of the self-sample kit. 1= Strongly disagree, 5= Strongly agree 
I would be worried about the self-sampling kit getting lost in the post and not reaching the laboratory.  
1= Strongly disagree, 5= Strongly agree 
Perceived 
susceptibility 
to HPV 
Compared to most women your age, how likely do you think it is that you will come into contact with HPV?  
1= Much less likely, 5= Much more likely 
Perceived 
severity of 
HPV 
How serious an infection do you think HPV is? 1= Not at all serious, 5= Extremely serious 
Benefits to 
cervical 
smear 
screening 
Going for cervical smear tests means that cervical abnormalities would be found early on. 
1= Strongly disagree, 5= Strongly agree 
Going for smear tests provides me with reassurance. 1= Strongly disagree, 5= Strongly agree 
I trust the nurse/doctor to take a good sample. 1= Strongly disagree, 5= Strongly agree 
Barriers to 
cervical 
smear 
testing 
Having a smear test is painful. 1= Strongly disagree, 5= Strongly agree 
Going for smear tests can be difficult because I have to make arrangements (e.g. time off work, childcare). 
1= Strongly disagree, 5= Strongly agree 
I worry about my sample getting lost. 1= Strongly disagree, 5= Strongly agree 
Having a cervical smear test is embarrassing. 1= Strongly disagree, 5= Strongly agree 
I worry that others (e.g. family members, friends, people at the GP surgery) will know that I am having cervical 
screening. 1= Strongly disagree, 5= Strongly agree 
Perceived 
susceptibility 
Compared to other women your age, how likely do you think it is that you would get cervical cancer at some time in 
your life? Would you say you are…? 1= Much less likely, 5= Much more likely 
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Table 4.1: Items used to measure intention to HPV self-sample and variables associated with HBM a priori constructs in 
relation to HPV self-sampling and cervical smear testing. 
 
to cervical 
cancer 
Perceived 
severity of 
cervical 
cancer 
If I got cervical cancer, it would be more serious than other cancers. 1= Strongly disagree, 5= Strongly agree 
 
Cues to 
action 
The reminders I get help me remember to attend my smear test appointments. 1= Strongly disagree, 5= Strongly agree 
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4.5 Statistical analysis plan 
 
Survey data were analysed using SPSS for Windows V20. Descriptive statistics were 
used to characterise the sample. Missing data were excluded from analysis and 
normality of data was examined using skewness and kurtosis statistics.  
 
Principal components analysis (PCA) with Varimax rotation (Tabachnick and Fidell 
2007) was conducted on HBM a priori items in order to construct HBM scales 
relating to HPV self-sampling. The adequacy of sampling for principal components 
analysis was first investigated through the Kaiser-Myer-Olkin (Kaiser 1970, 1974) 
statistic and Bartlett’s test of sphericity (Bartlett 1954). Initial unrotated and final 
rotated factor solutions were calculated for factor derived scales. Based on Keiser’s 
criterion it was decided that factors with eigenvalues over 1 would be retained. 
Research has shown that Keiser’s criterion is accurate when the number of 
variables is less than 30 and the average communality of the variables is greater 
than 0.6 (Jolliffe 1972, 1986). Items strongly loading above 0.364 (Field 2005) were 
retained. Internal reliability of multi-item scales was examined using Cronbach’s 
alpha with a minimum accepted value of 0.70 (Kline 1999). Inter-item correlation 
was investigated with an accepted range between 0.2 and 0.4 (Briggs and Cheek 
1986).  
 
Intention and self-efficacy scales were transformed into binary scales. The intention 
scale was transformed to measure lower and higher intention to self-sample, whilst 
the self-efficacy scale measured lower and higher HPV self-sampling related self-
efficacy.    
 
Associations between extended HBM constructs applied to HPV self-sampling were 
identified using Pearson’s correlations and t-tests. 
 
Univariate analyses examined preliminary associations between intention to HPV 
self-sample and sociodemographic, HBM and clinical variables. The univariate 
analysis used independent t-tests and chi-square tests, as appropriate for the 
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different types of independent variables, with a significance level of p≤0.05. The 
significance level of 0.05 ensured that there is only a 1 in 20 chance of a type 1 
error occurring during analysis. A type I error would result in the incorrect rejection 
of the null hypothesis and the incorrect finding that there is an association between 
variables, which is actually due to a random occurrence (Coolican 2004). 
Conversely, a type II error might occur when the null hypothesis is retained when it 
is false and an association is actually present. The lower the significance level, the 
higher the probability of a type II error occurring (Coolican 2004). Therefore, the 
significance level of 0.05 was suitable for this analysis as it was sensitive enough to 
reject the null hypothesis correctly (with a 1 in 20 chance of type I error) but it also 
wasn’t too low which would have increased the chance of a type II error occurring.  
 
Multilevel modelling of independent variables identified as statistically significantly 
associated with HPV self-sampling intention was conducted using a stepwise logistic 
regression analysis. A logistic regression analysis was performed to assess the 
impact of factors on the likelihood that participants would report being more or 
less likely to HPV self-sample. A stepwise format was selected to facilitate the 
identification of variables that contributed most to the prediction of the model. In 
addition, all extended HBM variables regardless of statistical significance in 
predicting intention were modelled for conceptual reasons. The logistic regression 
was used to identify the strongest predictors (p≤0.05) and effect sizes on intention 
to HPV self-sample, with a binary intention outcome measure (likely vs less likely to 
self-sample) entered as the dependent variable.  
 
4.6 Results: Principal components analysis and internal consistency of factor 
derived scales. 
 
4.6.1 Psychometric testing of HBM a priori constructs through principal 
components analysis. 
 
Principal components analysis (PCA) was used for the psychometric testing of a 
priori constructs.  PCA is an exploratory technique which identifies the maximum 
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number and nature of factors. PCA aims to produce a smaller number of linear 
combinations of original variables (Tabachnick and Fidell 2007). Therefore, PCA was 
particularly suitable for reducing the number of variables in the survey into a 
smaller number of components and therefore exploring whether the components 
reflected a priori constructs and their related items.  
Examination of the data indicated its suitability for PCA. The sample size was above 
n=150, the correlation matrix revealed the presence of many coefficients greater 
than 0.3, and a spot check of variable scatterplots showed linear relationships.  
The Kaiser-Meyer-Olkin value of sampling adequacy was 0.774. The Kaiser-Meyer-
Olkin (KMO) measure of sampling adequacy provides an index of the proportion of 
variance among variables that might be common and therefore signifies that 
underlying factors might be present. The KMO is scored between 0 and 1, with a 
minimum accepted value of 0.6 , values closer to 1 signify that an analysis of factors 
(through PCA) would be suitable (Tabachnick and Fidell 2007). Furthermore, 
Bartlett’s test of Sphericity reached statistical significance at p<0.001. Bartlett’s test 
of Sphericity tests for relationships between variables and if no relationships are 
present, all correlation coefficients would be zero. Therefore, to enable a principal 
components analysis, Bartlett’s test of Sphericity needed to be significant (p<0.05) 
(Field 2005).   
Examination of the KMO statistic and Bartlett’s test of Sphericity supported the 
ability to extract factors from the correlation matrix.    
 
4.6.1.1 Initial factor solution  
 
Items relating to the HBM a priori constructs were entered into PCA. Five factors 
with eigenvalues >1.00 were extracted, explaining 33.9%, 13.5%, 11.2%, 8.8% and 
8.5% of variance in item scores respectively. Eigenvalues represent the amount of 
variation that is explained by the factors identified through PCA and it has been 
recommended that factors with eigenvalues over 1 represent a significant amount 
of variation (Kaiser 1960). In order to aid interpretation of the factor solution, a 
Varimax rotation was performed. Varimax rotation was performed to maximise the 
dispersion of loadings on factors, therefore to maximising high correlations and 
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minimising low correlations between factors (Tabachnick and Fidell 2007). Varimax 
rotation loads a smaller number of variables (with a higher loading) on each factor 
resulting in more interpretable clusters of variables on each factor (Field 2005). As 
shown in Table 4.2, all a priori items loaded in line with theoretical expectations, 
apart from the item “Using a self-sample kit is convenient because it can be done at 
home and means that I would not have to make arrangements (e.g. going to the GP 
surgery/taking time off work/arranging childcare”. This item was expected to load 
onto component III with the interpretative label of perceived benefits to HPV self-
sampling, but actually loaded onto component I with the interpretative label of self-
efficacy. This item was removed from component I and from the whole analysis on 
conceptual grounds because it did not significantly load on the benefits scale.  
Two a priori items loaded >0.36 on two components (Table 4.2). Loading strength 
and conceptual issues were considered when deciding which a priori item should be 
retained on each component.   
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Factors were labelled as follows: Factor I perceived self-efficacy, Factor II perceived barriers, Factor III perceived benefits, Factor IV perceived susceptibility, 
Factor V perceived severity. 
Table 4.2:  Initial PCA of extended Health Belief Model constructs relating to HPV self-sampling.
Item Factor I II III IV V 
How certain are you that you would be able to place the swab into the tube?  .898     
How certain are you that you would be able to carry out the self-sampling procedure despite other 
commitments? 
 .892     
How certain are you that you would be able to carry out the sampling procedure?  .857     
How certain are you that you would be able to send off the completed test within the time allowed?  .857     
Using a self-sampling kit is convenient because it can be done at home and means I would not have to 
make arrangements (e.g. going to GP surgery/talking time off work/arranging childcare). 
 .798     
How certain are you that you would do the test well enough?  .669   -.407  
I wouldn’t trust the results of the self-sampling kit.   .840    
I would be worried about the self-sampling kit getting lost in the post and not reaching the laboratory.   .702   .424 
I am worried that I would hurt myself using the self-sample kit.  -.354 .586    
Using a self-sampling kit would be less embarrassing than having a GP or nurse do a smear test.    .816   
Using a self-sampling kit would mean that no-one will know that I am having cervical screening.    .716   
Compared with most women your age, how likely do you think it is that you will come into contact 
with HPV?  
    .829  
How serious an infection do you think HPV is?      .909 
 95 
 
4.6.1.2 Final factor solution 
 
The final PCA using Varimax rotation and excluding the item “Using a self-sample kit 
is convenient because it can be done at home and means that I would not have to 
make arrangements (e.g. going to the GP surgery/taking time off work/arranging 
childcare” extracted five factors with eigenvalues >1.00, explaining 34.9%, 14.2%, 
9.9%, 9.2% and 8.5% of variance in item scores (Table 4.3). Inspection of the scree 
plot (Figure 4.1) complemented findings based on Kaiser’s criterion outlining a 
break following the first two components and then a further break following the 
fifth component. 
 
  
 
Figure 4.1:  Scree plot 
 
Nine items strongly loaded on one component independently. Three items loaded 
on two components each. Statistical and theoretical considerations were 
undertaken when deciding which item should be retained on which factor. The item 
“I am worried that I would hurt myself using the self-sample kit” will be used to 
exemplify this process. It was decided that this item would be incorporated into 
component II because its factor loading was higher on component II than I, and the 
remaining variables in component II were theoretically related to the item. The 
same principles were applied to the other items that loaded onto more than one 
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component.  Overall, the results of the final rotated PCA supported the five a priori 
constructs and their related items. Table 4.4 presents the final factor-derived scales 
and items.
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Item Factor I II III IV V 
How certain are you that you would be able to place the swab into the tube?  .890     
How certain are you that you would be able to carry out the self-sampling procedure despite other 
commitments? 
 .884     
How certain are you that you would be able to carry out the sampling procedure?  .877     
How certain are you that you would be able to send off the completed test within the time allowed?  .836     
How certain are you that you would do the test well enough?  .703   -.378  
I wouldn’t trust the results of the self-sampling kit.   .834    
I would be worried about the self-sampling kit getting lost in the post and not reaching the 
laboratory. 
  .710   .417 
I am worried that I would hurt myself using the self-sample kit.  -.376 .576    
Using a self-sampling kit would be less embarrassing than having a GP or nurse do a smear test.    .818   
Using a self-sampling kit would mean that no-one will know that I am having cervical screening.    .738   
Compared with most women your age, how likely do you think it is that you will come into contact 
with HPV?  
    .837  
How serious an infection do you think HPV is?      .910 
Factors were labelled as follows: Factor I perceived self-efficacy, Factor II perceived barriers, Factor III perceived benefits, Factor IV perceived susceptibility, 
Factor V perceived severity. 
Table 4.3:  Final rotated PCA of Health Belief Model constructs relating to HPV self-sampling.
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Component number and 
corresponding  
HBM construct 
Item/s loading on component 
Component 1 
 
Perceived Self-Efficacy 
How certain are you that you would do the test well enough?  
 
How certain are you that you would be able to carry out the sampling procedure (placing swab in vagina)?  
 
How certain are you that you would be able to place the swab into the tube containing the special liquid without 
touching or dropping the swab?  
 
How certain are you that you would be able to carry out the self-sampling procedure despite other commitments 
(e.g. work/children)? 
 
How certain are you that you would be able to send off the completed test within the time allowed (2 weeks)? 
      
Component 2 
 
Perceived barriers to HPV self-
sampling 
I am worried that I would hurt myself using the self-sample kit. Please circle a number. 
 
I wouldn’t trust the results of the self-sample kit.  
 
I would be worried about the self-sampling kit getting lost in the post and not reaching the laboratory.  
 
Component 3 
 
Using a self-sample kit would mean that no-one will know that I am having cervical screening.  
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Table 4.4: Final factor-derived scales and items
Perceived benefits to HPV self-
sampling 
Using a self-sample kit would be less embarrassing than having a GP or nurse do a smear test.  
 
Component 4 
 
Perceived susceptibility to HPV 
infection 
 
Compared to most women your age, how likely do you think it is that you will come into contact with HPV?  
 
Component 5 
 
Perceived severity of HPV 
infection 
 
How serious an infection do you think HPV is? 
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4.6.1.3 Internal consistency of factor-derived scales 
 
Benefits and barriers to HPV self-sampling  
 
Internal consistency of the two perceived benefits items was low (Cronbach’s 
α=0.555). The inter-item correlation was r=.386, within the accepted range of 0.2 
and 0.4 (Briggs and Cheek 1986). Items were combined to form a perceived benefits 
scale, with a score range of 2 to 10 (a higher score indicating more perceived 
benefits of HPV self-sampling).  
 
Perceived barriers items had a Cronbach’s α of 0.582. Inspection of the mean inter-
item correlation r=0.315 suggested that the three items exhibited internal 
consistency and were aggregated into a perceived barriers to HPV self-sampling 
scale, with a score range of 3 to 15 (a higher score indicating more perceived 
barriers). 
 
Perceived benefits and perceived barriers to cervical smear tests  
 
Perceived benefits of cervical smear tests scale initially consisted of three items 
(Table 4.4, component 3). Items had a moderate Cronbach’s alpha value of 0.690 
with an inter-item correlation of r=0.416. Removing the item “Going for cervical 
smear tests means that cervical abnormalities would be found early on” improved 
the internal consistency of the scale (α=0.805, r=0.674). Therefore, the scale was 
formed with two items, with a score range of 2 to 10. 
 
Perceived barriers to cervical smear tests scale consisted of four items (Table 4.4, 
component 2). Internal consistency of perceived barriers items was low (α=0.448, 
r=.173). The scale was comprised of four items with a score range of 4 to 20. 
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Self-efficacy in relation to HPV self-sampling 
 
Perceived self-efficacy consisted of five items (Table 4.4) with high internal 
consistency (α=0.900, r=.664). Inter-item correlation indicated that Cronbach’s α 
would be slightly higher if item “How certain are you that you would do the test well 
enough?” was removed (0.917). Exploratory cross-tabulation indicated that 
responses to this item exhibited variation when compared to the other self-efficacy 
item responses. However, self-efficacy in relation to HPV self-sampling is a 
combination of both a general belief that one would be able to carry out self-
sampling (as measured by this item) as well as the succession of tasks associated 
with actually carrying out the self-sampling procedure (the other self-efficacy 
items). It was therefore decided to retain item “How certain are you that you would 
do the test well enough?” in the self-efficacy scale to reflect the complex nature of 
perceived self-efficacy. The self-efficacy scale therefore consisted of 5 items with a 
score range of 5 to 25 (a higher score indicating higher self-efficacy). 
 
The self-efficacy scale was recoded into a binary scale to help differentiate between 
individuals who perceived higher versus lower self-efficacy in their ability to 
conduct HPV self-sampling. Group one reflected lower self-efficacy (respondents 
who scored lower 1, 2, or 3 on any of the self-efficacy items), whilst group two 
reflected higher self-efficacy (individuals who scored consistently 4 or 5 on every 
self-efficacy item). As shown in Table 4.5, the recoded variables were then grouped 
to make up the self-efficacy scale (ranging from 5 to 10). Women who scored 10 
(therefore were in group two for each question) were defined as having a higher 
self-efficacy, whilst women scoring between 5-9 were defined has having a lower 
self-efficacy.  
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Recoded self-efficacy 
scale value 
Frequency Valid 
% 
Cumulative % Higher/Lower self-efficacy 
5 17 8.9 8.9 Lower self-efficacy 
6 4 2.1 10.9 
7 11 5.7 16.7 
8 29 15.1 31.8 
9 38 19.8 51.6 
10 93 48.4 100.0 Higher self-efficacy 
Table 4.5: Development of binary self-efficacy scale. 
 
Intention to HPV self-sample  
 
Intention to HPV self-sample was measured using four items (Table 4.1, component 
1).  
Internal consistency of the four intentions items was high (Cronbach’s α=0.916) 
with a mean inter-item correlation of r=0.749. Excluding the item “How likely would 
you be to use the self-sampling kit instead of going for a smear test?” would 
increase the Cronbach’s alpha value to α=.939, as well as the mean item correlation 
r=0.841. Exploratory cross-tabulations identified that responses to this item were 
not consistent compared with response to the other intention items. Therefore, it 
was decided to exclude this item. The intention scale was computed from three 
items, scored from 3 to 15 (a higher score indicating higher intention). 
 
The intention scale was negatively skewed, with the majority of respondents being 
in favour of HPV self-sampling. A binary intention variable was created: those who 
had a higher intention to HPV self-sample scored 4 or 5 on all three intention items, 
and those who were less likely to HPV self-sample scored 3 or under on any 
intention item. As shown in Table 4.6, a score of 1, 2 or 3 on the 5 point scale was 
recoded as 1, whilst a score of 4 or 5 was recoded as 2. The recoded variables were 
then computed to develop a scale (from 3 to 6). Women who scored 6 consistently 
answered 4 or 5 on all three intention items, whilst women scoring 3-5 scored 
either inconsistently between the three items or scored lower on all items.  
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Recoded Intention 
Scale Value 
Frequency Valid % Cumulative % Higher/Lower Intention 
3 25 13 13 Lower Intention 
4 17 8.9 21.9 
5 17 8.9 30.7 
6 133 69.3 100 Higher Intention 
Table 4.6: Development of binary intention variable. 
 
4.6.1.4 Relationships between factor-derived HBM scales  
 
Inter-relationships between extended HBM constructs were investigated in relation 
to HPV self-sampling (see Appendix 4.2). Statistically significant relationships were 
found between more perceived benefits to HPV self-sampling and less perceived 
barriers to HPV self-sampling (r=-0.28, p≤0.001), more perceived benefits to HPV 
self-sampling and higher perceived susceptibility to HPV infection (r=0.16, p≤0.05), 
as well as perceived barriers to HPV self-sampling and perceived self-efficacy 
(t188)=4.24, p≤0.001. No other statistically significant relationships were identified. 
 
4.7 Survey Results 
 
4.7.1 Sample Characteristics 
One hundred and thirty seven (16.31%) of 840 women who received a recruitment 
pack via Cervical Screening Wales completed the survey. A further 57 women were 
recruited opportunistically to increase sample representation. The final survey 
sample therefore consisted of a total 194 participants. Table 4.7 demonstrates the 
number of women recruited from different sites and figure 4.2 shows the response 
rate of CSW recruitment. 
 
Most participants were of white ethnicity, in the 31-49 year age group, highly 
educated and were home owners. The majority had attended a cervical screen 
within the last four years. Nearly half (43.0%) of participants had received an 
abnormal smear test result and approximately a quarter (18.2%) had received 
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treatment for cervical abnormalities. A small proportion of women knew a family 
member/friend diagnosed with cervical cancer (13.5%) and some had known 
someone die of cervical cancer (5.7%). Table 4.8 illustrates participant 
characteristics. 
 
 Recruitment Site/s Completed 
Surveys 
Healthcare 
providers 
Cardiff and Vale Sexual Health Clinics 4 
Newport Sexual Health Clinic 27 
GP Practices (Cardiff, Newport and 
Cwmbran) 
2 
Community 
centres 
Women’s coffee groups 17 
Community BME ladies group 6 
Snowball 
Sampling 
Hospital catering department  1 
 
Sub total 57 
Main 
recruitment  
Cervical Screening Wales 137 
Total 194 
 
Table 4.7 Survey recruitment sites  
 
 
 
Figure 4.2 Flow chart of response rate through CSW recruitment  
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Characteristic  N (%) 
Age  
Min- 20, Max 64 
Under 30 59 30.6 
Range- 44 31-49 78 40.4 
IQR*- 24 50+ 56 29.0 
    
Educational Level GCSE 43 22.8 
 Further education 69 36.5 
 Degree or above 77 40.7 
    
Home ownership Home owner 125 65.4 
 Not a home 
owner 
66 34.6 
    
Ethnicity White 169 88.5 
 Non-white 22 11.5 
    
Previous cervical 
screening 
Yes 
No 
185 
9 
95.4 
4.6 
    
Time elapsed since last 
smear test 
Within 4 years 
Over 4 years 
Don’t know 
169 
6.5 
2.7 
90.8 
6.5 
2.7 
    
History of abnormal 
smear test result 
Yes 
No 
75 
106 
43.0 
   57.0 
Treatment for cervical 
abnormalities 
Yes 
No 
Don’t know 
34 
151 
2 
18.2 
80.7 
1.1 
    
Family/friend diagnosed 
with cervical cancer 
Yes 
No 
Don’t know 
26 
164 
22 
13.5 
75.1 
11.4 
    
Family/friend 
bereavement due to 
cervical cancer 
Yes 
No 
Don’t know 
11 
164 
18 
5.7 
85.0 
9.3 
*Inter-quartile range 
Table 4.8: Participant characteristics 
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 HPV knowledge 
 
As shown in Table 4.9, HPV knowledge was generally low: 31.4% of participants had 
not heard of HPV before participating in the study, 32.3% of women believed that 
HPV could be treated with medicines and 51.6% believed that HPV cannot clear up 
on its own.  Most women (85%) had a correct understanding of HPV transmission 
and believed that HPV can be contracted through sexual contact.  
 
 
HPV Knowledge Item Response Frequency  (%) 
Knowledge of HPV prior 
to study 
Yes 127  68.6 
No 58  31.4 
HPV transmission    
Correct understanding 
 
Only sexual contact 153 85 
Partially correct 
understanding 
Sexual contact and/or dirty 
toilet seats 
11  6.1 
Sexual contact and/or 
kissing 
8  4.4 
Breathing same air and /or 
sexual contact and/or 
kissing  
1  0.6 
Sexual contact and/or 
sitting on dirty toilet seats 
and/or kissing 
3  1.7 
All factors 1  0.6 
Incorrect understanding Breathing same air 1 0.6 
Sitting on dirty toilet seats 1 0.6 
Kissing 1 0.6 
 
Belief that HPV can be 
treated with medicines 
Yes 
No 
Don’t know 
60  
46  
80  
32.3 
24.7 
43.0 
 
Belief that HPV can 
clear up on its own 
Yes 
No 
90  
96  
48.4 
51.6 
 
Table 4.9 HPV knowledge 
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Figure 4.3 HPV knowledge 
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4.7.2  Preliminary univariate analysis of factors associated with intention to HPV 
self-sample 
 
A total of 69.3% (n=133) of women were likely to use primary HPV self-sampling if it 
was available. Preliminary univariate analysis of factors associated with intention to 
HPV self-sample is shown in Tables 4.10 and 4.11. Women with educational level 
above GCSE and those educated up to degree level or above were significantly 
more likely to report a higher intention to HPV self-sample (p≤0.05) than women 
who were educated to or below GCSE level. Women who were of a white ethnicity 
(p≤0.01) compared to women who were non-white were also more likely to report 
a higher intention to HPV self-sample. Age (p=0.13), socioeconomic group (p=0.082) 
and home ownership (p=0.33) were not statistically significantly related to HPV self-
sampling intention. 
 
Women who were aware of HPV prior to this study were statistically significantly 
more likely to report intention to HPV self-sample (p≤0.05). History of cervical 
abnormalities (p=0.63), treatment for cervical abnormalities (p=0.70) and cervical 
abnormalities of family/friends (p=0.25) were not significantly associated with 
intention to HPV self-sample. There was insufficient sample variation to examine 
the effects of previous cervical screening, time elapsed since last smear and 
family/friend bereavement due to cervical cancer on intention to self-sample.  
 
Higher intention to HPV self-sample was statistically significantly associated with 
higher perceived HPV related self-efficacy (p≤0.001), more perceived benefits 
(p≤0.01) and fewer perceived barriers (p≤0.001) to HPV self-sampling, as well as 
higher perceived importance of HPV in cervical cancer (p≤0.01). Higher perceived 
susceptibility to HPV infection and higher perceived severity of HPV infection were 
not statistically significantly related to intention. Greater perceived benefits of 
cervical smear tests were significantly associated with higher intention to self-
sample (p≤0.01). However, perceived barriers to smear tests, perceived 
susceptibility to cervical cancer and perceived severity of cervical cancer were not 
statistically significantly associated with intention to HPV self-sample.
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 Independent Variables                                                                                                Self-Sampling Intention 
  Low 
intention 
    N          % 
  High 
intention 
 N          % 
Statistic 
Age groups Under 30 years 24 40.7 35 26.5 X²(1,191) =4.12, p=0.13,  
31-49 years 19 32.2 58 43.9 
50-64 years 16 27.1 39 29.5 
Educational Attainment 
 
Up to and including  GCSE 18 32.1 24 18.3 X²(1,187) = 7.50, p=0.024*  
Further education, no degree 23 41.1 46 35.1 
Degree or above 15 26.8 61 46.6 
Ethnic background 
 
White 44 77.2 124 93.9 X²(1,189) =9.672, p=0.002**  
Non-White 
 
13 22.8 8 6.1 
Socioeconomic status  
(by postcode deprivation level) 
 
1-most deprived quartile 23 42.6 30 23.6 X²(1,181) =6.697, p=0.082 
2 7 13.0 25 19.7 
3 9 16.7 27 21.3 
4-least deprived quartile 
 
15 27.8 45 35.4 
Home ownership 
 
Home owner 34 59.6 90 68.2 X²(1,189) = .93, p=0.33  
Not a home owner 
 
23 40.0 42 31.8 
Knowledge of HPV prior to study Yes 31 53.4 96 72.2 X²(1,191)= 5.54, p=0.02* 
No 27 46.6 37 27.8 
 
Smear test history: history of cervical  
abnormalities  
 
 
Yes 
 
20 
 
37.7 
 
54 
 
42.9 
 
X²(1,172) = .220, p=.639 
No 33 62.3 72 57.1 
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Cervical abnormalities: personal 
history of treatment for cervical 
abnormalities  
 
Yes 9 16.1 25 19.7 X²(1,183) =.139, p= .709 
No 47 83.9 102 80.3 
History of cervical abnormalities:  
family/friend history of cervical  
abnormalities 
 
Yes 24 40.7 62 47.0 X²(1,191) =.652, p=0.722  
No 20 33.9 40 30.3 
Don’t Know 15 25.4 30 22.7 
Cervical Cancer: family/friend history  
of cervical cancer 
 
Yes 5 8.5 21 15.9 X²(1,191) = 2.721, p=0.258  
No 45 76.3 98 74.2 
Don’t Know 
 
9 15.3 13 9.8 
Previous cervical screening Yes 
No             
                                                                  
56 
3 
94.9 
5.1 
127 
6 
95.5 
4.5 
^ 
Time elapsed since last smear On time (under 4 years) 
Overdue (over 4 years) 
 
53 
1 
94.6 
1.8 
114 
11 
89.1 
8.6 
^ 
Family/friend bereavement   
due to cervical cancer 
Yes 
No  
Don’t know 
1 
51 
7 
1.7 
86.4 
11.9 
11 
111 
10 
8.3 
84.1 
7.6 
^ 
*p<.05, ** p≤.01,*** p≤.001, ^ sample size not large enough in some cells to conduct statistical tests 
 
Table 4.10: Preliminary analysis of associations between HPV self-sampling intention and sociodemographic/clinical variables and HPV 
knowledge. 
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Independent Variables                                  HPV self-sampling intention          Statistic 
 Lower 
intention 
Mean (S.D.) 
Higher 
intention 
Mean (S.D.) 
 
Perceived benefits to HPV self-sampling  
 
6.88 (2.25) 7.90 (1.99) t(190)=-3.142, p=0.002** 
Perceived barriers to HPV self-sampling 
 
8.6 (2.5) 6.5 (2.3) t(104.27)= 5.368, p=0.000*** 
Perceived susceptibility to HPV infection 
 
3.07 (0.72) 3.02 (0.70) t(189)=0.487, p=0.627 
Perceived severity of HPV infection 
 
4.03 (0.91) 3.96 (0.90) t(187)=0.510, p=0.611 
Perceived importance of HPV in cervical 
cancer 
 
Perceived self-efficacy     Lower 
  
                                             Higher 
 
4.14 (0.91) 
 
 
53 (91.4)  
    
5 (8.6)+  
4.47 (0.62) 
 
 
46 (34.6) 
 
87 (65.4) 
t(189)= -2.75, p=0.007** 
 
 
X²(1,n=191) =49.927, p=0.000***  
Perceived severity of cervical cancer 
 
2.95 (1.05) 2.73 (1.03) t(189)=1.342, p=0.181 
Perceived susceptibility to cervical cancer 
 
3.07 (0.722) 3.02 (0.627) t(189)=0.487, p=0.627 
Perceived barriers to smear tests 
 
10.31 (3.48) 10.26 (3.00) t(186)= 0.098, p=0.922 
Perceived benefits to smear tests 
 
8.15 (2.34) 8.91 (1.58) t(78.85)=-2.237, p=0.028* 
*p<.05, ** p≤.01,*** p≤.001 
Table 4.11: Preliminary analysis of associations between HPV self-sampling intention and extended HBM 
variables. 
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4.7.3 Multivariate modelling of intention to HPV self-sample. 
 
All extended HBM variables and background variables that were significantly 
associated with intention to self-sample (ethnicity, educational level and HPV 
knowledge) were modelled to determine their effects on intention.  
The model contained 13 independent variables. Firstly, background and 
sociodemographic factors were entered into the stepwise regression model. It was 
found that the model was statistically significant [X² (5, N=174)=17.35, p≤.005], 
explained between 9.5% (Cox and Snell R2) and 13.5% (Nagelkerke R2) of variance in 
intention to self-sample, and correctly classified 70.1% of cases. Subsequently the 
extended HBM variables (apart from self-efficacy) were added to the model, which 
was statistically significant [X² (12,N=174)=69.98] and explained between 30.4% 
(Cox and Snell R2) and 43.1% (Nagelkerke R2) of variance in intention to self-sample, 
correctly classifying 77.6% of cases. Self-efficacy was added to the final model 
which consisted of all 13 variables (see Table 4.12). The full model was statistically 
significant [X² (14, N=174) = 98.12, p≤.0.001], indicating that the model was able to 
distinguish between respondents who were more/less likely to self-sample. The 
model as a whole explained between 43.1% (Cox and Snell R2) and 61.2% 
(Nagelkerke R2) of the variance in intention to self-sample, and correctly classified 
83.3% of cases. 
 
As shown in Table 4.12, six independent variables made a unique statistically 
significant contribution to the final model: perceived self-efficacy, educational level, 
perceived importance of HPV in cervical cancer, perceived benefits of HPV self-
sampling, perceived benefits of smear tests, and perceived barriers to HPV self-
sampling. Women who reported a higher self-efficacy in relation to HPV self-
sampling (OR=24.96, 95% CI 6.34-98.20), had a higher educational level (OR=6.06, 
95% CI 1.40-26.14), perceived HPV as more important in cervical cancer (OR=2.32, 
95% CI 1.06-5.07), perceived more benefits to smear tests (OR=1.43, 95% CI 1.07-
1.91) and HPV self-sampling (OR=1.36, 95% CI 1.07-1.70) and perceived fewer 
barriers to self-sampling (OR=.663, 95% CI 0.53-0.82) reported higher intentions to 
HPV self-sample. Ethnicity, perceived barriers to smear tests, HPV knowledge, 
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perceived susceptibility to HPV and cervical cancer, and perceived severity of HPV 
and cervical cancer were not statistically significantly associated with intention to 
self-sample.  
 
A cross-tabulation was conducted to confirm that the relationship between the two 
most influential variables, self-efficacy and education, acted independently on 
intention to HPV self-sample (Appendix 4.3). The cross-tabulation exemplified a 
variation between educational levels and levels of self-efficacy, showing that not all 
women who were highly educated had a higher self-efficacy level, and that not all 
women who had a lower educational level had a lower self-efficacy. This 
demonstrated that the effect of the variables on intention was independent.  
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 B S.E. Wald df   p Odds 
Ratio 
95% C.I. 
Lower  Upper 
           
Educational level 
Up to/including GCSE^ 
   
6.147 
 
2 
 
.046 
   
Further education, no degree 0.79 0.69 1.328 1 .249 2.21 .574 8.478 
Degree or above 1.80 .75 5.835 2 .016 6.06 1.405 26.144 
 
Ethnicity 
 
1.228 .789 2.423 1 .120 3.414 .727 16.028 
HPV knowledge prior to study -.191 .583 .107 1 .743 .826 .263 2.591 
Perceived self-efficacy  
0=lower, 1=higher self-efficacy 
 
3.22 .69 21.198 1 .000 24.96 6.346 98.201 
Perceived importance of HPV in 
causing cervical cancer  
1=not important, 5=very important 
 
.84 .39 4.502 1 .034 2.32 1.067 5.070 
 
Perceived benefits of HPV self-
sampling. 
2=less benefits, 10=most benefits 
.31 .12 6.306 1 .012 1.36 1.070 1.735 
Perceived barriers to HPV self-
sampling  
3=less barriers, 15=most barriers 
-.41 .11 14.136 1 .000 .66 0.535 0.821 
Perceived susceptibility to HPV 
infection 
1=less susceptible, 5=more 
susceptible 
.091 .318 .082 1 .774 1.095 .587 2.044 
Perceived severity of HPV infection 
1=not severe, 5=very severe 
-.538 .323 2.775 1 0.96 .584 .310 1.100 
Perceived barriers to cervical smear 
tests 
4=less barriers, 20=most barriers 
.178 .096 3.421 1 0.64 1.195 .989 1.444 
Perceived benefits of smear tests  
2=less benefits,10=most benefits 
.36 .145 5.830 1 .016 1.43 1.070 1.913 
Perceived susceptibility to cervical 
cancer 
1=low susceptibility, 5=high 
susceptibility 
-.528 .434 1.476 1 .224 .590 .252 1.382 
Perceived severity of cervical cancer 
1=not severe, 2=very severe 
-.098 .252 .151 1 .698 .907 .554 1.485 
              ^ used as a baseline group for regression analysis. 
             Table 4.12: Logistic regression predicting lower/higher intention to self-sample. 
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4.8 Discussion 
 
The current study examined the effect of HBM constructs on women’s intentions to 
HPV self-sample. The survey used in this study was able to assess the impact of 
HBM constructs on women’s intentions to HPV self-sample. The use of principal 
components analysis facilitated the validation of the survey for the extended HBM 
items, by detecting the underlying structure of items and classifying them into five 
separate components relating to extended HBM constructs. The final logistic 
regression model provided evidence that the constructs proposed by the extended 
HBM were important in influencing HPV self-sampling intentions, and that the 
model was able to correctly account for over 80% of intentions to self-sample.  
 
Similarly to Snijders et al. (2013), women’s intentions to self-sample were high, with 
69% of women reporting that they would be likely to HPV self-sample. Factors 
associated with lower intention included lower self-efficacy, lower educational 
level, lower perceived importance of HPV in cervical cancer development, fewer 
perceived benefits of HPV self-sampling and smear testing, and more perceived 
barriers to HPV self-sampling. Self-efficacy in relation to HPV self-sampling had the 
strongest association with intention to self-sample. A high odds ratio of 24 was 
observed, meaning that a woman who has a higher self-efficacy is 24 times more 
likely to self-sample compared to someone who has a lower level of self-efficacy. 
However, this result should be interpreted with caution as wide confidence 
intervals were also observed for self-efficacy, which might be a result of sampling 
error. The stepwise regression identified that the addition of self-efficacy to the 
regression model increased the amount of variance explained by the model. This 
suggests that women’s perceived self-efficacy is highly important in influencing 
women’s intentions to HPV self-sample. Previous studies have identified low self-
efficacy as a barrier to HPV self-sampling (Stewart et al. 2007; Huynh et al. 2010; 
Igidbashian et al. 2011). The effect of self-efficacy on intention to HPV self-sample 
was highly statistically significant and further exploration is needed to understand 
how self-efficacy influences intentions. 
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Barriers to self-sampling included worry about hurting oneself whilst carrying out 
the procedure, worry about the self-sampling kit being lost in the post and not 
reaching the laboratory, and a lack of trust in the results. The lack of trust in the 
self-sampling kit may be a result of women doubting their ability in being able to 
carry out the self-sampling procedure adequately. Facilitators of HPV self-sampling 
included perceived self-efficacy in personal ability to carry out the self-sampling 
procedure adequately as well as the belief that: self-sampling would be less 
embarrassing than cervical smear testing, no-one would be aware that the women 
would be having cervical screening, smear tests would pick up any cervical 
abnormalities early on and having smear tests provides reassurance. These findings 
reflect the findings of other studies, which have identified barriers to self-sampling 
(Barata et al. 2008). Concerns regarding personal ability to perform the self-
sampling procedure and a subsequent lack of trust in the results, have also been 
previously identified (Szarewski et al. 2009). The current study suggests that 
women who perceive fewer benefits of cervical smear tests (typically non-
responders), are not necessarily more likely to HPV self-sample.  
 
Perceived susceptibility to HPV and severity of HPV infection were found not to be 
statistically significantly associated with intention to HPV self-sample. Furthermore, 
no association between HPV intention and perceived susceptibility and severity to 
cervical cancer was observed.  It is interesting that perceived susceptibility was not 
associated with HPV self-sampling intention, as it has previously been associated 
with cervical smear test screening uptake (Nadarzynski et al. 2012). This finding 
might have occurred because perceived susceptibility to a virus such as HPV, which 
has been described in participant materials as prevalent and transient, might not be 
as influential as a perceived susceptibility to cervical cancer in influencing intention 
to uptake screening. The finding that perceived severity was not associated with 
HPV self-sampling intention might have been due to a lack of knowledge about HPV 
and cervical cancer interaction and treatments. Perceived susceptibility and 
perceived severity constructs could have been combined to form a perceived threat 
construct (Stretcher and Rosenstock, 1997). However, combination of the two 
constructs would not differentiate their independent influence on intention to HPV 
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self-sample. It was important that independent influences were investigated to help 
determine intervention content (Chapter 6). 
 
Finally, associations between extended HBM constructs relating to HPV self-
sampling were examined. Statistically significant relationships were identified 
between perceived: benefits and barriers to HPV self-sampling, benefits to HPV self-
sampling and susceptibility to HPV infection, barriers to HPV self-sampling and 
perceived self-efficacy. It is interesting to note that although perceived 
susceptibility was not statistically significantly associated with intention to HPV self-
sample, it was associated with perceived benefits to HPV self-sampling. This 
suggests that perceived susceptibility to HPV self-sampling might influence 
women’s perceived benefits to HPV self-sampling but that it was not significant 
enough to independently influence HPV self-sampling intentions. 
 
During univariate analysis, women from an ethnic minority background were 
significantly less likely to HPV self-sample; however, this relationship was not 
present following statistical modelling. The diminishing effect of ethnicity following 
statistical modelling suggested that although ethnicity may influence women’s 
intentions to self-sample, its effect was not strong enough to remain significant 
when other influencing variables were accounted for. Furthermore, the small 
sample size of women from ethnic minority backgrounds might also explain the 
diminished effect. Previous studies have identified that women from ethnic 
minority backgrounds are less likely to engage in cervical screening (Chapter 1). 
 
Educational level was related to intention to HPV self-sample with women from a 
lower educational level reporting lower intentions. Lower socioeconomic status has 
been reported as a risk factor for lower smear test attendance (Moser et al. 2009). 
Lower screening intention in women from a lower socioeconomic status may be 
due to a lack of knowledge. The current survey also found that women who 
perceived HPV as less important in causing cervical cancer were also less likely to 
intend to self-sample. This belief may be due to poor health education and lack of 
awareness of the aetiology of cervical cancer. This seems highly likely considering 
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that a third of respondents had not heard of HPV prior to this study and believed 
that HPV could be treated with medicines and half believed that HPV cannot clear 
up without medical intervention. Previous studies have reported low public 
knowledge regarding HPV (Waller et al. 2013). It is surprising that despite 
widespread HPV vaccination in the UK since 2008 and related advertising 
campaigns, HPV knowledge still remains low.   
 
4.8.1 Study strengths and limitations 
 
The survey enabled the identification of key variables for subsequent in-depth 
exploration in interviews, and facilitated focus on key issues for consideration 
during intervention development. Individual survey items were combined to form 
scales based on the HBM constructs. Some of the items exhibited a low Cronbach’s 
alpha, particularly items relating to perceived benefits to HPV self-sampling and 
perceived barriers to cervical smear. The low Cronbach’s alpha exhibited in these 
scales might be due to the breadth, such as the possible benefits associated with 
self-sampling or barriers associated with cervical screening, or number of items 
present in the scale (Briggs and Cheek 1986). Consequent examination of mean 
inter-item correlations revealed correlations within the accepted range of 0.2 and 
0.4 (Briggs and Cheek 1986). It has been reported that the accepted range of 0.2 to 
0.4 mean inter-item correlation is optimal to ensure that the complexity of items is 
represented and that the construct measured is not too narrow (Briggs and Cheek 
1986).  Therefore, it was decided to combine the items into scales. Although the 
items exhibited optimal mean intra-item correlations, they had low Cronbach’s 
alpha values therefore suggesting that there is a possibility that the scales might 
not be reliable. Alternative methods to scale formation could have been applied 
such as retention of single items for analysis. 
 
The self-efficacy and intention scales were recoded into binary scales to help 
differentiate between women who consistently reported higher self-efficacy and 
intention, from women who have a lower intention or self-efficacy by consistently 
scoring lower or scoring inconsistently between items. This method of creating a 
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dichotomous variable was particularly suitable as it was able to identify women 
who were consistently reporting higher intention or self-efficacy, as opposed to 
using an alternative method such as a median split to dichotomise the data. A 
median split dichotomises data based on a single threshold, the median of a 
particular sample and does not account for consistency which is important when 
trying to ascertain an overall high level of intention or self-efficacy. 
Although the method used in this analysis seems particularly suitable, it only 
classified individuals who have consistently scored highly on all items relating to 
intention or self-efficacy as higher intention/self-efficacy. Therefore, this method 
classified all individuals who did not score consistently high on every item, as having 
low intention or low self-efficacy. Therefore, a limitation of this form of analysis is 
that it could incorrectly classify women who score low on one item related to 
intention or self-efficacy but who might actually have a high level of self-efficacy or 
intention but have a particular concern in relation to an item.  
 
Although the cross-sectional nature of the survey was useful for identifying the 
prevalence of hypothetical intention to self-sample for the population within a 
given time (Levin 2006), it could not prove causality but could only indicate 
associations between different factors (Mann 2003). Furthermore, the 
measurement of variables at one time might have led to inflated associations 
between health beliefs and intention than might not have been found if they had 
been measured prospectively.  
 
 
Target sample size was not achieved through the primary recruitment source of 
Cervical Screening Wales, therefore supplementary recruitment was initiated to 
achieve sample size. Women from community centres, sexual health clinics and GP 
practices were targeted to try and account for non-response bias that is 
traditionally evident in postal surveys (MacDonald et al. 2009). Alternative 
recruitment helped to achieve target sample size. However, the response rate of 
supplementary recruitment was unknown because it was not possible to record 
number of potential participants that were approached and those who declined to 
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participate. Furthermore, because participants recruited from the main recruitment 
source and supplementary recruitment sources were combined for analysis, the 
effect of recruitment source is unknown.  
 
The very low response rate observed from the CSW recruitment and the self-
selected nature of the sample limits the generalisability of the study’s findings. 
Although recruitment was initiated through CSW to try and obtain a population 
based sample, the fact that recruitment cards were sent alongside cervical 
screening call/recall letters might have impacted the types of women who 
participated in the study. The recruitment card did not contain CSW or NHS logos, 
but it might have been perceived as coming from the cervical screening 
programme. This could have resulted in a sample of women who were particularly 
engaged with the cervical screening programme. Although supplementary 
recruitment was initiated to help reach sample size, the final sample of participants 
were primarily White, highly educated cervical screening responders, many of who 
had  experienced cervical abnormalities. 
A more representative sample could have been achieved through alternative 
approaches to recruitment such as distribution of the survey through agencies that 
recruit population representative samples, such as the National Survey for Wales, 
previously known as the Welsh Health Survey, (http://gov.wales/statistics-and-
research/national-survey/?tab=current&lang=en). Furthermore, the survey could 
potentially be incorporated into a large scale online study such as the new 
HealthWise Wales study (https://www.healthwisewales.gov.wales/homepage/). 
Alternatively, purposive recruitment strategies through different recruitment 
sources, for example community groups and social media, could be adopted to 
achieve a representative sample. 
 
Cervical screening status of the survey participants was not representative of the 
population as a whole, with 95% of respondents previously attending a smear test 
appointment. In Wales, approximately 20% of women do not attend cervical smear 
tests (Wales 2012-2013). The majority of research into attitudes towards HPV self-
sampling has been conducted in women who do not attend cervical screening (Gok 
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et al. 2010; Szarewski et al. 2011), hence it was considered important to identify 
HPV self-sampling intentions in screening attenders, due to the lack of routine HPV 
self-sampling. Exploration of the views of screening attenders was considered 
crucial to identify whether this would be an acceptable alternative method of 
screening.  
 
The majority of participants were from a white background, with 1 in 10 women 
being classified as non-white. Focusing on women who are non-responders to 
cervical screening might have increased the number of women from ethnic minority 
backgrounds who have been shown to be more likely to be cervical screening non-
responders (Chapter 1). Therefore, if this study had focused more on recruiting 
non-responders, more women from an ethnic minority background might have 
been recruited. However, the views of cervical screening non-responders have been 
investigated in previous studies and were therefore not the focus of the current 
research.  
 
The majority of respondents from ethnic minority backgrounds were recruited 
through Asian community groups. It might be possible that the individuals who 
attended the community groups were more integrated into the community and the 
healthcare system. Furthermore, all the women who attended these groups were 
fluent English speakers. Women who are non-English speakers might have different 
attitudes towards HPV self-sampling and would have to rely on family members or 
friends to translate the HPV self-sampling procedure and subsequent result. 
Anticipated anxiety about the impact of a HPV positive result on marital 
relationships has been reported in women from ethnic minority backgrounds, and 
the fact that someone else would be aware of the result may have an effect on 
family relations. Further work is needed to assess women’s intentions to primary 
HPV self-sample within ethnic minority groups where English language acquisition is 
low. 
 
The majority of survey respondents were educated above a degree level; however, 
representation was also present from women who were educated to below degree 
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and those who were educated to GCSE level. The proportion of women in each 
educational category was representative of the population in South-East Wales 
(ELLS 2013). It was important that a broad range of ages were represented in this 
survey, because it has been shown that  younger (under 30) and older women (over 
50) are less likely to attend cervical screening (Wales 2012-2013). It was therefore 
important to ascertain whether self-sampling would be an acceptable alternative to 
smear testing in these women.  It might be expected that women who are older 
and more likely to have habituated to attending cervical smears might be less likely 
to intend to primary HPV self-sample. However, analyses suggested that age was 
not a significant influential factor in intention to self-sample. The effect of age on 
intention to HPV self-sample will be further explored during the qualitative phase of 
this research.  
 
  
 
4.9 Next steps 
 
In-depth qualitative interviews were conducted to explore influences on women’s 
intentions to HPV self-sample. The interviews explored the role of self-efficacy, 
benefits and barriers to HPV self-sampling as well as HPV and cervical cancer 
knowledge on women’s intentions to HPV self-sample. Women’s informational 
needs regarding HPV and self-sampling and their preferred intervention content, 
format and style were also be explored. 
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Chapter 5:  Gaining further insight into women’s attitudes towards HPV self-
sampling. 
 
5.1 Overview 
The previous chapter demonstrated that women’s intentions to HPV self-sample in 
the context of cervical screening are complex, and involve a wide range of cognitive 
factors (Chapter 4). Factors associated with lower intention included perceived HPV 
self-efficacy, women’s belief that HPV is not very important in cervical cancer 
development, and barriers such as the perception that they may hurt themselves 
whilst carrying out self-sampling, their worry that the self-sampling kit may be lost 
in the post and a lack of confidence in the results. This chapter will describe the 
qualitative methods used to gain further insight into these findings, the rationale 
for the research design, recruitment, analysis, discussion of the results and 
strengths and limitations of the analysis. 
5.2 Introduction 
The previous chapter discussed the quantification of extended HBM variables 
associated with intention to self-sample. This chapter aims to gain further insight 
into relationships between factors that were previously identified as influencing 
HPV self-sampling intentions.  For example, a lack of confidence in HPV self-
sampling results among women might be due to their low perceived self-efficacy or 
it may be due to other unidentified factors. Unidentified factors refer to factors that 
are not part of the extended HBM, which was used to inform the development of 
the survey (Chapter 3 and 4). Accordingly, an in-depth understanding of how factors 
might affect intention to self-sample will be fundamental to understanding the 
processes involved in forming intentions to self-sample. This is an essential step 
towards developing intervention messages specifically aimed at alleviating 
women’s concerns about self-sampling and increasing women’s intentions to HPV 
self-sample. 
A change of cervical screening method may require that women not only consider 
barriers to self-sampling identified in the survey (Chapter 4), but that they also shift 
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from habitual and normative behaviours to a new method of cervical screening. 
Habits in health behaviour can be defined as actions that are triggered 
automatically in response to contextual cues that have been associated with their 
performance (Neala et al. 2012). Therefore, it can be argued that because of 
frequent performance in similar situations in the past, mental representations and 
the resulting action can be automatically activated by environmental cues (Aarts et 
al. 1998). For example, breast self-examination may be classed as a habitual 
behaviour because it must be carried out frequently (at least once a month) and 
automatic cues may be the action of changing of clothes. Social norms may also be 
important in understanding screening behaviour. It has been suggested that due to 
its infrequent nature engaging in cervical screening is not a habitual behaviour but 
one that requires a decision to be formed each time of whether to be screened or 
not (Bish et al. 2000). However, older women who have attended numerous 
cervical screens may have habituated smear testing as a habitual behaviour, while 
younger women who are close to screening age may expect to engage in routine 
smear testing due to modelling the behaviour of female family members who have 
engaged in screening over many years. Women’s perceptions regarding this 
potential shift need to be further investigated as they are likely to be influential in 
women’s intentions to self-sample. 
 
The aims of this part of the research are: (i) to gain a deeper understanding of the 
influence of self-efficacy on women’s intentions to self-sample; (ii) to provide 
further insight into women’s perceptions of benefits and barriers to self-sampling, 
and the ways in which these factors affect intention to self-sample; and (iii) to 
reveal influences on self-sampling intentions that were not identified in the existing 
literature or previous survey chapter. The results presented will be used to inform 
the content of an HPV self-sampling intervention by addressing women’s specific 
concerns regarding self-sampling. 
 
Women with low intention to self-sample were of significant interest. Women with 
a lower intention to self-sample were specifically targeted for interviews because 
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they would be the target audience for any intervention designed to increase self-
sampling intention. Perceptions regarding smear tests were sought to inform the 
feasibility of HPV self-sampling, should it become available for women who are 
cervical screening attenders.  
 
5.3 Methods 
Qualitative analysis was used as part of a mixed methodology. Mixed methods, in 
which both quantitative and qualitative methods are combined, were considered 
valuable because they capitalise on the respective strengths of each method (Jick 
1979). A mixed methods approach is able to enrich survey findings and to discover 
factors not identified in a survey by also utilising qualitative methods. The 
qualitative methods would be able to provide more insight and depth into 
understanding the influences on women’s intention to self-sample (Ritchie and 
Spencer 2002).  
 
During the quantitative phase of the study, explanations for HPV self-sampling 
intentions were initially derived from the HBM and literature to design 
questionnaire measures.  The survey facilitated the identification of significant 
factors that influenced women’s HPV self-sampling intentions. Qualitative methods 
were then used to gain richer insights into individual experiences, beliefs and 
practices in relation to the relationships identified during the quantitative phase 
regarding cervical screening and HPV self-sampling. Relationships that were of 
particular interest were the way in which self-efficacy influenced intention to HPV 
self-sample, as well as the effect of HPV knowledge on intention.  
Semi-structured qualitative interviews were therefore used to focus on specific 
factors associated with intention to self-sample. Although the survey and HBM 
were used to structure the exploration of women’s intentions to HPV self-sample, it 
was important to acknowledge that the researcher conducting the interviews was 
implicated in the construction of knowledge. It was acknowledged that the 
researcher was an active participant in the knowledge production and is not a 
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neutral bystander. The background of the researcher as well as their pre-conceived 
beliefs, biases and knowledge about HPV self-sampling, can influence the methods 
chosen for enquiry as well as the way data were analysed and the findings 
considered most relevant  (Malterud 2001). During the interview stage of the 
research, the researcher wrote reflective statements following interviews to reflect 
on the general atmosphere of the interview as well as researcher perceptions.  
This study received approval from the South-East Wales Local Research Ethics 
Committee C (REC: 11/WA/0213) (Appendix 5.1) and Public Health Wales Research 
and Development approval (REF:2012PHW0023) (Appendix 5.2). 
 
Inclusion criteria 
Women who had previously consented in the survey phase were purposively 
sampled for lower intention to HPV self-sample. Inclusion criteria stipulated that 
participants were between the ages of 20-64 years and had consented to be 
contacted for an interview. 
Interview participant recruitment 
Women who were classified by the survey as having a lower intention to self-
sample and who had indicated that they would be happy to be contacted by the 
researcher for an interview were sampled. Women were contacted directly by the 
researcher through the post and sent an information sheet and consent form 
(Appendix 5.3). Non-responders were not re-contacted. All participants who 
returned a signed consent form were contacted by telephone to arrange a 
convenient time and location for interview. During the telephone conversation, the 
researcher explained the purpose, format and duration (30-60 minutes) of the 
interview. Participants were also reminded that they were not obliged to 
participate in the study and were free to withdraw from the study at any point 
without providing a reason.  Further consent to participate and permission to 
audio-record interviews were taken at the point of interview. 
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Interviews were conducted in participants’ homes (N=16) or in a seminar room at 
Cardiff University (N=3), depending on participant preference. Interviews were 
conducted between January and February 2014.  
Interview schedule 
A semi-structured interview schedule (Appendix 5.4) was developed based on the 
extended Health Belief Model constructs previously identified as being significantly 
associated with HPV self-sampling intention (Chapter 4).  A mixed methods 
approach was applied when developing the interview schedule. This involved 
drawing on basic principles of survey development guidelines to try and minimise 
potential bias associated with question order effects (French and Sutton 2010a). 
Furthermore, it is also assumed that participants would have some prior knowledge 
of the field especially as they were previously involved in the completion of a 
survey about their attitudes towards HPV self-sampling (Chapter 4).  Intention to 
self-sample was the first topic for discussion, followed by potential influential 
factors such as HPV knowledge. By ascertaining women’s intentions to self-sample 
from the outset of the interview, the researcher was able to see how reflection 
upon further questions influenced their stated intention. Although the ordering of 
the questions was pre-determined, there was opportunity to diverge from the 
schedule by exploring further issues as they arose.    
The interview schedule was then divided into two sections: the first section 
identified perceptions relating to HPV self-sampling and HPV in general, whilst the 
second section focused on the current form of cervical screening (cervical smear 
tests). The interview guide invited discussion on the following topics: 
(i) intention to self-sample 
(ii) perceptions of self-efficacy in relation to carrying out the self-sampling 
procedure, the operational factors involved in self-sampling, and 
subsequent confidence in the self-sampling results 
(iii) benefits and barriers to HPV self-sampling 
(iv) experiences of using a different self-sampling kit (e.g. pregnancy test)  
(v) HPV perceptions  
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(vi) cervical cancer perceptions and smear test perceptions (benefits and 
barriers)  
 
At the end of the interview, participants were asked whether they would like to 
take part in the user testing of a potential HPV self-sampling intervention.  
Data management 
All interviews were audio-recorded with the participants’ consent and were 
subsequently transcribed verbatim for analysis. Verbatim transcription focused on 
the word-for-word reproduction of verbal data, with the written words forming an 
exact replication of the audiotaped conversation (Poland 1995). The interview data 
were entered into the qualitative analysis software programme NVivo 10 (QSR 
International Ltd, 2012) for storage, coding and indexing purposes.  
 
5.4 Analysis 
Framework analysis 
The interviews conducted in this study sought to organise the data according to a 
framework which was initially developed largely from a priori constructs but that 
was later expanded, making it particularly suitable for exploration through 
framework analysis. There was a specific interest in gaining further insight into a 
priori constructs and framework analysis enables the process to be primarily 
focused on the aims and objectives of the research. Furthermore, framework 
analysis does not aim to build a theory but focuses on the investigation of 
relationships between concepts that are of interest. Consequently, analysis of these 
data initially required a more deductive approach such as framework analysis 
(Ritchie and Spencer 2002). 
Framework analysis  was developed with the purpose of generating practice-
oriented findings, and addresses specific information needs by using a priori 
constructs to produce actionable outcomes (Green and Thorogood 2011). Whilst 
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allowing for a priori construct investigation, framework analysis is driven by the 
original accounts of the participants and is open to change, addition and 
amendment throughout the analytic process, whilst also remaining systematic in 
enabling the methodological treatment of all similar units of analysis (such as 
paragraphs) that were judged relevant to the question as defined by the aims and 
objectives of the qualitative phase, and therefore incorporating them into a 
framework (Ritchie and Spencer 2002).  
Framework approach involves a systematic, interconnected five-stage process of 
analysis. Although depicted as a linear progression, the process is overlapping and 
iterative (Figure 5.1). Analysis takes form as a rigorous and iterative process of 
moving back and forth through the five stages. This process leads to modification of 
the framework in order to best represent the views of participants and the 
interpretation of the researcher/s. During the analytical process, the approached 
developed over time from a theory driven framework analysis to a more inductive 
thematic analysis. A more inductive thematic analysis approach was developed due 
to the new themes emerging from the data and the subsequent multiple re-
iterations and re-evaluations of previously analysed interviews.    
The following sections provide an account of how data were analysed through 
framework analysis and how the analysis became increasingly inductive and 
thematic. The framework analysis steps used were suggested by Richie & Spencer 
(2002) (Ritchie et al. 2003). NVivo 10 was used for the development of the 
framework, coding and indexing of transcripts. The use of NVivo particularly 
facilitated the iterative re-development of the framework and the subsequent re-
coding of data.  
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Figure 5.1: Framework Analysis Approach (adapted from Richie & Spencer, 2002) 
Listening to audio-
recordings of interviews. 
Re-reading transcripts. 
Studying observational 
notes. 
Referring back to aims 
and objectives and a 
priori constructs. 
Referring back to 
interview schedule. 
Phase 1 
Labelling data into 
manageable ‘chunks’ by 
referring back to a priori 
constructs and objectives. 
Developing small 
categories from interview 
data. 
 
Phase 2 
Organising categories into 
larger concepts. 
Data are lifted 
from context and 
arranged 
according to 
appropriate 
thematic 
reference. 
Development and re-
iteration of thematic 
framework. 
Mapping and 
interpreting the data 
as a whole: Pulling 
together key 
characteristics of the 
data. 
Applying 
framework to all 
interviews in the 
dataset. 
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Familiarisation 
Familiarisation refers to the researcher’s immersion in the raw data with the aim of 
maintaining the integrity of respondents’ narratives, whilst also focusing on the pre-
defined research questions. The familiarisation stage of analysis was crucial to the 
analysis process as it helped build the foundation of the conceptual framework  
(Ritchie et al. 2003) used to understand participants intentions to self-sample. 
Familiarisation was achieved by listening to audio recordings of interviews, reading 
transcripts, reading the interview schedule and reflecting on interview notes. During 
this process, key ideas and recurrent themes were listed and the general atmosphere 
of the interviews and the ease or difficulty of exploring certain subjects during 
interviews was considered. The familiarisation process continued until it was felt that 
the diversity of responses within the data was understood. 
Index development: Identifying a thematic framework  
The aim of this stage was to develop a thematic framework. Following familiarisation 
with the data, data coding was initiated to sections of the transcript which were 
relevant to the research question (Ritchie and Spencer 1994). These sections were 
assigned a ‘code’ to categorise and summarise them. Coding was carried out in two 
phases: initial coding involved identification of numerous small categories (codes) from 
the interview data. The categories can be broadly described as reflections, attitudes, 
beliefs, personal experiences and contextual issues. Although questions were 
determined by a priori idea, the second phase of coding was inductive, reflexive and 
increasingly thematic. The second phase involved the organisation of categories into 
concepts. Secondary coding was developed by drawing on the initial phase codes as 
well as the a priori HBM constructs, interview schedule, and aims and objectives of the 
study. The relationships between the initial categories were considered in order to 
develop secondary categories. The index development stage of the analysis process 
facilitated the development of a clear initial coding structure that facilitated the 
exploration of women’s beliefs about and attitudes towards HPV self-sampling 
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Figure 5.2 outlines the development of the thematic framework. Some of these were 
identical to the specified areas of questioning (e.g. potential for physical harm), whilst 
others were newly defined from emerging themes during the interview (e.g. 
confidence in self-sampling programme). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Development of the thematic framework  
 
 
Interview schedule themes  
based on a priori constructs 
and study objectives 
(extract) 
Barriers to self-sampling 
Potential for physical harm. 
Worry over kit getting lost in 
the post. 
Lack of confidence in the 
results. 
 
Index (extract) 
Barriers to HPV self-sampling (other 
than those related to self-efficacy) 
Operational Factors: sample being lost 
in the post; sample contamination 
during transit; sample tampering 
Confidence in self-sampling 
programme- System transparency: 
confirmation; continuity; access to 
expert support  
Potential for harm (e.g. causing 
bleeding) 
 
 
Field note from (extract) 
Participant 10 
“Confidentiality: sending 
things through the post, 
identity theft because NHS 
numbers etc. would be 
present.” 
Transcript (extract) Participant 10 
“[…]well if it did get lost in the post 
and you know accessed the wrong 
people for instance you know, 
possibly there could be access to my 
own health records by my NHS 
number or via my name you know just 
things like that.”  
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Development of the conceptual framework 
 The thematic framework was developed by referring back to a priori constructs based 
on the HBM, research questions, study aims and objectives, and was modified 
throughout by the analytical themes that arose from the patterning of participant 
views. Once the recurring themes were identified, an initial conceptual framework 
(‘index’) was developed. Themes within the index were then grouped together under a 
smaller number of ‘main themes’ and used to structure the overall framework. 
Numbers were assigned to differentiate levels of the individual themes, with low 
numbers relating to the macro level (main) themes and higher numbers relating to 
micro level themes.  
The first version of the index was largely descriptive and heavily reliant on the a priori 
constructs derived from the extended HBM and the interview schedule. An iterative 
and reflexive process followed to facilitate further development of the framework. The 
analytical process became more inductive and thematic as interview analysis 
progressed. Therefore, although the first framework version was applied to a number 
of transcripts and was subsequently refined, it became more thematic and responsive 
to new themes, ensuring that they were encompassed in the framework. For example, 
the theme of barriers to self-sampling was expanded to include the second level theme 
of operational factors, and then further expanded to include the third level theme of 
identity theft, for example “if it did get lost in the post and you know accessed the 
wrong people…possibly there could be access to my own health records by my NHS 
number or via name…” (P10). Judgements were made relating to the meaning, 
relevance and importance of the issues presented in relation to self-sampling intention 
and how well they could be classified within the developing framework. This iterative 
and thematic process of framework application to transcripts and subsequent 
modification continued until the framework was able to account for all relevant 
classifications.  
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The framework was applied to all interview transcripts.  Chunks of data (at sentence or 
paragraph level) that were relevant to the research questions were indexed according 
to the framework. All transcripts were read and annotated according to the thematic 
framework. This became an increasingly iterative and thematic process, with the 
framework adapting and changing throughout the analysis.  The meaning conveyed for 
each passage of text was inferred, with consideration of its relevance within the 
passage as well as the whole interview and subsequently mapped it onto the 
framework. Indexing references were recorded by a descriptive textual system. It was 
often found that individual passages contained a number of different themes, leading 
to multiple referencing within a section of text. Multi-referencing facilitated the 
exploration of associations within the data (Ritchie et al. 2003). Indexing text to the 
framework facilitated an analytical process that was clearly visible and accessible to 
others ensuring transparency in how data were identified and organised.   
A proportion of the transcripts (N=5) were double coded by a qualitative researcher 
with expertise in framework analysis (MD). Transcripts were double coded to test the 
utility of the framework and to ensure a shared understanding and interpretation of 
the data being coded into the framework (Weston et al. 2001)  
Inter-rater agreement during double coding was 85% (690/826 codes). Although no 
base percentage of agreement has been defined, it is generally accepted that inter-
rater agreement over 85% is satisfactory (Saldana 2009).  Discrepancies were resolved 
through discussion.   
Thematic Charting 
Following the development and application of the thematic framework to all 
transcripts, the process of charting was initiated.  Richie and Spencer (1994) suggest 
that charts are developed for each key subject area and that entries are made for each 
respondent in the same order in every chart (Ritchie and Spencer 1994). However, the 
comprehensive framework developed for the present study would produce highly 
complex and large charts which would be difficult to cross-reference and compare. In 
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order to facilitate a clear chart development, it was therefore decided to chart 
illustrative quotations that were considered to best summarise the themes within the 
framework for all theme levels reflecting the increasingly inductive and thematic 
nature of the analysis. For example, the following quote was used to illustrate the main 
theme relating to confidence in the self-sampling programme “yeah it the whole, not 
just the test itself, but the whole process associated with the test, I would just be sort of 
like, then I might worry about whether or not it was any good…” (P5). 
Mapping and Interpretation 
The final stage of analysis involved in-depth thematic interpretation of the data by 
pulling together key characteristics and interpreting the data as a whole. During this 
process, the thematic framework and research notes were used to compare and 
contrast the perceptions and experiences of the participants, whilst searching for 
patterns and connections within the data. Mapping and interpretation involved the 
identification of expected and emerging influences on attitudes to self-sampling, and 
consideration of their relationship and relative importance. This process helped to 
further define the concepts in the framework. For example, the processes facilitated 
the identification of system as well as individual barriers to self-sampling. Some of the 
system barriers related to operational factors in the set-up of the self-sampling system 
which included sub-themes such as identity theft. Individual barriers such as low self-
efficacy were also multi-faceted and included sub-themes such lack of professional 
expertise, lack of practice and lack of confidence in result. 
 
5.5 Results 
Thirty seven potential participants who had indicated on their survey that they would 
be happy to receive information about a follow-up interview and were classified as less 
likely to HPV self-sample were sent an interview recruitment pack. Twenty two women 
returned a consent form and indicated that they would be happy to participate in the 
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interview study. Women were contacted via telephone to arrange a suitable interview 
date and venue. A total of nineteen participants were recruited. 
5.5.1 Sample Characteristics 
Participants were aged between 23 and 63 years (Table 5.1). The majority were from a 
white ethnic background (n=17) and educated to degree level (n=10). Participants were 
purposively sampled for low intention to HPV self-sample. Most participants reported 
having experienced an abnormal cervical smear test result in the past (n=12) and had 
heard of HPV prior to the study (n=14).  
Participant 
number 
Age Educational level Ethnicity Heard of 
HPV 
Previous 
abnormal 
cervical screen 
 
1 23 Degree White Yes No 
2 27 Degree White Yes No 
3 40 Degree White No Yes 
4 24 Left school at 15 White Yes Yes 
5 30 Degree White Yes Yes 
6 53 GCSE/O Level Other Yes Yes 
7 35 Degree White Yes Yes 
8 31 Degree Other Yes Yes 
9 53 Further education White No No 
10 57 Further education White Yes No 
11 27 Degree White Yes Yes 
12 28 Degree White No No 
13 63 GCSE/O Level White No Yes 
14 52 Further education White Yes No 
15 23 Degree White Yes No 
16 56 GCSE/O Level White Yes Yes 
17 44 Degree White Yes Yes 
18 23 GCSE/O Level White No Yes 
19 63 GCSE/O Level White Yes Yes 
Table 5.1 Interview participant characteristics 
 
5.5.2 Themes identified 
The full thematic framework contained nine 1st level categories (themes) (Table 6.2) 
and 109 2nd level categories (themes) (Appendix 5.5).  
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The nine themes were: general cancer perceptions, HPV and cervical cancer 
perceptions, women’s understanding of HPV self-sampling, women’s intentions to HPV 
self-sample, perceived intentions of other women to engage in HPV self-sampling, 
women’s confidence in their ability to perform HPV self-sampling properly, barriers to 
HPV self-sampling and facilitators to HPV self-sampling.  
Major theme Description 
Own intention to self-sample Explicit reference to own intention to 
self-sample. 
Other’s perceived intention to self-
sample 
Explicit reference to perception of other’s 
intention to self-sample. 
Understanding of self-sampling Placing self-sampling in the context of 
other screening methods 
Perceived self-efficacy Components of self-efficacy and its effect 
on intention to self-sample. 
Barriers to self-sampling Perceived barriers associated with self-
sampling, other than those related to 
self-efficacy. 
Facilitators to self-sampling Perceived advantages of self-sampling 
Cervical cancer perceptions Attitudes to causality, prevalence and 
impact of cervical cancer. 
General cancer perceptions Attitudes towards cancer. 
HPV perceptions Attitudes towards HPV and self-sampling. 
 
Table 5.2 Major themes identified in qualitative analysis. 
 
Nine charts were developed based on the nine main themes identified in the 
framework. Appendix 5.6 presents one of the charts used to provide more insight into 
the perceived benefits to self-sampling. Each theme will be discussed below in detail. 
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5.5.3 General cancer perceptions 
Participants often felt that the causes of cancer in general were still unidentified, but 
they had positive views of cancer screening and felt that the earlier a cancer is caught 
the better the chance of survival.  
sooner you catch cancers and they’re dealt with then it’s so much 
better you have a better chance. (P9) 
General cancer beliefs regarding fatalism and cancer prevalence were also discussed by 
women.  Fatalistic beliefs were influenced by a belief that the availability of screening 
and its ability to detect cancer at an earlier stage would result in it being more 
treatable. 
I think that cancer obviously is a deadly thing um but most people 
do survive if it’s found early enough (P18) 
However, one participant (P4) had a strong sense of severity of the disease, which may 
have been influenced by the death of her mother from cervical cancer when the 
participant was a teenager: 
I was listening to the radio this morning, and he was saying that 
on the radio the UK is the biggest place for cancer in the 
world...loads of sufferers of it, it’s a killing disease (P4)  
5.5.4 HPV and cervical cancer perceptions 
Cervical cancer causality 
Most women did not know what caused cervical cancer. Some attributed cervical 
cancer to lifestyle factors, genetic factors or something that just happens. 
I think it’s more a genetic thing and passed down […] (P18) 
lifestyle and your diet and um stress I guess, all sorts of things […] (P17) 
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General HPV knowledge 
One participant, who had completed a microbiology degree and had worked with HPV, 
had prior knowledge of HPV and understood its link with cervical cancer. All others had 
a lack of HPV awareness despite stating that they had heard of HPV prior to the study. 
Twelve women had minimal knowledge of HPV: when asked what they knew about 
HPV, they often referred to the HPV vaccine or said that they had “heard of it” (P12) 
without having an understanding of what the virus is and that it causes cervical cancer. 
The remaining six participants stated that they had no prior knowledge of HPV: 
   I don’t know nothing at all about it (P4)  
The women who were unaware of the link between HPV and cervical cancer often felt 
embarrassed by their lack of knowledge, and perceived HPV infection to be very 
serious. They were also shocked to learn that HPV is highly prevalent.  
I know it’s very serious and that’s why I’m a bit embarrassed that 
I don’t know more about it (P11) 
Other women talked about the sex education they had received at school and stated 
that they had not been taught about HPV or its link with cervical cancer. Some women 
acknowledged that they had been regular cervical smear attenders from a young age, 
but that the role of HPV in cervical cancer was never explained to them. Consequently, 
women felt that more education about cervical cancer and HPV was needed. 
…basically my generation was never educated in anything like 
that, you know especially with school with sex education … so  I 
think for me I’m a missed generation to understand what it is 
fully (P10) 
Missed opportunities for education included sex education classes during school, as 
well as abnormal cervical screening results and appointments. Some women referred 
to their experience of having an abnormal screening result and subsequent treatment, 
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and expressed surprise that they were not informed about HPV during these 
appointments. 
I had abnormal cells back from a smear test um once I had to go 
and have some treatment, but they never mentioned HPV to me, 
you know, that was never something that they mentioned…(P11) 
HPV transmission 
Women’s knowledge about HPV was reflected in their differing beliefs about HPV 
transmission, some of which were congruent with scientific understanding, whilst 
others were not congruent. Most women were unsure about how HPV is transmitted 
and often cited a number of different ways. However, the majority of participants 
believed that HPV is transmitted during sexual activity. 
…well I assume it’s sexually transmitted then… that sounds most 
logical (P14) 
The majority of participants believed that multiple sexual partners increased the risk of 
HPV transmission, with one participant stating that younger women would be at a 
higher risk of transmitting and catching HPV because they engage in more short–term 
relationships. This participant believed that the issue of HPV transmission would be 
irrelevant for her because she was in a long-term monogamous relationship, 
suggesting that she saw herself at a lower risk of HPV infection than younger or 
promiscuous women. 
I would think certainly for younger people it would be more 
relevant, or for unmarried people or something, but you know I’m 
in a stable relationship sort of thing now… I would imagine if 
people are single, or maybe if they’re sleeping around, or they’ve 
got a few different partners, or something like that then it would 
probably be more relevant… (P19) 
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Some participants also stated that HPV may be transmitted during unprotected sex 
with someone who was previously infected. 
…someone that’s carrying it, and you have unprotected sex with 
and then contract it… (P11) 
Participants also rationalised that because HPV was a virus its transmission may be air 
borne, similar to a common cold. 
   …catching it off someone else, air bound (P4) 
 
Participants also said that HPV may be something that is already in the individual’s 
body, remaining dormant and being activated by a certain trigger. 
Whether it’s just something that is you know like they say it’s just 
in your body, and sometimes you have it, sometimes you don’t 
maybe like a hormone imbalance will trigger something then you 
get it!” (P1) 
Another participant thought that HPV may be transmitted by insertion of foreign 
bodies (such as tampons) into the vaginal area. 
…other than things like tampons or something I don’t…how 
would you get a virus in that area (P1) 
Finally, another participant also believed that HPV may be transmitted by contact with 
contaminated objects such as toilet seats or bodily fluids from infected individuals. 
Obviously innit if someone’s bleeding or something and you 
touch that blood you try to help them and then you touch that 
blood, maybe you can catch it like that, or through I don’t know 
toilet seats coming out of peoples’ bodies (P4) 
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Incongruity 
Incongruity was also a common feature when discussing cervical cancer and HPV, 
especially when participants realised that HPV is a sexually transmitted virus. One 
participant whose mother had died from cervical cancer refused to believe that cervical 
cancer is caused by HPV and rationalised this belief by stating that her mother did not 
have multiple sexual partners, and that she was in a monogamous marriage. The 
participant became upset by the proposition that her mother had somehow been 
infected with HPV and stated that she did not believe that HPV was the only cause of 
cervical cancer. 
…well my mum had cervical cancer and she never had a lot, 
multiple partners she had one husband from the age of 16 and till 
she died which was 2 years ago… and I’m not sure whether it 
does and that’s the only reason, my mum didn’t have multiple 
partners (P6) 
When discussing the link between HPV and cervical cancer, some women believed 
cervical cancer to be less threatening than previously thought because it was caused by 
a virus which they thought might be treatable. 
…because it a virus [HPV] I would think is something that can be 
treated…if you said to somebody oh you’ve got this virus, which 
we can treat, or if you said...they’d be going “that’s great thank 
you very much” but if you said to someone “right you’ve got 
cervical cancer which we can treat” you’d be like...cancer, cancer! 
That’s how I would look at it, I’d think oh virus yeah people have 
viruses all the time (P1) 
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5.5.5 Women’s understanding of HPV self-sampling 
Women had a basic understanding of HPV self-sampling, which was attributed to the 
description of what HPV self-sampling would involve that was included in their 
participant information packs. Women clearly comprehended that self-sampling would 
involve a three step procedure of (1) sample collection, (2) placing the sample in a 
transport medium and (3) posting the completed kit to the laboratory.  
um well I imagine that it’s got some kind of brush […]that you’d insert 
and you know you’d move it around a bit and then you’d put it in a pot 
and then stick it in the post (P2) 
However, even though women understood the three steps of self-sampling, they 
rationalised their understanding in the context of cervical smear tests. They often 
compared the two screening methods and perceived similarities between them. Most 
women believed that the self-sampling kit would involve collection of material from 
the cervix and some also believed that a speculum might need to be used. 
My only concern would be am I putting it in far enough, because 
obviously when they do a smear test they open up your sort of cervix 
type thing and then they take, it’s in quite deep to take the sample and it 
would be “am I inserting it high enough?” (P17) 
Um uh and I sort of perhaps can’t quite imagine how using the 
contraptions the stuff they do how you can do a self-sample? (P9) 
The majority of women did not relate HPV self-sampling to other widely available self-
sampling tests, such as faecal occult blood test (FOBT) or pregnancy tests, with only 
one participant relating the FOBT self-sampling test for bowel cancer to HPV self-
sampling. Women did not see similarities between HPV self-sampling and pregnancy 
testing, and felt that the two tests were not comparable.  
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…to me a pregnancy test isn’t the same as that [HPV self-sampling], 
you’re just weeing on a stick, anybody could do that […] I wouldn’t even 
class that as the same… (P11) 
Confidence in HPV self-sampling results 
When questioned early in the interview about their confidence in the results obtained 
from self-sampling, women stated that they would have the same level of confidence 
for results produced from self-sampling as cervical smear tests.  
“yeah, yeah I would yes absolutely I mean just like my smear test I don’t 
know the ins and outs of that, but I just get a letter back saying your 
smear is abnormal or normal and then you take that as read you know I 
would never question it”( P11) 
5.5.6 Women’s own intention to HPV self-sample 
Women directly discussed their own intention to self-sample and contextualised 
intention according to a number of factors. Although women were sampled for a lower 
intention to HPV self-sample as determined by the survey, the majority now stated 
that they would be willing to try self-sampling if it was available. 
  yeah, I would have a go yeah (P 17) 
Most women perceived benefits to self-sampling. 
  I think it’s a really good idea (P15)   
Women often viewed self-sampling as a positive step in the advancement of cervical 
screening. One participant contextualised her intention to self-sample as helping the 
future screening availability for her children.  
I would love it for my children um in the years to come if they could just 
do it and could be hassle free then I’d be all up for it (P7) 
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Some women referred to their previous experience of cervical abnormalities as a direct 
factor in determining their positive intention to self-sample, and held particularly 
favourable attitudes towards screening. 
yeah I think it’s brilliant I would definitely embrace it, especially as I’ve 
had problems in the past with… potential cervical cancer I think it’s 
brilliant and if it’s, if  it’s another way of screening people and I welcome 
all screening,  (P11) 
Availability of cervical smear test 
Availability of a cervical smear was an important influence on intention to self-sample. 
Women stated that their intention would be highly influenced by the availability of an 
alternative, and often saw self-sampling as an inferior method of cervical screening 
compared to cervical smears. 
if it was the only option that I had then I would do it… but if I had an 
option of having a smear test with the nurse, or doing it myself then I’d 
go with the nurse. (P1) 
Women’s preference for cervical smear tests appeared to be linked to their confidence 
in the current form of cervical screening, and concerns about losing access to 
professional expertise. 
you know if you were to use, use the self-sampling would you still be able 
to go then to your GP…  (P3)  
The habitual nature of cervical screening behaviour influenced women’s intentions to 
self-sample, with women who expressed a preference for the habitual behaviour 
reporting a lower intention to self-sample. 
I don’t know....I think I’d stay with my GP because it’s what I’m used to. 
(P3) 
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Women felt that they would be more likely to engage in self-sampling once it had been 
established as routine cervical screening.  
…when it becomes more open and discussed with people to say oh look 
it’s quite natural now we just self-sample… (P3) 
Ease of self-sampling kit 
Intentions were also formed on the basis that the self-sampling kit would be easy to 
use and/or the instructions supplied with the self-sampling kit would be simple. 
Perceptions that the instructions provided were going to be simple could be attributed 
to women’s confidence in carrying out self-sampling (discussed later in this chapter). 
  …no as long as I’ve got idiot proof instructions I would give it a go. 
(P13)          
One participant found it difficult to fully form an intention to self-sample because the 
kit and the programme discussed were hypothetical. She wanted to have more 
information about the self-sampling kit and the proposed set-up of the programme. 
The effect of operational factors on perceived barriers to self-sampling is discussed 
later in this chapter. 
I would have to have all the details about the actual kit itself before I’d 
want to do something like that, especially with something that is to do 
with something kind of a very serious topic and illness I think (P15) 
The participant wanted to have more information before receiving the HPV self-
sampling kit which she felt would result in her not needing to seek extra information 
from experts. 
If I knew more about it before the kit landed on my doorstep I would be 
less inclined to call someone just to verify it if I knew more about it (P15) 
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5.5.7 Perceived intentions of other women engaging in HPV self-sampling 
Women often referred to the perceived intentions of others to engage in self-sampling 
when questioned about their own intention. Primarily, women thought that cervical 
screening non-attenders would be particularly in favour of self-sampling. Women often 
cited barriers to cervical screening, such as embarrassment, and perceived benefits to 
self-sampling, such as carrying out the procedure at their own convenience in the 
comfort of their home.  
I think it would be a fantastic idea because a lot of women are nervous 
and a bit apprehensive about going to the surgeries to have smear tests 
and different, you know just to be looked at down that area… (P10) 
I think to do it from the comfort of your own home would make sure that 
more women would do it (P8) 
Age 
Women identified age as an influential factor on other women’s intentions to self-
sample. Women perceived self-sampling as being less intrusive than cervical smear 
tests, and believed that it might be particularly favoured by younger women who had 
not yet engaged in sexual activity. Conversely, some participants thought that older 
women might be more inclined to prefer a cervical screening procedure that was 
carried out by a health professional. 
I think it might be a generational thing, but I think maybe people of an 
older  age maybe less inclined to do it because of um that, that kind of 
authoritarian voice saying “you need to come to the doctors, doctors and 
nurses are the only ones that are going to be able to give you the 
decision about it” I think that might be an issue (P15) 
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5.5.8 Women’s confidence in their ability to perform HPV self-sampling properly 
Women generally felt that their lack of confidence in performing self-sampling 
adequately would affect their intention to self-sample, for example, by delaying 
completing the kit. While self-efficacy appeared to have been an additional barrier for 
some, it was found among others that low-self efficacy directly influenced intention. 
Low self-efficacy beliefs influenced intention by outweighing any possible benefits to 
self-sampling that women perceived. This reflected the significant impact of women’s 
lack of confidence in their ability to carry out self-sampling properly. 
Lack of confidence (low-self-efficacy)  
Most women in the sample were worried that they would not be able to carry out self-
sampling properly. 
I’d carry it out by all means, but then I would also be worried in the back 
of my mind that I hadn’t done it properly (P10) 
Underlying this concern was a perceived lack of personal expertise to be able to carry 
out self-sampling properly. Women referred back to cervical smears and said that they 
lacked the professional training needed to carry out a screening test.  
I guess my concern would be if a medical person had been doing this for 
all this time, would your sample be um good enough…  (P9) 
Lack of skills was also a factor that was prominent in women’s discussions about their 
worry that they would not be able to carry out self-sampling properly.  Women 
associated their lack of confidence with the novelty of the procedure.  
I think perhaps I would question if I had done it correctly the first time 
(P11) 
Women’s belief that they might not carry out the self-sampling properly influenced 
their confidence in the self-sampling results.  Some women expressed concern that if 
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they received a ‘negative’ result stating that no high risk HPV was found within their 
sample, they would worry whether they had actually carried out the self-sampling 
procedure correctly, and had “missed” something due to not having sampled from an 
area in their vagina that might have contained the high risk HPV. 
I think if it was negative I’d be worrying whether I’d done it right […] 
because if there’s nothing there then there’s a chance that you might’ve 
missed it (P2) 
These women felt that they would have low confidence in the results obtained from 
self-sampling and would seek expert support. 
I can see the potential for people rushing to the GP who wouldn’t like 
myself included, who wouldn’t go if they’d had the procedure done by a 
professional but would go because they were like I’ve done it, I might’ve 
done it wrong (P5) 
Women often talked about the consequences of not performing self-sampling 
correctly. Women were worried that an incorrect ‘healthy’ diagnosis might be made if 
they had not performed self-sampling properly.  Women felt that if they had carried 
out the test incorrectly and were given a wrong diagnosis, that it would be a further 
three years before they would be able to repeat the test and receive a correct 
diagnosis. One participant referred to carrying out self-sampling incorrectly and 
receiving a wrong diagnosis as a catastrophic event. 
if you don’t do it right and there is a problem, you’re talking of 
maybe a life and death situation (P1) 
High confidence (high perceived self-efficacy) 
Although the majority of women felt that they may not be able to carry out self-
sampling properly, two participants expressed high confidence in their ability to carry 
out self-sampling properly. 
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I would be happy to carry that out myself I wouldn’t feel you know 
anxious to do it myself, or nervous or anything like that I think I’d be 
more confident to carry it out myself rather than somebody doing it for 
me you know (P10) 
I think the only person you can trust is yourself so do it all yourself innit? 
(P4) 
 
Participant four in particular was highly confident in her ability to carry out self-
sampling properly throughout the interview. Participant four was a 24 year old woman 
who had left school before obtaining any formal qualifications. The participant stated 
that her mother had died due to cervical cancer and lived with her grandparents and 
her young daughter. She distrusted health professionals (this is discussed later in this 
chapter in the barriers to self-sampling section) and felt that she would be the best 
person to carry out the sampling; however it must be noted that most of the sample 
did not share her view. She felt that she would make every effort to ensure that the 
self-sampling had been done correctly, whilst alluding to the belief that an individual 
who was not carrying out the procedure on themselves (e.g. health professional) might 
take less care. 
When discussing confidence in self-sampling results, participant four was the only one 
to state that she would have more confidence in the self-sampling test result than a 
cervical smear test result, because she felt that she would ensure that the three step 
procedure was followed correctly. 
yeah I would, I’d trust them more because I, I don’t know, I don’t 
want to die like, I’d make sure it was the right thing to go in the 
right bottle, or whatever like… (P4) 
 
 
 151 
 
Other women who reported higher confidence in their ability to carry out self-sampling 
referred to their experience with using other feminine technologies such as tampons.  
I do use tampons so I’d be like fine, maybe if I didn’t use tampons 
I might be a bit more worried… (P5) 
Increasing confidence in ability to self-sample (increasing self-efficacy) 
Women stated that they would be more confident in carrying out self-sampling if they 
felt that they were provided with clear information outlining how to carry out self-
sampling and what the sampling was actually looking for. 
it’s just filling that information gap and sort of you know saying 
it’s okay because you know if the virus is there, it’s everywhere so 
you’re bound to find it (P7) 
Women also talked about practice and felt that if they had carried out self-sampling a 
number of previous times and received a result, they would feel more confident 
engaging in self-sampling. Women also talked about habituation to self-sampling as the 
usual method of cervical screening through repeated sampling exposure. 
I think it’s around practice if it became the norm and you knew it 
was part of your lifestyle um I suppose you’d get used to it… (P3) 
The issue of receiving a result was highly salient to women’s perceptions of how their 
confidence might be increased. Some women reported that receiving a result would 
provide reassurance that they had self-sampled correctly, whilst others stated that 
they would be particularly reassured if the result had led to the identification of any 
abnormalities. 
if it was positive you know if it was a...if it had detected some 
cellular abnormalities then I’d probably be reassured that I’d 
done it right…(P2) 
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5.5.9 Barriers to HPV self-sampling 
Women often felt apprehensive about the potential introduction of HPV self-sampling. 
They were worried about the efficacy of a new screening method and felt that there 
might be a “grey area” (P14) of whether self-sampling would be an efficient method of 
cervical screening. Some women also struggled with the hypothetical nature of the 
questions and felt that they could not accurately predict whether they would wish to 
engage in self-sampling until the method was actually available to them. Two main 
constructs were identified as reflecting women’s salient concerns: operational factors 
and confidence in the self-sampling programme.  
Operational factors 
When women were discussing operational factors associated with HPV self-sampling, 
they referred to the logistical issues involved with the self-sampling programme and 
the way in which they might affect their intention to self-sample. The majority of 
women were concerned with the postal nature of the self-sampling kits, especially that 
the completed kit would have to be sent to the laboratory through the Royal Mail as 
opposed to hospital services. Women were primarily concerned that their kit might get 
lost during transit or not reach the designated laboratory. 
…the sending it off would worry me hoping it reached where it was 
reaching and not got lost in the post…(P10) 
just putting it in the post it’s just relying on the postman to pick it 
up…but I know in big companies…letters have places to go and sections 
and there’s a TNT in everything it’s had its correct place (P11) 
Participant 11 referred to a well-established and organised postal system used in her 
workplace and compared that to the generic postal system, which she believed to be 
basic. There was an overall preference for the use of expert systems: 
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I think I would prefer to take it to like a doctors and they can send it to 
the hospital, or send it wherever it needs to go (P1) 
Other women thought that the self-sampling kits might not reach the laboratory 
because postal workers might not wish to handle them, or that their sample might 
become spoilt if their kit took a long time to reach the laboratory. 
…if I was a post lady I wouldn’t want to handle someone’s thing that has 
been in places… “I’m not taking that to get delivered, I’ll leave that one 
in the box” like they’d put it in the box and pretend they’d never seen it 
(P4) 
The women were also concerned about any potential contamination or damage caused 
during postage leading to inaccurate results.  
I’ve had mail sometimes come through and it’s soaking wet and opened 
you know it’s that not just the packaging damaged is the sample itself 
gonna be damaged? Or contaminated maybe? (P3)    
Some women felt that individuals might seek to tamper with their kit during transit, 
whilst others were worried about the possibility of identity theft. Women felt that 
identity theft might be an issue, because the self-sampling kits would contain DNA, as 
well as women’s personal details such as their name, address, date of birth and/or 
hospital number.  
that would be a big thing for me because something so personal has 
gone missing so you’ve got my DNA, you’ve got probably all my personal 
details…that would be an issue (P1) 
Confidence in the programme 
Women’s confidence in the self-sampling programme was also a potential barrier to 
self-sampling. Women were concerned about the quality and reasoning behind the 
new programme, not just the self-sampling kit itself. One of the most salient barriers to 
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self-sampling was a perceived lack of confirmation of receipt of the self-sampling kit 
from the laboratory. All women wanted reassurance (in the form of a text message/e-
mail/letter) that the sample had arrived safely to its destination. One woman in 
particular had very strong feelings about the availability of such provision and felt that 
if it was not in place, her confidence in the self-sampling programme would be low. 
If there’s nothing about acknowledgment of samples, I might be 
concerned about the fact that there was nothing in place, you know not 
specifically “oh my sample is definitely going to get lost” but more like 
“this is a bit stupid, why isn’t there something like this in place?” um and 
it would definitely make me perceive things more negatively if I felt like it 
wasn’t being rolled out in an organised manner, you know it would make 
me have entirely less confidence in the whole process…” (P5) 
Women had a lack of confidence in the reasons for offering self-sampling. The women 
thought that any ‘glitch’ in the organisation of self-sampling might result in a lack of 
confidence in the programme as a whole. Women thought that self-sampling might be 
a method that is “politically motivated” or simply “rushed through” (P5). A lack of 
confidence in the reasons for offering self-sampling was primarily shaped by the 
perception that self-sampling was simply going to be offered to help cut NHS costs, 
rather than as a benefit to health. This was reflected in women questioning why 
research was being carried out into this form of cervical screening. 
Um I’m not sure, if the benefit to doing self-sampling as in a 
benefit to health because more people would do it more often, or 
is it a benefit because it was reduce costs within the NHS or is it a 
mixture of both? I don’t know quite what was driving, driving um 
research (P9)  
The notion of cost-cutting was related to women’s perceived lack of confidence in the 
motivating factors behind self-sampling provision. If it was perceived that the 
transition to self-sampling was motivated by cost, confidence in the programme would 
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be low. However, women felt that if self-sampling was optional, they would be happy 
to participate and help save funds for the NHS as well as staff time.  
Very happy with it if it’s optional, um less happy if it’s forced… 
(P5)   
Two participants (P5 and P13) voiced concerns about a withdrawal of service if self-
sampling replaced cervical smears as an initial screening test, and even felt that they 
would be denied a right to have a cervical smear. 
   Are they taking away my rights to have a smear test…(P13) 
Service continuity was also an influential factor in women’s confidence in the new HPV 
self-sampling system. Women thought that they would be more confident in the self-
sampling programme if the same individuals were involved as those currently involved 
in cervical cytology. 
Are they going to the same person, I mean so I get my sample 
and I’ve sent it off, would it go to the same place as when I have 
a smear test? (P1) 
Apprehension concerning a lack of access to expert support was also a barrier to self-
sampling. Women wanted to have the opportunity to talk to an expert should they 
come into difficulty whilst doing the self-sampling or to ask any questions. Other 
women wanted to have access to expert support following self-sampling, especially if 
they felt that they might not have carried out the sampling properly and they wanted 
to have the option to access their GP. 
I think that it would be a good idea…try and give it a go, knowing 
that you’ve got the option of still going to your GP… (P3)  
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Confidence in cervical smear tests 
Women saw cervical smear tests as beneficial to their health. They often mentioned 
that that although they might be difficult to schedule and they can be embarrassing, 
they were in general happy to attend. Attending for a cervical smear test was often 
represented as habitual behaviour. 
But I’m so used to going every 3 years. Every 3 years that you 
know it’s become normal now routine… (P10) 
Women who had a previous history of cervical abnormalities particularly felt that the 
cervical smear test was a tried-and-tested method of cervical screening, and 
questioned the motivation for developing a new system. These women were confident 
that smear tests were able to identify cervical abnormalities and often referred to 
cervical smear tests as being able “to pick up a problem”. Women also felt reassured 
that a cervical smear test was carried out by an expert. They felt that the individual 
taking the sample was trained to carry out the sampling and would have expertise in 
this form of screening method. In addition to the perceived benefit of having an expert 
take the cervical smear sample, women perceived the smear test as a general 
gynaecological health check, with an all seeing expert carrying out the procedure. 
…there might be problems you know infections, or um well 
anything really that they could see, like I’ve got the coil fitted, so 
they could check that that’s in place… (P1) 
Contamination of sample during self-sampling 
Women were concerned about the potential for contamination when carrying out the 
self-sampling procedure. Women were concerned that they might drop the self-
sampling kit or that the environment they were to carry out self-sampling would not be 
as clean as a GP surgery.  
 
 157 
 
…there would be things around hygiene…cos you know you wash 
your hands, it’s cross contamination its things like that again, in 
surgeries you wonder sometimes how clean they are, but you 
automatically assume I’m in a surgery, health environment, 
everything is fine. (P3) 
Women were also concerned about a potential delay in completing the self-sampling 
kit, which was often attributed to everyday tasks taking priority over completion of the 
kit, as well as a potential lack of privacy within the home to carry out the procedure. 
You know you need to have privacy in your own home, you’ve got 
the children you are rushing when you are doing it (P3) 
New method of cervical screening 
The fact that self-sampling would be a new method of cervical screening and women’s 
lack of knowledge about the test were also identified as potential barriers. Women felt 
that the method would need to be well publicised and evidence that it was safe and 
efficient would need to be widely distributed. Women were particularly concerned 
with the efficacy of the test being able identify any abnormalities and its efficacy 
compared with cervical smear tests. Women wanted reassurance that self-sampling 
would not be an inferior cervical screening compared to cervical smears. 
…because it’s new I think long-term with evidence demonstrating 
that it’s just the same as on a par, I’d have no problem with that, 
with evidence (P3)  
As a result, women were worried about having to exert double the effort if engaging in 
self-sampling. This refers to women’s belief that if carrying out self-sampling the first 
time was not effective, for example if an insufficient sample was taken, they would 
then have to repeat the procedure. 
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If they say “sorry  you need to do it again” or whatever, un then 
you might think, oh actually no I’d rather go to the doctor’s, at 
least know that it’s done and I haven’t got to have it re-done 
(P12) 
5.5.10 Facilitators to self-sampling 
Advantages compared with attending for cervical smear 
Women perceived facilitators to self-sampling in terms of the advantages that self-
sampling might have over attending a cervical smear test. Negative perceptions of 
smear tests acted as facilitators to HPV self-sampling. Participants who felt that cervical 
smear tests were inconvenient, embarrassing or painful were more likely to report 
intentions to self-sample. The inconvenience of arranging a cervical screening 
appointment was discussed by all participants. 
…yeah inconvenient would be the best word particularly now 
with the little boy who there’s always something that needs to be 
organised”  (P12) 
Women highlighted convenience as the most salient facilitator to self-sampling. 
Women particularly liked the idea that self-sampling would be a time-efficient method 
of cervical screening because the sampling could be conducted whenever they had a 
chance, meaning that no planning would be required. 
I think is the most beneficial bit because it doesn’t kind of eat into 
your working day or eat into whatever else, you can kind of fit it 
in into your lifestyle and fit it in around you (P8) 
A general dislike for the cervical smear procedure in terms of embarrassment and 
discomfort was discussed. Women believed that self-sampling would be a more 
comfortable and less embarrassing form of cervical screening by being less invasive 
and home-based.   
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…well if it’s slightly less invasive [than a smear test] I very 
occasionally have a little bit of bleeding [following smear test], I 
wouldn’t have that, that would be nice… (P5) 
The physiological and psychological effect of having children was referred to by women 
when discussing cervical smear testing. In general, most women felt that they were 
psychologically better prepared for having a smear test following childbirth. However, 
one participant (P3) felt that the physical trauma endured during childbirth and the 
resulting scar tissue, actually made having cervical screening physically more difficult.  
…as I said after having 2 children I’ve got a lot of scar (tissue)… 
you know your body changes  and it’s a case that they need to be 
a bit more sensitive…(P3)  
Facilitating practitioner availability and funds for the NHS 
Women believed that participating in self-sampling could release medical practitioners’ 
time which could be reallocated to individuals with urgent medical conditions. The 
altruistic nature of women’s beliefs was conditional on the availability of practitioners’ 
extra time to see others, as opposed to taking some workload from doctors/nurses to 
help them. 
…and not just for me, but also for the fact that I wouldn’t then be 
taking up time of a nurse who might need to see somebody (who 
may) actually got a problem, you know it would free up 
appointments for other people (P5) 
Women also talked about how self-sampling might save money for the NHS and 
benefit others. This altruistic notion was conditional on the saved money being 
invested into a worthwhile cause such as treating women who have cervical cancer, 
and not for profit for the NHS as an institution. 
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…in the ideal world it would be nice to think that yes okay we’ll 
go through this learning process and it’s worthwhile because the 
funds would then go to maybe you know actually treating people 
with cervical cancer and then getting....better care (P5) 
Lack of confidence in health professionals 
A lack of confidence in health professionals was identified by one participant. This was 
in contrast to all of the other participants who felt that a health professional was 
someone whom they could trust to perform a cervical screen. Participant four was a 
twenty four year old woman whose mother had died from cervical cancer when she 
was a teenager.  She had an inherent lack of trust of health professionals and felt that 
they might not exert effort in obtaining a correct cervical sample because they were 
not performing the screening test for their own benefit.  Participant four explained her 
lack of confidence in health professionals by referring to high staff turn-over and the 
limited rapport/poor communication with staff whose native language might not be 
English:  
they’re different every day you know, some of them can’t even 
speak my language and I don’t got to get my kecks down in front 
of that person, not only have I got to get my kecks down in front 
of them, I’ve got to trust them and I can’t understand what they 
are saying, you know I’d rather do it myself. (P4)  
 The participant’s lack of confidence in health professionals may have been due to 
psychosexual issues. The participant referred to health professionals conducting 
cervical screening as an intimate procedure. This is exemplified by the following 
extract: 
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I don’t want my kid I don’t want any old man touching her, I 
know they’re a doctor or whatever but there are still a man, or 
you’ve got a lady there she, she no, no-one can be trusted these 
days… (P4) 
A lack of confidence and psychosexual factors seem to have been extremely salient 
influences on participant four’s perceived self-sampling intention. These issues were 
especially evident when she reflected that the only person who could be trusted to 
carry out a cervical screening procedure properly and with care would be the individual 
themselves. 
I think the only person you can trust is yourself so do it all 
yourself innit? (P4) 
Confidence in system 
Positive views of the operational factors associated with self-sampling were also 
facilitators to favourable self-sampling intentions. Some women were confident that a 
system would be in place to alert women if they had not sampled correctly, providing 
reassurance. 
I presume somebody would come back and say “you didn’t do it 
right we haven’t got what we need” then that would be fine. 
(P12)  
Women who believed that self-sampling would be managed by the same organisation 
as cervical smear screening had a higher confidence in the new system. 
…knowing that the sample would go to the same, basically the 
same  sort of people the same sort of qualified lab staff I’d have 
equal confidence in them… (P5) 
Confidence in the postal services also facilitated positive intention to self-sample, with 
six out of nineteen women stating that they would not worry about sending their self-
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sampling kit in the post. One participant expressed the belief that Royal Mail are “quite 
good these days” (P6), whilst other participants referred to the use of postal services in 
other screening methods:  
“I know they do it with the bowel don’t they, with the bowel 
screening, so I don’t think I would worry unduly” (P14) 
The availability of research data was also an influential facilitator to positive self-
sampling intentions. Women said that they would feel reassured if data were available 
regarding the effectiveness of HPV self-sampling.  
…reassurance in that you know it’s been, it’s been tried and 
tested and you know trying to instil confidence… (P8) 
5.6 Discussion 
The present chapter enabled further insight into the factors associated with women’s 
hypothetical intention to HPV self-sample, and provided further insight into how the 
HBM constructs influence women’s intentions to self-sample. The chapter also 
revealed new factors that were highly salient in forming women’s perceptions of self-
sampling and that had not been previously reported in the literature. The new factors 
were operational factors and confidence in the system set-up, reflecting the need for 
transparency of any new screening programme, preferences for the availability of 
professional expertise, and a lack of confidence in the postal system. 
 
As previously identified in the literature (Pitts and Clarke 2002; Waller et al. 2003; 
Marlow et al. 2013), interviews highlighted a lack of HPV knowledge. Most women 
believed that that there was no specific cause of cervical cancer, whilst some proposed 
genetic or lifestyle factors. This finding is similar to other studies which have also 
reported that women were not aware that cervical cancer is caused by HPV (Low et al. 
2012). Low awareness that HPV causes cervical cancer is even more striking in the 
present study because this was not the first point of contact with participants in 
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relation to HPV and cervical cancer. That the majority of participants still did not 
identify HPV as the exclusive cause of cervical cancer could be attributed to three 
factors: women might not have read the provided information about HPV during the 
previous study stage; they might have forgotten the information they were given, or 
they might not have believed that HPV was the only cause for cervical cancer. The 
latter participants may have been expressing a form of cognitive dissonance, which 
refers to a state of psychological discomfort that arises from conflicting attitudes or 
beliefs (Festinger 1957).  
 
In common with Marlow et al. (2013) women reported that they had heard of HPV 
prior to engaging in the study and the majority were aware that HPV is sexually 
transmitted. However, most participants did not perceive HPV as the sole cause of 
cervical cancer and believed that HPV might be transmitted in other ways. It was also 
interesting to note that although the majority of women thought that HPV was sexually 
transmitted, consistent with other studies (Bowyer et al. 2013), a number also believed 
that it might be transmitted through the air, similarly to the common cold virus or 
through contaminated bodily fluids.  
 
Although participants were sampled for a lower intention to self-sample (as 
determined by the survey in Chapter 4), similarly to other studies (Forrest et al. 2004; 
Crofts et al. 2015; Llangovan et al. 2016) the majority of participants reported 
acceptability of HPV self-sampling in general. However, conversely to Crofts et al 
(2015) and Llangovan et al. (2016), participants had reservations regarding conducting 
the test properly as well as test efficacy, system set-up and confidence in results. This 
might be due to the different sample populations and setting of the other studies. The 
Llangovan et al (2016) study investigated the acceptability of HPV self-sampling in 
Latina and Haitian women in the U.S., many of which had not ever participated in 
cervical screening and therefore were unable to compare HPV self-sampling and 
cervical smear tests. The participants in the current study were all cervical screening 
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responders and some had experience with cervical abnormalities and were therefore 
engaged within the current cervical screening system. The Crofts et al (2015) study was 
conducted in Cameroon which is a country that does not have an organised cervical 
screening programme and participants were involved in a lecture explaining cervical 
cancer, HPV and self-sampling with an opportunity for questions. Therefore the 
women had more knowledge of HPV self-sampling and had any questions answered 
before conducting actually conducting the procedure.  In the current study, women’s 
hypothetical intentions were explored and they were not provided with thorough 
information explaining cervical cancer, HPV and self-sampling, therefore any concerns 
would not have been addressed as they were in the Crofts et al (2015) study. 
Furthermore, the intention-behaviour gap must be considered as women may behave 
differently to their reported intentions if HPV self-sampling is available (Chapter 1).  
Similarly, Forrest et al. (2004) also found that intention to self-sample was high when 
asking women about their hypothetical self-sampling intentions. Although the present 
study and that of Forest et al both report a hypothetical HPV self-sampling intention, 
they utilised different methodologies and populations. Forest et al used a quantitative 
approach only and excluded women who had previous cervical abnormalities. 
However, the current study explored women’s intentions to HPV self-sample in depth 
through qualitative methods and provided insight into the attitudes of women who 
have previously had cervical abnormalities.  
 
Women’s belief that they would not be able to carry out the self-sampling procedure 
properly was highly important in determining their self-sampling intentions and their 
level of confidence in the results.  Although women’s concerns about their ability to 
conduct self-sampling properly have been identified in previous research (Barata et al. 
2008; Szarewski et al. 2009; Fargnoli et al. 2015), others have identified the ability for 
women to conduct HPV self-sampling themselves as a facilitator to conducting self-
sampling (Bosgraaf et al. 2014). However, this was the first study to provide insight into 
how self-efficacy influenced women’s intentions to self-sample. Low self-efficacy was 
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exhibited by women’s concern that they would not be able to carry out self-sampling 
properly. Lack of confidence in self-sampling result was attributed to a lack of personal 
expertise, lack of practice, age, lack of information and lack of expert support. It is 
interesting to note that, very early in the interview, women disclosed a higher level of 
confidence when discussing their understanding of HPV self-sampling. As the 
interviews progressed however, many stated that they might not be confident in the 
results of HPV self-sampling, due to a fear of carrying out the procedure incorrectly. It 
is therefore plausible to infer that when discussing confidence in the  self-sampling 
results in the context of understanding self-sampling, women might not have thought 
about how confident they would be in their ability to carry out the sampling correctly 
and the impact that belief might have on their confidence in the results obtained.   
 
The effect of self-efficacy as a direct influencing factor, as well as part of a multitude of 
perceived barriers to self-sampling, was also identified (Zumbo and Wu 2008). When 
self-efficacy was part of multiple barriers that would be weighed up against perceived 
benefits in determining self-sampling intention, it appeared to be an additional barrier. 
Conversely, when women stated that worry about not carrying out self-sampling 
properly (low self-efficacy) would be the most influential factor in determining 
intention to self-sample, despite all other barriers and benefits, self-efficacy acted as a 
direct influence. 
Waller et al (2006) found that women reported higher self-efficacy in their ability to 
carry out self-sampling compared to that observed in the current study. Waller et al. 
(2006) examined the acceptability of HPV self-sampling among British women who 
actually carried out self-sampling and also received a health professional cervical 
screen as part of the study. Their survey found  that over 90% of women felt ‘fairly’ or 
‘very’ confident that they had carried out self-sampling properly, with 44% of women 
not being more confident that the clinician administered test had been done properly. 
The discrepant study findings may reflect the different methods used. The current 
study asked women about hypothetical intention to self-sample and to discuss factors 
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that might impact their intention, whilst Waller et al (2006) involved women self-
sampling in a clinic environment. Although women were left on their own in the clinic 
to carry out the self-sampling (therefore potentially replicating a scenario at home), 
they were nevertheless in a health care setting which may have reassured them that 
the environment was suitably clean for them to self-sample (a barrier identified in the 
present study). They also had contact with a healthcare provider or researcher who 
would have explained the study, providing an opportunity for questions and immediate 
access to expert advice. Furthermore, women would have been aware that they were 
carrying out self-sampling for the purpose of a study and were also receiving a clinician 
administered test. This might have reassured them that even if they had not conducted 
the self-sampling properly, any abnormalities would have been identified by the clinical 
test. In the current study, women were asked to discuss self-sampling without the 
availability of an alternative clinical test. This could have led women to identify self-
efficacy as a more salient factor in forming their intention to self-sample as they felt 
that it would be the only opportunity for a cervical screen. This might have caused 
them to reflect on the factors that might impact their decision to self-sample in more 
depth, with further insight being facilitated by the use of qualitative methodology 
adopted.    
 
Barriers to HPV self-sampling that emerged in the present study reflected women’s 
concerns about safety and, similar to previous studies, included perception of physical 
harm to self, lack of confidence in the results, and worry about sending the kit through 
the post. However, this study is the first to provide insight into the potential influence 
of operational and system-related barriers to HPV self-sampling. Women were worried 
about the self-sampling kit getting lost or contaminated and the possibility of identity 
theft, and wanted to receive an acknowledgment that their kit had arrived at the 
laboratory safely.  
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Confidence in the self-sampling programme was also identified as very important in 
determining women’s self-sampling intention, with some women even being sceptical 
as to why the present research was being conducted. Similarly to Sultana et al. (2015) 
women wanted information about the organisation that would be responsible for HPV 
self-sampling. Furthermore, participants wanted to understand the motives behind a 
new cervical system set-up and expressed concerns that it will be motivated by cost 
cutting for the NHS and compromise patient safety.  
 
Barriers such as worry about potential kit contamination due to dropping the kit swab 
or sampling in an ‘unclean’ environment and a perceived delay in completing the kit 
due to privacy issues and distractions within the home were also identified. Whilst 
some of these barriers are similar to those previously identified by research into 
attitudes towards FOBT sampling, such as worry about sending kit through the post 
(Palmer et al. 2014), others were different. When discussing FOBT individuals reported 
concerns that their bathroom may become contaminated with faecal matter and 
therefore become dirty (Palmer et al. 2014). In contrast for HPV self-sampling women 
were concerned that their home environment may not be clean enough to carry out 
self-sampling. Perceived benefits of and reassurance associated with cervical smear 
tests were also identified as barriers to self-sampling, particularly the perception that 
the health professional conducting the smear test would also carry out a general 
gynaecological health check, which would not be possible if women were engaging in 
self-sampling. 
 
The current study revealed a number of HPV self-sampling enablers, including 
convenience, time efficiency and the perception that self-sampling would be less 
embarrassing, uncomfortable and invasive than having a cervical smear. These are 
similar to the findings of previous studies (Harper et al. 2002; Barata et al. 2008; 
Bosgraaf et al. 2014; Sultana et al. 2015). However, the present study also identified 
conditional altruism, psychosexual issues and devolved responsibility as facilitator to 
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self-sampling. Some women felt that participating in self-sampling might result in more 
health practitioner appointment availability for the benefit of individuals who need 
access to health care. Women thought that by participating in self-sampling they would 
be contributing to reduced costs for the NHS, which could be redistributed to enhance 
available treatments. Altruistic beliefs were conditional because women were only 
happy to contribute to cost and time-saving as long as it benefited patients and not the 
NHS as an institution. For one participant, fear and mistrust of health professionals 
taking cervical smears were highly salient motivators for engaging in HPV self-sampling.  
Psychosexual issues in women who have been sexually abused have been identified as 
barriers to cervical smear testing (Cadman et al. 2012). Finally, devolved responsibility 
was also evident as a facilitator to self-sampling. This was a facilitator in women who 
felt reassured that a system would be in place to alert them if they had not sampled 
correctly. 
 
5.6.1 Strengths and limitations of the current study 
In this study, sampling continued until ‘data saturation’ was achieved. However, it is 
important to acknowledge that true data saturation would be something that is very 
difficult to achieve as every individual will have a slightly different perception relating 
to HPV self-sampling. Therefore, data saturation in this context refers to the 
identification of no new significant or relevant themes of interest to the study 
objectives. The type of information that is obtained from qualitative studies is very rich 
in detail, necessitating relatively small sample sizes so that the data can be analysed in 
depth (Ritchie et al. 2006). Furthermore, because participants were purposively 
recruited based on low intention to self-sample as measured by the survey (Chapter 4), 
different themes might have been identified if other women had been recruited. The 
potential for sampling bias is acknowledged as the sample was not representative of 
the population as a whole. The sample was not representative as it included a high 
number of highly educated white women and women who had all previously attended 
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a smear test appointment, and many of whom had previously received abnormal 
smear test results.  
The majority of research into attitudes towards HPV self-sampling has been carried out 
in women who do not attend cervical screening, and is helpful if self-sampling is to be 
offered as an additional method for cervical screening in non-attenders. However, it 
was considered important to understand the attitudes of cervical screening attenders if 
self-sampling is to potentially replace routine cervical smear screening or be used as a 
method of triage. It was also important to ascertain the self-sampling intentions of 
women who have had an abnormal smear test result because many of them would 
eventually be returned to the screening programme and may have to utilise HPV self-
sampling. However, this study investigated women’s attitudes towards HPV self-
sampling in a hypothetical scenario where women were asked to predict their 
intention to self-sample should it become incorporated into the cervical screening 
programme. Therefore, it may be argued that women’s intentions may be different if 
they were physically presented with a HPV self-sampling kit for cervical screening.  
Although all women interviewed had been classified as less likely to self-sample by the 
survey, some reported that they would engage in HPV self-sampling. This discrepancy 
might have been observed because the survey stated that the women were less likely 
to self-sample as opposed to not intending to self-sample at all. It therefore might have 
identified women who had more questions about self-sampling and were more 
apprehensive about this screening method. Furthermore, the survey utilised 
quantitative methods to ascertain women’s intentions to self-sample, whilst the 
interviews provided further insight and depth on how intentions were formed. The 
high level of self-sampling intention observed is contrary to that observed in some 
other studies (Bais et al. 2007; Sanner et al. 2009a; Gok et al. 2010), where only around 
a third of women reported that they would be likely to self-sample. It is important to 
note that the majority of these studies involved women who were cervical screening 
non-responders and were therefore a difficult group of women to engage in screening. 
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In contrast, all of the participants in the current study had attended a cervical smear 
screen and were already engaged in the cervical screening programme, which might 
explain the high intention rate.  The qualitative approach was able to provide more 
insight and depth in understanding the way in which intentions to self-sample were 
formed by acknowledging the world view of the participants (Ritchie and Spencer 
2002). Interviews were an appropriate data collection method as they facilitated the 
in-depth exploration of interactions between factors previously identified (Chapter 4) 
as being associated with intentions to self-sample (Smith 1995). The semi-structured 
interview schedule consisted of open ended questions, probes and follow up 
questions, ensuring that the topics covered in each interview were standardised. This 
ensured that all participants  responded to the same questions, representing a range of 
views (Bourgeault et al. 2010). However, due to the flexible and reflexive nature of 
interviews, deviations from the interview schedule were often observed, and therefore 
interviews allowed new themes to emerge (Green and Thorogood 2011).   
Verbatim transcription was conducted and was a useful method in bringing the 
researcher closer to the data than selective transcription (Halcomb and Davidson 
2006). Verbatim transcription was beneficial for facilitating the development of the 
conceptual framework by enabling the researcher to check the relevant primary data.  
It also provided an audit trail (Halcomb and Davidson 2006) for the data analysis and 
framework modification process. Nevertheless, the process of transcription is prone to 
human error and interpretation of phrases might have been altered if the intonation of 
words transcribed were also noted. To minimise this risk, the researcher listened to all 
the interview recordings before the transcript analysis and was familiar with the tone 
of the interview.  
Framework analysis was particularly suitable for the present study, because findings 
will be used to inform the content of a behavioural intervention and to help inform 
policy and practice (Green and Thorogood 2011). A detailed framework analysis was 
conducted which was highly time consuming but was able to provide a rich, clear and 
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structured representation of women’s attitudes towards HPV self-sampling. Although 
the framework originally started deductively from pre-set categories relating to the 
HBM and findings from the survey, it was modified extensively throughout the 
analytical process which became more thematic and therefore became a highly 
complex multi-level framework. The structured nature of the framework facilitated the 
viewing and assessment of the data analysis process by people other than the primary 
analyst (Pope et al. 2000).   
5.6.2 Conclusion 
The present chapter facilitated a rich understanding of potential facilitators and 
barriers to primary HPV self-sampling. This is the first study to highlight the potentially 
important influence of system factors on intentions to self-sample. To encourage 
uptake of HPV self-sampling, an intervention is needed that aims to increase women’s 
HPV knowledge, confidence in their ability to carry out HPV self-sampling and 
confidence in the set-up of a potential self-sampling programme.  
The following chapter will describe how factors identified in this PhD research were 
synthesised to form the content of a theoretically-based intervention designed to 
increase engagement with HPV self-sampling.
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Chapter 6  
Intervention development and user testing 
6.1 Chapter Overview 
This chapter will present the development, preliminary user testing and subsequent 
modification of an intervention to enhance uptake of HPV self-sampling.  
6.2 Introduction 
Findings from the previous phases of work were used to develop a draft intervention to 
enhance uptake of HPV self-sampling. Barriers and enablers to HPV self-sampling 
identified in Chapters 4 and 6 were synthesised in the draft intervention, which was 
designed to increase women’s HPV related knowledge, address identified barriers, 
highlight benefits of self-sampling and to increase self-efficacy. Self-efficacy refers to 
the users’ confidence in their ability to carry out self-sampling correctly.  Increasing 
self-efficacy beliefs was highly important because self-efficacy was shown to be the 
strongest predictor of intention to self-sample (Chapter 4) and influenced women’s 
confidence in HPV self-sampling results.  
Interventions to promote health protective behaviour can be developed at an 
individual level, community level and organizational level or societal level (Westmaas 
et al. 2007). Interventions designed to promote healthy behaviour can be targeted 
directly at the individual, by attempting to alter attitudes and beliefs through an 
intervention directly distributed to the individual such as a leaflet. Interventions that 
attempt to alter societal or community attitudes attempt to influence whole 
communities. Such interventions can include media campaigns such as posters and 
social organisations to promote healthy behaviours. The population based 
interventions are wide spread interventions designed to portray simple messages and 
include laws such as wearing seat belts whilst in cars and the prohibition of smoking in 
social spaces. The Behaviour Change Wheel (BCW) (Michie et al. 2011) can be used to 
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design interventions that capture different sources of behaviour, such as individual 
perceptions regarding capability, motivation and opportunity, as well policy 
considerations. Therefore, the BCW could have been used to develop an intervention 
designed to address both individual, as well as social and policy level considerations 
associated with HPV self-sampling intention. However, as a HPV self-sampling 
programme is currently not available, policy considerations are still to be debated. 
Therefore, it was decided that although the BCW would be a useful model for 
intervention development that can account for individual, societal and policy 
considerations, an intervention that focused on the individual level would be 
preferable in this context.  It was decided that the intervention would be based on the 
extended Health Belief Model (Rosenstock, 1988), which focused the investigation and 
exploration of women’s intentions to HPV self-sample throughout this research. 
Therefore, the intervention was developed to address the identified barriers and 
facilitators to HPV self-sampling and was structured around the HBM constructs.   
Guidance for developing quality health-related information (Charnock 1998) was also 
used to structure the draft intervention. In line with MRC guidance for developing 
complex interventions, key empirical findings and theoretical concepts were linked to 
each section of the draft tool. The DISCERN handbook (Charnock 1998) was used to 
guide intervention development. DISCERN determines the quality criteria for consumer 
health information on treatment choices. Although the HPV self-sampling intervention 
does not provide information about treatment choices, the principles of the DISCERN 
handbook were transferrable in terms of helping to ensure the clear presentation of 
information. A small sample of potential intervention users and providers were 
recruited to explore the usability of the draft intervention to help ensure that it is user-
friendly and reflective of a potential future HPV self-sampling system. 
This chapter aims to (1) describe the creation of the first draft HPV self-sampling 
intervention, (2) outline usability and acceptability testing of the draft intervention 
during a small pilot study, and (3) present modifications to the intervention based on 
the findings of preliminary user testing. 
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6.3 Development of the HPV self-sampling intervention 
6.3.1 Intervention format and content preferences 
Women who participated in the interview study (Chapter 5) were asked to provide 
hypothetical suggestions for preferred intervention content and format at the end of 
their interviews. A framework analysis approach was applied (Ritchie and Spencer 
2002). The framework analysis approach is described in Chapter 5.  
Participants made suggestions relating to the design and layout of a hypothetical HPV 
self-sampling intervention. Participants felt that a simple layout stating the facts about 
HPV self-sampling with a question and answer format would be the most appropriate, 
for example in the form of “frequently asked questions” (P7). 
Participants felt that their confidence in the credibility of the information presented 
would be increased if the hypothetical intervention appeared to look official: 
I’d like colours for sure…I think that for my confidence if it felt like a proper, 
proper document that would feel good (P5) 
 
There was also a preference for visual representations. 
 
I want it to have like a sort of, I want it to have pictures, quite a lot of 
pictures, because I think that when I’m nervous I find it hard to take in too 
much text (P5) 
Two of the participants felt that as well as a paper-based intervention, they would also 
hypothetically like to have access to a video (on-line). They felt that a video with a 
health professional explaining what self-sampling is and demonstrating the way self-
sampling should be conducted would provide them with more confidence. Although 
the provision of a video in addition to a paper-based intervention was suggested by 
some participants, they felt that this form of intervention would potentially act as 
supplementary to a paper-based intervention. Therefore, the development of a paper-
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based intervention was prioritised because the development of both paper and video 
interventions was beyond the scope of this study. Future research should develop an 
on-line educational and instructional HPV self-sampling video to compliment the 
paper-based intervention developed. 
6.3.2 Information quality  
Based on DISCERN guidelines the draft intervention was designed to include: 
(1) a clear statement of aims at the beginning of the publication. 
(2) a clear format of the intervention to help achieve the aim of increasing self-
sampling intentions 
(3) explanation of the relevance of the information to the individual 
(4) clear reference to sources of information 
(5) production date of sources of information and version number of intervention 
(6) a balance of information 
(7) provision of additional sources of support and information 
Evidence for the fulfilment of these requirements will be shown in the description of 
the intervention. 
To ensure that the content of the draft intervention was user friendly, the Plain English 
Campaign guidelines (http://www.plainenglish.co.uk/free-guides.html) were followed. 
Sans serif type font was chosen because serif fonts can be confusing for readers, 
headings were made bigger than the text size and emphasis was shown in bold type 
and not italics or underlining. Sentences were kept to a maximum of around 20 words. 
A preference for active verbs was applied throughout the text, following a subject, verb 
and object pattern as much as possible. This facilitated the content to sound more 
active, less confusing and more engaging. A question and answer format was adopted 
throughout most of the intervention to enable the reader to easily navigate through 
the text. 
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To help ensure that the intervention was accessible to the majority of the target 
population, a Flesch reading ease score of 87.1 was obtained, which is equivalent to the 
reading ability of an eight to nine year old. 
6.4 Content of draft HPV self-sampling intervention 
Content development is presented below, with each section of the intervention linked 
to empirical findings and theoretical concerns. A graphic design company (Jessica 
Draws) was commissioned to design the characters and diagrams included in the 
intervention. The intervention only included information relating to HPV and cervical 
cancer and did not include information about other HPV related cancers and 
conditions, such as genital warts and cancer of the vulva, vagina, anus and oropharynx 
(Parkin and Bray 2006). It was thought that provision of such information might have 
resulted in too much information for participants to meaningfully interpret and might 
also have resulted in unnecessary elevation of anxiety relating to a potential HPV 
positive status.   
Front page 
Following guidance from DISCERN point 1 (Charnock 1998), the front cover of the 
intervention included a clear statement of its aims: “This guide will help you 
understand what HPV self-sampling is and how easy it is for you to do”. Self-efficacy in 
relation to HPV self-sampling was addressed in the form of a statement highlighting 
that self-sampling is “easy... for you to do”. 
The second section of text explained what the intervention does not do (explain how to 
conduct HPV self-sampling) and directed individuals to an information source where 
they could access that information: “The instructions in your self-sampling kit will show 
you how to do HPV self-sampling.” 
 
 177 
 
 
Figure 6.1: Front page 
System continuity and confidence in a new screening method were previously 
identified as barriers to self-sampling. The Cervical Screening Wales logo was therefore 
located at the bottom of the front page to signify a form of system continuation and 
confidence in the self-sampling method by referring to an agency that women were 
already familiar with.  
The first section of the leaflet entitled “What is it all about” provided information to 
help increase HPV knowledge and perceived susceptibility to HPV infection and provide 
reassurance about perceived severity. The section was comprised of five question and 
answer sub-sections that are discussed below. 
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“Who is organising self-sampling?” 
As identified in Chapter 5, women had more confidence in HPV self-sampling if they 
perceived continuity with the existing cervical screening programme. Low confidence 
was identified as a barrier to self-sampling intention; therefore alleviating this barrier 
should help users to form a more positive intention. The information within this 
section was designed to increase confidence by identifying the professional 
organisations involved in self-sampling. This sub-section explicitly identified two 
familiar organisations: the National Health Service (NHS) and Cervical Screening Wales.  
 
Figure 6.2: Design and content of Who is organising HPV self-sampling? 
 
“What is HPV self-sampling?” 
The qualitative interview phase (Chapter 5) identified that when first presented with 
the idea of HPV self-sampling, most women had misconceptions regarding what HPV 
self-sampling would involve and perceived that self-sampling was the same as cervical 
smear testing. This resulted in concerns regarding the complexity of self-sampling and 
acted as a potential barrier. An initial statement pertaining to speed and ease of self-
sampling was included to help address this misconception. The second sentence in the 
sub-section section related to women’s concerns that HPV self-sampling is a new 
method that has not been tried and tested, as identified in the qualitative phase 
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(Chapter 4). The sentence aimed to reassure the user that research has been 
conducted into self-sampling and that it is a good method of cervical screening. The 
third sentence explained the purpose of HPV self-sampling, in order to help increase 
understanding of the test. 
 
Figure 6.3: Design and layout of What is HPV self-sampling? 
 
What is HPV? How can I get HPV? Can HPV be treated? 
The following three sub-sections were primarily designed to increase women’s HPV 
related knowledge. Both the survey (Chapter 4), the interviews (Chapter 5) and other 
studies (Marlow et al. 2013) have highlighted women’s low knowledge in relation to 
HPV and cervical cancer.  
 
Figure 6.4: Design and layout of What is HPV? 
The first sub-section “What is HPV?” aimed to increase the users’ HPV knowledge by 
explaining that the cause of cervical cancer is HPV. It was considered important that a 
simple and bold statement about the causal agent of cervical cancer was included 
because many of the interview participants did not perceive HPV as the sole cause of 
cervical cancer and cited other factors. Belief that HPV is the main cause of cervical 
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cancer was shown to be significantly associated with intention to self-sample (Chapter 
4).  
As well as addressing knowledge, the sub-sections “How can I get HPV?” and “Can HPV 
be treated?” addressed the issues of perceived susceptibility to HPV and perceived 
severity of HPV infection. The sub-section “How can I get HPV?” aimed to increase 
women’s perceived susceptibility to HPV by highlighting its high prevalence rate and 
addressing the misconception that having a small number of sexual partners would be 
protective against HPV, therefore making the publication relevant to the user (as 
required by point 3 in the DISCERN checklist). These misconceptions were identified in 
the previous phases of work (Chapter 5).  
 
Figure 6.5: Design and layout of How can I get HPV? 
 
Figure 6.6: Design and layout of Can HPV be treated? 
The sub-section “Can HPV be treated?” aimed to increase users’ knowledge by 
providing information about the treatment of abnormal cells but not HPV. The section 
also addressed women’s perceived severity to HPV infection by stating that the 
infection cannot be treated with medicines and that the infection is usually cleared 
away by the immune system. This section had to be balanced to ensure that it would 
not elevate women’s anxiety at the prospect of HPV infection, but would encourage 
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the infection to be perceived as something that would warrant monitoring through 
self-sampling.  
The second section of the intervention entitled “Tell me more” aimed to minimise 
perceived barriers and maximise perceived benefits of self-sampling, as well as 
increase HPV related self-efficacy. According to the HBM, maximising benefits, 
minimising barriers and increasing self-efficacy beliefs about self-sampling would result 
in an increase in intention to self-sample. This section also aimed to increase the users’ 
confidence that they would not be receiving an inferior test compared to a cervical 
smear. This section was comprised of six question and answer sub-sections as well as a 
graphical representation of the female genital tract. These are discussed below. 
“Is HPV self-sampling as good as a smear test?” 
Confidence in the reasons for the introduction of HPV self-sampling was identified as a 
salient barrier to HPV self-sampling during the qualitative aspect of this study (Chapter 
5). The purpose of this sub-section was to reassure the user that self-sampling was an 
effective and credible method of cervical screening. Research findings indicating that 
HPV self-sampling is a good method of cervical screening were used to highlight this. 
During the qualitative phase and when asked for suggestions for intervention content 
women expressed a strong desire for information based on research.  
 
Figure 6.7: Design and layout of Is HPV self-sampling as good as a smear test? 
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“What is good about HPV self-sampling?” 
The benefits of self-sampling were highlighted in this sub-section. The benefits that 
were most commonly reported by women during the previous survey (Chapter 4) and 
interview (Chapter 5) phases related to perceived convenience of HPV self-sampling. 
Although conditional altruism was also identified as a benefit during the qualitative 
phase, it was not included in the intervention because it was not one of the most 
salient benefits, was very difficult to summarise and would have made the sub-section 
too long.   
 
Figure 6.8: Design and layout of What is good about HPV self-sampling? 
“I am not a doctor/nurse, can I do HPV self-sampling?” 
The focus of this sub-section was to increase the users’ confidence that they could 
carry out HPV self-sampling correctly, therefore increasing their perceived self-efficacy. 
Consequently, a statement outlining that most women can carry out self-sampling 
correctly was first in this sub-section. Women reported being worried that they were 
not health professionals and held no expertise in conducting self-sampling, thus a 
statement was included to explain that the user does not need to be a health 
professional. The last sentence addressed women’s concerns that the self-sampling 
test would be complicated and that instructions provided with the kit would be easy to 
understand, therefore not necessitating practice. The combination of the information 
provided in the three sentences of this sub-section was designed to address common 
self-efficacy concerns. 
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Figure 6.9: Design and layout of I am not a doctor/nurse, can I do self-sampling? 
 
“Will someone tell me if I haven’t done the HPV self-sampling right?” and “What if I 
don’t reach far enough inside or miss something?” 
During the interviews, women were concerned that they might sample incorrectly and 
that the laboratory staff would be unaware of this. As a result, women felt that they 
might be provided with false negative results due to their improper sampling 
technique. When referring to inaccurate results, women were concerned that they 
might have failed to collect a sample from a HPV infected area within their vagina. This 
lack of confidence was seen as a highly salient barrier to self-sampling and is a crucial 
factor within the HBM in determining intentions to engage in behaviour. A statement 
and diagram were therefore developed to highlight that if HPV was present, it would 
be in the whole genital tract. The diagram was a simple way to show the location of 
HPV, and to demonstrate that HPV would not be solely present in a small differentiated 
area which could be ‘missed’.  
It was considered important that a statement differentiating the HPV self-sampling 
procedure from cervical smear testing was incorporated in this sub-section, because 
the previous phases of research identified that many women believed that self-
sampling would involve collection of cells from the cervix.  Evidence suggests that 
visual representations of clinical information can be beneficial to aiding understanding 
(Edwards et al. 2002). 
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Figure 6.10: Design and layout of Will someone tell me if I have not done the HPV self-
sampling right? and What if I do not reach far enough inside or I miss something? 
Diagram of operational aspects of HPV self-sampling  
Concern regarding the operational factors associated with self-sampling was identified 
as an important influence on women’s intentions to self-sample (Chapter 5). The 
intervention therefore included a visual representation of the operational factors 
associated with self-sampling. The operational factors are textually explained in the 
preceding question and answer section. 
 185 
 
 
Figure 6.11: Design and layout of diagram of operational aspects 
“Do I have to send my completed kit through the post”, “How will I know if my kit has 
been lost?” and “How will I receive my results?”  
Women wanted to have as much information as possible about how a new HPV self-
sampling programme would function. Specific barriers associated with operational 
factors, such as concerns that their self-sampling kit might get lost, damaged or 
contaminated in the post, contributed to low confidence in self-sampling results. It was 
considered important that the effect of any barriers to self-sampling was minimised to 
help promote positive beliefs about self-sampling. 
The first two question and answer sub-sections: “Do I have to send my completed kit 
through the post?” and “How will I know if my kit has been lost?” aimed to address 
women’s concerns about sending their completed self-sampling kit through the post. It 
was important to reassure women that they would be alerted if their sample was not 
received, and that they would be provided with an opportunity to re-sample. The lack 
of an acknowledgment that a sample has reached a testing laboratory safely was a 
significant barrier to intention. However, because the self-sampling programme is not 
yet developed, the procedures applied to the Bowel Screening Programme in regards 
to sample loss/contamination or damage were stated: that another self-sampling kit 
would be sent to women for re-sampling. 
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The final question and answer sub-section related to the receipt of self-sampling 
results. The aim of this sub-section was to increase women’s self-efficacy beliefs in 
being able to carry out self-sampling by suppressing negative emotional arousal. 
Emotional arousal has been cited as a source of influence on perceived self-efficacy 
(Bandura 1997). In this context, emotional arousal referred to women’s apprehension 
about not carrying out self-sampling properly, which may make them feel less capable 
of mastering self-sampling. Therefore, a clear statement was included with the aim of 
reassuring women that if they were provided with a result, then they had self-sampled 
correctly.   
 
Figure 6.12: Design and layout of Sending your kit and receiving your results 
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Visual representation of 99/100 women   
 
Due to the significant effect of women’s perceived ability to conduct self-sampling 
correctly on intention to self-sample (as identified in Chapters 4 and 6), it was 
considered necessary to include a visual aid to represent the high proportion of women 
who have been shown to carry out self-sampling properly (Szarewski et al. 2011).  
Icon array diagrams can help aid accurate understanding of probabilities (Trevana et al. 
2012), by reducing biases such as denominator neglect and framing effects. Icon array 
diagrams can be particularly useful in individuals who have high graphical literacy and 
those who have problems with understanding and applying numerical data (Trevana et 
al. 2012). 
The icon array diagram used in the intervention was designed to represent 99 women 
(portrayed by female icons) who had conducted self-sampling properly, along with a 
positive character representation of one woman who had not conducted self-sampling 
properly. The positive framing of the text and the smiling character aim to decrease 
any apprehension in women, which has been shown to be important in increasing 
perceived self-efficacy (Bandura 1997). 
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Figure 6.13: Icon array of 99/100 
women 
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Vignette: “Miriam’s worry: Doing HPV self-sampling properly” 
 
Figure 6.14: Vignette 
A vignette was included to help balance out the benefits versus barriers equation 
within the HBM and to increase self-efficacy. The benefits, barriers and self-efficacy 
concerns used within the vignette were the most prominent ones identified in the 
previous phases of work. 
The vignette was designed to represent a real-life situation and required a degree of 
contextualisation (West 1982). It was used within the intervention to help emulate a 
source of vicarious experience. Through social comparison processes, vicarious 
experience was used to increase perceived benefits and self-efficacy beliefs when a 
model person that is similar to the individual is shown to have mastered a specific 
behaviour (Bandura 1997). 
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The character ‘Miriam’ in the vignette represents the most salient barrier to self-
sampling: self-efficacy. The character on the left presented self-efficacy as a barrier to 
self-sampling in stating that she would be concerned about carrying out self-sampling 
properly, and whether she may have failed to obtain a sample from a HPV infected 
area. The character subsequently presents a further barrier that was identified as 
highly salient: lack of trust in self-sampling results. The character on the right 
represents a model person. The model person exhibits mastery of self-sampling by 
stating that she had conducted self-sampling and reassures ‘Miriam’ that the 
procedure was easy. The model person also highlights one of the most salient benefits 
of self-sampling as identified by this study (convenience) and other studies, for 
example Barata et al. (2008). The model person further reassures ‘Miriam’ by stating 
that she would be informed if she had conducted self-sampling incorrectly and that it 
would be difficult for her to miss a HPV infected spot if she followed the instructions. 
The aims of this last statement were to increase confidence in the programme and self-
efficacy. An explanation of the concerns presented in the vignette was included to 
provide a rationale for its inclusion and to reiterate that most women are able to self-
sample correctly.  
“Do you have any more questions about self-sampling?” and logos, further support 
and sources of information 
This section provides the reader opportunity to contact a relevant body relating to self-
sampling should they have any further questions.  The study identified the need to 
provide a telephone number that women could contact should they need to discuss 
self-sampling. It was identified previously (Chapter 5) that women felt that the 
opportunity to speak to a health professional might result in them being more likely to 
conduct self-sampling.  
This relates to point 4 of the DISCERN handbook regarding information. Sources of 
research evidence quoted in the intervention were also included. The section outlines 
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the developers of the intervention and states that women from South Wales were 
involved with development, helping women to identify with the content.  
The logos presented identify the institutions involved in the development of the leaflet 
(Cardiff University, HealthCare Communication and Quality group), and the service 
providers (The NHS and Cervical Screening Wales). It was important that logos were 
presented in the intervention to help highlight that the same agencies responsible for 
the current cervical screening programme would be involved in HPV self-sampling. 
 
 
Figure 6.15: Further information 
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6.5 User testing study 
The usability of the HPV self-sampling intervention was investigated with the aim of 
incorporating any suggested improvements into a further draft of the intervention. This 
phase involved a small pilot study to examine the acceptability of the draft 
intervention.  
Specific objectives were to: 
1. To explore whether the self-sampling intervention is acceptable to women by 
exploring ease of understanding, whether it adequately addresses the most 
salient barriers to self-sampling, and whether it sufficiently engaged users in 
terms of language and graphical representations. 
2. To discuss perceived barriers and facilitators to implementation with potential 
providers. 
3. To pilot test the feasibility of using a before and after questionnaire that can be 
used to examine whether the intervention is able to increase intention to self-
sample by addressing identified barriers and facilitators to self-sampling.  
 
6.5.1 Study design  
Semi-structured qualitative interviews were carried out with a small sample of 
potential intervention users and providers. In addition, intervention users completed 
questionnaires before and after exposure to the intervention, in order to examine the 
impact of the intervention on key outcomes. The aim of the questionnaires was to 
identify participant HPV knowledge and HPV self-sampling intentions and beliefs to 
enable a basic comparison of before intervention exposure and after intervention 
exposure effects. The purpose of the semi-structured interviews was to explore the 
usability of the intervention and to seek feedback regarding intervention improvement. 
 Objective 1 was addressed by a pre-and post-intervention questionnaire, as well as 
discussion during semi-structured interviews. Objective 2 was explored during the 
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interview stage; however participants were also encouraged to complete a free-text 
box during the questionnaire which also addressed this objective. Objective 3 was 
explored during interviews with Cervical Screening providers. 
 
6.5.2 Materials and Measures 
 
Intervention users 
 
Women completed pre- and post-intervention questionnaires (Appendix 6.1) and semi-
structured interviews (Appendix 6.2) to assess the face validity of the intervention. 
Questionnaire measures included HPV self-sampling intention, HPV knowledge and 
health beliefs based on the extended HBM and process measures. HPV knowledge was 
investigated by a free text item at the beginning of the questionnaire “What do you 
think causes cervical cancer?” as well as items adapted from a validated HPV measure 
(Waller et al. 2013), which were scored using true or false response options.  
Intention to HPV self-sample was measured using three items previously developed 
during this research (Chapters 3 and 4). Intention was scored on a Likert scale that 
ranged from 3 (lowest intention) to 15 (highest intention). 
 
Items relating to health beliefs as measured by the extended HBM were HPV self-
sampling self-efficacy, severity of HPV, susceptibility to HPV and benefits and barriers 
to HPV self-sampling. These items were developed during an earlier phase of this 
research (Chapters 3 and 4) and were all scored on a Likert scale. The self-efficacy scale 
ranged from 4 (lowest intention) to 20 (highest intention); the severity scale ranged 
from 1 (not at all serious) to 5 (very serious); the benefits scale ranged from 2 (least 
benefits) to 10 (most benefits); the barriers scale ranged from 3 (least barriers) to 15 
(most barriers).  
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Knowledge and health belief items were identical in the pre- and post-intervention 
questionnaires. The pre-intervention questionnaire contained additional basic 
information about what conducting HPV self-sampling would entail. The post-
intervention questionnaire included process measures to ascertain what women 
thought about the HPV self-sampling leaflet. Process measures included items to 
identify if intervention users found the leaflet “useful”, “easy to understand”, if they 
thought the information included was “too much”, “too little”, or “just right” and if 
they though that the vignette was “helpful”. Response options included tick boxes as 
well as space for free text comments. Further items investigated whether there was 
anything that intervention users wanted to “know more about”, if they “found any 
sections less useful” and if they had any suggestions for improvement. Response 
format for these items was space for free text comments. 
 
A semi-structured interview schedule (Appendix 6.2) was designed to explore the 
general acceptability of the HPV self-sampling intervention in terms of content and 
graphical representations. The interview schedule also explored women’s views on 
their whether their hypothetical intention to HPV self-sample, perceived benefits and 
barriers to self-sampling and self-efficacy were affected by the intervention. The 
interview schedule also invited suggestions for improvements to the intervention.  
 
Intervention providers 
The interview schedule for potential providers (Appendix 6.3) explored opinions 
relating to ease of understanding of the intervention, as well as its layout, accuracy of 
content and potential implementation. Implementation issues related to the feasibility 
of implementing the intervention within the cervical screening programme should 
primary HPV self-sampling be incorporated, as well as best point of implementation 
(e.g. alongside HPV self-sampling kit or prior to receipt of HPV self-sampling kit).  
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6.5.3 Participants 
Cervical Screening Wales service users and service providers were recruited. 
Inclusion criteria (not applicable to providers):  ability to converse in English, aged 
between 20 and 64 years, and able to provide written informed consent. 
6.5.4 Recruitment  
The study received ethical approval from the Cardiff University School of Medicine 
Research Ethics committee (SMREC number: 14/63) (Appendix 6.4) 
Users were opportunistically recruited using snowball sampling (e.g. afterschool clubs) 
and health professionals were recruited via e-mail invitation through established links 
with Cervical Screening Wales (please refer to Chapter 4).  
All participants were provided with a participant pack containing an information sheet 
(Appendix 6.5 and 6.6), consent form (Appendix 6.7) and pre-addressed envelope. All 
participants who consented to take part in the study were contacted to arrange a 
suitable time and date for interview. Interviews were audio recoded. The same process 
was used as in the main qualitative study (Chapter 5). 
 
6.5.5 Methods 
Service users completed a four step process: (1) completion of a pre-intervention 
questionnaire, (2) exposure to the intervention, (3) completion of the post-intervention 
questionnaire, (4) participation in a semi-structured interview (face-to-face interviews 
with women and telephone interviews with health professionals). The service 
providers only participated in step 4. 
 
For intervention users, steps one to three involved the following procedure: 
participants were provided with two sealed, numbered envelopes and instructed to 
firstly open envelope one and complete the pre-intervention questionnaire enclosed 
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and to return it back in the envelope. Participants were then instructed to open 
envelope number two and take time to read the enclosed intervention and to 
complete the post-intervention questionnaire enclosed and return it in the envelope. 
At the end of the study participants were instructed to return both envelopes to the 
researcher but to retain the HPV self-sampling intervention.  All participant instructions 
were stated on the questionnaires and envelopes. 
 
Participants were informed that they were free to withdraw from the study at any 
point without giving a reason and were fully debriefed at the end of the study. 
Participants were offered £10 to reimburse their time. 
6.5.6 Analysis 
Statistical analysis 
 
Baseline questionnaire data were summarised in terms of age, HPV knowledge and 
HPV self-sampling health beliefs. Descriptive statistics were used to assess potential 
influences of the intervention on outcomes including knowledge and health beliefs. 
Frequencies of scores were compared pre and post intervention. 
Qualitative analysis 
 
Interviews were transcribed and analysed using thematic analysis. Thematic analysis 
involved familiarisation with the data by reading transcripts and listening to interview 
recordings, generating initial codes, searching for broader themes among codes and 
reviewing and re-defining themes (Braun and Clarke 2006). 
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6.5.7 Results 
Participant characteristics 
Six women aged between 27 and 52 years were recruited.  
Participant 
number 
Age Education 
1 42 A level 
2 27 GCSE 
3 52 GCSE 
4 40 A level 
5 39 GCSE 
6 39 A level 
Table 6.1 Characteristics of users 
Health Professionals 
Two female health professionals were recruited from the Screening Division in Public 
Health Wales. The Screening Division in Public Health Wales is responsible for cervical 
screening within Wales. 
Questionnaire results 
HPV knowledge 
An increase in HPV related knowledge following intervention exposure was evident in 
the following: free-text identification of HPV as cause of cervical cancer, belief that HPV 
is common, belief that most sexually active individuals would get HPV at some point in 
their lives, belief that HPV can transmitted sexually and that men can also get HPV. 
Please refer to Figure 16. No changes in HPV knowledge following intervention 
exposure were observed in the following items: HPV does not need treatment, HPV has 
many different types, HPV cannot be cured with antibiotics, and HPV is an extremely 
serious infection. 
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Figure 6.16: Increase in intervention users correctly identifying HPV knowledge items 
post intervention.  
Intention to HPV self-sample, HPV self-sampling related self-efficacy, barriers and 
benefits to self-sampling. 
Table 6.2 provides summary statistics for HPV self-sampling intention, self-efficacy and 
perceived benefits and barriers to self-sampling before and after exposure to the 
intervention. A ceiling effect was observed for self-sampling intention, with four 
participants reporting the highest possible score for intention both at baseline and 
follow-up. A small increase in intention score (from 12 to 15) was observed for one 
participant, whilst intention score remained low for one participant. Self-efficacy 
scores were high overall at both time points level, and remained unchanged in three 
participants. A slight increase in self-efficacy was observed in two participants, and a 
slight decrease in one participant. One participant reported a small increase in 
perceived benefits of self-sampling, whilst the rest remained unchanged. Two 
participants reported a decrease in perceived barriers to self-sampling, two reported 
an increase in barriers, and two remained unchanged. 
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Participant 
 number 
Pre/post 
intervention 
Intention to 
self-sample 
(range 3-15) 
^   
Self-efficacy  
(range 4-20) 
^ 
Benefits 
(range 2-10) 
^ 
Barriers 
(range 3-15) 
^ 
1    Pre 15 18 9 4 
Post 15 20* 9 3* 
2 Pre 15 20 10 7 
Post 15 20 10 9* 
3 Pre 15 20 8 12 
Post 15 19* 9 14* 
4 Pre 3 16 10 9 
Post 3 16 10 7* 
5 Pre 15 20 10 3 
Post 15 20 10 3 
6 Pre 12 15 7 3 
Post 15* 20* 7 3 
  
 
 
 
 
 
 
 
 
 
 
 
 
* Change observed following intervention.   
^ Higher scores denote a higher intention to self-sample, higher self-efficacy and more perceived 
beliefs and barriers to HPV self-sampling.   
 
Table 6.2 Pre- and- post questionnaire responses    
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Process measures 
All women stated that the intervention was useful and five users stated that it made 
them feel more confident in their ability to carry out self-sampling correctly (Table 6.3). 
Process measure Responses 
(N=6) 
Overall, did you find the leaflet useful? 
  Yes 
  No 
 
6 
0 
Did you find the leaflet easy to understand? 
Yes 
No 
 
6 
0 
Did you think the amount of information in the leaflet was: 
Too much 
Too little 
Just right 
 
0 
0 
6 
Did the leaflet make you feel more confident in doing HPV self-sampling? 
Yes 
No 
 
5 
1 
Did you think Miriam’s story was helpful? 
Yes 
No 
 
6 
0 
 
 
 Interview Results 
All participants reported that they understood that the intervention was not a HPV 
self-sampling instructional leaflet. All participants understood that additional material 
would be supplied alongside the HPV self-sampling kit which would demonstrate how 
self-sampling should be conducted.  
Three main themes were identified from the interviews: positive aspects of the 
intervention, negative feedback and recommendations.  
Quotes presented in this section exemplify identified themes. Quotes are presented in 
italics, insertions to clarify content topic are presented in square brackets “[…]” and 
sections of irrelevant text are presented as “…”. Participants will be denoted as follows: 
Table 6.3: Process measures 
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health professionals will be denoted as HP7 or HP8 and users will be denoted as P1 to 
P6. 
6.5.7.1 Positive aspects of intervention 
The intervention was generally viewed very favourably. Positive comments were made 
regarding aspects of design and content that were viewed by participants as promoting 
HPV knowledge, self-efficacy and perceived benefits of HPV self-sampling. 
Purpose of intervention 
Participants reported that they clearly understood the purpose of the intervention, 
which was described as encouraging women to participate in HPV self-sampling and to 
make them feel confident enough to engage in self-sampling: 
to get people to do self-sampling and to tell them about the HPV virus 
(P2) 
  not to be afraid really to have a go yourself, that’s what comes across to 
   me (P4) 
  um I guess explaining what HPV self-sampling is (HP7) 
Format of intervention 
Participants reported that they liked the format of the intervention and found it simple 
and easy to understand: 
  very plain and simple, it is easy to understand (P4) 
The layout was positively perceived and facilitated participant understanding: 
easy to read […] it’s nice and spaced out so it’s not just one big block and 
it’s fine, good (P2) 
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Content of intervention 
The content of the intervention was well-received. Participants reported that the 
information provided was adequate. 
  the content was great. It told you everything you needed to know (P2) 
Participants also commented that the intervention was “very easy” to understand (P1) 
and that they believed that it would be understood by a range of different women. 
it’s simple isn’t it, I don’t think you could get it much simpler than that … 
so everybody would understand it I suppose, it doesn’t matter what your 
background … it’s clear (P4)  
The information content was positively described as “straightforward really” (P5) and 
“pretty informative” (P6), whilst one participant reported that the content was 
engaging “you can get through it very quickly and it’s not boring me” (P4). 
Participants also reported that they identified with the vignette presented. Participants 
felt that it represented a real life situation that they could relate to, and referred to 
themselves as the character that might have been unsure about engaging in self-
sampling. 
it is good because I think it’s probably the conversations lots of women 
would have with their friends anyway (P6) 
I liked the conversation bits, I thought that was quite nice” (HP8) 
I really like seeing on the back there was a real example of real women              
talking about it (HP7) 
 
The vignette was also described by one participant as helping to ensure that the 
intervention was reassuring and potentially helped to avoid increased anxiety in 
women regarding HPV and cervical cancer. 
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the conversation bit on the back is good , it’s a bit more light hearted 
almost, a little bit, so people don’t worry too much because you don’t 
want to sort of go “oooh my god and panic I’ve got HPV” …it’s reassuring 
as well (P1) 
 
HPV knowledge 
HPV information was viewed as clear and useful. Participants reported that their HPV 
related knowledge had increased due to the question and answer sections. 
I think it’s really clear, like I said I didn’t know anything about it really 
before I read that (P6) 
it told you everything you needed to know really, yeah (P5) 
[when questioned about the content of the intervention] well I didn’t 
know that HPV clears up on its own in most cases (P2) 
 
Self-efficacy 
Participants reported feeling more confident about their ability to undertake self-
sampling effectively following the intervention. Participants stated that the 
intervention made them feel that self-sampling would be simple to perform. Women 
felt reassured that they would not have to replicate a cervical smear procedure or to 
sample from a specific area within the vagina or the cervix. 
I didn’t think I’d be able to do it at first, but reading it and it explain in 
detail and I think I’d be able to do it, yeah (P3) 
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it makes me feel really confident, like I say I didn’t think it would be as 
simple as it is, this sounds really simple as it’s not like a smear where 
you’ve got to go so far internally (P6) 
pretty confident because you don’t have to get a specific spot (P2) 
When referring to feeling confident about being able to carry out self-sampling 
correctly, participants often referred to the diagram of the female anatomy. 
Participants liked how the diagram exemplified that HPV would be present in the 
whole of the inside vaginal area and found this reassuring. 
“I think the diagram of the anatomy, I think it’s a really useful thing to 
have (HP7) 
“ …the diagram you know it just reassures you I suppose (P1) 
Participants reported that the diagram helped them to specifically understand how far 
the swab would have to be inserted into the vagina and that the cervix would not need 
to be directly sampled.  
where um obviously the swab can go and how far … and obviously with 
the cervix and yeah it’s more detailed that’s what I like (P3) 
it’s not like a smear where you have to do so far internally (P6)  
Although the icon array diagram was not favourably viewed (discussed below), most 
participants found the information stating that 99 out of 100 women are able to carry 
out self-sampling correctly reassuring.  
Benefits and barriers to HPV self-sampling 
Participants reported an increase in benefits of self-sampling and a decrease in barriers 
to self-sampling following the intervention. Participants often referred to “not having 
to go to the doctor and finding childcare” (P2) as benefits of self-sampling. Participants 
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also reported that the intervention helped them perceive self-sampling as a simple and 
easy procedure that would be difficult to conduct incorrectly. 
“I don’t think I thought self-sampling would be as easy as that so yeah I 
think it’s a benefit for me…” (P6)  
“it explains and reassures me that it would be quite difficult to do it 
wrong” (P1) 
 “to me it’s simple in actually showing you how to do it, I mean it’s got 
the diagrams everything, it’s simple” (P4) 
Most participants felt reassured that there would be a system by which they would be 
informed if they had carried out self-sampling incorrectly. The provision of this system 
was perceived as a benefit to self-sampling. 
even if you make a mistake they’d send you another kit, so you don’t 
think you’ve got to get it right that time, cos even if it’s not right, or it 
gets lost you’ll get another kit! (P6)  
Barriers to self-sampling were not thoroughly discussed by participants.  The barriers 
referenced by one participant during the interviews were the potential to conduct self-
sampling incorrectly and not trusting the self-sampling result because the participant 
was used to having cervical screening conducted by a healthcare professional.   
I don’t know if I would be happy in doing it myself, purely because I’d be, 
I’m used to having it done professionally…even though it says that you 
can’t go wrong in my mind, Oh my God, you know I don’t think I did that 
right (P4)   
Although participant 4 reported that the vignette was useful, it had evidently not 
addressed her concerns as presented in the above quote. The participant may have 
been referring to perceived usefulness of the vignette for other people. 
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6.5.7.2 Negative aspects of intervention 
When probed about aspects of the intervention that were perceived as negative or 
required further clarification, most participants referred to the icon array diagram 
exemplifying 99 out of 100 women being able to conduct self-sampling correctly. 
Some participants described the icon array diagram as having no impact on their 
intention to self-sample and therefore being superfluous.   
[when questioned if the icon array diagram made any impression on the 
participant] um no, I just passed over it (P1) 
um, I didn’t really take much notice of that [referring to icon array 
diagram] to be honest, I just read all that [referring to the text stating 
99/100] (P3) 
Other participants described the icon array diagram as confusing and potentially 
misleading. 
I think that was a little bit confusing actually you know, I didn’t quite 
understand that then I had to look at it a bit more, it’s only a little bit of 
information you know 99 out of 100 but it looks quite hang on, what are 
they on about here … I don’t suppose you need to see all the pictures 
really (P5)  
when I looked at that first reading down, that my first impression was 99 
out of 100 women don’t have HPV and 1 does or something like that 
(HP7) 
[referring to the icon array] I wouldn’t, I don’t think that adds                   
very much (HP8) 
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One of the health professionals suggested that a modification be made to the vignette 
depicting a conversation between two women, because it referenced an incorrect 
appointment type.  
Cervical screening isn’t a doctor’s appointment it’s a nurse appointment 
(HP8) 
The icon array image depicting 99 out of 100 women being able to conduct self-
sampling correctly was not liked by most participants, and viewed by some as 
superfluous: 
I don’t suppose you needed to see all the pictures really, yeah, um but I 
suppose you’re filling the leaflet’s page up (P5) 
 I’m not sure I would have put a whole side on that (HP7) 
 
6.5.7.3 Recommendations 
Design issues 
Although participants stated that the intervention was easy to read and generally liked 
the layout and contents, one participant commented that the font of the main text of 
the ‘Answer’ sections was slightly difficult to read and suggested that it was made a 
darker colour. Health professionals also highlighted that the font size was slightly small 
and recommended that it was increased to help promote ease of readability.  
the writing with the black needs to be … a bit bolder, but I think it’s my 
eyesight, which is not 100% so if you’re trying to read it and sometimes it 
sort of … blends back (P2) 
I wonder whether the text is maybe a bit small … [referring to the font 
size] my guess is that it might be 10 because we’ve recently done some 
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stuff with RNIB recently and they said minimum 12 and 14 if you can 
(HP7) 
The health professionals commented that the intervention colour scheme and 
characters seemed more suited to a younger audience. They suggested that the colour 
scheme was modified to make the intervention also appealing to an older audience. 
It struck me as being quite young … I think it’s the colours … the lady as 
well, I mean what we have on some of our things … the newer stuff we 
are trying to develop it’s a couple of people on it you know like you’ve 
got younger women and an older woman (HP7)  
I don’t think the font and colours really work. I like the cartoony bits on 
it, but that actually makes it quite young (HP8) 
Additional information 
The health professionals suggested that it was crucial that the NHS be presented on 
the front page of the intervention. They felt that it needed to be obvious from the 
outset that HPV self-sampling would be provided by the NHS. This would ensure that 
women took notice of the intervention and would reassure them that self-sampling 
was a method that was routinely offered. 
I guess on the front cover it wasn’t obvious it was a NHS thing … it’s 
something at feedback we’ve had about our leaflets like with the bowel 
screening kit … people didn’t take notice of things if it wasn’t obvious 
(HP7) 
okay so if we were hypothetically in a situation where we were doing 
HPV self-sampling then actually it would be important to have our logo 
on it, yeah so actually have the NHS (HP8) 
The addition of a website on the back page of the intervention was suggested.  
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on the contact bit on the back you’ve put “please ring” whether you 
could put a website address or something like that as well (HP7) 
The inclusion of clarification of the purpose of cervical screening as well as clarification 
of how women would obtain a self-sampling kit was suggested by one of the health 
professionals. 
cos in smear letters we kind’ve  say the point of doing a smear test is to 
reduce your risk of cervical cancer, whereas I am not sure that comes 
across  all that clearly…I think you could do with a bit on saying…maybe 
right aim of HPV self-sampling is… (HP7)  
it doesn’t clearly say what will actually happen, so there isn’t a section 
that says you will get sent a kit (HP7) 
Further clarification was also sought about whether men could also get HPV and the 
time-frames involved in sending the sample and receiving results and what would 
happen after receiving a self-sampling result. 
  one question whether the HPV whether men could contract it (P2) 
when it’s posted off and stuff would it get there …if I did do it, obviously 
it’s getting the results or whatever. (P3)  
it’s the bit what happens next isn’t it, if you get a positive you know what 
happens next (HP8) 
One health professional felt that more in-depth information was required about 
cervical cancer. 
Implementation 
Some discordance was observed when women were asked when they would like to 
receive the HPV self-sampling intervention, with some stating that they would prefer 
to receive it before receiving the HPV self-sampling kit, whilst others felt that it would 
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be useful to receive the intervention alongside the kit. The health professionals felt 
that the intervention would be best presented before receipt of the HPV self-sampling 
kit and at community engagement events. 
 
6.5.8 Amendments  
Amendments that were made to the intervention following usability testing are 
outlined in Table 6.4. The final version can be seen in Appendix 6.8. The readability of 
the final intervention was assessed using two readability formulas, Flesch-Kincaid and 
SMOG (Friedman and Hoffman-Goetz 2006). The Flesch-Kincaid Grade score was grade 
five (10-11 year olds) and the SMOG score was grade six (11-12 year olds).  
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Intervention main 
sections 
Modifications made 
All sections Pale blue font colour changed to navy blue and black font 
changed to be a darker more bold black. Increase in font size to 
12 point. Removal of ‘female’ signs in main sections to facilitate 
increase in font size and addition of extra sections. 
Front cover Addition of NHS logo. Modification of characters: addition of 
older character and a character from an ethnic minority 
background.  
What is it all about? Addition of “Why is it important to take part in cervical 
screening” sub-section.  
Addition of sentence “You will be sent a free self-sampling kit 
through the post by Cervical Screening Wales” and removal of 
sentence “Research has shown that it is a good way of cervical 
screening [1]” in “What is HPV self-sampling?” subsection.   
Modification of sub-section “How can I get HPV?” from “HPV is 
very common and most of us will come into contact with it” to 
“HPV is very common and most men and women will come into 
contact with it”. 
Tell me more “Can HPV be treated?” sub-section has been moved to this main 
section from “What is it all about?” main section due to a lack of 
space. 
Addition of “I have had the HPV vaccine, do I need to do HPV self-
sampling?” sub-section. 
Addition of sentence “Self-sampling is less uncomfortable than 
smear tests.” in “What is good about HPV self-sampling?” sub-
section. 
Image of female anatomy has been deleted and a new version 
has been included in the new “99 out of 100 women can do HPV 
self-sampling properly” section. 
Sending your kit and 
receiving your 
results 
This main section has been replaced with a main section titled 
“99 out of 100 women can do HPV self-sampling properly” The 
sub-sections of this main section have been moved to the back 
page of the intervention and replaced the vignette which has 
been moved. 
New section: 99 out 
of 100 women can 
do HPV self-
sampling properly. 
“I am not a doctor/nurse can I do HPV self-sampling?” and “What 
if I do not reach far enough inside or I miss something?” sub-
sections have been moved to this section. 
Images of self-sampling kit and female anatomy have been 
included. 
Original section: 99 
out of 100 women 
Icon array has been deleted. Section no longer exists in original 
form. Section now contains the vignette conversation between 
two women which was originally at the back of the intervention. 
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Table 6.4: Modifications made to the HPV self-sampling intervention 
 
6.5.9 Discussion 
The aim of this stage of the research was to test the acceptability of the HPV self-
sampling intervention. It was important that the intervention was engaging, clear and 
easy to understand. The HPV self-sampling intervention was well received overall by 
participants. All participants understood the purpose of the intervention, which was to 
encourage women to HPV self-sample.  
Most participants reported high pre-existing intention to engage in HPV self-sampling.  
Participants reported low HPV knowledge: all failed to identify HPV as a cause of 
cervical cancer prior to receiving the intervention. As expected, an increase in HPV 
knowledge was observed following intervention exposure. The pattern of findings 
can do HPV self-
sampling properly. 
Vignette Modification of characters, removal of original characters and 
addition of new characters to represent a range of ages and 
ethnicities. 
Removal of “or finding someone to watch the kids”. Removal of 
“The people testing the kit would tell you if you did it wrong, and I 
don’t think you could miss anything if you follow the instructions.” 
which was replaced with “Just follow the instructions, they are 
simple. You will be sent another kit if you do it wrong.” 
Removal of sentence “Most women worry that they will not be 
able to do HPV self-sampling properly or that they will miss 
something.” 
Addition of “Will someone tell me if I have not done the HPV self-
sampling right?” sub-section. This sub-section was initially in the 
“Sending your kit and receiving results” main section. 
Back page  The vignette has been moved and replaced with sub-sections 
originally found in the “Sending your kit and receiving results” 
main section.  
The further questions, logos and sources of information sub-
sections have remained on this page. 
Jo’s cervical cancer trust logo has been removed. 
A website address and contact details for Jo’s cervical cancer 
trust have been added to the “Do you have any more questions 
about HPV self-sampling?” sub-section. 
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observed for self-efficacy and perceived barriers was unexpected and did not reflect 
the findings of the qualitative interviews. Although most women reported during 
interviews that the intervention made them feel more well-disposed towards HPV self-
sampling and more confident in their ability to carry out self-sampling, this was not 
reflected in their post-intervention questionnaire scores. This may be because their 
intention scores were already high at pre-intervention or because a very small and 
unrepresentative sample of women were recruited for user testing, suggesting that 
qualitative methods are more useful and informative in small samples. Self-efficacy 
scores increased in only two participants and decreased in one participant following 
intervention exposure. Furthermore, an increase in perceived barriers was observed in 
some participants. These counterintuitive findings might be attributed to the extra 
time spent by participants reflecting on the self-sampling method and their ability to 
carry out the procedure correctly, by the time they completed the post-intervention 
questionnaire.  It is possible that the pre-intervention questionnaire captured 
participants’ automatic reaction to self-sampling before they were presented with the 
intervention which provided more detailed information. This might have encouraged 
participants to deliberate and therefore score more cautiously on the post-intervention 
measures.  
Interviews identified that the intervention was perceived to be engaging, easy to 
understand and of an appropriate length. The characters, layout and balance of text to 
graphics in the intervention were positively viewed.  The vignette ‘Miriam’s worry’ was 
included to help increase women’s self-efficacy by referring to the notion of vicarious 
experience, a method proposed to increase self-efficacy. The vignette was particularly 
praised and women reported that it was easily identifiable and exemplified a real life 
situation. 
Participants reported that the intervention increased their HPV knowledge and made 
them feel better able to carry out self-sampling successfully. The inclusion of the 
female anatomy diagram was well received, and alleviated worries about sampling 
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directly from the cervix.  Participants described an increase in perceived benefits to 
self-sampling, particularly the belief that self-sampling was an easy procedure, a belief 
that they often attributed to the female anatomy diagram as well as the statement: 
You do not have to reach far inside the vagina. HPV is a virus so it will be in the whole 
area inside your vagina.  
Implementation of the HPV self-sampling intervention was discussed. Healthcare 
professionals and most participants felt that the intervention would be particularly 
suited for promoting positive health beliefs about HPV self-sampling prior to receiving 
the kit. However, some participants felt that the intervention would be best included 
alongside the HPV self-sampling kit as they feared that they may not engage with the 
intervention if it arrived prior. Further research is needed to determine the best point 
of implementation. 
The 99 out of 100 icon array diagram was the least favourably viewed component of 
the intervention, and was described as confusing, unnecessary and potentially 
misleading. Visual displays have been shown to reduce biases such as framing effects 
(Garcia-Retamero and Cokely 2011) and have been proposed as an aid for accurate 
understanding of probabilities (Charnock 1998). However, individuals vary in their 
ability to extract meaningful data from visual arrays and it has been shown that people 
who have low graphic literacy may be better presented with numbers (Gaissmaier et 
al. 2012). This may have been observed with the participants in this study. 
Alternatively, it is possible that the icon array diagram did not significantly help the 
participants’ understanding.   
The modification to the female anatomy diagram was made following suggestions from 
health professionals. The diagram was modified to outline a basic representation of the 
self-sampling procedure. The aim of the diagram was not to provide instruction on how 
to perform self-sampling, as that would be presented with the actual self-sampling kit, 
but to provide a simple idea of what self-sampling would involve once women received 
the kit.  
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Although the vignette was very positively received by all participants, the health 
professionals suggested modifications to some of the phrasing. The health 
professionals felt that some of the phrasing which was meant to reassure participants 
that they would not carry out self-sampling incorrectly was over-emphasised and could 
be misleading. The DISCERN handbook explicitly states that author opinion is not a 
credible source of information that would help readers discriminate between good and 
poor quality interventions and warns authors to pay particular attention to field testing 
(Charnock 1998). Therefore, this section was modified and the potentially misleading 
text was removed. 
It was decided not to include additional in-depth information about cervical cancer 
because it was important that the aims of the tool were clearly reflected in its content. 
The previous chapter (Chapter 5) highlighted participants’ difficulty in differentiating 
HPV self-sampling and cervical smear tests. The aim of the tool was not to provide 
thorough and in-depth information about the development of cellular abnormalities 
and their progression to cervical cancer but to increase women’s intentions to HPV 
self-sample by increasing HPV knowledge and promoting positive beliefs about self-
sampling. Providing further information about cervical cancer would have deviated 
from the aims of the intervention and may prove confusing for the reader. It was 
therefore considered important to maintain the intervention’s focus on HPV (Charnock 
1998).  
6.5.9.1 Study limitations  
Although eight participants were considered sufficient for the purposes of the 
interview study, only six completed the survey. This number was too small to allow 
meaningful statistical comparisons of changes in outcome measures before and after 
intervention exposure. The process measure items were positively framed which might 
explain the uniformly positive response of participants. Nevertheless, the 
questionnaire data provided an indication of potential intervention acceptability and 
effects which were further explored during interviews.  
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Ultimately, the survey was not able to meaningfully identify the effect of the 
intervention on women’s intentions to self-sample, perceived self-efficacy level, HPV 
knowledge or the associated benefits and barriers of HPV self-sampling. The use of the 
survey was useful as a pilot to determine whether its use would be acceptable to the 
participants, whether the participants were able to understand the sequential nature 
of the pre and post intervention survey and to establish whether using the pre and 
post intervention surveys was feasible.                                                         
The sample recruited was biased as it did not include any participants from ethnic 
minority backgrounds, who have been shown to be less receptive to cervical screening  
(Marlow et al. 2015) and may subsequently present lower intention to HPV self-
sample. Furthermore, most of the participants recruited into this study had a high 
intention to self-sample at baseline and therefore may have interpreted the 
intervention more favourably than a group with low self-sampling intentions. It would 
be useful to explore the effect of the intervention on women who have low self-
sampling intentions.  
Data collection was carried out using different methods: face to face interviews with 
women and telephone interviews with health professionals. Some research suggests 
that interview modes may yield different results (Sturges and Hanrahan 2004), 
primarily because of the absence of non-verbal signals during telephone interviews. 
However, because the health professionals were a distinctively different group than 
the women interviewed and their feedback did not need to be directly compared, the 
use of different interview methods was deemed suitable. 
The use of interviews could be criticised for potential of bias (Willis 2005). The selected 
variety of questions used may have influenced participants’ answers. Nevertheless, the 
aim of this study was to identify and understand the positive aspects of the 
intervention as well as the sections that needed further clarification/addition/removal. 
The interview technique facilitated investigative focus to particular areas that may 
have needed modification by actively searching for problems. However, focus groups 
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have been shown to be useful in developing patient information materials (Franics et 
al. 2008) as they facilitate dialogue between individuals and could have been and 
alternative method for exploring participant’s views about the intervention.   
The intervention could be criticised for not being primarily designed according to a 
scientific evidence-base for intervention development. The intervention was primarily 
developed based on what women said they would like to see in an intervention 
designed to address barriers associated with intention to HPV self-sample. However, 
the intervention did follow guidelines for the development of clear patient 
information, such as the DISCERN guidance, the plain English campaign guidelines, and 
the inclusion of a vector diagram to represent the probability (Trevana et al. 2012) of 
conducting HPV self-sampling properly. The intervention was subsequently modified 
(e.g. the removal of the vector diagram) based on the comments of potential users, 
who represented a close as possible scenario to women receiving the HPV self-
sampling intervention as part of a screening programme. A similar approach was 
adopted for the development of informed choice information about breast screening 
for the English breast screening programme (Forbes and Ramirez 2014). The 
development and presentation of information was based on recommendations from a 
scientific evidence-base, experts and a citizen’s jury. However, subsequent user testing 
suggested that the information presented was too detailed leading to a hindering of 
understanding by the users. Similarly to this study, the authors concluded that the 
views of the individuals who were involved in the user testing overrode that of the 
experts and the citizen’s jury, as they represented a scenario that was as closer to the 
experience of an individual receiving the information as part of the screening 
programme. 
 
Finally, the intervention did not address the issue of informed consent and thus did not 
present any negative aspects of engaging in cervical screening, such as the potential for 
false positive and false negative results. The focus of the intervention was on 
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increasing intention to HPV self-sample, therefore it was considered that inclusion of 
information about the risks and benefits of cervical screening would distract from the 
aim of the intervention. It was also assumed that such information would be provided 
by Cervical Screening Wales at the point of kit receipt or within the kit itself. 
 
6.5.9.2 Future research 
A HPV self-sampling intervention was developed with the purpose of increasing 
intention to HPV self-sample. The user testing presented in this chapter has formed an 
important initial step in the development of the intervention (Craig et al. 2008). The 
intervention was positively viewed by both women and healthcare professionals and 
has been amended according to feedback. Further research should seek to identify a 
larger and more ethnically diverse sample to i) examine best point of implementation, 
ii) examine whether the intervention is able to increase intention to HPV self-sample, 
HPV self-sampling self-efficacy and perceived benefits to HPV self-sampling and iii) 
investigate whether the intervention will increase women’s actual HPV self-sampling 
behaviour
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Chapter 7  
 
General Discussion 
 
7.1 Introduction 
The research presented in this thesis explored women’s attitudes towards primary HPV 
self-sampling, and developed an evidence and theory based intervention designed to 
address barriers and promote benefits of primary HPV self-sampling. In the present 
chapter, the research findings will be summarised and located within the broader field, 
and methodological strengths and weaknesses will be discussed. Future utility of the 
primary HPV self-sampling intervention and suggestions for further evaluation and 
implementation will be presented. 
 
7.2 Summary of study findings  
The research presented in this PhD thesis investigated women’s attitudes towards 
cervical screening through primary HPV self-sampling. By exploring views about a new 
method of screening, it was possible to establish the factors that might lead women 
not to participate in primary HPV self-sampling, should this new method be introduced. 
This research was conducted in response to an evolving cervical screening programme 
in the UK: recent years have seen the incorporation of HPV testing, calls for primary 
HPV testing and an interest in future primary HPV self-sampling. 
The evidence presented in this thesis identified a lack of research into women’s 
attitudes towards primary HPV self-sampling, and the need for a theoretically driven 
intervention designed to address barriers associated with primary HPV self-sampling 
uptake. Subsequently, women’s hypothetical intentions and attitudes towards primary 
HPV self-sampling were investigated using a mixed-methods approach involving a 
cross-sectional survey and qualitative interviews. Findings were used to develop an 
evidence and theory-based intervention. 
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Although some of the findings in this PhD research reflect previous findings reported in 
the literature, novel insights into the determinants of women’s attitudes and 
intentions regarding primary HPV self-sampling were identified. Similarly to previous 
research (Pitts and Clarke 2002; Waller et al. 2003; Marlow et al. 2007; Barata et al. 
2008; Galbraith et al. 2014), it was found that convenience and the perception that 
HPV self-sampling would be less uncomfortable and embarrassing than cervical smear 
testing acted as facilitators to HPV self-sampling intentions, whilst a lack of HPV 
knowledge and low self-efficacy regarding HPV self-sampling were identified as 
barriers. Operational and system-related barriers to HPV self-sampling identified in the 
current study included fears about sample contamination, loss, identity theft, concerns 
about willingness of postal workers to handle samples and the need for confirmation of 
receipt of completed self-sampling kit from relevant laboratory. Although preference 
for returning samples directly to healthcare providers rather than through the post has 
previously been identified (Cadman et al. 2014), this was the first study to highlight 
specific concerns about identity theft, unwillingness of postal workers to handle 
samples and the need for a confirmatory receipt of sample from a relevant laboratory. 
Confidence in the self-sampling programme was also influential because women 
wanted to understand the motives behind the set-up of a new cervical screening 
system, and expressed concerns that it might be motivated by political and financial 
gains.  
Habituation and overall preference for screening tests being conducted by healthcare 
professionals, have previously been identified as barriers to HPV self-sampling 
(Cadman et al. 2014) and FOBT self-sampling (Palmer et al. 2014). In this study, women 
reported an overall preference for medical procedures such as collection of material 
for testing (self-sampling) to be conducted by healthcare professionals, due to an 
expectation of expertise needed to conduct the procedure.     
Although confidence in conducting HPV self-sampling has previously been identified as 
a barrier (Forrest et al. 2004; Cadman et al. 2014), a deeper understanding of the way 
in which confidence affects intention and attitudes towards primary HPV self-sampling 
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was lacking. This PhD study was the first to quantify and explore the way in which 
women’s perceived confidence (self-efficacy) in being able to conduct HPV self-
sampling properly, affected their attitudes and intentions to engage in HPV self-
sampling. It was found that perceived self-efficacy in relation to HPV self-sampling not 
only influenced women’s confidence in conducting self-sampling properly, but also 
affected their confidence in the subsequent result. Although trust in HPV self-sampling 
results has previously been reported as a barrier to HPV self-sampling by Sultana et al 
(2015), this study was able to explain why women might not trust their results. 
The lack of trust reported in this study related to women’s concerns about not 
conducting HPV self-sampling properly: women believed that they might fail to take 
the sample from a HPV infected area within their vagina. Consequently, women were 
worried that this could lead to a false negative result and that they would not get an 
opportunity for repeat screening until the next routine screening round. When 
rationalising their lack of confidence in self-sampling results, women referred to a lack 
of personal expertise, lack of practice and a lack of knowledge.  
Similarly to previous research (Marlow et al. 2007; Dodd et al. 2014; Daley et al. 2015), 
a low level of HPV knowledge was observed in women. Previous research has reported 
that a lack of HPV knowledge is associated with low understanding of HPV test results 
and negative emotional consequences (Daley et al. 2015). However, the current study 
was the first to identify the influence of women’s beliefs about the importance of HPV 
in the development of cervical cancer, on intentions to engage in HPV self-sampling. 
The current study found that women who perceived HPV as less important in the 
development in cervical cancer to be less likely to HPV self-sample. 
 
7.2.1 Summary of novel findings 
 
This was the first study to explore and quantify the effect of self-efficacy on women’s 
intention to HPV self-sample. The study identified the way in which women’s lack of 
confidence in conducting HPV self-sampling properly influenced their intentions, 
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namely by affecting their trust in self-sampling results, because of the fear that they 
might have failed to sample from a HPV infected area whilst conducting HPV self-
sampling. This was also the first study to explore the influence of operational factors on 
women’s intention to self-sample and to identify concerns about identity theft and 
unwillingness of postal workers to handle samples. Additionally, this was also the first 
study to identify the way trust in the set-up of a new programme can be affected by 
the omission of a simple confirmation of receipt of completed self-sampling kit from 
relevant laboratory, as well as scepticism about the motives behind the set-up of a new 
programme. Finally, this study was to first to identify the influence of the belief that 
HPV in important in the development of cervical cancer (and not just HPV knowledge in 
general) as an influence on intention to HPV self-sample. 
 
7.3 Policy, practice and research recommendations 
This PhD research identified the impact of personal and system barriers on women’s 
attitudes towards primary HPV self-sampling, and their hypothetical intention to self-
sample.  As well as identifying barriers and benefits associated with HPV self-sampling 
this study was able to provide important insight into women’s perceptions regarding a 
potential change from a familiar and established healthcare system (cervical smear 
testing) to a new and different type of cervical screening system. Therefore, public 
concerns about safety and acceptability should be addressed if primary HPV self-
sampling is to become incorporated into the cervical screening programme. As well as 
addressing identified barriers and facilitators to HPV self-sampling, particular efforts 
should be focused on communicating the reason for a shift in screening method, by 
providing evidence that the change is not driven simply by political or financial gain. An 
effort must also be made to increase women’s HPV related knowledge to facilitate the 
belief that the primary cause of cervical cancer is HPV. Efforts should also be focused 
on helping increase women’s HPV self-sampling self-efficacy, and the belief that if a 
HPV self-sampling result has been provided, that the HPV self-sampling procedure has 
been conducted properly.  Operational factor concerns such as the possibility of 
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identity theft and potential reluctance of postal workers to handle samples must also 
be addressed. As well as feeding into policy and practice recommendations, findings 
highlighted a need for the development of an information resource that can be used to 
address identified barriers regarding primary HPV self-sampling. Consequently, a 
theory and evidence based intervention that could potentially be incorporated into the 
cervical screening programme was developed.  
However, the findings of this research are based on the reported barriers and 
facilitators to HPV self-sampling from women who were primarily White, well-educated 
cervical screening responders, many of whom had experienced an abnormal cervical 
smear. Further research should focus on identifying whether the facilitators and 
barriers identified in this research are also applicable to women from different 
sociodemographic and screening backgrounds. 
 
7.4 Research strengths and limitations  
 
7.4.1 The utility of the mixed methods approach 
 
This section will discuss what was gained through the use of mixed methods. 
Methodological strengths and weaknesses will also be discussed.  
 
7.4.1.1 Quantitative phase 
The quantitative phase of this research facilitated the identification of health beliefs, 
knowledge, sociodemographic and clinical background factors that were associated 
with women’s intentions to HPV self-sample. The survey was able to quantify the 
influence of extended HBM constructs including perceived barriers and facilitators to 
self-sampling, perceived susceptibility and severity of HPV infection, and HPV self-
sampling related self-efficacy.   Although concerns about performing self-sampling 
correctly have been previously identified, the quantitative survey was the first to 
quantify the strength of the relationship between self-efficacy and intention to self-
sample. Therefore, the survey helped identify key variables for subsequent in-depth 
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exploration in interviews and facilitated focus on key issues during intervention 
development.  
The development of the survey was informed by the extended HBM as well as 
identified barriers and benefits to HPV self-sampling in previous literature (Chapter 1). 
The development of the survey was an iterative process that involved several 
modifications of questionnaire items based on the validation methods used. Validation 
methods investigated that items were able to accurately measure the constructs of 
interest as well as ensuring that they were understood and acceptable to the 
participants. Statistical measurement of the completed survey provided evidence that 
the underlying factor structure corresponded to a priori HBM constructs, and 
measurement of internal reliability facilitated the exploration of whether the survey 
was able to measure constructs consistently.  Although content validity analysis, 
cognitive interviews, PCA and internal reliability analysis were useful methods for 
testing the internal reliability and validity or the questionnaire items, alternative 
validation methods could have been applied. For example, prospective administration 
of the survey would have facilitated the measurement of test-retest reliability. 
However, the possibility of practice effects that can artificially inflate the estimate of 
test-retest reliability (Sushil and Verma 2010). Due to time constraints this form of 
validation was not possible. A further form of validity is that of predictive validity, 
which would have shown how well the intentions measured by the survey predict 
future behaviour. However, it was not possible to measure predictive validity of this 
survey because a HPV self-sampling programme is not currently available.   
 
7.4.1.2 Qualitative phase 
The qualitative phase in this PhD research facilitated the exploration of constructs that 
influence women’s intentions to HPV self-sample, which were identified as significant 
in the quantitative phase. The qualitative phase also facilitated the identification of 
novel influences.  Semi-structured interviews facilitated further exploration of the way 
in which extended HBM constructs affected women’s intentions to self-sample (Emery 
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et al. 2013). The qualitative findings explained the way perceived barriers and benefits 
influenced women’s intentions to self-sample. Importantly, the qualitative research 
stage was able to explain the way in which perceived self-efficacy affected intentions 
to primary HPV self-sample and was also able to identify novel insights into operational 
and system-related barriers.  Interviews were an appropriate data collection method as 
they complemented the survey findings by facilitating an in-depth exploration of 
extended HBM constructs and factors identified as being associated with HPV self-
sampling intention in the survey (Smith 1995). In particular, the findings from the 
interviews facilitated a deeper understanding of the relationship between low self-
efficacy on women’s attitudes towards HPV self-sampling and facilitated the 
identification of novel findings. 
Although the qualitative phase was extremely useful in exploring women’s intentions 
to HPV self-sample further and facilitated the identification of novel influences, the 
interviews were conducted with a highly selective sample of women who were white, 
in general well educated, many had experienced cervical abnormalities and some had 
received treatment for cervical abnormalities. Therefore, the generalisability of 
findings is limited to the population sampled. Furthermore, although semi-structured 
interviews were a useful method of exploring facilitators and barriers to HPV self-
sampling intentions, it is questionable whether women could accurately reflect on 
barriers and facilitators to HPV self-sampling in a hypothetical scenario compared to a 
real life deliberation. This issue is further discussed later in this chapter.   
 
7.4.2 The utility of the extended HBM in understanding women’s intentions towards 
primary HPV self-sampling. 
 
The extended HBM was central to this research and provided guidance for all aspects 
of the research process from survey development to the interview schedule and 
intervention development. The use of the extended HBM throughout the research 
facilitated an understanding of women’s attitudes towards primary HPV self-sampling 
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and how women’s intentions were influenced by health beliefs. The theoretical 
understanding gained through this research facilitated the development of the 
intervention, in line with MRC guidance (Craig et al. 2008).  The use of theory was 
crucial in the development of the intervention because it not only provided a basis for 
tool development, but also facilitated the detection of strengths and weaknesses 
within the intervention through user testing. In addition, the use of theory informed 
the choice of constructs that should be measured pre and post intervention exposure 
in order to assess changes brought about by the intervention (Craig et al, 2008).   
The use of the extended HBM constructs has highlighted that although providing 
information about HPV in the cervical screening context is needed to raise awareness 
of the association of HPV with cervical cancer, information alone is not sufficient to 
form intentions. Health beliefs such as perceived benefits and barriers to primary HPV 
self-sampling as well as perceived self-efficacy were found to be important in 
determining women’s intentions to self-sample. The findings of the logistic regression 
(Chapter 4) supported the inclusion of extended HBM constructs in identifying 
intention to engage in primary HPV self-sampling. Extended HBM constructs, in 
addition to educational level and the belief that HPV is important in cervical cancer 
development, were able to explain between 43.1 and 61.2% of the variance in 
women’s intentions to engage in primary HPV self-sampling, and correctly classified 
83.3% of cases. Although the variance explained by the model is of quite a high 
percentage, it does not explain all cases suggesting that other constructs not measured 
by the model might have been influencing intentions. Possible explanations will be 
presented below. 
There were a number of limitations regarding the use of the extended HBM in this 
research.  Emotional consequences in the form of “perceived threat” (Stretcher and 
Rosenstock, 1997) are an important predictor of health behaviour (Jones et al. 2014), 
but were not measured in the survey. Perceived severity and perceived susceptibility 
were measured and analysed separately regarding their relationships with HPV self-
sampling intention, rather than being combined to form an underlying perceived threat 
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construct, as conceptualised in Stretcher and Rosenstock’s (1997) version of the 
extended HBM. Further research could investigate the effect of perceived threat on 
women’s intentions to HPV self-sample.  
A further limitation is that the role of subjective norms was not investigated in the 
quantitative analysis of influences on HPV self-sampling intentions. The construct of 
subjective norms has been the attention of debate because of an overall weak 
performance in predicting intention (as theorised in the TPB) compared with attitudes 
and perceived behavioural control (Pasick et al. 2009). However, it has been suggested 
that subjective norms might have a role in influencing health beliefs (Armitage and 
Conner 2001). An association between mammography screening uptake and the belief 
that significant others endorse attending for mammography screening has been 
observed in women from ethnic minority groups (Stewart et al. 2009). Subjective 
norms were explored during the qualitative phase of this study when some participants 
alluded to hypothetical subjective norms in relation to HPV self-sampling, but these did 
not seem highly influential on women’s HPV self-sampling intentions.  
 
7.4.3 Sample limitations  
 
Sample limitations associated with opportunistic recruitment are acknowledged.  Non-
response bias is an issue commonly identified in postal surveys (MacDonald et al. 2009) 
and is also a feature in qualitative research. Target sample size was not achieved 
through the primary recruitment source (CSW), and therefore there was a need for 
supplementary recruitment. The response rate from CSW recruitment was very low 
and did not achieve target sample size. Only 137 participants completed a 
questionnaire out of 12,000 who were initially sent a recruitment leaflet informing 
them of the study. The low participation rate necessitated supplementary recruitment 
through community groups, G.P’s and sexual health clinics to help achieve sample size 
as well as to increase heterogeneity of the sample. The response rate of the 
supplementary recruitment was unknown because it was not possible to record the 
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number of individuals who were approached to participate and those who 
subsequently declined. However, although supplementary recruitment helped achieve 
sample size, it wasn’t able to increase substantially increase the heterogeneity 
between participants with the majority being white, highly educated, cervical screening 
responders. Women who were cervical screening non-attenders, less educated and 
from an ethnic minority background were less likely to participate. Although the 
majority of women were educated to a degree level, representation was also present 
from women who were educated to GCSE and college level, with the proportion of 
women in each educational category being representative of the population of South-
East Wales (ELLS, 2013). Participants represented a broad range of ages, which was 
important as previous research (as discussed in Chapter 1) has identified that women 
who are older (over 50) and younger women (under 30) are less likely to participate in 
cervical smear testing. Therefore, the broad range of ages facilitated the investigation 
of whether self-sampling was an acceptable alternative to cervical smear tests in 
women. Furthermore, many of the participants had experienced cervical abnormalities, 
which might have influenced their perceptions of the utility of primary HPV self-
sampling compared to cervical smear testing. The majority of women were recruited 
through Cervical Screening Wales and might have been more likely to take part in 
research because they were already engaged in the cervical screening process. The 
health beliefs of women who participate in research may be different to those of 
women who do not participate, and therefore may not represent population views. 
Furthermore, the majority of participants who were recruited through supplementary 
recruitment sources were recruited at a sexual health clinic. The health beliefs of 
women who attend sexual health clinics may be different to the health beliefs of 
women from the general population. Additionally, although the same study materials 
(questionnaires/interviews) were used for women from the main and supplementary 
recruitment samples, temporal differences in the data collection methods for the two 
samples mean that they may not be entirely comparable.  
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Although the majority of the sample was drawn from a cohort of women who were 
resident in South East Wales and were due to receive an invitation for cervical smear 
test from CSW on a given month, data are not available to verify the screening status 
or demographic characteristics of the women who received an invitation to participate 
in the study but chose not to participate. The availability of such data would have 
enabled comparison of responders and non-responders, facilitating a more accurate 
characterisation of the women who were less well represented in study findings.   
 
 
7.4.4 Cross-sectional research design 
 
The use of a cross-sectional research design facilitated the exploration of factors that 
influenced women’s attitudes towards HPV self-sampling and their hypothetical 
intentions within a given time (Levin 2006). This approach facilitated the identification 
of factors that can inform policy and practice considerations in public health planning 
(Levin 2006), should primary HPV self-sampling be introduced into the cervical 
screening programme. However, a limitation of cross-sectional research is that it does 
not allow causal relationships to be inferred (Mann 2003), and may have led to the 
observation of inflated associations between variables because they were all measured 
at one time. Prospective research is required to test causal effects of perceived barriers 
and facilitators on women’s intentions to HPV self-sample. Unfortunately, the large 
scale timeframes and associated costs made prospective research unachievable within 
the scope of this PhD study. 
 
7.4.5 Hypothetical intention 
 
A limitation of this research was that it explored women’s hypothetical intention to 
engage in primary HPV self-sampling. It would have been optimal if a primary HPV self-
sampling trial was being conducted at the time of this PhD research, where real time 
investigation of women’s attitudes, intentions and actual utilisation of primary HPV 
self-sampling would have been possible.  However, due to the lack of such research 
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and because a primary HPV self-sampling programme was not available, the PhD study 
explored hypothetical intentions with the aim of informing policy and practice 
recommendations. 
Intention was considered to be the proximal determinant of HPV self-sampling 
behaviour. It has been proposed that intentions reflect an individual’s motivation to 
engage in a certain behaviour as well as how hard they are prepared to try to conduct 
the specific behaviour (Ajzen 1991). However, intentions do not always translate into 
behaviour. For example, although public attitudes towards colorectal cancer screening 
in the U.K. are broadly positive, with more than 80% (Taskila et al. 2009) of 
respondents indicating that they thought it was a ‘good idea’ and 95% (Vart 2010) of 
respondents in another study stating that they would intend to conduct FOBT if 
available, actual uptake rates are actually much lower (Chapter 1). Lower uptake may 
be due to failure to translate positive intentions into actions (Lo et al. 2014). Therefore, 
the findings of this thesis should be interpreted with caution when considering the 
likely uptake of primary HPV self-sampling because women’s intentions might not 
translate to real life actions if the programme becomes available. Nevertheless, it was 
important that women’s views regarding the possible implementation of a primary 
HPV self-sampling programme were explored prior to a possible introduction because 
findings can be used in policy and practice recommendations as well as to guide further 
research.    
 
7.5 Intervention development and user testing 
 
The processes utilised by this PhD study highlight the continuous process of developing 
complex health behaviour interventions (Craig et al, 2008). Based on findings from the 
previous phases of work, a pilot HPV self-sampling intervention was developed and 
tested. Examples of interventions with a wide variety of formats, design and content 
were considered when deciding on the format of the HPV self-sampling intervention 
which was ultimately designed as a leaflet. It was important that information was 
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embedded within an intervention that can be incorporated into a future primary HPV 
self-sampling programme by being easily accessible (e.g. sent with or before the self-
sampling kit) and low cost (to maximise potential exposure and impact). It was felt that 
a leaflet would be the best intervention format. Usability and acceptability were 
investigated through a sample of potential users as well as potential service providers.  
Through opportunistic sampling, a range of women participated in user testing to 
ensure that barriers to HPV self-sampling were addressed adequately and to ensure 
that no salient barriers or benefits were overlooked. Involvement of a variety of people 
including potential users and providers highlights the iterative and rigorous 
development process of the intervention. User testing with women ensured that the 
intervention was user friendly, whilst the testing with healthcare professionals ensured 
that the factual information was correct and that the hypothetical operational factors 
included within the intervention would be feasible in the future. However, the user 
testing was only able to establish preliminary face validity of the HPV self-sampling 
intervention, and further testing is needed to determine the effect of the intervention 
of women’s intentions and behaviours. 
 
 
7.5.1 Informed consent  
 
Informed consent is important in any screening programme so that individuals are 
aware of the benefits and risks associated with participating in screening. Importantly, 
information suitable for promoting informed consent should also be thorough enough 
to enable informed dissent. Fully informed dissent refers to having enough information 
to withdraw from screening by outlining risks and benefits of engaging in HPV self-
sampling, as well as the consequences of not engaging in self-sampling (Public Health 
England 2009).   
The intervention developed in this PhD study was not developed to encourage 
informed consent or dissent because it was envisaged that information relating to 
informed consent/dissent in primary HPV self-sampling would be developed by the 
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screening programme providers (Public Health England 2009). The intervention was 
therefore specifically designed as a health behaviour change intervention with the aim 
of increasing intention to engage in primary HPV self-sampling. The intervention 
content did not include detailed information on the possible risks associated with 
engaging in HPV self-sampling, or what would happen if a positive HPV result was 
obtained. Previous phases of the research highlighted system barriers associated with 
HPV self-sampling including lack of trust in reasons for the set-up of a new programme 
and concerns relating to operational factors, hence it was considered that including 
information relating to possible risks of taking part in HPV self-sampling would have a 
detrimental effect on women’s trust in primary HPV self-sampling. The omission of risk 
information highlights that the HPV self-sampling intervention is not in itself a solution 
to all informational needs relating to HPV self-sampling; rather, the HPV self-sampling 
intervention is a tool that should help form intention to self-sample by initiating 
thoughts and discussion about HPV self-sampling. Other materials ensuring that 
participants are fully informed of risks associated with HPV self-sampling should also 
be available. 
 
7.5.2 Under-representation of attitudes of women who are in favour of HPV self-
sampling   
 
The intervention content was designed to address the concerns of women who were 
less likely to engage in primary HPV self-sampling classified by the HBM-HPV survey 
(Chapter 4). The views of women less likely to engage in HPV self-sampling were 
explored in depth through semi-structured interviews (Chapter 5) and were used to 
understand barriers and to help inform the content of the intervention. Therefore, the 
attitudes of women who were in favour of HPV self-sampling as classified by the survey 
were under-represented. The aim of the intervention was to address concerns of 
women who were less likely to engage in primary HPV self-sampling should this 
method become incorporated into the cervical screening programme, therefore 
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women who were less likely to engage were targeted. However, the views of a small 
sample of women who reported that they would be likely to self-sample as well as 
those who reported that they would not be likely to self-sample, were explored during 
pilot testing (Chapter 6). In general, women reported that the intervention was user 
friendly, addressed their concerns and highlighted salient benefits.      
 
7.5.3 Intervention format 
 
In order to promote ease of access, the HPV self-sampling intervention was created in 
the form of a leaflet, which could potentially be sent through the mail via the cervical 
screening programme before or alongside receipt of a HPV self-sampling kit. This 
format would also facilitate the inclusion of the intervention alongside reminder letters 
prompting women to complete a HPV self-sampling kit not yet returned. However, 
some participants reported that they would also like to have access to electronic 
content about HPV self-sampling in the form of an educational video or a website that 
they could access for more detailed information. This should be considered in future 
research. 
Interventions to increase uptake of screening designed in a form of a leaflet have also 
been developed for the only other self-sampling programme, the FOBT bowel 
screening programme. The bowel cancer screening programme is the only established 
self-sampling programme for cancer screening in the U.K. and many similarities can be 
drawn regarding the operational factors associated with the colorectal cancer 
screening programme and a potential HPV self-sampling programme. As discussed in 
Chapter 1, the U.K. colorectal cancer screening programme has seen a relatively low 
uptake of around 60%, with the lowest uptake reported in populations in the most 
deprived quartile (Wardle et al. 2016) and this might also be an issue with a HPV self-
sampling programme. Research has identified competing time demands, lack of social 
support and stress as barriers to participation in FOBT self-sampling (von Wagner et al. 
2011). Furthermore, literacy might also account for the lower uptake of FOBT self-
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sampling, as all information associated with the screening is sent to individuals through 
the post, including screening invitation letter as well as a leaflet explaining FOBT self-
sampling and the risks and benefits of participating. Therefore, individuals are 
presented with a large amount of information which they need to digest and 
understand before considering whether to participate in FOBT self-sampling. Similar 
issues will need consideration if HPV self-sampling is incorporated as a cervical 
screening method, as it seems highly likely that information about HPV self-sampling 
and instructions on how to conduct self-sampling would also be sent through the post. 
A recent randomised controlled trial (Wardle et al. 2016) demonstrated that additional 
leaflets (gist and narrative based) alongside standard patient information were not able 
to increase uptake of FOBT in deprived populations, even though the leaflets 
demonstrated improved comprehension and intention to conduct FOBT in previous 
studies (McGregor et al. 2015; Smith et al. 2015). The only intervention that increased 
participation in FOBT was the tailoring of the invitation letter to include individual’s 
own G.P. practice name. A number of factors might have influenced the effectiveness 
of the leaflets. Firstly, they were sent in addition to the standard information sent to 
individuals, which might have resulted in an increased information burden. It would be 
interesting to explore the effect of the leaflets if they were sent independently of the 
standard information. Health professionals interviewed during the user testing phase 
of this PhD study suggested that an intervention leaflet might be best sent before the 
formal information pack and self-sampling kit, to help reduce potential information 
overload  and to help increase intention to self-sample. Furthermore, the leaflets 
developed for the ASCEND trial did not address one of the most commonly reported 
barriers to FOBT which is the unpleasantness of the procedure itself. It is possible that 
uptake might have been increased if that prominent barrier had been addressed. 
Furthermore, although interventions such as leaflets that are designed to reduce 
socioeconomic inequalities in cancer screening by being specifically tailored for 
individuals from more deprived groups, it is difficult to address all barriers associated 
with screening uptake including competing time demands and life stressors. Therefore, 
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as suggested by the ASCEND team the availability of direct contact with professionals 
would be a useful supplement to paper-based interventions.  
However, although it is useful to draw inferences from research focusing on FOBT self-
sampling, it must also be acknowledged that the HPV self-sampling programme would 
involve screening for a different cancer. Furthermore, the HPV self-sampling 
programme will target a different population and will involve a completely different 
type of self-sampling test that only needs to be conducted once every screening round, 
unlike FOBT self-sampling. 
 
7.5.4 User and provider involvement 
 
The target audience and the potential providers of the intervention were consulted in 
phases of the work, allowing key stakeholders to be influential in the intervention 
development process. The development of the intervention would not have been as 
thorough without user and provider involvement. The interviews with potential users 
of the intervention facilitated an in-depth understanding of the usability of the tool, as 
well as the identification of problems with the tool. This processes enabled issues 
relating to the intervention to be identified and modified before the development of 
the final intervention.  Importantly, the feedback was gained from different views due 
to the inherent attitudinal and sociodemographic differences in women sampled, as 
well as the feedback that was obtained from the service providers. Women provided 
feedback regarding the usability and the clarity of the information presented in the 
HPV self-sampling intervention. Service providers were able to comment on the 
accuracy of the information presented in the intervention as well as the feasibility of 
the operational factors presented. It was especially crucial that providers of a potential 
HPV self-sampling programme were involved during the development of the 
intervention because the operational factors presented in the intervention are largely 
based on the feedback from Cervical Screening Wales as well as the operational factors 
of the FOBT self-sampling programme. Therefore, potential provider feedback was 
important to ensure that the intervention represented a self-sampling programme as 
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close to a future HPV self-sampling programme as possible. The provider feedback was 
also useful in informing the best point of implementation of the intervention within a 
proposed primary HPV self-sampling programme.   
 
7.6 The future of the HPV self-sampling intervention 
 
The current research has demonstrated the need for the development of a primary 
HPV self-sampling intervention that provides women with information about primary 
HPV self-sampling and increases their confidence in their ability to self-sample and 
confidence in the set-up of a primary HPV self-sampling programme. Further research 
to evaluate the utility of the intervention and its practical application should HPV self-
sampling be introduced as a primary screening method will be required. 
 
7.6.1 Feasibility testing 
 
Potential user attitudes towards the HPV self-sampling intervention could be explored 
by a before and after exposure to the HPV self-sampling intervention questionnaire in a 
sample of women. This can assess feasibility as well as whether the intervention affects 
desired outcomes i.e. increase in intention to self-sample through an increase in 
knowledge, self-efficacy and perceived benefits to self-sampling. Although a before 
and after questionnaire was used to identify any change in women’s knowledge, 
attitudes and intentions towards HPV self-sampling in this study (Chapter 6), it was 
only conducted on a very small number of women and therefore was simply a 
descriptive survey and unable to statistically detect any effect of the intervention on 
women’s intentions to self-sample. Field testing with a larger cohort of providers and 
potential users can be used to further explore the acceptability of the intervention 
content and the feasibility of the operational factor information (e.g. time-frame for 
results) presented in the intervention. The intelligence gained from conducting the 
field study could be used to help inform further intervention testing studies regarding 
the feasibility of the measures used, recruitment and retention of participants. 
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7.6.2 Controlled evaluation  
 
A controlled evaluation of the effect of the HPV self-sampling intervention would be 
optimal and a randomised controlled trial (RCT) design should be considered because 
individual outcomes may be dependent on other processes such as screening history 
and time of invitation. For example, women are currently called in cohorts for cervical 
screening on a monthly basis and differences in women’s intentions to engage in 
cervical screening may be influenced by the month of their screening invitation, for 
example women called in traditionally busy months such as December may be less 
likely to attend at point of invitation due to other commitments. An RCT should 
account for this by dividing monthly cohorts, with one half of women being 
randomised to receive an intervention whilst the other half being randomised not to 
receive an intervention. A similar process could be followed for screening history. A 
possible RCT could involve participants completing measures pre- and post-
intervention exposure to assess the impact of the intervention on HPV self-sampling 
behaviour. The RCT would also enable an evaluation of the moderating role of self-
efficacy, knowledge, benefits and barriers to HPV self-sampling in influencing intention 
and behaviour. Additionally, if HPV self-sampling is introduced in the future, an RCT 
could be used as a direct behavioural measure of HPV self-sampling uptake in women 
who have been exposed to the intervention compared with women who have not. 
However, because RCTs involve large numbers of participants to detect effect sizes cost 
and time limitations need to be considered.  
 
7.6.3 Future implementation consideration and challenges 
 
The HPV self-sampling intervention was based on a hypothetical HPV self-sampling 
programme and potential set-up was informed by the FOBT self-sampling programme. 
Therefore, it must be noted that the intervention will need to be modified to reflect 
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primary HPV self-sampling programme characteristics, should a primary HPV self-
sampling programme be developed.  
The most likely dissemination of the intervention would be alongside HPV self-
sampling kits, which could be sent through the post. Further dissemination 
opportunities include public health events as well as primary healthcare providers, for 
example displaying leaflets in G.P. surgeries. However, as well as the identification of 
suitable implementation sites, research has identified the need for ‘buy-in’ of those 
involved in the implementation of interventions. In order for leaflets to be hosted and 
distributed in primary care settings, the distribution preferences of host sites, costs and 
additional workload need to be considered and presented (Evans et al. 2014). This 
further supports the need for evaluation of the intervention (as discussed previously) 
as well as the need for the assessment of implementation practices and costs.    
 
7.7 Conclusion 
 
The incorporation of HPV testing in the changing cervical screening programme in the 
U.K. has presented an opportunity for future incorporation of primary HPV testing and 
the possibility of primary HPV self-sampling. Evidence presented in this thesis suggests 
that personal barriers such as a lack of knowledge and lack of self-efficacy in ability to 
self-sample correctly and system barriers such as concerns about reasons for 
establishing a new method for cervical screening and operational factors are influential 
in determining intention to engage in primary HPV self-sampling. Ultimately, the 
insights gained from this research can be used to guide further enquiry into the 
possibility of primary HPV self-sampling and to help inform future policy and practice. 
The HPV self-sampling intervention can be a mechanism through which intention to 
engage in primary HPV self-sampling is increased. Further research is needed to 
evaluate the acceptability of the intervention and its impact on women’s attitudes and 
intentions towards primary HPV self-sampling.  
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Appendix 3.1: Literature search to identify previously developed Health Belief Model 
Based HPV self-sampling surveys. 
 
Two literature searches were conducted (2010 and 2012) to identify any previously 
identified scales based on the Health Belief Model which investigated women’s 
attitudes towards HPV self-sampling. 
 
Search Strategy and Inclusion Criteria 
 
Search terms limited to:  
Title  
Abstract 
 
Electronic databases: 
PsychInfo 
PubMed 
Web of Knowledge 
CINAHL 
EMBASE 
SCOPUS 
 
Supplementary search: 
Hand search of references in identified papers. 
 
Search terms:  
Health Belief Model 
HBM 
Human Papillomavirus 
HPV 
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Self-sampling 
Home testing 
Search terms were combined to form the following searches: 
Health Belief Model and Human Papillomavirus self-sampling 
Health Belief Model and Human Papillomavirus home testing 
HBM and HPV self-sampling 
HBM and HPV home testing 
  
Inclusion criteria:  
Participants were female 
The focus of the study was HPV self-sampling 
The study utilised the Health Belief Model in its material development 
The study investigated attitudes to behaviour 
 
Exclusion criteria: 
Male participants 
Laboratory based studies 
Focus on HPV vaccination 
 
Results of 2010 search 
 
N= 18 studies identified 
    N=14 duplicate studies through (title screen and abstract screen) 
         
        N= 4 studies  
  N=3 studies did not meet inclusion criteria (abstract/full text screen)  
 
N= 1 study met inclusion criteria (full text screen) 
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Results of 2012 search 
 
N= 108 studies identified 
           N=78   duplicate studies (title screen and abstract screen) 
       N=30 studies 
 N= 29 did not meet inclusion criteria (abstract/full text screen) 
 
N= 1 study met inclusion criteria (study originally identified in 2010) (full text screen)
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Appendix 3.2: Studies identified from 2010 literature search 
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Appendix 3.3:  Initial HPV self-sampling survey 
 
Research study: Women’s attitudes towards HPV self-sampling 
Home screening kits have been made which can allow women to carry out a cervical 
screening procedure themselves in their own homes. These kits test for Human 
Papillomavirus (HPV). HPV is a very common infection that most women will have at 
some point in their lives. Most of the time this infection will not cause any problems and 
will clear up on its own, but in some cases it can cause cervical cancer. 
To carry out the home test a woman will need to put a swab (a cotton bud with a long 
handle) into the vagina. She will then need to put the swab into a sealed tube with a 
liquid already inside, and post it to a laboratory using a special pre-addressed envelope.  
We would like to ask you a few questions about these kits and your views on cervical 
cancer and testing. Some of the questions are a little sensitive but it’s important for us 
to know about your views so please try and fill in as much as you can. All of responses 
will be kept strictly confidential. Your opinions are very important and will help us to 
plan future health services to reduce cervical cancer. 
 
Please read the instructions for each question carefully. There are questions on both 
sides of each page. You will mostly need to tick a box or circle a number and the 
survey shouldn’t take too long to complete. This survey is not a test, but we are 
interested in your views and would like you to answer questions as honestly as 
possible. 
 
Once you have completed the survey, please return it to us in the PRE-PAID and 
addressed envelope provided. 
 
We look forward to receiving your survey and would like to thank you for taking the 
time to help with this study. 
 
If you wish to take part could you firstly fill in your name, address and contact details 
below: 
Full name: ……………………………………….. 
Address:……………………………………………………………………………………………………………………
………………………………………………….. 
 
Contact Number:………………………………… E-mail address:…………………………………… 
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Your views on home testing 
 
1. Overall, how likely do you think that you would be to use a home testing kit?  
(please circle) Please circle a number. 
 
 
1                 2               3               4             5               
Not at                                                          Very likely 
all likely 
 
2. How sure are you that doing the test yourself will provide accurate results? Please 
circle a number. 
 
1                 2               3               4             5               
Not sure                                                      Very sure 
at all 
 
3. How sure are you that you will be able to understand the instructions provided in 
the home test kit? Please circle a number. 
 
 
1                 2               3               4             5               
Not sure                                                      Very sure 
at all 
 
4. How sure are you that you will be able to carry out the sampling procedure (placing 
swab in vagina)? Please circle a number. 
 
1                 2               3               4             5               
Not sure                                                      Very sure 
at all 
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5. How sure are you that you will be able to place the swab into the tube containing 
the special liquid without touching or dropping the swab? Please circle a number. 
 
1                 2               3               4             5               
Not sure                                                      Very sure 
at all 
 
6. How sure are you that you will be able to send off the completed test within the 
time allowed (2 weeks)? Please circle a number. 
 
1                 2               3               4             5               
Not sure                                                      Very sure 
at all 
 
7. How sure are you that your completed test kit will be good enough for testing? 
Please circle a number. 
 
1                 2               3               4             5               
Not sure                                                      Very sure 
at all 
 
8. Below are a few comments about doing home testing, please circle how much you 
agree with them.  
 
a. Using a home kit is convenient, as it can be done at home I would not have to take 
time off work/arrange childcare. Please circle a number. 
 
1                 2               3               4             5               
Strongly                                                       Strongly 
disagree                                                        agree  
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b. I am worried that I may hurt myself using the home kit. Please circle a number. 
 
1                 2               3               4             5               
Strongly                                                      Strongly 
disagree                                                       agree 
 
c. Using a home kit can help make sure no-one will know that I am being screened for 
cervical cancer. Please circle a number. 
 
1                 2               3               4             5               
Strongly                                                      Strongly 
disagree                                                       agree  
 
d. Using a home kit is less embarrassing than having a GP or nurse carrying out a smear 
test. Please circle a number. 
 
1                 2               3               4             5               
Strongly                                                      Strongly 
disagree                                                      agree  
 
e. I wouldn’t trust the results of the home kit. Please circle a number. 
 
1                 2               3               4             5               
Strongly                                                      Strongly 
disagree                                                      agree  
 
 
f. Using a home kit seems less painful than a smear test. Please circle a number. 
 
1                 2               3               4             5               
Strongly                                                      Strongly 
disagree                                                      agree  
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9. If you have any other comments about the home kits, please write them below:  
 
………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………   
 
 
Your views on HPV 
 
We would like to ask you a few questions about HPV. Please remember that this is 
not a test and we would just like to get to know a bit more about you and your 
views. 
 
10. How likely do you think you are to be infected with HPV? Please circle a number.  
 
1                 2               3               4             5              
Not at                                                         Very likely 
all likely 
 
 
11. Before taking part in this study had you heard of Human Papillomavirus (HPV) 
before? Please tick a box 
 
Yes            
No            
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12. If you had to guess, how do you think HPV spreads from person to person? Please 
tick all that apply. 
 
 
 
Through sexual contact                                                                                                
 
Through sitting on dirty toilet seats                                                                           
 
Through kissing                                                                                                              
 
13. How important do you think HPV is in developing cervical cancer? Please circle a 
number from 1 (Not at all important)  to 5 (Very important) 
 
1                 2               3               4             5              
 Not                                                             Very important 
 important 
 at all 
 
14. Do you think that HPV can be treated with medicines? Please tick a box. 
 
Yes  
No   
 
15. Do you think that HPV can clear up by itself? Please tick a box. 
 
Yes  
No   
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16. How serious of an infection do you think HPV is? Please circle a number.  
 
1                 2               3               4             5              
Not at                                                        Extremely  
all severe                                                  severe 
 
 
Your thoughts about cervical cancer.  
 
17. Compared to most other women your age, how likely do you think it is that you will 
get cervical cancer at some time in your life? Would you say you are…? Please circle 
 
1                                     2                             3                        4                       5                
Much                            A little less              About the         A little             Much more  
less likely                     likely                        same                more likely      likely 
 
18. How confident, are you that you would notice a symptom of cervical cancer? 
 
1                                     2                3                4                        5                                     
Not at all                    Slightly         About the same              Fairly                Very  
confident                    confident                                     confident           confident  
 
19. Please tell us whether you agree or disagree with each of the following statements 
by circling a number from 1 (strongly disagree) to 5 (strongly agree). 
 
a) Going for regular smear tests means that   1           2          3        4       5 
cervical cancer can be found early on. 
 
b) The three yearly reminders I get help me   1           2          3        4       5 
remember to attend my cervical                 
screening appointments. 
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c) Having a smear test is embarrassing       1           2          3        4       5 
and that puts me off attending.  
 
d) If I got cervical cancer, it would be            1           2          3        4       5 
more serious than other diseases. 
 
 
20. Have you made any lifestyle choices to try and reduce your risk of cervical cancer? 
 
Yes      If Yes, please describe them below. 
No   
 
……………………………………………………………………………………… 
……………………………………………………………………………………… 
 
 
Your experiences of cervical cancer screening and cervical cancer. 
 
21. Have you ever had a smear test? Please tick a box                 
 
Yes     
No      
 
22. If you have previously had a smear test, how long ago did you have your last 
smear? Please tick a box                 
 
Under 3 years  
3-4 years          
4+ years           
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23. Have you ever had an abnormal smear test result?  Please tick a box.                 
 
Yes         
No          
 
24. Have you ever received treatment for abnormal cervical cells?  Please tick a box.                 
 
Yes       
No        
 
25. Has anyone close to you ever had abnormal cervical smear results?   Please tick a 
box                 
 
Yes       
No        
 
26. Has anyone close to you ever been diagnosed with cervical cancer? Please tick a 
box                 
 
Yes                 
No                  
 
27. Has anyone close to you ever died from cervical cancer? Please tick a box                 
 
Yes           
No            
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Demographic details 
Finally we would like to ask you a few background questions. 
 
28. What is your age? 
…………………… 
 
29. What is your postcode 
 
What is the highest level of education you have? 
 
Left school at or before age 15    
GCSE or O level or equivalent                
A level or equivalent      
Further education but not a degree  
Degree or higher (e.g. Masters, PhD)   
None of the above     
……………………… 
 
30. Do you own your own home? Please tick a box 
 
Yes  
No   
 
31. Which of the following do you feel best describes your ethnic group? Please tick 
one or more boxes  
 
English                                   Caribbean                            Arab                     
Irish                                         African                               Chinese                 
Scottish                                   African Indian                  Bangladeshi          
Welsh                                       Indian                               Any other group  
British                                    Pakistani                 
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Thank you very much for completing the survey. Your contribution to this research is 
invaluable and will help make decisions regarding future cervical screening.  
 
 
Could you please return the survey using the PRE-PAID and addressed envelope 
provided. 
 
We look forward to receiving your survey. 
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Appendix 3.4 : Content Validity Analysis Protocol 
 
 
Background  
  We have developed a survey to investigate women’s attitudes and beliefs towards 
Human Papillomavirus (HPV) self-sampling. Many of the questions in the survey will be 
based around constructs of the extended Health Belief Model and will particularly 
focus on the concept of self-efficacy. The survey will also investigate women’s 
knowledge of HPV infection, screening behaviour and family history of cervical cancer.  
 
Purpose of this protocol 
  This protocol covers the assessment of content validity. Content validity provides 
evidence of the extent to which the components of the instrument are relevant to, and 
representative of, the construct of interest.1  In this definition, the term ‘construct’ 
refers to the concept or variable that is the target of the survey.  ‘Relevance’ refers to 
the appropriateness of the items in relation to both the construct and the function of 
the survey.  ‘Representativeness’ refers to the degree to which the items reflect and 
measure all facets of the construct.   
  The measure is not a comprehensive assessment of all possible factors that might 
influence women’s attitudes towards HPV self-sampling and their predicted intention 
to self-sample. Rather, items have been selected to represent key theoretical 
constructs, reflecting the extended Health Belief Model2-4 and screening behaviour and 
experiences that may be the determinants of women’s attitudes and intentions.   
 Content validity takes the form of a quantitatively based judgement.  This is often 
carried out by experts who are asked to ally assess if the items in a survey reflect the 
area of interest and will successfully meet the aims of the research.  Content validity is 
similar to face validity, but the process differs in that face validity more usually refers 
to the superficial validity, based on intuitive judgements of a target audience, or other 
untrained observers. 
  An assessment of content validity is generally carried out using a panel of expert 
raters who score the survey items on several different criteria.1 5 6 The proportion of 
raters giving high scores is known as the content validity index.  
  This protocol outlines the methods to be used for measuring content validity index for 
a survey measure in UK English. 
 
Methods 
 The content validity of the survey will be investigated by asking raters to assess each 
item in terms of relevance and representativeness. We will then calculate the content 
validity index for each item and group: the percentage of raters who give a high score 
in terms of relevance and representativeness.  
Panel of raters 
 The panel of raters should consist of six or more academics with some experience in 
the field of measurement of knowledge, attitudes and beliefs. Ideally, ten raters should 
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be recruited because the probability of drawing spurious conclusions due to chance 
agreement diminishes to a negligible level with this number.7  However, six raters is 
considered adequate if positive agreement is at least 78%.7 
 
The raters may be doctoral students, post-doctoral researchers or more senior 
academics. They need not be screening behaviour or cervical cancer experts, but 
should have some knowledge of the field of awareness and beliefs about cervical 
cancer and screening behaviour. They must have a good mastery of English.  
Description of constructs 
 
The survey aims to measure the following constructs: 
 
 Perceived severity: Perception of comparative severity of HPV infection or 
cervical cancer. 
 Self-efficacy:  A belief regarding one’s ability to exert effective control over 
behaviours associated with self-sampling or attending smear testing.  
 Perceived susceptibility:  Perception of comparative personal susceptibility of 
cervical cancer or HPV infection. 
 Perceived benefits: Beliefs about the benefits associated with self-sampling or 
attending for smear testing. 
 Perceived barriers: Beliefs about the barriers associated with self-sampling or 
attending for smear testing. 
 Intention: The overall predicted intention to HPV self-sample (hypothetical). 
 Cues to action: External event that prompts a desire to make a health decision: 
whether to attend smear testing. 
 Baseline knowledge: An assessment of participant knowledge about HPV or 
cervical cancer aetiology and prognosis, with the provision of minimal 
information (information sheet and survey). 
 Screening history: An assessment of participants past smear test attendance 
and adherence to the recommended 3yearly testing. 
 Treatment history: An assessment of previous cervical cell abnormalities. 
 Family history: An assessment of participant experiences associated with 
cervical abnormality and cervical cancer.  
 
Scoring 
Each rater will independently score each of the items in the HPV self-sampling survey 
(items QV1 to QV27, with the exception of Q 9 which is a free text field question). 
Items 28-31 have been excluded from the content validity analysis as they are 
questions asking about demographic details.  The survey can be located in Appendix 1 
and must be scored using the score instruction sheet provided in Appendix 2, the 
content validity score card is provided in Appendix 3. Scoring must take place according 
to the following criteria: 
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 Relevance: the appropriateness of the items in relation to both the construct 
and the function of the survey 
 Representativeness: whether the items cover a representative sample of the construct 
 
Raters should score each domain on a scale of 1 to 4 (from poor to very good – defined 
in scorecard). Raters should provide comments, particularly if they give a score of less 
than 3 to any item. 
 
Analysis 
For each item, we will calculate the number of raters giving a rating of 3 or 4 for 
relevance and representativeness. We will divide this by the total number of raters to 
give a content validity index for relevance and representativeness. A low content 
validity index will, therefore, arise if few raters score an item 3 or 4.  
 
Definition of adequate content validity 
There is no universal agreement on the definition of adequate content validity; we will 
consider content validity to be adequate if the index is greater than 78%.4  This is a 
level at which chance agreement is unlikely to explain the high score.4 
Action taken if content validity index <78%  
If the content validity is less than 78% for any of the items on any dimension, we will 
seek to improve the wording of the item and consider: 
 whether the item(s) in the domain are not comprehensive enough to collect 
data on the construct 
 whether the domain measures other constructs than the one of interest 
If it is not possible to reach agreement on the most appropriate wording of component 
items it may be appropriate to test different versions during the cognitive interviewing 
phase.  
Timescale 
June 2011.  
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Content validity instructions  
 
The following constructs are investigated in the HPV self-sampling survey. Please find 
a definition of the constructs below: 
 
 Perceived severity: Perception of comparative severity of HPV infection or 
cervical cancer. 
 Self-efficacy:  A belief regarding one’s ability to exert effective control over 
behaviours associated with self-sampling or attending smear testing.  
 Perceived susceptibility:  Perception of comparative personal susceptibility of 
cervical cancer or HPV infection. 
 Perceived benefits: Beliefs about the benefits associated with self-sampling or 
attending for smear testing. 
 Perceived barriers: Beliefs about the barriers associated with self-sampling or 
attending for smear testing. 
 Intention: The overall predicted intention to HPV self-sample (hypothetical). 
 Cues to action: External event that prompts a desire to make a health decision: 
whether to attend smear testing. 
 Baseline knowledge: An assessment of participant knowledge about HPV or 
cervical cancer aetiology and prognosis, with the provision of minimal 
information (information sheet and survey). 
 Screening history: An assessment of participants past smear test attendance 
and adherence to the recommended 3yearly testing. 
 Treatment history: An assessment of previous cervical cell abnormalities. 
 Family history: An assessment of participant experiences associated with 
cervical abnormality and cervical cancer.  
 
Scoring of questions 
 
Please score according to the following criteria: 
 
Relevance: the appropriateness of the questions in relation to both the construct and 
the function of the survey 
1. The question is not relevant and is not appropriate for the construct or to the 
function of the survey. 
2. The question needs major revisions in order to be relevant to the construct or 
to the function of the survey. 
3. The question needs minor revisions in order to be relevant to the construct or 
to the function of the survey 
4. The question is relevant to the construct and to the function of the survey  
 
 
 279 
 
Representativeness: the questions and response scales reflect and measure a 
representative sample of the construct 
 
1. The question and/or response scale is not representative. 
 
2. The question and/or response scale needs major revisions to make it 
representative  
 
3. The question and/or response scale need minor revisions to make it 
representative 
 
4. The question and/or response scale is representative 
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Content validity scoring card  
 
 
Construct 
 
Item 
number 
Domain 
SCORE 
Notes (please note why you have given a low score, and provide 
suggestions for improvement if possible) 
R
e
le
v
a
n
c
e
 
R
e
p
re
s
e
n
ta
ti
v
e
n
e
s
s
 
Intention QV 1 Intention to HPV self-sample.    
 
Self-efficacy QV 2 Self-sampling result accuracy.    
Self-efficacy QV 3 
Understanding self-sampling 
procedure instructions. 
   
Self-efficacy QV 4 
Executing self-sampling 
procedure. 
   
Self-efficacy QV 5 Self-sampling: Sample storage    
Self-efficacy QV 6 
Self-sampling: Time 
management.                                
  
 
 
Self-efficacy QV 7 Self-sampling: Sample quality   
 
 
Self-sampling QV 18 
Cervical cancer: symptom 
identification 
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Construct 
 
Item 
number 
Domain 
SCORE 
Notes (please note why you have given a low score, and provide 
suggestions for improvement if possible) 
R
e
le
v
a
n
c
e
 
R
e
p
re
s
e
n
ta
ti
v
e
n
e
s
s
 
Self-efficacy QV 20 
Reducing cervical cancer risk: 
lifestyle modification 
  
 
 
 
 
Perceived 
Benefits   
QV 8a) 
Perceived benefits to self-
sampling: additional 
arrangements. 
  
 
 
Perceived 
Benefits   
QV 8(c) 
Perceived benefits to self-
sampling: confidentiality. 
  
 
 
Perceived 
benefits 
QV 8(d) 
Perceived benefits to self-
sampling: embarrassment. 
  
 
 
Perceived 
benefits 
QV 8(f) 
Perceived benefits to self-
sampling: reduction in pain 
  
 
 
Perceived 
benefits 
QV 19(a) 
Perceived benefits to cervical 
smear testing: early cancer 
identification 
  
 
 
 
 
Perceived 
barriers 
8 (b) 
Perceived barriers to self-
sampling: fear of pain 
   
Perceived 
barriers 
QV 8 (e) 
Perceived barriers to self-
sampling: trust in results. 
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Construct 
 
Item 
number 
Domain 
SCORE 
Notes (please note why you have given a low score, and provide 
suggestions for improvement if possible) 
R
e
le
v
a
n
c
e
 
R
e
p
re
s
e
n
ta
ti
v
e
n
e
s
s
 
Perceived 
barriers 
QV19(c) 
Perceived barriers to smear test 
attendance: embarrassment. 
  
 
 
 
 
Perceived 
susceptibility 
QV 10 
Perceived susceptibility to HPV 
infection. 
  
 
 
Perceived 
susceptibility 
QV 17 
Perceived susceptibility to 
cervical cancer. 
  
 
 
 
Perceived 
severity 
QV 16 
Perceived severity of HPV 
infection. 
   
Perceived 
severity 
QV19(d) 
Perceived severity of cervical 
cancer. 
   
 
Cues to action QV19(b) 
Cues to action: smear test 
attendance 
   
 
Baseline 
Knowledge 
QV 11 Knowledge of HPV.   
 
 
Baseline 
Knowledge 
QV 12 Transmission of HPV infection.   
 
 
Baseline 
Knowledge 
QV 13 Role of HPV in cervical cancer.    
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Construct 
 
Item 
number 
Domain 
SCORE 
Notes (please note why you have given a low score, and provide 
suggestions for improvement if possible) 
R
e
le
v
a
n
c
e
 
R
e
p
re
s
e
n
ta
ti
v
e
n
e
s
s
 
 
Baseline 
Knowledge 
QV 14 Treatment of HPV infection.    
Baseline 
knowledge 
QV 15 HPV etiology    
 
Screening history QV 21 Smear test attendance.    
Screening history QV 22 Last smear test attendance.    
Screening history QV 23 Experience of abnormal result.    
 
Treatment history QV 24 
Experience of cervical 
treatment. 
   
 
Family history QV 25 
Family history of cervical 
abnormalities. 
   
Family history QV 26 Family history of cervical cancer    
Family history QV 27 
Family history of cervical cancer 
prognosis. 
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Appendix 3.5 : CVA scores 
Question 
no 
Rater 
1 RM 
Rater 
2 FL 
Rater 
3 JW 
Rater 
4 
Rater 
5 
Rater 
6  
Rater 
7 
Rater 
8  
Rater 
9 
Total % 3 or 4 
 A B A B A B A B A B A B A B A B A B A       B 
1 4 4 4 4 4 4 4 4 4 4 3 3 4 4 4 3 3 4 100 100 
2 4 4 4 4 3 3 2 4 1 1 2 3 2 3 4 3 4 4 55 89 
3 4 4 2 4 4 4 3 4 4 4 4 4 4 4 4 3 4 3 89 100 
4 4 4 4 3 4 4 4 4 4 4 4 4 4 4 4 3 4 4 100 100 
5 4 4 3 4 4 4 4 4 4 4 4 4 4 4 4 3 4 4 100 100 
6 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 3 4 4 100 100 
7 4 4 3 4 4 4 2 4 3 3 2 2 2 2 4 3 3 4 67 78 
8 (a) 4 4 4 4 4 4 4 4 3 3 4 4 4 4 3 2 4 4 100 89 
   (b) 4 4 4 4 4 4 4 4 4 3 4 4 4 4 4 2 4 4 100 89 
   (c) 4 4 4 3 4 4 2 4 3 4 4 4 4 4 4 3 4 4 89 100 
   (d) 4 4 3 4 4 4 4 4 4 4 4 4 4 4 4 2 4 4 100 89 
   (e) 4 4 4 4 4 4 4 4 4 3 4 4 4 4 4 4 4 4 100 100 
   (f) 4 4 3 4 4 4 4 4 4 4 3 3 4 4 4 2 4 4 100 89 
10 4 4 4 3 4 4 4 4 3 4 4 4 4 4 4 2 4 4 100 89 
11 4 4 4 4 4 4 4 4 4 4 2 2 4 4 4 2 4 4 89 78 
12 4 4 4 4 4 4 4 2 4 4 4 4 4 4 3 3 4 3 100 89 
13 4 4 2 3 4 4 2 2 4 4 4 4 3 3 4 3 4 4 78 89 
14 4 4 4 4 4 4 4 3 4 4 4 2 4 4 4 4 4 4 100 89 
15 4 4 1 1 4 4 4 3 4 1 4 2 4 4 4 4 4 4 89 67 
16 4 4 4 4 4 4 4 1 3 4 4 3 2 3 3 2 4 4 89 78 
17 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 100 100 
18 3 3 4 4 4 4 4 3 1 1 2 2 4 4 4 2 4 4 78 67 
19 (a) 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 3 4 4 100 89 
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(b) 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 100 100 
(c) 3 3 4 4 4 4 4 4 4 3 3 3 4 4 4 4 4 4 100 100 
(d) 3 3 4 3 4 4 2 3 4 4 4 4 2 2 3 2 4 4 78 78 
20 4 3 3 3 4 4 4 4 1 1 4 4 4 4 2 2 4 4 78 78 
21 4 4 4 4 4 4 2 3 4 4 4 4 4 4 4 4 4 4 89 100 
22 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 100 100 
23 4 4 4 4 3 4 4 4 4 3 4 4 4 4 4 4 4 4 100 100 
24 4 4 4 4 4 4 4 4 4 3 4 4 4 4 4 4 4 4 100 100 
25 3 3 4 3 3 3 4 4 3 4 3 3 3 3 4 4 4 4 100 100 
26 3 3 4 4 3 3 4 4 4 4 4 4 3 3 4 3 4 4 100 100 
27 3 3 4 4 3 3 4 4 4 4 4 4 3 3 4 3 4 4 100 100 
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                   Appendix 3.6: Content Validity Analysis; Rater Comments  
Construct Question   number Relevance 
(% of raters 
awarding 
3/4)  
Representativeness 
(% of raters awarding 
3/4) 
Comments 
Intention 1. Overall, how likely do you think that you 
would be to use a home testing kit? (please 
circle) Please circle a number. 
 
1      2      3     4     5               
Not at             Very        
likely              likely                                                                
 
100 100 R6: I think this needs a slight 
adjustment of wording eg Overall, 
how likely do you think it is that you 
would use a home testing kit 
R8: Clumsy wording.  Quiet 
sophisticated linguistically and too 
many words.  Eg could use How 
likely are you to use a home testing 
kit? 
R9: To focus home testing on the self 
sampling from the cervix for HPV the 
phrasing of the question may need 
to be more specific eg. ‘HPV self-
sampling cervical test kit’. 
Self-efficacy 2. How sure are you that doing the test 
yourself will provide accurate results? 
Please circle a number. 
 
1    2     3     4   5               
Not sure            Very sure                                                 
55 89 R3: Does this measure self-efficacy 
or potentially beliefs in self-
administered versus clinically 
administered tests (i.e. belief in 
better quality of tests from clinic 
(independent from ability of self) 
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at all 
 
versus belief in ability of self-
sampling)? – Consider rewording 
R4: Could also be measuring 
participants attitude towards the 
effectiveness of the test and not just 
the individual’s ability to do the test 
correctly 
R5: This item seems to measure their 
belief in the effectiveness of self-
sample rather than their ability to do 
the test well. So I don’t think this is 
self-efficacy. You could re-phrase to 
ask ‘how sure are you that you are 
able to do the self test well enough 
to provide an accurate result?’. This 
may overlap somewhat with QV7. 
R6: I don’t think this question 
necessarily relates to one’s own 
ability to exert control over 
behaviour, it could be interpreted to 
mean how well do they perceive the 
home kit itself as a valuable 
diagnostic tool 
R7: Could be re-worded slightly to 
make it clearer and less wordy. E.g. 
How likely are you to use home 
testing kits? 
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R8: As above.  Also, use of word 
‘sure’.  Ambiguous affective and 
conceptual relevance in relation to 
perception unless literature can 
clarify ‘surety’.  Would suggest 
considering ‘certain’ / ‘confident’ / 
or similar.  But need to check this in 
relevant literature.  Previous 
experience shows that people will 
rate the same question using 
‘certainty, and ‘confident’ differently 
– i.e. people can be certain but not 
confident etc.  So these words are 
critical to study.  Are you looking for 
surety, certainty (self-efficacy), 
confidence…or what?  As far as I am 
aware self-efficacy usually uses 
‘certain’ as the key word. 
Self-efficacy 3. How sure are you that you will be able to 
understand the instructions provided in the 
home test kit? Please circle a number. 
 
 
1    2     3     4    5               
Not sure            Very sure                                                 
at all 
 
89 100 R2: Is there an example of the 
instructions included in the survey? 
Don’t know if you can understand it 
until you see what it says 
R4: Could possibly measure the 
literacy, i.e., if they feel they would 
not be able to understand the 
instructions 
R 7: This item could be confused 
with the efficacy and trustworthiness 
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of the testing kit, not my own self-
efficacy to perform the test myself 
R8: As above.  Also, when measuring 
SE it is standard practice to use a ten 
(10) point rating scale.  The fewer 
the questions the more important 
this becomes.  That having been 
said, I have used a four (4) point 
rating scale (nominal) with good 
results.  However, this was based on 
20 years of literature that indentified 
5 relevant factors with a great deal 
of certainty.  I think these questions 
need further consideration in terms 
of the scale, the wording, and the 
items themselves. 
R9: I believe the women will not be 
receiving the kits and so will not 
have an example of the types of 
instructions that they will need to 
follow. Without that information, 
how meaningful will the outputs be 
from this question? 
Self-efficacy 4. How sure are you that you will be able to 
carry out the sampling procedure (placing 
swab in vagina)? Please circle a number. 
 
1    2     3     4    5               
100 100  
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Not sure            Very sure                                                 
at all 
 
Self-efficacy 5. How sure are you that you will be able to 
place the swab into the tube containing the 
special liquid without touching or dropping 
the swab? Please circle a number. 
 
1    2     3     4    5               
Not sure            Very sure                                                 
at all 
 
100 100 R2: Maybe just say – after you have 
sampled the swab? 
Self-efficacy 6. How sure are you that you will be able to 
send off the completed test within the time 
allowed (2 weeks)? Please circle a number. 
 
1    2     3     4    5               
Not sure            Very sure                                                 
at all 
 
 
100 100  
Self-efficacy 7. How sure are you that your completed 
test kit will be good enough for testing? 
Please circle a number. 
 
1    2     3     4    5               
Not sure            Very sure                                                 
at all 
67 78 R2: Will they know what that means? 
If they don’t know what the screen 
really does how will they know it is 
good enough for testing? 
R4: Could also be measuring 
participants attitude towards the 
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 effectiveness of the test and not just 
the individual’s ability to do the test  
R5: This question could be 
understood as asking if they think 
HPV self testing per se is good enough 
for testing. I would suggest re-
phrasing to ‘How sure are you that 
you will be able to do the test well 
enough for testing?’ 
R6: As above, I don’t think this 
question necessarily relates to one’s 
own ability to exert control over 
behaviour, it could be interpreted to 
mean how well do they perceive the 
home kit itself as a valuable 
diagnostic tool 
R7: Be careful with this item, some 
people may think that you are talking 
about good and bad test results, e.g. 
a good test result means I don’t have 
HPV a bad one means I do. This items 
needs to be more explicit that you are 
talking about how well I will perform 
the test myself, to make it adequate 
enough for testing in the lab. 
R9:  Again with this question as the 
women will have no concept of the 
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device, asking and interpreting their 
responses in terms of how effective 
they would be at using it, seems 
difficult. 
 
Perceived 
benefits 
8 (a) .Using a home kit is convenient, as it 
can be done at home I would not have to 
take time off work/arrange childcare. 
Please circle a number. 
 
1     2     3    4    5               
Strongly       Strongly      
disagree        agree         
                                                                                  
100 89 R2: Maybe try not to repeat home? 
R5: Another additional arrangement 
not described here might be having 
to make/get a Drs appointment. This 
could be added to the question or it 
could be left as ‘Using a self-test kit is 
convenient because it can be done at 
home’ or Using a self-test kit is 
convenient because I do not have to 
make arrangements (eg. Drs 
appointment/childcare/time off 
work)’. 
R8: Poor use of English.  Punctuation 
makes question read badly.  This is 
two questions, not one. 
 
Perceived 
barriers 
(b) I am worried that I may hurt myself 
using the home kit. Please circle a number. 
 
1     2     3    4    5               
Strongly      Strongly         
disagree      agree  
100 89 R5: Does there need to be a similar 
question with regards to going for a 
cervical smear (i.e. is having 
someone do the cervical smear test 
is less painful than using the self test 
kit) 
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 R8: Use of English.  ‘may’  I wonder if 
this should be ‘could’.  ‘may’/’might’ 
implies permission and choice.  
‘can’/’could’ is more related to 
outcome of a possible action. 
Perceived 
benefits 
(c) Using a home kit can help make sure no-
one will know that I am being screened for 
cervical cancer. Please circle a number. 
 
1    2     3    4  5               
Not           Strongly       
relevant     agree                                                    
 
89 100 R4: I find this question confusing as it 
mentions that the home kit is 
screening for cervical cancer, should 
this be screening for HPV?  
 
Also if a person does not mind people 
knowing about having screening 
would they answer strongly 
disagree? If so can this be interpreted 
as them not seeing home testing as a 
benefit?  
R5: In comparison to going for a 
smear test? 
R8: Poor use of English.   
 
 
Perceived 
benefits 
(d) Using a home kit is less embarrassing 
than having a GP or nurse carrying out a 
smear test. Please circle a number. 
 
 
100 89 R2: Need a “don’t know” for those 
who haven’t had a smear test yet or 
phrase it to include “Using a home kit 
is / I think will be less embarrassing” 
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1    2     3    4  5               
Strongly    Strongly       
disagree     agree                                                  
 
 
R8: Poor use of English (NOT ‘carrying 
out’; could be ‘carry out’ or just ‘…do 
a smear test’. 
If you are asking sensitive questions 
then the wording of the questions is 
crucial as the wording will have an 
impact whether or not the 
respondent is aware of it.  I’s suggest 
this survey is piloted specifically for 
the use of language.  A cognitive 
analysis with a group is advisable. 
 
Perceived 
barriers 
(e) I wouldn’t trust the results of the home 
kit. Please circle a number. 
 
1    2     3    4  5               
Strongly       Strongly                                                            
disagree        agree                                             
 
100 100 R5: Would they trust a cervical 
smear test more? Add a similar 
question with regards to a smear 
test or draw a comparison in the 
question 
Perceived 
benefits 
(f) Using a home kit seems less painful than 
a smear test. Please circle a number. 
 
1    2     3    4  5               
Strongly    Strongly       
disagree     agree                                                  
 
 
100 89 R2: “less painful than a smear test 
carried out by a nurse or GP” 
R4: Might be dependent on the 
participant having a smear test in the 
past? 
R6: I think the wording needs to be 
adjusted slightly, “sounds” rather 
than “seems”, presuming this survey 
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comes before they use the home 
testing kit 
R8: This question could lead to the 
assumption that the person has used 
a home kit before.  Is that the 
intention? 
 
Perceived 
susceptibility  
10 How likely do you think you are to be 
infected with HPV? Please circle a number.  
 
1      2      3    4     5              
Not at            Very        
all likely        Likely 
 
100 89 R2: Maybe say – in your life time? Or 
give another time scale 
R5: Changing the wording of this to 
the same format as QV17 might help. 
It would then be in comparison to 
other women and also with a specific 
time frame (in your life) which might 
be useful when it comes to analysis. 
R8: This question can be read two 
ways; 1) You are asking if I think I have 
been infected; 2) you are asking if I 
think I could become infected.  Which 
one is it? 
 
 
Baseline 
Knowledge 
11 Before taking part in this study had you 
heard of Human Papillomavirus (HPV)? 
Please tick a box 
 
Yes           
89 78 R6: “Hearing” about something 
doesn’t imply you have knowledge of 
it. Might be better worded “How 
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No            
 
would you rate your knowledge of 
HPV” 
R8: ‘Before’ is used twice.  Poor 
English. 
 
Baseline 
Knowledge 
12 If you had to guess, how do you think 
HPV spreads from person to person? Please 
tick all that apply. 
 
Through breathing the same air as 
someone who is infected (like catching a 
cold)                                          
 
Through intimate skin-to skin contact 
(sexual)                                                             
 
Through sitting on dirty toilet seats                                                                                           
 
Through kissing                                                                                                                                                                 
 
100 89 R4: I think some of the responses for 
12 are too vague. Perhaps be useful 
to have e.g., for one such as sexual 
contact (intercourse, oral sex…) 
which would reduce the potential 
ambivalence of the kissing option 
(people might include kissing 
intimate parts which I would think 
would come under the sexual 
contact. Also, I think the responses 
should be YES/NO/I DO NOT KNOW 
for each option. This way you would 
be able to gauge complete baseline 
knowledge (and true missing 
responses). You could also give 
people a comment box so they have 
the option to comment on other 
causes they may feel are important.  
R8: What if the person knows and 
doesn’t have to guess.  You can 
simply use a forced choice question 
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(i.e. no ‘don’t know’ option).  Just ask, 
how do you think… 
R9: Colds are transmissible through 
droplets from infected individuals 
rather than directly through the air. I 
think the responses may need re-
phrasing slightly. 
 
 
 
Baseline 
Knowledge 
13 How important do you think HPV is in 
developing cervical cancer? Please circle a 
number from 1 (Not at all important)  to 5 
(Very important) 
 
 
1       2      3     4    5             Not                 Very 
important   important         
at all 
 
78 89 R2: Not sure if this will be 
understood, maybe instead of 
important which is a positive word, 
use high risk or another more 
negative term? 
R4: If participants answer ‘not at all 
important’ what does this mean, that 
they do not think HPV causes cancer? 
You have however, told them at the 
start that it does which may influence 
their response.  
 
 
Baseline 
Knowledge 
14 Do you think that HPV can be treated 
with medicines? Please tick a box. 
 
100 89 R4: Is there only one correct answer 
for this? 
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Yes  
No   
 
R5: There is no mention in the 
knowledge construct of cervical 
cancer. This question could 
therefore be split in two so that 
there is also a question ‘ Do you 
think that cervical cancer can be 
treated with medicines?’ 
R6: I think you need a don’t know 
option, having Yes or No responses 
suggests that you have some 
knowledge 
Baseline 
Knowledge 
15. Do you think that HPV can clear up by 
itself? Please tick a box. 
 
Yes  
No   
 
89 67 R2: You tell them this in the intro to 
the survey, so this will not give you 
any reliable answers as everyone 
who reads the information will say 
that yes it can clear up by itself 
R4: Is there only one correct answer 
for this? You have told them this at 
the start which may influence their 
response. 
R5: This question is relevant, but I 
don’t think it measures the etiology 
of HPV. Something like HPV is caused 
by a) a virus, b) bacteria, c)other…. 
Etc similarly there could be a 
question for cervical cancer? 
R6: I think you need a don’t know 
option, having Yes or No responses 
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suggests that you have some 
knowledge 
R8: Should this be aetiology? 
Perceived 
Severity 
16. How serious of an infection do you 
think HPV is? Please circle a number.  
 
 
1      2       3     4    5              
Not at      Extremely 
all           severe  
severe                               
89 78 R2: Maybe re-word it? “How serious 
do you think a HPV infection is?” 
R4: I think it should be serious and 
not severe. 
R5: This could be made comparative 
to other diseases so it is similar to 
QV19d 
R6: Responses need to relate to 
seriousness, 
R7: Anchors don’t match the 
question. E.g. serious and severe. 
R8: Poor English.  Reword.  ‘…serious 
of an infection…’ – the English is 
probably correct but it reads badly 
and does not make sense as a quick 
read.  Try ‘How serious do you think 
an HPV infection is?’ or ‘How serious 
an infection do you think…’ 
Perceived 
susceptibility 
17. Compared to most other women your 
age, how likely do you think it is that you 
will get cervical cancer at some time in your 
life? Would you say you are…? Please circle 
1          2            3          4          5                
Much  A little About  A little  Much 
less     less       the       more     more 
100 100  
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likely  likely   same    likely    likely 
Self-efficacy 18. How confident, are you that you would 
notice a symptom of cervical cancer? 
 
1     2          3        4      5 
Not     Slightly     About     Fairly   Very 
at all   confident   the      confident confi- 
confident              same                   dent 
78 67 Rater 1: Is it worth asking if they know 
what symptoms are? 
R4: Is this not dependent on if they 
know the symptoms of cervical 
cancer therefore I am not sure a ‘Not 
at all’ confident response would 
indicate low self-efficacy? 
R5: I don’t see the relevance of this 
question with regards to the 
definition of self-efficacy being used 
as it is asking about a behaviour 
(symptom detection) associated with 
cervical cancer not self-sampling or 
smear testing. 
R6: This sounds more like 
‘knowledge’ rather than self-efficacy 
R7: Think this is self efficacy as well? 
R8: Are you looking at confidence or 
certainty?  If it is definitely 
confidence then this is fine.  Why 
confidence and not certainty?  Why 
not make this a SE question?  What 
will confidence tell you?  Do you want 
to compare and contrast confidence 
and SE?  Confidence and surety? 
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 19 Please tell us whether you agree or 
disagree with each of the following 
statements by circling a number from 1 
(strongly disagree) to 5 (strongly agree). 
   
Perceived 
benefits 
 (a) Going for regular smear tests means 
that cervical cancer can be found early on. 
 
1           2          3        4       5 
 
100 89 R2: The numbers need to be moved 
across slightly to make it clearer 
R5: Should there be an equivalent 
question for HPV self testing kit? E.g. 
Completing a self-testing HPV test 
means that cervical cancer can be 
found early on? 
R8: Use of word ‘found’?  Is this the 
best word?  Found or diagnosed?  
Indications found or the cancer 
actually diagnosed or actual cancer 
found? 
 
 
 
Cues to 
action 
(b) The three yearly reminders I get help 
me   remember to attend my cervical                 
screening appointments. 
 
100 100  
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1           2          3        4       5 
 
 
Perceived 
barriers 
(c) Having a smear test is embarrassing and 
that puts me off attending.  
 
1           2          3        4       5 
 
 
100 100 R1: Similar to QV 8 (d)? 
R5: This its partially covered in QV8d 
for the comparison to using the self-
test kit 
R6: I think “having a smear test is 
embarrassing” relates to the 
construct but “puts me off attending” 
is a consequence of that 
R8: But scale should be anchored on 
the instrument – Srongly Disagree 
and Strongly Agree should be at top 
of scale so that they are visible at all 
timew 
 
Perceived 
severity 
(d) If I got cervical cancer, it would be more 
serious than other diseases. 
 
1           2          3        4       5 
 
78 78 R1: Depends which disease - what 
about other cancers? 
R2: is disease the right word? 
Illness… condition..? 
R4: Question is vague (there are so 
many diseases you are asking people 
to compare this to) and therefore I 
think hard for people to answer and 
for you to interpret.(what would a 3 
mean?_ Not sure what an alternative 
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would be, could you ask people to 
rank the importance of severity to 
them of other diseases including 
cervical cancer? 
R7: Not sure about this. Wouldn’t 
someone think it was a serious 
disease regardless of whether they 
actually got it or not, and therefore, 
taking preventative measures like 
screening? 
R8: More serious than which other 
diseases?  The question works, but it 
could raise questions which in turn 
leads to messy responses due to 
dissonance. 
Self-efficacy 20. Have you made any lifestyle choices to 
try and reduce your risk of cervical cancer? 
 
Yes      If Yes, please describe them below. 
No    
 
78 78 R1: Meaning slightly ambiguous 
R2: Could give an example? 
R5: As in QV18, this is regarding 
cervical cancer rather than self-
sampling or smear testing. Also it 
seems to be asking about actual 
behaviour change in the past rather 
than future behaviour/ability to carry 
out behaviour in the future 
Overall the self-efficacy construct 
items could be improved in their 
representativeness by including 
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items on smear testing too (e.g.s How 
sure are you will be able to attend 
for/make an appointment for a smear 
test?) 
R8: What does this have to do with 
SE?  Why not a short list of key 
choices including ‘all of the above; 
none of the above; other?  Open 
questions such as this tend to 
produce standard responses that 
usually lack relevance.  This is NOT a 
SE question.  Please make sure your 
constructs are correctly identified.  I 
think you may need to polish up the 
construct validity. 
 
 
 
Screening 
history 
21. Have you ever had a smear test? Please 
tick a box                 
 
Yes   
No    
Not Known   
 
89 100 R6:  Again Don’t know option 
missing  
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Screening 
history 
22. If you have previously had a smear test, 
how long ago did you have your last 
smear? Please tick a box                 
 
Under 3 years  
3-4 years 
4+ years  
Not Known   
 
100 100 R6:  Again Don’t know option 
missing 
 
 
Screening 
history 
 
Construct 
name 
change: 
Screening 
Results 
23. Have you ever had an abnormal smear 
test result?  Please tick a box.                 
 
Yes          
No           
Not Known   
 
100 100 R2: Maybe provide a “prefer not to 
say” box  R3: Your current construct 
definition does not include screening 
experience/results (only 
‘attendance’ and ‘adherence’); 
however I feel this is an important 
question and the construct could be 
amended to include ‘experience’ or 
‘results’, as these do fall under 
‘screening history’. Currently, the 
construct is not fully represented by 
this question; however I have 
awarded a 3, since it is not the 
question/scale that should be 
revised, but the construct. 
R4: You do not ask them if they have 
had cervical cancer nor if they have 
been diagnosed with HPV, do you 
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think this may impact on their 
responses? 
R5: Do you want to include a 
measure of how many times this has 
happened? 
Treatment 
history 
24. Have you ever received treatment for 
abnormal cervical cells?  Please tick a box.                 
 
Yes       
No          
Not Known   
 
100 100 R2: Again, “prefer not to say” 
R5: Do you want to include a 
measure of how many times this has 
happened? 
 
 
Family 
history 
 
 
Construct 
name 
change: 
Experience 
Construct 
domain 
change: 
Family/ 
Friend 
history of 
cervical 
cancer 
25. Has anyone close to you ever had 
abnormal cervical smear results?   Please 
tick a box                 
 
Yes       
No          
Not Known   
 
100 100 R1: For all 3 of these questions: if 
only interested in family history this 
needs re-wording otherwise you 
won’t be able to distinguish family 
from e.g. close friends 
R2: “Don’t know” could be an 
option, may not be something that is 
discussed in some families 
R3: The wording of this question 
does NOT ask about ‘Family history’ 
as it asks about ‘anyone close to 
you’, which may be interpreted as a 
close friend/other non-blood 
relation, which would not be defined 
as family history per se. I do however 
think these questions are relevant to 
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 the function of the survey and 
experience with cervical 
issues/cancer outside the family are 
also important, therefore I propose a 
renaming of the construct to 
something along the lines of 
‘experience’. (Note: the current 
description of the construct does not 
require the person to be a ‘family 
member’ at the moment, so this 
does fit just fine. It is just the 
heading that is not quite fitting.). 
Currently, the question is not really 
relevant or representative of the 
construct of ‘family history’; 
however I have awarded a 3, since it 
is not the question/scale that should 
be revised, but the construct. 
R5: You might want to add a ‘don’t 
know’ option or rephrase the 
questions ‘As far as you know has 
anyone….. 
R6: Needs clarity, on those close to 
you eg friends and family 
R7: You might want to determine 
how close you mean. Some people 
will think of their close friends, 
neighbours living close by etc. not 
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their family. You should state that 
that you mean family and define 
how close, e.g. fist degree relatives 
etc. or ask them to state what 
relation they were to the person. 
Family 
history 
 
Construct 
name 
change: 
Experience 
Construct 
domain 
change: 
Family/ 
Friend 
history of 
cervical 
cancer 
 
26. Has anyone close to you ever been 
diagnosed with cervical cancer? Please tick 
a box                 
 
Yes                  
No                   
Not Known   
 
100 100 R1: For all 3 of these questions: if 
only interested in family history this 
needs re-wording otherwise you 
won’t be able to distinguish family 
from e.g. close friends 
R8: ‘close to you’ – what does that 
mean?  Geographically close?  Family 
member?  Friend? 
Family 
history 
 
Construct 
name 
change: 
Experience 
27. Has anyone close to you ever died from 
cervical cancer? Please tick a box                 
 
Yes            
No              
Not Known    
 
100 100 R1: For all 3 of these questions: if 
only interested in family history this 
needs re-wording otherwise you 
won’t be able to distinguish family 
from e.g. close friends 
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Construct 
domain 
change: 
Family/ 
Friend 
history of 
cervical 
cancer 
 
R8: As above.  (‘close to you’ – what 
does that mean?  Geographically 
close?  Family member?  Friend?) 
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Appendix 3.7: Cognitive Interview Information sheet and consent form 
Participant Information Sheet: Cognitive Interview 
 
 Study Title: Women’s attitudes towards HPV self-sampling. 
 
Background 
We have developed a survey to investigate women’s attitudes and beliefs towards 
Human Papillomavirus (HPV) self-sampling.  
Human Papillomavirus (HPV) is a very common infection. In most cases HPV does 
not cause any problems, but in some women it can cause cervical cancer. There are 
kits that you can use to test for HPV at home (HPV self-sampling). You would then 
send the kit to a laboratory to be tested and would be told your results through a 
letter in the post. 
We would like to invite you to take part in an interview to see if the survey we have 
developed makes sense and is easy to answer.  
Why have I been chosen? 
You have been asked to take part because you are a woman aged between 20-64 
years, which is the age range in which women are eligible for cervical screening. 
Do I have to take part? 
It is up to you to decide if you want to take part in this study. You are free to pull 
out of this study at any point and do not have to give a reason. 
What will happen to me if I take part? 
The aim of the interview is to see if any questions in the survey are difficult to 
answer or understand and may need to be changed. 
You will be asked to complete each question of the survey one at a time. The 
researcher (Mrs Denitza Williams) will ask specific questions relating to how easy or 
not it was to answer each question and how you managed to get to that answer.  
The interview should last no more than 1 hour. 
The discussion will be audio taped, however all details will be anonymised, so no 
one will know what you have said.  
The interview may be carried out face-to face or over the telephone. If it is carried 
out over the telephone, the survey will be sent to you through the post before the 
interview. You will be asked not to read the survey until the telephone interview 
has started.  
If the interview is to be carried out face-to face then you will be given the survey at 
the time of the interview. 
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What are the possible disadvantages of taking part? 
Taking part in this study will require you to complete a survey and talk about how 
you answered the questions. It is highly unlikely that anything should go wrong. If 
you would like to talk about any of the issues raised in this study, a contact name 
and details are provided at the end of this information sheet. 
 
What are the possible benefits to taking part? 
There will be no direct clinical benefit to you from taking part in this study. 
However, information we gather through this study will help us develop our survey 
better and therefore ensure that women who will be sent this survey are able to 
understand it and answer it easily. 
 
What if I don’t want to carry on or if there is a problem? 
You can pull out of this study at any time and it will not affect your future care. It is 
highly unlikely that you may be upset or inconvenienced by this study. However, if 
you feel that you need to make a complaint about the way you have been 
approached or treated by the researcher, you should contact: Prof. C. Butler, Head 
of Department, 
Department of Primary Care and Public Health, Neuadd Meirionnydd, Heath Park, 
Cardiff. 
 
In the event that something does go wrong and you are harmed in this interview, 
there are no special compensation arrangements. If you are harmed and this is due 
to someone’s negligence then you have grounds for legal action for compensation 
against Cardiff University but you may have to pay legal costs. The normal National 
Health Service complaints mechanisms will also be available to you. Details can be 
obtained from your hospital. 
What will happen to the results of the interview? 
The comments you provide to us in this interview will be used to change any 
questions that may have been problematic. 
Who is organising and funding this study? 
The study is organised by Denitza Williams at Cardiff University. It is directed by an 
advisory group and is funded by the Medical Research Council. No-one will be paid 
for including you in this study. 
Who has reviewed this study? 
This study has been examined by the Medical Research Council and it has received 
ethical permission by The South East Wales Research Ethics Committee and Cardiff 
University Medical and Dental School Ethics Committee. 
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Who should I contact for more information about this study? 
If there is anything that is not clear or you would simply like more information 
please contact Denitza Williams on 02920687851 or stoilovado@cf.ac.uk. 
For free impartial information and support about cervical cancer, please contact Jo’s 
Cervical Cancer Trust: Email: info@jostrust.org.uk  Tel:020 7936 7498.
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Appendix 3.8: Cognitive Interviews Standard Operating Procedure 
 
 Present participant with the survey. 
 Allow time to read the information provided on the first page. 
 The interviewer reads the following: ‘Firstly, thank you for agreeing to take 
part in this interview. I would like to remind you that you can stop the 
interview at any point, without giving a reason. This will have no impact on 
your healthcare. If it is ok with you, I would like to tape-record our 
conversation. All identifiable information will be removed to ensure that no-
one will know that you have talked to us.  
The interview shouldn’t last any longer than an hour. 
The focus of this interview is to see if the questions make sense and are easy 
to understand and respond to. We are not interested in the answers you give 
to the question, but we are interested in how you got to that particular 
answer.  
Are you happy to proceed?’ 
 
 If participant is happy to proceed then ask them to fill in and sign the 
consent form. 
 
 The following should then be said ‘ I would like you to read through each 
question one at a time and fill in its answer. I would like you to report aloud 
everything you are thinking about when answering the question. I would also 
like you to comment on the question, for example on things like the way it’s 
worded and how you hard or easy it was to answer it. I may then ask you 
what you understand by certain words in the question, how you managed to 
get to the answer that you have given or I may ask you to rephrase the 
question in your own words. There are no right or wrong answers.’ 
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Appendix 3.9: Probes used in examining the survey and cognitive processes 
explored. 
Probe question  Cognitive process explored 
‘Can you repeat the question 
in your own words’ 
Exploration of participant’s 
ability to recall information 
confidently.  
‘How easy/hard was this 
question to answer’ 
Determination of the likely 
level of difficulty in answering 
a question and subsequent 
likelihood of guessing 
‘How sure are you of your 
answer’ 
Determination of confidence 
in answer. 
‘What do you understand by 
the phrase ....’ 
Exploration of question term 
comprehension. 
’Do the answer categories 
make sense to you?’ 
Exploration of how 
participants ‘mapped’ 
response to response 
categories provided. 
‘What makes you think that/ 
Why do you think this’ 
‘How did you arrive to answer 
x’ 
Exploration of individuals’ 
overall cognitive strategy in 
answering a particular 
question. 
‘How well do you remember 
this’ 
Exploration of recall of 
relevant information. 
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Appendix 3.10: Cognitive Interview Schedule 
 
Interview Schedule: Question number followed by possible probes and their 
function 
 
Please note that as well as scripted probes, spontaneous probes will also be used 
throughout interviews. 
 
1. I want to use a self-sampling kit for HPV. Please circle a number. 
 
Not at all 
likely 
   Very likely 
1 2 3 4 5 
 
 
 How hard was this question to answer? 
(to determine level of difficulty/likelihood of guessing) 
 
 
 
 
 
 
2  I expect that I would use a self-sampling kit for HPV? Please circle a number. 
 
Not at all 
likely 
   Very likely 
1 2 3 4 5 
 
 What do you understand by the phrase ‘I expect that’? 
(to determine level of term comprehension) 
 Do the answer categories make sense to you? 
(mapping of the response) 
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3. If made available to me, I intend to use the self-sampling kit for HPV? Please 
circle a number 
 
Not at all 
likely 
   Very likely 
1 2 3 4 5 
 
 Can you repeat the question in your own words? 
(testing how well the subject comprehends the question) 
 How sure are you of your answer? 
(to determine overall level of confidence) 
 
 
 
4. How likely are you to use the self-sampling kit instead of going for a smear test? 
Please circle a number. 
 
Not at all 
likely 
   Very likely 
1 2 3 4 5 
 
 What does the term a ‘smear test’ mean to you? 
(to determine level of term comprehension) 
 
 
 
5. How certain are you that you will do the test well enough? Please circle a 
number.  
Not certain    Very certain 
1 2 3 4 5 
 
 Can you repeat the question in your own words? 
(to test how well the participant understands the question) 
 What do you understand by the term’ well-enough’? 
(to determine level of term comprehension) 
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6. How certain are you that you will be able to carry out the sampling procedure 
(placing swab in vagina)? Please circle a number. 
Not certain    Very certain 
1 2 3 4 5 
 
 What does ‘certain’ mean to you? 
(to determine level of term comprehension) 
 
 
 
 
7. How certain are you that you will be able to place the swab into the tube 
containing the special liquid without touching or dropping the swab? Please circle 
a number. 
Not certain    Very certain 
1 2 3 4 5 
 
 Can you repeat the question in your own words? 
(to determine level of question comprehension) 
 
 
 
 
 
8. How certain are you that you will be able to send off the completed test within 
the time allowed (2 weeks)? Please circle a number. 
Not certain    Very certain 
1 2 3 4 5 
 
 How sure are you of your answer? 
(confidence probe) 
 
 319 
 
 
 
 
 
9. Below are a few comments about doing HPV self- sampling. Please tell us how 
much you agree or disagree with each comment by circling a number from 1 
(strongly disagree) to 5 (strongly agree).  
 
a. Using a self-sample kit is convenient because it can be done at home and means 
that I would not have to make arrangements (e.g. going to a GP surgery/taking time 
off work /arranging childcare.  Please circle a number. 
 
Strongly 
disagree 
   Strongly 
agree 
1 2 3 4 5 
 
 What does the term ‘arrangements’ mean to you? 
(to determine level of term comprehension) 
 
 
 
 
 
b. I am worried that I could hurt myself using the self-sample kit. Please circle a 
number. 
Strongly 
disagree 
   Strongly 
agree 
1 2 3 4 5 
 
 What do you understand by the term ‘hurt myself’ in this context 
(to determine level of term comprehension) 
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c. Using a self-sample kit means that no-one will know that I am being screened 
for cervical cancer. Please circle a number. 
Strongly 
disagree 
   Strongly 
agree 
1 2 3 4 5 
 
 What do you understand by ‘no-one will know’. Who would be ‘no-one.’ 
(to determine level of term comprehension) 
 
 
 
d. Using a self-sample kit would be less embarrassing than having a GP or nurse 
do a smear test. Please circle a number. 
Strongly 
disagree 
   Strongly 
agree 
1 2 3 4 5 
 
 
 
 
 
e. I wouldn’t trust the results of the self-sample kit. Please circle a number. 
Strongly 
disagree 
   Strongly 
agree 
1 2 3 4 5 
 
 Can you repeat the question in your own words? 
      (to determine level of question comprehension) 
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f. I would be worried about the self-sampling kit getting lost in the post and not 
reaching the laboratory. Please circle a number. 
Strongly 
disagree 
   Strongly 
agree 
1 2 3 4 5 
 
 What does the term ‘laboratory’ mean to you. 
(to determine level of term comprehension) 
 
 
 
 
11. Compared to most women your age, how likely do you think it is that you will 
be infected with HPV? Please circle a number.  
Much less 
likely 
A little less 
likely 
About the 
same 
A little more 
likely 
Much more 
likely 
1 2 3 4 5 
 
 What makes you think that? 
(to determine overall cognitive strategy used) 
 What do you understand by ‘most other women your age’. 
(to determine level of term comprehension) 
 
 
 
 
 
13. If you had to guess, how do you think HPV spreads from person to person? 
Please tick all that apply. 
Through breathing the same air as someone who is infected (like catching a cold)  
Through sexual contact (e.g. intercourse, oral sex)   
Through sitting on dirty toilet seats                                                                              
Through kissing                                                                                                            
 
 What do you understand by the phrase ‘spreads from person to person’ 
(to determine level of term comprehension) 
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 How sure are you of your answer?  
(confidence probe) 
 
 
 
14. How much of a risk factor do you think HPV is in developing cervical cancer? 
Please circle a number. 
Not important 
at all 
   Very 
important 
1 2 3 4 5 
 
 What do you understand by ‘risk factor’? 
(to determine level of term comprehension) 
 
 
 
15. Do you think that HPV can be treated with medicines? Please tick a box. 
Yes  
No  
Don’t know  
 
 How did you arrive to your  answer x? 
(to determine overall cognitive strategy used) 
 
 
 
 
16. Do you think that HPV can clear up by itself? Please tick a box. 
Yes  
No  
Don’t 
Know 
 
 
 Why do you think this? 
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(to determine overall cognitive strategy used, to check if the person is guessing) 
 
 
 
 
17. How serious an infection do you think HPV is? Please circle a number.  
Not at all 
serious 
   Extremely 
serious 
1 2 3 4 5 
 
 What do you understand by ‘serious’. 
(to determine level of term comprehension) 
 What does the term ‘infection’ mean to you? 
(to determine level of term comprehension) 
 
 
 
 
 
18. Compared to most other women your age, how likely do you think it is that 
you will get cervical cancer at some time in your life? Would you say you are…? 
Please circle 
 
Much less 
likely 
A little less 
likely 
About the 
same 
A little more 
likely 
Much more 
likely 
1 2 3 4 5 
 
 Can you repeat this question in your own words? 
(to determine level of question comprehension) 
 Who do you see as ‘most other women’? 
(to determine level of term comprehension) 
 What do you understand by the term ‘your age’. 
(to determine level of term comprehension) 
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19. How confident, are you that you would notice a symptom of cervical cancer? 
 
Not at all 
confident 
Slightly 
confident 
About the 
same 
Fairly 
confident 
Very 
confident 
1 2 3 4 5 
 
 How easy/hard was this question to answer? 
(to determine overall level of confidence) 
 What makes you think this? 
(to determine overall cognitive strategy used) 
 
 
 
 
 
 
20. Please tell us whether you agree or disagree with each of the following 
statements by circling a number from 1 (strongly disagree) to 5 (strongly agree). 
 
a) Going for regular smear tests means that cervical cancer can be found early on.   
Strongly 
disagree 
   Strongly 
Agree 
1 2 3 4 5 
 
 
 What do you understand by ‘found early on’? 
(term comprehension) 
 
 
 
 
b) The three yearly reminders I get help me remember to attend my smear test 
appointments. 
 
Strongly 
disagree 
   Strongly 
Agree 
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1 2 3 4 5 
 
 
 
 
c) Having a smear test is painful. 
 
Strongly 
disagree 
   Strongly 
Agree 
1 2 3 4 5 
 
 Why do you think this? 
(overall cognitive strategy used) 
 How well do you remember this? 
(recall of relevant information) 
 
 
 
 
d) Going for smear tests can be difficult because I have to make arrangements 
(e.g. time off work, childcare). 
 
Strongly 
disagree 
   Strongly 
Agree 
1 2 3 4 5 
 
 Can you repeat the question in your own words. 
(question comprehension) 
 
 
 
 
 
 
e) Going for smear tests provides me with reassurance.  
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Strongly 
disagree 
   Strongly 
Agree 
1 2 3 4 5 
 
 What does ‘reassurance’ mean to you? 
(term comprehension) 
 
 
 
 
f) I trust the nurse/GP to take an adequate sample. 
 
Strongly 
disagree 
   Strongly 
Agree 
1 2 3 4 5 
 
 What to you is an ‘adequate sample’. 
(term comprehension) 
 
 
 
 
 
 
g) I worry about my sample getting lost. 
 
Strongly 
disagree 
   Strongly 
Agree 
1 2 3 4 5 
 
Why do you think this? 
(overall cognitive strategy) 
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h) Having a smear test is embarrassing    
    
Strongly 
disagree 
   Strongly 
Agree 
1 2 3 4 5 
 
 What do you understand by ‘having a smear test’ i.e. the procedure, going 
for a smear, arranging the appointment etc 
(term comprehension) 
 
 
 
 
i) If I got cervical cancer, it would be more serious than other cancers. 
 
Strongly 
disagree 
   Strongly 
Agree 
1 2 3 4 5 
 
 Why do you think this? 
(overall cognitive strategy) 
 
 
 
 
 
 
j) I don’t trust the results of the smear test. 
 
Strongly 
disagree 
   Strongly 
Agree 
1 2 3 4 5 
 
 What do you understand by ‘trust’ 
(term comprehension) 
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k) I worry that others (e.g. family members, friends, people at the GP surgery) will 
know that I am being screened for cervical cancer. 
 
Strongly 
disagree 
   Strongly 
Agree 
1 2 3 4 5 
 
 How hard/easy was this to answer? 
(level of difficulty, and likelihood of estimation/guessing 
 
 
 
 
 
 
 21. Have you made any lifestyle choices to try and reduce your risk of cervical 
cancer? 
Please tick any that are relevant 
Attending smear appointments  
Practicing safe sex  
Limiting number of sexual partners  
Not smoking  
Getting immunized against HPV  
Other (please describe)  
I have not made any specific lifestyle choices to reduce my risk of cervical cancer  
 
 Why did you decide to x ? 
(to determine cognitive processes/social desirability) 
 
 
 
 
 
22. Have you ever had a smear test? Please tick a box                 
Yes  
No  
Don’t know  
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23. If you have previously had a smear test, how long ago did you have your last 
smear? Please tick a box                 
Under 3 
years 
 
3-4 years  
4+ years  
Don’t know  
 
 How did you figure out that it was  x years? 
(to determine overall recall strategy) 
 How sure are you of this? 
(to determine ability to recall information confidently) 
 
 
 
24. Have you ever had an abnormal smear test result?  Please tick a box.                 
Yes  
No  
Don’t know  
 
 What does ‘abnormal’ mean to you?  
(to determine term comprehension) 
 
 
 
25. Have you ever received treatment for abnormal cervical cells?  Please tick a 
box.                 
Yes  
No  
Don’t know  
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 What does ‘treatment’ mean to you? 
(to determine term comprehension) 
 
 
 
26. Has any family member/friend ever had abnormal cervical smear results?   
Please tick a box                 
Yes  
No  
Don’t know  
 
 What does family ‘member/friend’ mean to you? 
(to determine term comprehension) 
 
 
 
 
27. Has any family member/friend ever been diagnosed with cervical cancer? 
Please tick a box                 
Yes  
No  
Don’t know  
 
 Did you find this question hard to answer? 
(to determine possibility of any psychological harm) 
 
 
 
28. Has any family member/friend ever died from cervical cancer? Please tick a 
box                 
Yes  
No  
Don’t know  
   
 Did you find this question to answer? 
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(to determine possibility of any psychological harm) 
 
 
 
 
 
Questions 29-33 
 
No specific probes
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Appendix 3.11: Final Questionnaire 
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Appendix 4.1: Cervical Screening Wales recruitment card. 
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Appendix 4.2: Relationships between extended Health Belief Model constructs in 
relation to HPV self-sampling. 
 
Items  Statistic  
 
Perceived  
severity of HPV 
 
Perceived benefits of HPV self-
sampling. 
 
r= -.117, n=192, p=.106 
 Perceived barriers to HPV self-
sampling. 
r= .070, n=188, p=.341 
 Perceived susceptibility to HPV r= .113, n=189, p=0.123 
 Perceived self-efficacy  t(186.491) = -0.234, p=0.816 
Perceived benefits to 
HPV self-sampling 
 
Perceived susceptibility to HPV 
 
r= .167, n=192, p=0.020 
 Perceived barriers to HPV self-
sampling. 
r= -0.281, n=189, p=0.000 
 Perceived self-efficacy  t(.170.617) =-1.282, p=.201 
 
Perceived barriers to 
HPV 
Perceived self-efficacy t(188) =4.246, p=0.000 
 Perceived susceptibility r= -.014, n=189, p=0.845 
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Appendix 4.3: Cross tabulation of most influential variables in the regression model. 
 
Educational 
Level 
Intention to 
self-sample 
Lower Self-
efficacy (N, %) 
Higher Self-
efficacy 
(N, %) 
Total 
(N, %) 
GCSE Lower 15 (88.2)   2 (11.8) 17 (100) 
Higher   4 (16.7) 20 (83.3) 24 (100) 
Further 
Education 
Lower 21 (91.3)     2 (8.7) 23 (100) 
Higher 19 (41.3)  27 (58.7) 46 (100) 
Degree or above Lower 14  (93.3)    1 (6.7) 15 (100) 
Higher  23 (37.7)  38 (62.3)  61(100) 
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Appendix 5.1: South-East Wales Local Research Ethics Approval 
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Appendix 5.2: Public Health Wales Research and Development Approval 
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Appendix 5.3: Participant: Invitation letter, information sheet and consent form 
Invitation letter 
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Information sheet 
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Appendix 5.4: Interview schedule 
Interview schedule rationale 
 
  Semi-structured interviews will facilitate in-depth exploration of the factors associated 
with intention to self-sample and will be guided by an interview schedule. 
The interview schedule will be based on the original constructs of the Health Belief Model 
(perceived: susceptibility to and severity of HPV infection/cervical cancer, benefits/barriers 
to HPV self-sampling and cervical screening, self-efficacy in carrying out the self-sampling 
test). A particular focus will be given to the significant factors identified during the 
multivariate analysis of the questionnaire data.  
 
Interview Schedule Structure 
 
Questions were ordered to try and avoid any influence posed by questions 
pertaining to HPV knowledge when discussing intention to self-sample and 
perceived self-efficacy. This has resulted in the intention question being the first 
question that the interviewees are asked with the second question investigating 
perceived self-efficacy. 
 
The first half of the interview is focused around HPV whilst the second half of the 
interview is focused on cervical screening in general. It is hoped that this will 
minimise any order effects that might have been imposed by cervical screening 
questions on answers provided relating to HPV questions. However, it is 
acknowledged that interviews are flexible and reflexive and therefore it is predicted 
that the interview schedule might need to be amended following each interview. 
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Question number Theme/Construct Investigated 
1 Intention to self-sample 
2,3,4 Self-efficacy 
5 Benefits to self-sampling 
6 The effect of self-efficacy on 
benefits to self-sample 
7 Barriers to self-sampling 
8 Previous experience with other 
self-sampling kits 
9,10,12 HPV knowledge 
11 Attitude: HPV causes cervical 
cancer 
13 Attitude: cervical cancer in 
general 
14 Attitude: smear tests 
15 Benefits to smear testing 
16 Barriers to smear testing 
17 Overall attitude towards HPV 
self-sampling 
18-23 Intervention 
24 Anything further to add  
 
 
The self-sampling procedure will be explained before the interview commences. 
The interviewer will be aware of the participant’s intention to self-sample and their 
perceived self-efficacy before the interview has commenced (by referring to the participants 
questionnaire before meeting with the participant). 
Wherever possible questions will be related back to the interviewee’s perception of self-
efficacy in carrying out self-sampling and the way this may influence overall intention.  
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PROLOGUE  
 
Introduce myself, explain where I am from and ensure that the participant is comfortable. 
 
Check that the participant understands the reason for the interview and provide an 
opportunity to ask any questions. 
 
Alert the participant that I am a researcher on the psychological study so can answer 
questions about this study but that I’m not medically trained, so I do not have the expertise 
to answer questions of a clinical nature. 
 
The focus of the interview then needs to be set. This will be based on the following script: 
Recently you agreed to take part in the Women’s attitudes towards HPV self-sampling 
study. Thank you for agreeing to take part. 
 
Just to remind you, we are interviewing women who are eligible for cervical screening and 
who live in South-East Wales. We will ask women about their feelings about cervical cancer 
and screening in general, how they think people get cervical cancer, and how they feel 
about the proposed HPV self-screening kit, and if they have had experiences of any other 
types of self- sampling kits. We will then look at arguments for and against self-sampling 
which are important to each woman. It is entirely up to you if you decide to take part in the 
interview. The results will be used to help inform researchers and medical professionals 
about women’s attitudes towards self-sampling. The interview should take less than an hour 
to complete. We will use a tape recorder to record it but we will make sure that your 
identity is kept confidential. The recording will be kept safely and only used by the research 
team. You can pull out of the interview at any time, and you don’t have to give a reason. 
The interview will last up to 1 hour. 
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Are you happy to continue? 
 
HPV SELF-SAMPLING  
 
 
1. How do you feel about HPV self-sampling? 
Prompts: How likely would you be to use the self-sampling kit? Why do you think that 
you would you be (likely/less likely)? What do you think doing self-sampling involved? 
 
2. How do you feel about carrying out the self-sampling yourself? 
Prompts: Which part of the sampling would you be more confident in doing? Which 
part of the sampling would you be less confident in doing? Probe for understanding 
instructions, obtaining the cells with the swab, placing the swab in the container 
without touching anything else, returning the kit within 2 weeks of taking the 
sample, and any other aspects. 
 
3. How would you feel about sending the sample in the postage paid envelope? 
Prompts: Would you worry about it getting lost? Would you feel embarrassed? 
Would you worry while waiting for results? 
 
4. How would you feel about the results that you will receive? 
Prompts: Will anything affect your trust in the results? Will you trust the results the 
same/less or more than the results from a cervical smear test- Can you tell me about 
that? 
 
Rationale: Exploring intention to self-
sample, perceived self-efficacy, benefits 
and barriers to self-sampling and how 
these are influenced by self-efficacy. 
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5. Do you feel there are any benefits to HPV self-sampling/ having a kit at home to self-
sample?  
Prompts: What things do you think are good about being able to do the kit at home? 
If the self-sampling kit was made available would it change your screening 
attendance habits? Can you tell me a bit more about this?  
 
6. How do you think that your confidence would have an effect on the good things you 
feel about self-sampling?  
Prompts: Can you tell me a bit more about that? How may that affect your intention 
to self-sample? 
 
7. Can you imagine having any issues/problems with doing HPV self-sampling? 
Prompts: Would you worry that you may hurt yourself carrying out the procedure? 
Would you be worried about the kit getting lost in the post? Would you trust the 
results? Why would you not trust the results (if possible relate back to the answers 
given in Question 2) 
 
8. Have you ever used any kind of self-sampling kit before and how did you feel about 
it? For example, a pregnancy test kit?  
Prompts: How did you find it to use? Can you tell me more about how you confident 
you felt doing the test and in the results.  
 
HPV KNOWLEDGE AND CERVICAL CANCER 
 
9. What do you think causes cervical cancer? 
Prompt: Why do you believe (X) causes cervical cancer? 
Rationale: Establishing 
extent of HPV and cervical 
cancer knowledge. 
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10. The main cause of cervical cancer is HPV, can you tell me what you know about HPV 
at all? 
Prompts: Had you heard of HPV before taking part in this study- if so- What did you 
know about it? How do you think HPV can clear up? Do you feel that HPV could clear 
up my itself? How serious do you think HPV infection is? How important do you think 
HPV is in cervical cancer? Can you tell me a little more about that? 
 
11. How do you feel about HPV causing cervical cancer? 
Prompts: Would it affect your view of cervical cancer?  How may it affect your view? 
 
12. How do you think a person may get infected with HPV?  
Prompts: Can you tell me a little more about that?  
 
CERVICAL CANCER AND SCREENING ATTITUDES 
 
13. How do you feel about cervical cancer in general? 
Prompts: Do you know of anyone who has been diagnosed? How serious do you think 
it is? Do you ever worry about getting cervical cancer? 
 
14. How do you feel about smear tests? 
Prompts: Do you go for a smear test? Why do you go/not go? What are the 
good/bad things about smear tests?  
 
15. What do you think are the benefits to having smear tests? 
Prompts: Can you tell me a little bit more about that? 
Rationale: Establishing 
effect of previous screening 
on intention to self-sample. 
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Trust in the doctor to take a good enough sample for testing? Having smear tests 
means that cervical abnormalities would be picked up earlier on? Does having a 
smear test provide you with reassurance? 
 
16.  Do you see any problems with having smear tests at all? 
Prompts: Have you ever had any practical issues arranging a smear test? Have you 
ever had any strong emotional feelings regarding smear tests? How do you feel 
about the results of a smear test? 
 
17. Overall, how do you feel about the possible introduction of HPV self-sampling kits as 
a method of cervical screening? 
Prompt: Is there anything that you feel we have not discussed that you would like to 
add?   
18. If HPV self-sampling was available, what kind of information would you like to see on 
a leaflet that would be alongside the kit? 
 
19.  Is there anything further that you would like to add? 
 
 Future contact 
 
Ensure that participant knows how to contact researcher for further 
help/information/to add further information. 
Check if it is okay to contact participant after listening to the conversation if there is 
anything the researcher may want to clarify. 
Ask participant if they would be happy to be contacted following intervention 
development for usability testing of the intervention. 
Thank the participant for their time! 
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Appendix 5.5: Thematic Framework 
1st Level theme 2nd Level theme 3rd Level theme   
Own intention to self-sample 
(Explicit reference to own 
intention to self-sample) 
 
 
 
 
 
Attitudes towards transition from 
habitual behaviour 
 
 
 
 
 
The belief that the test/instructions 
are going to be easy 
 
 
Perceived availability of cervical smear 
 
Dependent on trials/research 
 
Becoming the norm 
 
History of abnormalities 
(Intention directly affected by previous 
history of cervical abnormalities) 
 
 
Pragmatism: dependent on availability 
of alternative  
(intention contextualised in the 
absence/presence of smear tests) 
 
 
Access to professional expertise 
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(preference for a smear test due to 
professionals carrying it out) 
 
Good idea 
 
 
Knowledge 
 
 
 
Instructions 
Other 
 
Other’s perceived intention to 
self-sample 
(Explicit reference to perception of 
other’s intention to self-sample) 
Convenience  
Comfort 
Knowledge 
Age  
Symptoms 
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Expertise (smear is done properly due 
to health professional) 
Privacy 
Embarrassment 
Pragmatism (intention contextualised 
in absence/presence of smear tests) 
Becoming the norm 
Support (availability of support for 
those who are not confident) 
 
 Other  
Understanding of self-sampling 
(Placing self-sampling in context 
of other screening methods) 
Comparison with smear 
 
 
Perceived parallels with smear test 
 
 
 
Confidence in HPV self-sampling vs 
smear test results 
 
Comparison with screening for other 
cancers/ technologies 
 
  
3 steps of HPV self-sampling 
(understanding of the self-sampling 
procedure) 
 
Other 
 
Perceived Self-efficacy 
(Components of self-efficacy and 
its effect on intention to self-
sample) 
 
High self-efficacy 
(the belief that the individual is able to 
carry out self-efficacy)  
 
 
 
Previous use of technologies (e.g. 
tampons, pg tests) 
 
 
   
Previous experience of childbirth 
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Receiving a result 
(receipt of a result for a self-sampling 
kit, providing reassurance that the 
individual has carried out the test 
correctly) 
 
  
Autonomy 
(the belief that cervical screening is so 
important that the individual will make 
sure they get it right) 
 
 
 
 
Practice 
 
Information 
 
Age 
Low self-efficacy 
(the belief that the individual is not 
able to carry out self-sampling 
properly) 
 
 
Lack of professional expertise 
 
Lack of practice 
 
  
Worry over carrying out test properly 
 
 
Consequences of not doing test 
properly 
 
Lack of confidence in result 
 
Access to professional expertise 
(access to professional after/during 
sampling) 
Effect of self-efficacy on intention  Moderator  
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Mediator 
Previous use of sampling technologies  
 
 
 
Other 
 
Barriers to HPV self-sampling 
(other than those related to self-
efficacy) 
Operational Factors 
(the logistical issues involved with the 
self-sampling programme and how 
they may affect intention to self-
sample) 
 
 
 
Sample being lost in the post 
 
 
 
Doubt of postal workers willing to 
handle samples 
Sample contamination or damage 
during transit 
Possibility of tampering with sample 
during transit 
 
Identity theft 
 
‘Expert systems’ Preference for  
Lack of 
Confirmation   
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Confidence in self-sampling 
programme 
(quality and reasoning behind 
programme) 
 
 
 
(of receipt of kit by the laboratory) 
 
 
Continuity (e.g. are reminders still sent 
or are same people involved in 
programme) 
 
Access to expert support 
(during HPV self-sampling e.g. 
telephone or after receiving self-
sampling result) 
 
 
Reassurance of Research and trials 
 
  
Lack of confidence in reasons for 
offering self-sampling 
 
 
Cost-cutting 
 
Self-
sampling 
not optional 
 
 
 
 
Cutting corners 
 
 
 
 Withdrawal of 
service 
 
 
Potential for contamination 
 
 
Unclean environment 
 
 
Dropping kit (swab) 
 
Delay in completing test Privacy 
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Potential for harm (e.g. causing 
bleeding) 
 
 
Own responsibility 
 
New 
 
Test efficacy compared to cervical 
smear 
 
Test efficacy 
 
Lack of knowledge 
 
Double effort (having to attend clinic 
despite doing ss) 
 
Other 
 
Benefits to smear tests 
(perceived benefits to smear tests that 
may act as barriers to self-sampling) 
 
 
 
Pick up a problem (cervical 
abnormality) 
 
 
Gynaecological Health Check 
 
 
Expert reassurance  
 
All seeing 
Previous history of abnormalities 
 
 
Expertise 
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Habitual behaviour 
 
 
Procedure is acceptable  
 
 
 
Age 
 
 
Effect of having children- smear tests 
not as embarrassing 
 
 
 
Facilitators to self-sampling 
(Perceived advantages to self-
sampling compared to smear tests 
facilitators) 
 
 
Convenience 
 
  
Comfort 
 
Less embarrassing than smear 
 
Less uncomfortable than smear 
 
Less invasive than smear 
 
Time efficient: Can be done whenever 
one has a chance (no planning 
required) 
 
Altruism  
 
 
 
Can free up medical practitioners time 
 
 
Can help save money 
 
Barriers to smear tests Embarrassing 
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(Negative perceptions of smear tests 
that may act as facilitators to self-
sampling) 
 
 
 
Painful 
Inconvenience 
 
Lack of confidence in health  
Professionals 
 
Effect of having children (negative) 
 
 
Waiting for results 
 
 
Timetabling 
 
 
Psycho-sexual issues 
 
 
Perceived service continuity (similar 
service procedures as smear test) 
 
 
 
 
Confidence in postal services 
 
Availability of research data 
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Devolved responsibility 
 
Family support 
 
Cervical cancer perceptions 
(attitudes to causality, prevalence 
and impact) 
 
 
Causality 
(perceptions of cervical cancer causes) 
 
 
 
 
 
 
None attributed 
 
 
 
No idea 
 
 
Still 
unidentified 
 
Something that 
just happens 
 
Genetics 
 
 
A ‘trigger’ 
 
Lifestyle 
 
Having children 
 
Weak/weakened immune system 
 
 
 
 
 
 
Sex 
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HPV  
Prevalence 
 
 
 
Affects younger women (more than 
other cancers) 
 
 
High perceived prevalence 
 
Prognosis Cervical cancer impact 
Symptoms 
 
 
Cervical cancer is symptomless 
 
 
Reducing risk: Protective behaviour 
 
 
Cervical cancer is scary 
 
 
Personal experience  
 
 
 
Uncertainty 
 
Family member 
 
Need for education 
 
 
Fatalism 
 
 
HPV perceptions 
(attitudes towards HPV and self-
sampling) 
Previous knowledge of HPV 
 
 
None 
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Minimal (heard of it, reference to 
vaccination) 
 
HPV transmission 
(perceptions about how HPV may be 
transmitted) 
 
 
 
Air bound, a virus like a cold 
 
Insertion of foreign bodies e.g. tampon 
 
Something that’s already in the body 
 
Touching infected places/individuals 
Sexual contact 
 
 
 
Multiple partners 
 
Unprotected 
 
HPV awareness 
(perceptions relating to the knowledge 
that a virus causes cervical cancer) 
 
 
 
Treatable 
 
 
Cervical cancer is less threatening 
because a virus is treatable 
 
Incongruity- ‘how have I got that’ 
 
 
Need for education 
 
HPV vaccination 
 
HPV prevalence 
 
Prognosis 
 
Disbelief 
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(that HPV causes cancer) 
Other 
Participant suggestions 
(in relation to intervention content 
to help build confidence and self-
efficacy) 
Website   
Helpline 
Simple language 
Content 
Colour 
Layout 
Increase self-efficacy 
Professional finish (leaflet to be glossy 
and look professionally made) 
Trial results Statistics 
Expectations Of individual 
Of professionals  
Visual/Auditory aids Pictures/diagrams 
Video 
General cancer perceptions Fatalism  
Causality 
The young 
Positive perceptions of cancer 
screening 
 374 
 
Appendix 5.6 Thematic Charting: Perceived facilitators and barriers to HPV self-sampling 
Barriers to 
HPV self-
sampling 
(other than 
those related 
to self-
efficacy) 
Operational Factors 
(the logistical issues involved with the 
self-sampling programme and how 
they may affect intention to self-
sample) 
 
“I mean the only thing I’d be thinking 
of, if you put the swab in the test tube 
would it be accurate enough...you 
know if you were post it in the 
doctors it would be sent off in a day, 
if it was in the post would they have it 
for a couple of days, if you see that’s 
the only thing I’m thinking, would it 
affect it slightly the results, if it was 
left you know, you know if someone 
had left it in a bag for a week you 
know[…]” P18 
 
 
 
 
Sample being lost in the post 
 
“I think possibly the sending it off would 
worry me hoping it reached where it was 
reaching and not got lost in the post[…]” 
P10  
 
 
 
Doubt of postal workers willing to 
handle samples 
 
“[…] “I’m not taking that to get 
delivered, I’ll leave that one in the box” 
like they’d put it in the box and pretend 
they’d never seen it”” P4 
 
 
Sample contamination or damage during 
transit 
 
“I’ve had mail sometimes come through 
and it’s soaking wet and opened you 
know it’s that, not just the packaging 
damaged is the sample itself gonna be 
damaged? Or contaminated maybe? P3” 
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Possibility of tampering with sample 
during transit 
 
“well if it did get lost in the post and you 
know accessed the wrong people for 
instance you know, possibly there could 
be access to my own health records by 
my NHS number or via my name you 
know just things like that” P10 
 
 
Identity theft 
 
“well if it did get lost in the post and you 
know accessed the wrong people for 
instance you know, possibly there could 
be access to my own health records by 
my NHS number or via my name you 
know just things like that” P10 
 
‘Expert systems’ Preference for 
 
“I think I would prefer to take it to like a 
doctors and they can send it to the 
hospital, or send it to wherever it needs to 
go” P1 
 
 
 
 
Lack of 
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“I would be worried that women maybe 
um might move, might to a different area, 
how are you going to catch up with that 
person?  Young women that go off and 
they’re sleeping with their staying with 
their partners in a flat somewhere and they 
move on again, I wonder whether, how 
you’re going to catch up with them?  Is it 
gonna be like right through your GP?  You 
know are they gonna know through the GP 
where these people are, where the women 
are?” P6 
 
 
 
Confidence in self-sampling 
programme 
(quality and reasoning behind 
programme) 
 
“P – yeah it the whole, not just in the 
test itself, but the whole process 
associated with the test, I would just 
be sort of like, then I might worry 
about whether or not it was any 
good[…]” P5 
 
 
Confirmation 
(of receipt of kit by the laboratory) 
 
“[…]I’d want reassurance that I know my 
sample has arrived somewhere” P3 
 
  
Continuity (e.g. are reminders still sent 
or are same people involved in 
programme) 
 
“are they going to the same person, I 
mean so I get my sample and I’ve sent it 
off, would it go to the same place as 
when I have a smear test?  Cos if it does 
then obviously the same people are 
doing it?” P1 
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Access to expert support 
(during HPV self-sampling e.g. telephone 
or after receiving self-sampling result) 
 
“ I think that perhaps initially it’s done, 
you know you get the opportunity if you 
wanted to do it with a medically trained 
person maybe? “ P9 
 
“I think it would be a good idea um 
again I think around the option of try it, 
give it a go, knowing that you’ve got the 
option of still going to your GP I think 
possibly dual[…]” P3 
 
 
 
Reassurance of Research and trials 
 
“yeah I suppose, yeah I would want it to 
explain how we know that it’s as 
effective as a smear test, not in matters 
of detail, but just why is it as good 
really” P7 
 
“yeah I suppose, yeah I would want it to 
explain how we know that it’s as 
effective as a smear test, not in matters 
of detail, but just why is it as good really, 
because otherwise you’re not going to 
have any confidence you know the 
confidence is not there is it, and then 
when you start to get issues I suppose of 
people not doing it, although I would do 
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it anyway, but it’s just you know yeah” 
P7 
 
Lack of confidence in reasons for 
offering self-sampling 
 
“going from thinking, being quite 
positive about it and thinking like “yeah 
you know it’s a good thing and it’s 
saving the NHS money” all hail the NHS 
and all the rest of it, to sort of “it’s just 
been rushed through it’s just another 
one of those politically motivated things, 
oh it’s gonna be rubbish it’s not gonna 
be any good and it’s all gonna fall apart 
in a couple of years anyway” P5 
 
 
Cost-cutting 
 
“um I’m not sure, is the benefit to 
doing self-sampling as in a benefit 
to health because people would do 
it more often, or is it a benefit of 
because it was reduce costs within 
the NHS or is it just a mixture of 
both?   I don’t know quite what 
was driving, driving the um 
research” P9 
 
 
Self-sampling 
not optional 
 
“if it’s, very 
happy with it 
if it’s 
optional, um 
less happy if 
it’s forced[…] 
P5 
 
 
 
Cutting corners 
 
“’m just realistic about it in as 
much as my perception of it is that 
we need we’ve got to cut corners 
somewhere and if we can as the 
NHS has got to cut corners 
somewhere cos it’s too expensive 
and you know, I don’t want to see 
it disappear as a person, I don’t 
want to see it disappear as an 
institution and so if if this helps 
keep it alive and stops it from 
being like a case of if you’re poor 
you can’t go to the doctor, or we 
end up in a situation that if you’re 
poor you don’t just have to take 
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your own sample, you have to 
analyse your own sample 
((laughs)) you know because 
there’s no funding for people, 
that’s you know, I’d rather keep 
the service going in some capacity 
than not going at all […]” P5 
 
 
 Withdrawal of service 
 
“P – are they taking away my 
rights to have those smear tests, 
um you know as I should do so I 
would think, yeah I would think like 
that” P13 
 
 
 
Potential for contamination 
 
“I would be worried about 
contaminating it somehow” P15  
 
 
Unclean environment 
 
“[…]there would be things around 
hygiene I suppose and things like that, 
cos you think you know you wash your 
hands, it’s cross contamination it’s 
things like that again, in surgeries you 
wonder sometimes how clean they are, 
but you automatically assume I’m in a 
surgery, health environment, everything 
is fine.” P3 
 
 
Dropping kit (swab) 
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“[…]it’s around making sure you’re not 
touching, or dropping it you know when 
you finished doing it because it’s like the 
door-bell could go and I’d think oh I’ve 
got to answer that and I’d put it down 
on a surface[…]” P3 
 
Delay in completing test 
 
“I’d probably put it in a cupboard 
somewhere and I’d be thinking it 
would pop into my head “oh I need to 
do that” and then something else 
would pop in[…]” P14  
 
Privacy 
 
“you know you need to have a privacy in 
your home, you’ve got the children are 
you rushing when you’re doing it[…]” P3 
 
 
Potential for harm (e.g. causing 
bleeding) 
 
“um just being wary that you weren’t 
going to actually hurt yourself” P14 
 
Own responsibility 
 
“yeah, yeah, because it’s quite 
isolating doing this you know”P4 
 
“um again it’s around the onus on 
yourself to make sure you do go and 
send it[…]” P3 
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New 
 
“um no I just think it would need to 
kind’ve be um quite well publicised if 
it, if it did go ahead because you 
know a lot people are very wary 
about anything that’s new[…]” P15 
Test efficacy compared to cervical 
smear 
 
“I’ve got no issue at all with the self-
sampling, as long as somebody 
explains to me that it is equally as 
valid a test for you know HPV, 
abnormal cells as having it done in 
the surgery” P7 
 
Test efficacy 
 
“um again I think, because it’s new I 
think long-term with evidence 
demonstrating that it’s just the same 
as on a par, I’d have no problem with 
that, with the evidence, you know 
with the results, um […]” P3 
 
 
 
Lack of knowledge 
 382 
 
 
“I’d like to know what the chances 
are of me getting it right you know 
myself and if I didn’t get it right, what 
that would mean[…]” P5 
 
“So it’s knowing what’s involved in 
the kit I suppose as well you know 
[…]” P3 
 
Double effort (having to attend clinic 
despite doing ss) 
 
“yeah it’s just the hassle of it getting 
lost in the post, and having to do the 
test again[…]” P2 
 
“if they say “sorry you need to do it 
again” or whatever, um then you 
might think, oh actually no I’d rather 
go to the doctors, at least know that 
it’s done and I haven’t got to have it 
re-done” P14 
Other 
 
“so it’s one of those “if it’s not broke, 
don’t fix it” so for me it works out 
exactly the way it is” P12 
 
 
 
Benefits to smear tests Pick up a problem (cervical abnormality) 
 
 
 383 
 
(perceived benefits to smear tests 
that may act as barriers to self-
sampling) 
 
“well just because you know this 
system works, it’s good for me” P14 
 
 
“yes, well like yes, it’s um, oh it’s just 
knowing that you know it’s gonna pick 
up something, or not pick up something” 
P1 
 
Gynaecological Health Check 
 
“ yeah, yeah, because there might be 
problems you know infections, or um 
you know well anything really that they 
could see, like I’ve got a coil fitted, so 
they could check that that’s in place, you 
know things just like a general health 
check maybe?” P1 
 
 
 
Expert reassurance  
 
“I think the knowledge that someone 
that’s trained to do it, would probably 
you know it kind of reassures you that 
they’re doing a proper job[…]” P2 
 
 
 
All seeing 
 
“maybe they know what they’re looking for if there is 
issues, I don’t know um so that’s my feeling on why I 
would go for a nurse” P1 
 
 
Previous history of abnormalities 
“me personally, I would like to have one 
even if it was every 2 years, because I’ve 
had abnormal cells in the past, I’d feel 
reassured by just having that little bit of 
a backup um[…]” P16 
 
 
Expertise  
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“so when you go for your smear it seems 
to be a sort of exact science of where 
they’re getting cells” P12  
 
Habitual behaviour 
 
“but I’m so used to going every 3 years? 
Every 3 years, that you know it’s become 
normal now routine[…]” P10 
 
 
 
 
Procedure is acceptable  
 
“P – for me it I’m quite easy, it don’t 
bother me going for a screening or a 
something like that, surgery because I 
know that it is essential for my health 
you know so it doesn’t bother me[…]” 
P10 
 
 
Age 
“you know and maybe that’s because 
I’m older as well, obviously when you’re 
20 odd it’s all embarrassing[…]” P12 
 
 
 
 
Effect of having children- smear tests 
not as embarrassing 
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“I mean sometimes when you have a 
smear test it can be embarrassing, I say 
embarrassing, I mean prior to me having 
children it was embarrassing, after 
children, don’t care[…]” P1 
 
 
 
 
 386 
 
Appendix 6.1 : Pre and post intervention questionnaires 
 
PI Questionnaire 
 
 
 
Questionnaire I.D. Number  
 
 
 
 
 
 
PLEASE ANSWER THIS QUESTION FIRST, BEFORE 
TURNING OVER AND STARTING THE 
QUESTIONNAIRE. ONCE YOU HAVE STATED YOUR 
ANSWER, PLEASE DO NOT RETURN AND EDIT. 
 
 
What do you think causes cervical cancer? 
 
…………………………………………………………………
…………………………………………………………………
…………………………………………………………………
…………………………………………………………………
……………………………… 
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Once you have completed this question, 
you may turn over the page and begin the 
questionnaire. Thank you. 
 
 
Please do not leave any questions unanswered. 
 
 
HPV= Human papillomavirus 
 
 
1 HPV is very rare. Please tick 
 
 True                False  
 
2 HPV always has visible signs or symptoms. Please tick 
  
True                False  
 
 
3 HPV can cause cervical cancer. Please tick 
 
True                False  
 
 
4 How important do you think HPV is in developing cervical cancer? Please circle 
 
Not important 
at all 
   Very 
important 
1 2 3 4 5 
 
 
5 HPV can be passed on by genital skin-to-skin contact. Please tick 
 
True                False  
 
 
6 There are many types of HPV. Please tick 
 
True                False  
 
 
7 HPV can cause HIV/AIDS. Please tick 
 
True                False  
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8 HPV can be passed on during sexual intercourse. Please tick 
 
True                False  
 
 
9 HPV can cause genital warts. Please tick 
 
True                False  
 
 
10 Men cannot get HPV. Please tick 
 
True                False  
 
 
11 Using condoms reduces risk of getting HPV. Please tick 
 
True                False  
 
 
12 HPV can be cured with antibiotics. Please tick 
 
True                False  
 
 
13 Having many sexual partners increases the risk of getting HPV. Please tick 
 
True                False  
 
 
14 HPV usually doesn’t need any treatment. Please tick 
 
True                False  
 
 
15 Most sexually active people will get HPV at some point in their lives. Please tick 
 
True                False  
 
 
16 A person could have HPV for many years without knowing it. Please tick 
 
True                False  
 
 
17 Having sex at an early age increases risk of getting HPV. Please tick 
 
True                False  
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18 Someone who has had the HPV vaccine cannot develop cervical cancer. Please 
tick 
 
True                False  
 
19. How serious an infection do you think HPV is? Please circle.  
Not at all 
serious 
   Extremely 
serious 
1 2 3 4 5 
 
20. Compared to most other women your age, how likely do you think it is that you 
would get cervical cancer at some time in your life? Would you say you are…? 
Please circle 
Much less 
likely 
A little less 
likely 
About the 
same 
A little more 
likely 
Much more 
likely 
1 2 3 4 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please turn over 
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Please read the information below and answer the questions on the 
next page. 
PLEASE DO NOT GO BACK AND RE-EDIT ANY OF YOUR 
PREVIOUSLY ANSWERED QUESTIONS. 
 
 
Smear tests offer the best protection against developing cervical cancer and save 
thousands of lives each year. Not going for a smear test is one of the biggest risk 
factors for developing cervical cancer. This is why it is important that all women 
attend their smear appointments. 
 
However, things in research are constantly changing and there may be a possibility 
that in the years to come women may be offered a different type of cervical 
screening test, HPV self-sampling. 
 
Please note: This test is not currently available through the NHS and may never 
be.  
 
This test looks at the presence of a virus called Human Papillomavirus (HPV) in the 
vagina.  
 
HPV could be tested for by using a kit at home. This kit is called a self-sampling kit. 
The kit would allow a woman to collect a sample from her vagina, which would then 
be sent off to be tested for the presence of HPV in a laboratory 
   
To carry out the home test a woman would need to put a swab (a cotton bud with a 
long handle) into the vagina. She would then need to put the swab into a sealed tube 
with a liquid already inside, and post it to a laboratory using a special pre-addressed 
envelope.  
 
                   
The introduction of HPV self-sampling is being discussed however no policy has 
been set yet. This is why we would like to ask you a few questions about these kits 
and your views. 
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Please proceed with answering the 
questions on the following pages. Thank 
you. 
 
 
 
 
 
 
Your views on using a self-sampling kit for HPV 
 
Please circle below 
 
 
21 I would be likely to use a self-sampling kit for HPV.  
 
Not at all 
likely 
   Very likely 
1 2 3 4 5 
 
 
22 If made available to me, I would use the self-sampling kit for HPV.  
 
Not at all 
likely 
   Very likely 
1 2 3 4 5 
 
23 I expect that I would use a self-sampling kit for HPV.  
 
Not at all 
likely 
   Very likely 
1 2 3 4 5 
 
24 How certain are you that you would do the test well enough?  
 
Not at all 
certain 
   Very certain  
1 2 3 4 5 
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25 How certain are you that you would be able to carry out the sampling procedure 
(placing              swab in vagina)?  
 
Not at all 
certain 
   Very certain  
1 2 3 4 5 
 
26 How certain are you that you would be able to place the swab into the tube  
 containing the special liquid without touching or dropping the swab?  
 
Not at all 
certain 
   Very certain  
1 2 3 4 5 
 
27 How certain are you that you would be able to send off the completed test 
within  
 the time allowed? 
 
Strongly 
disagree 
   Strongly agree  
1 2 3 4 5 
 
 
 28 Using a self-sample kit would mean that no-one will know that I am having 
cervical screening.  
Not at all 
certain 
   Very certain  
1 2 3 4 5 
 
29 Using a self-sample kit would be less embarrassing than having a GP or nurse do 
a smear test.  
Strongly disagree    Strongly agree 
1 2 3 4 5 
 
30 I am worried that I would hurt myself using the self-sample kit. Please circle a 
number. 
Strongly disagree    Strongly agree 
1 2 3 4 5 
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31 I wouldn’t trust the results of the self-sample kit.  
Strongly disagree    Strongly agree 
1 2 3 4 5 
 
32 I would be worried about the self-sampling kit getting lost in the post and not 
reaching the laboratory.  
Strongly disagree    Strongly agree 
1 2 3 4 5 
 
 
 
 
 
 
 
Thank you, please return the questionnaire in the envelope and seal 
it. Proceed to open envelope 2. 
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POI questionnaire 
 
 
Questionnaire I.D. Number  
 
 
Name: 
 
Age: 
 
Ethnicity: 
 
 
 
PLEASE ANSWER THIS QUESTION FIRST, BEFORE 
TURNING OVER AND STARTING THE 
QUESTIONNAIRE. ONCE YOU HAVE STATED YOUR 
ANSWER, PLEASE DO NOT RETURN AND EDIT. 
 
 
What do you think causes cervical cancer? 
 
…………………………………………………………………
…………………………………………………………………
…………………………………………………………………
…………………………………………………………………
……………………………… 
 
 
 
Once you have completed this question, you may 
turn over the page and begin the questionnaire. 
Thank you. 
 
 
 395 
 
Please do not leave any questions unanswered. 
 
 
HPV= Human papillomavirus 
 
 
1 HPV is very rare. Please tick 
 
 True                False  
 
2 HPV always has visible signs or symptoms. Please tick 
  
True                False  
 
 
3 HPV can cause cervical cancer. Please tick 
 
True                False  
 
 
4 How important do you think HPV is in developing cervical cancer? Please circle 
 
Not important 
at all 
   Very 
important 
1 2 3 4 5 
 
 
5 HPV can be passed on by genital skin-to-skin contact. Please tick 
 
True                False  
 
 
6 There are many types of HPV. Please tick 
 
True                False  
 
 
7 HPV can cause HIV/AIDS. Please tick 
 
True                False  
 
 
8 HPV can be passed on during sexual intercourse. Please tick 
 
True                False  
 
 
9 HPV can cause genital warts. Please tick 
 
True                False  
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10 Men cannot get HPV. Please tick 
 
True                False  
 
 
11 Using condoms reduces risk of getting HPV. Please tick 
 
True                False  
 
 
12 HPV can be cured with antibiotics. Please tick 
 
True                False  
 
 
13 Having many sexual partners increases the risk of getting HPV. Please tick 
 
True                False  
 
 
14 HPV usually doesn’t need any treatment. Please tick 
 
True                False  
 
 
15 Most sexually active people will get HPV at some point in their lives. Please tick 
 
True                False  
 
 
16 A person could have HPV for many years without knowing it. Please tick 
 
True                False  
 
 
17 Having sex at an early age increases risk of getting HPV. Please tick 
 
True                False  
 
 
18 Someone who has had the HPV vaccine cannot develop cervical cancer. Please 
tick 
 
True                False  
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19. How serious an infection do you think HPV is? Please circle.  
Not at all 
serious 
   Extremely 
serious 
1 2 3 4 5 
20. Compared to most other women your age, how likely do you think it is that you 
would get cervical cancer at some time in your life? Would you say you are…? 
Please circle 
Much less 
likely 
A little less 
likely 
About the 
same 
A little more 
likely 
Much more 
likely 
1 2 3 4 5 
 
 
 
 
Your views on using a self-sampling kit for HPV 
 
Please circle below 
 
21 I would be likely to use a self-sampling kit for HPV.  
 
Not at all 
likely 
   Very likely 
1 2 3 4 5 
 
 
22 If made available to me, I would use the self-sampling kit for HPV.  
 
Not at all 
likely 
   Very likely 
1 2 3 4 5 
 
23 I expect that I would use a self-sampling kit for HPV.  
 
Not at all 
likely 
   Very likely 
1 2 3 4 5 
 
 
 
24 How certain are you that you would do the test well enough?  
 
Not at all 
certain 
   Very certain  
1 2 3 4 5 
 
 398 
 
25 How certain are you that you would be able to carry out the sampling procedure 
(placing              swab in vagina)?  
 
Not at all 
certain 
   Very certain  
1 2 3 4 5 
 
26 How certain are you that you would be able to place the swab into the tube  
 containing the special liquid without touching or dropping the swab?  
 
Not at all 
certain 
   Very certain  
1 2 3 4 5 
 
27 How certain are you that you would be able to send off the completed test 
within  
 the time allowed? 
 
Strongly 
disagree 
   Strongly agree  
1 2 3 4 5 
 
 
 28 Using a self-sample kit would mean that no-one will know that I am having 
cervical screening.  
Not at all 
certain 
   Very certain  
1 2 3 4 5 
 
29 Using a self-sample kit would be less embarrassing than having a GP or nurse do 
a smear test.  
Strongly disagree    Strongly agree 
1 2 3 4 5 
 
30 I am worried that I would hurt myself using the self-sample kit. Please circle a 
number. 
Strongly disagree    Strongly agree 
1 2 3 4 5 
 
31 I wouldn’t trust the results of the self-sample kit.  
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Strongly disagree    Strongly agree 
1 2 3 4 5 
 
32 I would be worried about the self-sampling kit getting lost in the post and not 
reaching the laboratory.  
Strongly disagree    Strongly agree 
1 2 3 4 5 
 
 
The leaflet 
 
 
32 Did you refer back to the HPV self-sampling leaflet when answering these 
questions? Please tick one box: 
 
Yes                No  
 
 
33 Overall, did you find the leaflet useful?  
 
Yes                No  
 
Please tell us more: 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………… 
 
34 Did you find the leaflet easy to understand? 
 
Yes                No  
 
Tell us more 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………… 
 
35.  Did you think the amount of information in the leaflet was:  
 
Too much           
 
Too little             
 
Just right         
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Please tell us why you thought this: 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………… 
 
36 Did the leaflet make you feel more confident in doing HPV self-sampling? 
 
Yes                No  
 
 
Tell us more 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………… 
 
 
37 Did you think ‘Miriam’s story’ was helpful? 
 
Yes                No  
 
Tell us more 
 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………… 
 
 
 
 
 
38 Was there anything you wanted to know more about? 
 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………… 
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39 Were any sections of the leaflet less useful? 
 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………… 
 
40 Do you have any suggestions for improving the leaflet? 
 
 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………………………… 
 
 
 
 
 
 
 
Thank you for your time! 
 
Your comments will be used to improve the HPV self-
sampling leaflet. 
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Appendix 6.2: Interview Schedule for women 
 
What do you think about the leaflet? 
Does it explain its purpose? What do you think the purpose of the leaflet is? 
When do you think the leaflet will be used? 
 
Does the leaflet affect what you think about self-sampling in general? 
What effect does it have? What part of the leaflet made you feel this way? 
 
How does the leaflet make you feel about doing HPV self-sampling? 
Does it make you feel more or less inclined to do self-sampling? 
How does it affect your intention? Is there a particular part of the leaflet that has the most 
effect on your intention? 
 
How does the leaflet make you feel about being able to do HPV self-sampling? 
Does it make you more or less confident? 
Why does it make you feel that way? Which part/s of the leaflet makes you feel that way? 
 
How does the leaflet make you feel about the way the HPV self-sampling programme will 
be set-up? 
Does it make you feel more or less confident about the set-up? 
Why does it make you feel this way? What part/s of the leaflet make you to feel this way? 
 
Do you find the leaflet easy to understand? 
How clear do you find the content? 
How easy or difficult to follow do you find the content? 
What do you think about the way the information is structured? 
To what extent is the factual information understandable and acceptable? 
Do you think the information in the leaflet is easily understandable for all people who may 
be facing this decision? 
  
What do you think about the different sections of the leaflet? 
What do you think of the question and answer sections? 
What do you think of the ‘story’ section? 
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Are there sections of the leaflet that need changing? 
Language, font, format, size, graphic elements, information clarity (statistics)?  
 
Do you have any suggestions for improvement? 
Are there any important questions or pieces of information missing from the leaflet?   
Is there anything you do not like about the leaflet? Why? How could it be improved? 
 
Do you have any other comments or suggestions? 
 
Can I get back to you about the leaflet and or if there is anything to clarify from the 
interview? 
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Appendix 6.3: Interview schedule for providers 
 
 
What do you think about the leaflet? 
Does it explain its purpose? What do you think the purpose of the leaflet is? 
When do you think the leaflet will be used? 
 
How do you think the leaflet would be best implemented? 
Why do you think this would be the best point of implementation? 
 
Is there any information on the leaflet that is inaccurate/ misleading? 
Information about HPV? Information about ease of self-sampling?  
 
Are the service provision Q&A sections (e.g. How will I know if my kit has been lost?) 
feasible/realistic? 
Can you tell me a bit more about how you envisage HPV self-sampling being implemented 
into the cervical screening programme? Is this reflected in the information provided in the 
leaflet?  
 
What do you think about the layout of information in the leaflet? 
Is there anything (text/graphics) that you feel should be moved? If so, where do you think it 
should be placed? 
 
Do you find the leaflet easy to understand? 
How clear do you find the content? 
Do you think the information in the leaflet is easily understandable for all people who may 
be facing this decision? 
  
What do you think about the different sections of the leaflet? 
What do you think of the question and answer sections? 
What do you think of the ‘story’ section? 
  
Are there sections of the leaflet that need changing? 
Language, font, format, size, graphic elements, information clarity (statistics)?  
 
Do you have any suggestions for improvement? 
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Are there any important questions or pieces of information missing from the leaflet?   
Is there anything you do not like about the leaflet? Why? How could it be improved? 
 
Do you have any other comments or suggestions? 
 
Can I get back to you about the leaflet and or if there is anything to clarify from the 
interview? 
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Appendix 6.4: Ethical Approval 
 
 
 
 
 
 407 
 
Appendix 6.5: Information sheet for women 
 
 
Research Study: Women’s attitudes towards HPV self-sampling- Pilot field 
testing 
 
Information sheet for women 
 
You are being invited to take part in a study looking at the views of women about a 
different method of cervical screening, called HPV self-sampling, as well as the 
efficacy of a leaflet developed to encourage women to take part in self-sampling. 
 
Before you decide if you want to take part in this study, it is important for you to 
understand why the research is being done and what it will involve. Take time to 
read the following information carefully and discuss it with others if you wish. Part 1 
of this information sheet tells you the purpose of the study and what will happen if 
you take part. Part 2 gives you more detailed information about the conduct of the 
study.  
If there is anything that is not clear or you would like more information please 
contact Denitza Williams, Department of Primary Care and Public Health, Neuadd 
Meirionnydd, Heath Park, Cardiff, CF14 4YS or on 02920687142. 
Part One 
 
Is HPV self-sampling currently available? 
 
HPV self-sampling is not currently available, so it’s important that you attend for a 
smear appointment when invited by Cervical Screening Wales. 
 
What is the purpose of this study? 
 
We would like to find out if a leaflet given to women may affect their HPV knowledge 
and intentions to self-sample. We would also like to know what women think of the 
leaflet and what they may like to change on the leaflet. 
 
Why have I been chosen? 
 
You have been asked to take part because you are a woman aged between 20-64 
years. 
 
Do I have to take part? 
 
No. It is up to you to decide if you want to take part in this study. 
You are free to pull out of this study at any point and do not have to give a reason. 
Pulling out of this study will not affect your medical care or your invitation to 
screening by Cervical Screening Wales. 
 
If you are interested in taking part, please keep this information sheet and sign the 
consent form. 
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What will happen to me if I take part? 
 
Taking part would mean completing a questionnaire, having a look at an 
informational leaflet about HPV and self-sampling and then completing the same 
questionnaire again. 
 
You will then be interviewed about your thoughts regarding the information leaflet. 
 
The whole study should take no longer than an hour, however if you feel that taking 
part in both tasks would be too arduous, you may choose to only participate in the 
interview. 
 
Will my GP be involved? 
 
We are not intending to inform your GP of your involvement in this study. 
 
What are the possible disadvantages of taking part? 
 
Taking part in this study will require you to complete two questionnaires, look at a 
leaflet and discuss your thoughts regarding the leaflet. It is highly unlikely that 
anything should go wrong. If you would like to talk about any of the issues raised in 
this study, a contact name and details are provided at the end of this information 
sheet. 
 
What are the possible benefits to taking part? 
 
There will be no direct clinical benefit to you from taking part in this study. However, 
information we gather through this study will help us to understand if the information 
leaflet developed is able to increase women’s knowledge about HPV and their 
intentions to self-sample. It will also help us understand if the leaflet is easy to use 
and understand and what improvements may need to be made. 
 
You will be given £10 as a ‘thank-you’ for participating in the study. 
 
What if I don’t want to carry on or if there is a problem? 
 
You can pull out of this study at any time and it will not affect your future care. It is 
highly unlikely that you may be upset or inconvenienced by this study. However, if 
you feel that you need to make a complaint about the way you have been 
approached or treated by the researcher, you should contact: Professor Adrian 
Edwards, Institute Director, Institute of Primary Care and Public Health, Neuadd 
Meirionnydd, Heath Park, Cardiff, CF14 4YS. 
 
What will happen to the results of the research study? 
 
Results from this study will be reported in scientific, policy and professional journals. 
You may request a copy of the study results. 
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Who is organising and funding this study? 
 
The study is organised by Denitza Williams at Cardiff University. It is directed by an 
advisory group and is funded by the Medical Research Council. No-one will be paid 
for including you in this study. 
 
Who has reviewed this study? 
 
This study has received ethical permission from The School of Medicine Research 
Ethics Committee, Cardiff University. 
 
Who should I contact for more information about this study? 
 
If there is anything that is not clear or you would simply like more information please 
contact Denitza Williams, Department of Primary Care and Public Health, Cardiff 
University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS. Email: 
stoilovado@cf.ac.uk Tel:02920687142 or 07877857292. 
 
 
Further information on cervical cancer is available from Jo’s Cervical Cancer Trust 
http://www.jostrust.org.uk/ and their helpline number is 0808 802 8000.
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Appendix 6.6: Information sheet for professionals 
 
Research Study: Women’s attitudes towards HPV self-sampling- Pilot field 
testing 
 
Information sheet for health professionals 
 
You are being invited to take part in a study exploring health professional’s attitudes 
towards a leaflet developed to encourage women to take part in HPV self-sampling 
(should it be available in the future). 
 
Before you decide if you want to take part in this study, it is important for you to 
understand why the research is being done and what it will involve. Take time to 
read the following information carefully and discuss it with others if you wish. Part 1 
of this information sheet tells you the purpose of the study and what will happen if 
you take part. Part 2 gives you more detailed information about the conduct of the 
study.  
If there is anything that is not clear or you would like more information please 
contact Denitza Williams, Department of Primary Care and Public Health, Neuadd 
Meirionnydd, Heath Park, Cardiff, CF14 4YS or on 02920687142. 
 
Part One 
 
What is the purpose of this study? 
 
We would also like to know what health professionals think about the proposed 
leaflet and to discuss how the leaflet would be best implemented if HPV self-
sampling was available through the NHS. 
Why have I been chosen? 
 
You have been asked to take part because you are a health professional with 
expertise in cervical screening. 
 
Do I have to take part? 
 
No. It is up to you to decide if you want to take part in this study. 
You are free to pull out of this study at any point and do not have to give a reason. 
 
If you are interested in taking part, please keep this information sheet and sign the 
consent form. 
 
What will happen to me if I take part? 
 
Taking part would mean being interviewed about your thoughts regarding the 
information leaflet. 
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The interviews can be conducted over the telephone or face-to-face. The whole 
study should take no longer than 30 minutes. 
 
What are the possible disadvantages of taking part? 
 
Taking part in this study will be asked to comment on a HPV self-sampling leaflet. It 
is highly unlikely that anything should go wrong. If you would like to talk about any of 
the issues raised in this study, a contact name and details are provided at the end of 
this information sheet. 
 
What are the possible benefits to taking part? 
 
There will be no direct clinical benefit to you from taking part in this study. However, 
information we gather through this study will help us to understand what 
improvements may need to be made to the leaflet. 
 
You will be given £10 as a ‘thank-you’ for participating in the study. 
 
What if I don’t want to carry on or if there is a problem? 
 
You can pull out of this study at any time. It is highly unlikely that you may be upset 
or inconvenienced by this study. However, if you feel that you need to make a 
complaint about the way you have been approached or treated by the researcher, 
you should contact: Professor Adrian Edwards, Institute Director, Institute of Primary 
Care and Public Health, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS. 
 
 
What will happen to the results of the research study? 
 
Results from this study will be reported in scientific, policy and professional journals. 
You may request a copy of the study results. 
 
Who is organising and funding this study? 
 
The study is organised by Denitza Williams at Cardiff University. It is directed by an 
advisory group and is funded by the Medical Research Council. No-one will be paid 
for including you in this study. 
 
Who has reviewed this study? 
 
This study has received ethical permission from The School of Medicine Research 
Ethics Committee, Cardiff University. 
 
Who should I contact for more information about this study? 
 
If there is anything that is not clear or you would simply like more information please 
contact Denitza Williams, Department of Primary Care and Public Health, Cardiff 
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University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS. Email: 
stoilovado@cf.ac.uk Tel:02920687142 or 07877857292. 
 
 
Further information on cervical cancer is available from Jo’s Cervical Cancer Trust 
http://www.jostrust.org.uk/ and their helpline number is 0808 802 8000. 
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Appendix  6.7 
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Appendix 6.8: Final version of draft HPV self-sampling intervention 
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